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MHB...............................................................................................Mueller	Hinton	broth	
MMP.......................................................................................Matrix	metalloprotease	
MRSA..........................................................Methicillin-resistant	Staphylococcus	aureus	
MT....................................................................................................Masson’s	trichrome	
MT-MMP......................................................Membrane	type-matrix	metalloproteinase	
NEM....................................................................................................N-ethylmaleimide	
NPT........................................................................................Negative	pressure	therapy	
PBMCs.....................................................................Peripheral	blood	mononuclear	cells	
PCM..............................................................................Planktonic-conditioned	medium	
PDGF................................................................................Platelet-derived	growth	factor	
PDT..............................................................................................Photodynamic	therapy	
PMN...............................................................................Polymorphonuclear	leukocytes	
PMSF................................................................................Phenylmethylsulfonyl	fluoride	
PNA-FISH.........................Peptide	nucleic	acid-based	fluorescence	in	situ	hybridisation	
RT-PCR...............................................Reverse	transcriptase	polymerase	chain	reaction	
SDF-1..................................................................................Stromal	cell-derived	factor	1	
SEM..................................................................................Scanning	electron	microscopy	
TGF-β...........................................................................Transforming	growth	factor-beta	
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TIMP....................................................................Tissue	inhibitors	of	metalloprotease	
TLCK...................................................1-chloro-3-tosylamido-7-amino-2-heptanone	HCl		
TLR........................................................................................................Toll-like	receptor	
TNF-α................................................................................Tumour	necrosis	factor-alpha	
VAP.............................................................................Ventilator-associated	pneumonia		
VEGF.........................................................................Vascular	endothelial	growth	factor	
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Abstract	
A	large	number	of	bacteria	are	able	to	secrete	extracellular	proteases	that	play	vital	
roles	 in	 nutrient	 acquisition	 and	 biofilm	 formation	 but	 are	 also	 important	
biochemical	 mediators	 in	 bacterial	 virulence,	 facilitating	 host	 invasion.	
Microorganisms	 within	 chronic	 wounds	 have	 been	 hypothesised	 to	 form	 biofilms,	
which	 result	 in	 perpetuated	 inflammation	 and	 delayed	wound	 closure.	Whilst	 it	 is	
thought	that	exaggerated	secretion	of	host-derived	proteases	within	chronic	wounds	
prevents	successful	wound	closure,	the	contribution	of	bacterial	proteases	secreted	
from	planktonic	microorganisms	and	biofilms	in	chronic	wound	pathology	has	yet	to	
be	elucidated.		
It	 is	 therefore	 the	 primary	 research	 aim	 of	 this	 thesis	 is	 to	 assess	 the	 proteolytic	
activity	of	Pseudomonas	aeruginosa	and	Staphylococcus	aureus	isolated	from	equine	
and	human	chronic	wounds	and	determine	whether	there	 is	a	difference	in	activity	
between	 planktonic-conditioned	 medium	 (PCM)	 and	 biofilm-conditioned	 medium	
(BCM).	 The	 next	 aim	 will	 be	 to	 identify	 these	 bacterial-derived	 proteases	 using	
zymography	and	mass	spectrometry,	and	determine	whether	these	proteases	reduce	
wound	closure	 in	 in	 vitro	 scratch	wound	models.	More	 specifically,	 the	effect	of	P.	
aeruginosa	and	S.	aureus	PCM	and	BCM	from	equine	and	human	clinical	isolates,	and	
also	purified	proteases	of	these	preparations,	on	the	in	vitro	wound	closure	of	equine	
normal	fibroblasts	(NFs),	equine	chronic	wound	granulation	tissue	fibroblasts	(GTFs)	
and	human	dermal	fibroblasts	(HDFs),	shall	be	investigated.	In	these	wound	models,	
zymography	 will	 be	 utilised	 to	 determine	 the	 release	 of	 host-derived	 matrix	
metalloproteases	(MMPs).		
In	 this	 thesis	 I	 have	 identified,	 for	 the	 first	 time,	 high	 protease	 activity	 in	 equine	
chronic	 wound-derived	 P.	 aeruginosa	 PCM	 and	 BCM,	 by	 which	 52kDa	 and	 42kDa	
proteases	were	detected.	P.	aeruginosa	PCM	and	BCM	were	shown	 to	 significantly	
reduce	the	wound	closure	of	NFs	(P	<0.0001)	and	GTFs	(P	<0.0001).	Furthermore,	the	
soluble	products	of	P.	aeruginosa	biofilms,	but	not	planktonic	P.	aeruginosa,	elicited	
the	release	of	metalloproteases	 from	equine	NFs	and	GTFs.	 In	human	studies,	high	
protease	 activity	 specific	 to	 P.	 aeruginosa	 BCM	 but	 not	 PCM	 (P	 <0.0001)	 was	
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determined.	P.	aeruginosa	BCM	significantly	reduced	the	wound	closure	of	HDFs	(P	
<0.0001)	 and	 cell	 viability	 (P	 <0.0001),	 and	 further	 induced	 the	 release	 of	
metalloproteases	 from	 HDFs.	 P.	 aeruginosa	 in	 biofilm	 form	 secreted	 62kDa	 and	
52kDa	proteases,	however,	through	the	partial	purification	of	these	proteases,	it	was	
determined	 that	 these	 proteases	 did	 not	 play	 a	 role	 in	 the	 reduction	 of	 wound	
closure	 in	HDFs.	The	P.	aeruginosa-derived	partially	purified	proteases	did	however	
reduce	HDF	cell	viability	(P	<0.05).	
The	 results	 in	 this	 thesis	 support	 the	 theory	 that	 bacterial-derived	 proteases	may	
contribute	 to	 the	 emphasised	 proteolytic	 environment	 of	 human	 chronic	 wounds.	
Furthermore,	 the	presence	of	bacterial	biofilms	within	chronic	wounds	may	 induce	
the	 release	 of	 host-derived	 proteases.	 However	 the	 role	 of	 these	 specific	 P.	
aeruginosa-derived	 bacterial	 proteases	 in	 chronic	 wound	 pathology	 remains	
undetermined.		
	
	
	
	
	
	
	
	
	
	
	
	
	 22	
Chapter	1:	Introduction	
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1 Introduction	
Cutaneous	tissue	repair	is	a	complex	biological	process	that	has	been	well	researched	
in	 terms	 of	 the	 cellular	 mechanisms	 that	 take	 us	 from	 initial	 tissue	 injury	 to	
granulation	 tissue	 formation,	 successful	 tissue	 remodelling	 and	 re-epithelialisation.	
Despite	 this,	 the	mechanisms	 involved	 in	 the	 development	 of	 chronic,	 non-healing	
wounds	have	not	been	fully	elucidated.	A	wound	that	fails	to	heal	in	a	timely	manner	
or	results	in	compromised	tissue	integrity	is	defined	as	a	chronic	wound	(Stadelmann	
et	 al.	 1998).	 Common	 examples	 of	 chronic	 wounds	 in	 humans	 include	 pressure	
ulcers,	venous	ulcers	and	diabetic	 foot	ulcers,	which	pose	a	considerable	economic	
burden,	costing	the	National	Health	Service	(NHS)	an	estimated	£2.3-£3.1	billion	per	
year	 (Posnett	 and	 Franks	 2008).	 The	 physiological	 processes	 of	 tissue	 repair	 in	
chronic,	 non-healing	 wounds	 are	 disturbed	 and	 are	 halted	 in	 the	 inflammatory	
phase,	 manifesting	 clinically	 as	 persistent	 inflammation,	 increased	 tissue	
degradation,	and	excessive	exudate	and	malodour	(Gardner	et	al.	2001).	Whilst	there	
are	a	number	of	physical	 factors	 that	are	 thought	 to	 lead	 to	 the	development	of	a	
chronic	wound,	 including	 reduced	blood	 flow	 in	the	elderly	and	diabetic,	vasculitis,	
mechanical	 pressure	 and	 burns;	 evidence	 of	 localised	 imbalances	 in	 protease	
production	 is	 thought	 to	be	one	 theory	as	 to	why	wounds	 fail	 to	heal	within	 these	
patient	 groups.	 Matrix	 metalloproteases	 (MMPs)	 play	 a	 fundamental	 role	 in	 all	
aspects	of	tissue	repair.	Essentially,	the	primary	role	of	these	proteases	 is	to	cleave	
components	of	the	extracellular	matrix	(ECM),	a	process	that	is	carefully	regulated	by	
tissue	inhibitors	of	metalloproteases	(TIMPs).	MMPs	also	play	alternative	roles	in	the	
release	of	growth	factors	and	activation	of	other	proteases.	
The	 recognition	 of	 microbial	 biofilms	 in	 the	 context	 of	 the	 healthcare-associated	
infections	 has	 come	 to	 the	 forefront	 in	 recent	 years	 due	 to	 its	 association	 with	
increased	 antimicrobial	 resistance	 (Donlan	 2001).	 Biofilms	 can	 be	 described	 as	
complex	 communities	 of	 microorganisms	 that	 can	 attach	 to	 each	 other	 and	 both	
biotic	and	abiotic	surfaces,	and	reside	within	extracellular	polysaccharide	substances	
(EPS)	 (Donlan	 2002).	 Biofilms	 have	 been	 associated	 with	 various	 pathologies	
including	cystic	fibrosis,	endocarditis	and	periodontal	disease	(Paju	and	Scannapieco	
2007,	Nallapareddy	et	al.	2006).	Indeed,	the	presence	of	bacterial	biofilms	in	chronic	
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wounds	has	also	been	recognised	and	it	has	been	hypothesised	that	the	presence	of	
biofilms	within	the	wound	could	be	a	contributing	factor	to	delayed	wound	healing	
(James	 et	 al.	 2008).	 Despite	 the	 amplified	 proteolytic	 milieu	 observed	 in	 chronic	
wounds	and	the	presence	of	bacterial	biofilms,	 the	effect	of	bacterial	proteases	on	
wound	closure	and	indeed	their	contribution	in	the	pathogenicity	of	chronic	wounds	
has	not	been	researched.		
The	 aim	 of	 this	 chapter	 was	 to	 summarise	 mammalian	 wound	 healing,	 drawing	
attention	to	the	similarities	and	differences	between	chronic	wounds	in	both	humans	
and	 horses.	 Furthermore,	 the	 role	 of	 endogenous	 MMPs	 in	 physiological	 and	
pathophysiological	 tissue	 repair	 human	 shall	 be	 reviewed.	 I	 have	 paid	 special	
attention	to	the	involvement	of	biofilms	in	delayed	wound	healing	and	the	potential	
role	of	bacterial	proteases	in	the	development	of	chronic	wounds.			
	
1.1 Wound	Healing	
1.1.1 Physiological	Cutaneous	Tissue	Repair	
Cutaneous	tissue	repair	 in	humans	comprises	of	a	series	of	overlapping	events	that	
occur	 in	 order	 to	 clear	 contaminating	 bacteria	 and	 cellular	 debris	 and	 to	 produce	
new,	vascularised,	granulation	tissue	and	a	protective	epithelial	barrier.	The	wound	
healing	 process	 can	 be	 categorised	 into	 three	 major	 phases:	 haemostasis	 and	
inflammation,	re-epithelialisation	and	granulation	tissue	formation	and	finally,	matrix	
remodelling	(Epstein	et	al.	1999).	
Upon	initial	tissue	injury,	the	extravasion	of	blood	components	into	the	wound	leads	
to	haemostasis	through	the	initiation	of	the	coagulation	cascade	and	constriction	of	
blood	vessel	walls.	The	process	of	clot	formation	and	the	infiltration	and	aggregation	
of	platelets	helps	to	prevent	blood	loss.	The	subsequent	de-granulation	of	platelets	
within	 the	 clot	 results	 in	 the	 release	 of	 alpha	 granules	 (α-granules),	which	 secrete	
growth	 factors	 such	 as	 platelet-derived	 growth	 factor	 (PDGF),	 insulin-like	 growth	
factor-1	 (IGF-1),	 epidermal	 growth	 factor	 (EGF),	 transforming	 growth	 factor-beta	
(TGF-β),	and	platelet	factor-IV.	The	release	of	these	growth	factors	not	only	initiates	
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the	 coagulation	 pathways	 leading	 to	 fibrin	 clot	 formation,	 but	 also	 initiates	 the	
inflammatory	 phase	 of	 tissue	 repair	 through	 the	 recruitment	 of	 several	 cellular	
mediators	(Stadelmann	et	al.	1998).		
Within	 the	 early	 phase	 of	 inflammation,	 within	 24-36	 hours	 of	 tissue	 injury,	
neutrophils	 are	 the	 first	 cells	 to	 infiltrate	 the	 wound	 site	 through	 a	 number	 of	
chemoattractants	 including	cleaved	ECM	components,	TGF-β,	complement	proteins	
and	 bacterial-derived	 formyl-methionyl	 peptide	 products	 (Velnar	 et	 al.	 2009).	 The	
primary	role	of	neutrophils	in	the	wound	site	is	to	phagocytose	invading	bacteria	and	
foreign	 material.	 However	 earlier	 research	 has	 shown	 that	 the	 presence	 of	
neutrophils	at	the	wound	site	is	not	a	necessary	cellular	component	in	wound	repair	
(Simpson	and	Ross	1972).	Within	this	time	frame,	epithelial	cells	at	the	wound	edge	
begin	to	migrate	and	proliferate	along	the	dermis,	 forming	a	basement	membrane.	
The	 later	 stages	 of	 inflammation,	 within	 48-72	 hours,	 are	 characterised	 by	 the	
recruitment	of	monocytes	in	response	to	cytokines	and	growth	factors	including	TGF-
β,	 PDGF	 and	platelet	 factor	 IV,	 but	 also	 cleaved	 fragments	 of	 collagen	 and	 elastin.	
The	monocytes	soon	differentiate	into	tissue	macrophages.	These	macrophages	then	
dominate	 this	phase	of	wound	 repair,	phagocytosing	 invading	bacteria	and	causing	
local	debridement	 (Leibovich	and	Ross	1975).	 Interestingly,	 research	by	Martin	and	
colleagues	 (2003)	has	 since	shown	that	 the	 infiltration	of	 inflammatory	neutrophils	
and	 macrophages	 is	 not	 essential	 for	 wound	 healing.	 This	 study	 showed	 scarless	
wound	 healing	 in	 the	 PU.1	 null	 mouse,	 a	 model	 lacking	 both	 neutrophils	 and	
macrophages,	 in	 which	 wound	 healing	 was	 comparable	 to	 wild-type	 siblings	 and	
cellular	debris	was	alternatively	engulfed	by	fibroblasts	(Martin	et	al.	2003).	
Following	haemostasis	and	an	appropriate	host	immune	response,	the	wound	enters	
the	 proliferative	 phase	 of	 tissue	 repair.	 The	 proliferative	 stage	 of	 wound	 healing,	
occurring	 between	 day	 3	 and	 week	 2,	 is	 predominated	 by	 the	 fibroblast-driven	
deposition	of	ECM	and	the	subsequent	generation	of	granulation	tissue	(Velnar	et	al.	
2009).	Fibroblasts	are	recruited	to	the	wound	due	to	the	presence	of	factors	such	as	
TGF-β	 and	 PDGF,	 whereby	 they	 then	 proliferate	 and	 produce	 matrix	 proteins	
including	 fibronectin,	 hyaluronan,	 collagens	 and	 proteoglycans.	 The	 production	 of	
new	granulation	 tissue	brings	about	 the	 formation	of	new	blood	vessels,	a	process	
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known	as	angiogenesis,	from	pre-existing	vessels	at	the	wound	site.	At	this	stage	of	
physiological	wound	repair,	epithelialisation	is	complete.	
The	lengthiest	phase	of	the	wound	repair	process	is	tissue	remodelling,	also	referred	
to	as	‘maturation’,	which	can	take	up	to	several	years.	Within	this	phase,	there	is	a	
vascular	 regression	 of	 many	 of	 the	 newly	 formed	 capillaries	 formed	 in	 the	
proliferative	phase,	and	thus	vascular	density	returns	to	normal.	There	is	a	constant	
synthesis	and	breakdown	of	ECM	components,	particularly	collagen,	until	the	tissue	
architecture	of	the	wound	resembles	that	of	normal	tissue	(Velnar	et	al.	2009,	Guo	
and	DiPietro	2010).		
	
1.1.2 Chronic	Wounds:	The	pathological	mechanisms	
The	implications	of	infection	within	chronic	wounds	are	numerous,	including	delayed	
wound	 healing,	 increased	 patient	 discomfort,	 increased	 rates	 of	 morbidity	 and	
mortality	 and	 increased	 costs	 of	 treatment	 (Reynolds	 and	 Chow	 2013).	 In	 chronic,	
non-healing	 wounds,	 the	 normal	 responses	 to	 tissue	 damage	 are	 impaired	 and,	
wound	 healing	 is	 thought	 to	 be	 halted	 in	 the	 inflammatory	 phase,	 therefore	 a	
persistent	 state	 of	 inflammation	 is	 observed	 (Enoch	 and	 Price	 2004).	 The	
mechanisms	behind	why	some	wounds	fail	to	heal	or	take	excessively	long	periods	of	
time	to	heal	 is	still	unclear,	however	 in	humans,	 factors	such	as	smoking,	 infection,	
reduced	mobility,	diabetes	mellitus	and	nutrient	deficiency	are	 thought	 to	 increase	
the	risk	of	developing	a	chronic	wound	(Guo	and	DiPietro	2010).		
A	 number	 of	 cellular	 mechanisms	 have	 been	 described	 in	 the	 pathophysiology	 of	
chronic	wounds.	 Firstly,	 the	 cellular	 activity	 of	 chronic	wounds	differs	 greatly	 from	
that	 of	 acute	 wounds.	 A	 common	 feature	 of	 chronic	 wounds	 is	 the	 failure	 of	
epithelialisation	 across	 the	 wound	 area,	 which	 is	 thought	 to	 be	 due	 to	 altered	
keratinocyte	migration.	For	instance,	Usui	and	colleagues	assessed	the	expression	of	
keratin-67	(a	marker	of	keratinocyte	proliferation)	and	LM-3A32	(a	precursor	for	the	
alpha-3	chain	of	laminin	5	and	a	marker	present	in	migrating	epithelium)	and	found	
that	 keratinocytes	 in	 the	 margins	 of	 chronic	 diabetic	 ulcers,	 showed	 increased	
expression	of	keratin-67	and	decreased	LM-3A32	when	compared	to	normal,	acute	
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wound	keratinocytes	(Usui	et	al.	2008).	Further	to	this,	the	proliferative	capacity	of	
cultured	 fibroblasts	 isolated	 from	 human	 diabetic	 foot	 ulcers	 was	 greatly	 reduced	
when	 compared	 with	 cultured	 fibroblasts	 from	 normal,	 healthy	 skin.	 Fibroblasts	
within	diabetic	foot	ulcers	are	much	larger	in	size	and	are	spaced	further	apart	in	the	
tissue	when	compared	to	normal	skin	fibroblasts	(Loots	et	al.	1999).		
Host	immune	cells	such	as	CD3+	and	CD4+	T-cells	have	also	shown	to	be	significantly	
reduced	 in	 chronic	diabetic	 and	 venous	ulcers	when	 compared	 to	 an	acute	wound	
model.	Furthermore,	CD20+	B-cells,	CD79a+	plasma	cells	and	CD68+	macrophages	are	
found	 at	 higher	 levels	 in	 chronic	 diabetic	 and	 venous	 wounds	 than	 acute	 wounds	
(Loots	et	al.	1998).	A	characteristic	influx	of	neutrophils	has	been	observed	in	chronic	
pressure	ulcers,	which	 leads	 to	 the	release	of	neutrophil-derived	proteases	such	as	
elastase	 and	 MMPs,	 contributing	 to	 ECM	 degradation	 (Nwomeh	 et	 al.	 1999).	 For	
instance,	neutrophil-derived	elastase	 is	 known	 to	degrade	growth	 factors	 including	
PDGF	and	TGF-β,	both	beneficial	growth	factors	for	the	release	of	ECM	components	
from	resident	fibroblasts	(Eming	et	al.	2007).	Indeed,	imbalances	in	the	secretion	of	
extracellular	 matrix	 (ECM)	 degrading	 proteases	 and	 the	 counteracting	 release	 of	
their	 inhibitors	within	chronic	wounds	has	been	well	published	(Menke	et	al.	2007,	
Widgerow	 2011)	 and	 will	 be	 discussed	 in	 more	 detail	 in	 the	 next	 section	 of	 this	
introductory	chapter.		
Finally,	the	presence	of	bacteria	within	a	chronic	wound	is	thought	to	be	a	potential	
reason	 as	 to	 why	 chronic	 wounds	 will	 not	 heal.	 Bjarnsholt	 and	 colleagues	 (2008)	
hypothesised	 that	 it	was	 the	 bacterial	 burden	 of	 a	wound	 that	 prevents	 a	 chronic	
wound	 from	 healing,	 in	 particular	 the	 Gram-negative	 bacteria	 Pseudomonas	
aeruginosa.	More	specifically,	 they	hypothesised	 that	 this	was	due	 to	 the	ability	of	
this	microorganism	to	form	a	biofilm	within	the	wound,	which	effectively	 is	able	to	
resist	 the	 action	 of	 antimicrobials,	 evade	 host	 immune	 responses	 and	 release	
virulence	factors	(Bjarnsholt	et	al.	2008).	
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1.1.3 Wound	repair	in	the	horse:	A	good	model?	
Studies	 into	wound	 healing	 and	 aberrant	 wound	 healing	 generally	 use	 laboratory-
bred	 models	 such	 as	 rabbits	 or	 mice,	 however	 there	 are	 considered	 to	 be	 great	
differences	 in	 these	 models	 when	 compared	 to	 wound	 healing	 in	 humans	
(Greenhalgh	2005).	For	example,	commonly	used	mouse	models	have	been	heavily	
criticised	 as	wound	healing	predominantly	 relies	 on	muscle	 contraction	due	 to	 the	
presence	 of	 the	 panniculus	 carnosus	muscle	 in	 the	 subcutaneous	 tissue,	 unlike	 in	
humans,	which	 lack	this	muscle	and	therefore	wound	healing	 is	primarily	driven	by	
epithelialisation.	Wound	repair	in	the	horse	however,	is	steadily	being	acknowledged	
as	 a	more	physiologically	 relevant	model	 for	wound	healing	 research	 (Theoret	 and	
Wilmink	2013).	
Physiological	wound	repair	 in	 the	horse	 is	 similar	 to	 that	of	human	wound	healing,	
consisting	 of	 an	 inflammatory	 phase,	 proliferative	 phase	 and	 a	 maturation	 phase	
(Stashak	 and	 Theoret	 2009).	Wounds	 on	 the	 trunk	 of	 the	 horse	 heal	more	 rapidly	
through	 contraction	 than	 wounds	 on	 the	 lower	 limb,	 which	 rely	 more	 heavily	 on	
epithelialisation,	resulting	in	slow-to-heal	wounds	and	therefore	drawing	similarities	
to	 human	 chronic	 wounds	 (Knottenbelt	 1997).	 Furthermore,	 equine	 lower-limb	
wounds	 can	 develop	 fibroproliferative	 complications	 as	 seen	 in	 humans.	 For	
instance,	 the	 spontaneous	 over-production	 of	 granulation	 tissue	 (exuberant	
granulation	 tissue),	 which	 leads	 to	 a	 protrusion	 of	 tissue	 with	 high	 fibroblast	
densities,	is	similar	to	that	of	human	keloids	(Theoret	et	al.	2013)	(see	Figure	1.1).		
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Figure	1.1	Images	of	human	and	equine	chronic	wounds.		
Human	 chronic	 lower-leg	 wound	 (A)	 shows	 characteristic	 presence	 of	 slough,	
indicated	by	 the	black	 arrow,	 and	 the	 chronic	 equine	 lower-limb	wound	 (B)	 shows	
exuberant	 granulation	 tissue,	 indicated	by	 the	 yellow	arrow.	 Permission	 to	 include	
these	pictures	was	obtained	from	Dr	Christine	Cochrane	(University	of	Liverpool).			
	
	
1.2 Matrix	Metalloproteases:	An	Introduction	
Proteases	 are	 enzymes	 that	 are	 able	 to	 break	 down	 proteins	 and	 peptides	 and,	
depending	 on	 their	 activity,	 can	 be	 classified	 as	 either	 exoproteases	 or	
endoproteases.	An	exoprotease	generally	cleaves	a	peptide	near	the	end	of	the	N-	or	
C-termini	 of	 the	 polypeptide	 chain	 and	 can	 be	 classified	 as	 amino-	 or	
carboxyproteases.	 An	 endoprotease,	 or	 proteinase,	 can	 cleave	 internal	 peptide	
bonds	 and	 are	 grouped	 into	metallo-,	 serine-,	 aspartic-	 or	 threonine-proteases.	 To	
date,	 there	 are	 569	 known	 human	 proteases,	 the	 most	 abundant	 of	 which	 are	
metalloproteases,	or	matrixins,	which	account	 for	194	proteins,	closely	 followed	by	
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serine	 proteases	 which	make	 up	 176	 of	 these	 proteins	 (Moali	 and	 Hulmes	 2009).	
Matrix	metalloproteases	 (MMPs)	 are	a	matrixin	 subfamily	of	 zinc	metalloproteases	
belonging	 to	 the	 M10	 family	 of	 peptidases	 according	 to	 the	 MEROPS	 peptidase	
database	 (http://merops.sanger.ac.uk/cgi-bin/famsum?family=M10)	 (Rawlings	 et	 al.	
2012).	In	humans,	there	are	23	known	MMP	genes	(see	Table	1.1)	most	of	which	are	
multi-domain	proteins	(Visse	and	Nagase	2003).		
	
1.2.1 Molecular	structure	
MMPs	 belong	 to	 a	 group	 of	 peptidases	 known	 as	 ‘metzincins’,	 named	 after	 a	
conserved	methionine	C-terminal	 to	 the	 zinc	 ligands,	 known	as	a	 ‘Metturn’.	MMPs	
are	grouped	into	gelatinases,	collagenases,	membrane-type	(MT)-MMPs,	matrilysins,	
stromelysins	 and	 others,	 based	 on	 their	 domain	 arrangement	 and	 substrate	
preference.	 MMPs	 all	 have	 a	 similar	 basic	 structure	 in	 that	 they	 all	 have	 a	 signal	
peptide,	a	pro-peptide	and	a	catalytic	domain.	However	they	differ	in	the	presence	of	
fibronectin-type	II	repeats	in	the	catalytic	domain,	as	seen	in	the	gelatinases	MMP-2	
and	 MMP-9	 (see	 Figure	 1.2).	 Furthermore,	 all	 MMPs	 except	 MMP-7	 have	 a	
haemopexin	domain	that	is	 involved	in	substrate	recognition	and	some	MMPs	have	
an	additional	transmembrane	domain	with	a	cytoplasmic	tail	(MMP-14,	-15,	-16	and	
24)	or	GPI	anchor	(MMP-17	and	MMP-25)	(Nagase	et	al.	2006).	The	pre-proenzyme	
contains	a	cysteine	switch	located	in	the	pro-peptide	and	a	zinc	binding	motif	within	
the	catalytic	domain.	The	interaction	between	the	conserved	cysteine	within	the	pro-
peptide	 and	 the	 zinc	 ion	 in	 the	 catalytic	 domain	 keeps	 the	 pro-MMP	 inactive	 by	
preventing	the	binding	of	a	water	molecule	(essential	for	catalysis)	to	the	zinc	atom	
(Nagase	et	al.	2006).		
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Figure	 1.2	 Schematic	 domain	 structure	 of	 human	 matrix	 metalloproteinases	
(MMPs)	
MMPs	generally	consist	of	three	domains,	the	pro-peptide,	catalytic	and	a	C-terminal	
haemapexin-like	domain.	 The	 figure	 represents	 the	 inactive	MMP	precursor	with	a	
pro-peptide	 domain.	 MMP	 precursors	 are	 cleaved	 between	 the	 pro-peptide	 and	
catalytic	domain,	resulting	in	the	release	of	the	active	enzyme.	
	
	
1.2.2 Synthesis	and	activities	
The	synthesis	of	an	MMP	occurs	within	the	cells	and	begins	by	the	production	of	an	
inactive	precursor,	or	an	inactive	pre-proenzyme.	The	signal	peptide	of	the	pro-MMP	
is	cleaved	intracellularly	during	translation.	Many	MMPs	are	secreted	from	the	cell	as	
pro-MMPs,	 whereby	 regions	 of	 the	 pro-peptide,	 known	 as	 ‘bait	 regions’,	 are	
susceptible	to	proteolytic	cleavage	by	extracellular	proteases.	Often	the	cleavage	of	
the	pro-peptide	by	extracellular	proteases	is	only	partial,	and	therefore	the	complete	
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removal	of	 the	pro-peptide	 is	carried	out	by	other	MMPs	or	 through	auto-catalytic	
cleavage,	thus	resulting	in	an	active	MMP.	Some	MMPs	are	activated	intracellularly,	
whereby	 the	 inactive	 pro-MMP	 is	 proteolytically	 cleaved	 in	 the	 Golgi	 apparatus,	
resulting	 in	 an	 active	 peptide	 that	 can	 then	 be	 secreted.	 MMP	 activity	 can	 be	
regulated	by	Tissue	Inhibitors	of	MMPs	(TIMPs)	-1,	-2,	-3	and	-4,	to	variable	extents.	
TIMPs	 are	 endogenous	 inhibitors	 belonging	 to	 the	 family	 I35	 according	 to	 the	
MEROPS	 database	 (Rawlings	 et	 al.	 2012),	 which	 can	 inhibit	 MMPs	 in	 a	 1:1	
stoichiometry,	 playing	 an	 important	 physiological	 role	 in	 tissue	 remodelling	 (Visse	
and	Nagase	2003).	TIMPs	are	able	to	bind	to	the	zinc	ion	within	the	catalytic	domain	
of	 active	 MMPs,	 thus	 expelling	 the	 water	 molecule	 bound	 to	 the	 zinc	 ion	 and	
inhibiting	the	MMP.		
	
1.2.3 Biological	function	
The	primary	role	of	MMPs	is	to	degrade	components	of	the	ECM	including	collagens,	
elastin	 and	 proteoglycans	 (see	 Table	 1.1),	 mediating	 processes	 such	 as	 tissue	
remodelling	and	facilitating	cell	migration.	However	it	has	been	recognised	that	the	
breakdown	 of	 ECM	 by	 MMPs	 also	 releases	 growth	 factors	 bound	 to	 the	 matrix,	
increasing	growth	factor	availability	to	receptors.	Furthermore,	MMPs	play	a	role	in	
in	 other,	 equally	 as	 important	 biological	 processes	 through	 the	 cleavage	 of	 other	
substrates	(Nagase	et	al.	2006).	For	instance,	macrophage-derived	MMP-9	has	been	
shown	 to	 cleave	 the	 chemokine	 CXCL12	 or	 stromal	 cell-derived	 factor	 1	 (SDF-1),	
which	inhibits	the	recruitment	of	endothelial	progenitor	cells	(EPCs),	a	key	player	in	
the	promotion	of	 vasculogenesis,	 in	 a	wounded	diabetic	mouse	model	 (Feng	et	 al.	
2014).	
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Enzyme	name	 MMP		 Substrates	
Interstitial	collagenase/	
Collagenase	1	
MMP-1	 Collagen	I,	II,	III,	VII,	VIII,	X,	gelatin	
Neutrophil	 collagenase/	
Collagenase	2	
MMP-8	 Collagen	I,	II,	III,	VII,	VIII,	X,	aggrecan,	gelatin	
Collagenase	3	 MMP-13	 Collagen	I,	II,	III,	IV,	IX,	X,	XIV,	gelatin	
Gelatinase	A	 MMP-2	 Gelatin,	collagen	I,	II,	III,	IV,	V,	VII,	X,	aggrecan,	
elastin,	fibronectin	
Gelatinase	B	 MMP-9	 Gelatin,	collagen	I,	III,	IV,	V,	elastin,	aggrecan	
Stromelysin	1	 MMP-3	 Collagen	 II,	 IV,	 IX,	 X,	 XI,	 gelatin,	 elastin,	
aggrecan,		
Stromelysin	2	 MMP-10	 Collagen	 IV,	 elastin,	 aggrecan,	 laminin,	
fibronectin	
Matrilysin	1	 MMP-7	 Fibronectin,	 laminin,	 collagen	 IV,	 gelatin,	
elastin	
Matrilysin	2	 MMP-26	 Gelatin,	casein,	fibronectin,	fibrinogen	
Stromelysin	3		 MMP-11	 Collagen	IV,	fibronectin,	laminin,	aggrecan	
MT1-MMP	 MMP-14	 Gelatin,	 fibronectin,	 laminin,	 aggrecan,	 casein	
elastin,	collagen	I,	II,	III	
MT2-MMP	 MMP-15	 Gelatin,	fibronectin,	laminin,	aggrecan	
MT3-MMP	 MMP-16	 Gelatin,	fibronectin,	laminin	
MT5-MMP	 MMP-24	 Gelatin,	fibronectin,	laminin	
MT4-MMP	 MMP-17	 Gelatin,	fibrinogen,	fibrin	
MT6-MMP	 MMP-25	 Gelatin	
Macrophage	elastase	 MMP-12	 Gelatin,	 elastin,	 fibronectin,	 laminin,	 collagen	
IV	
-	 MMP-19	 Gelatin,	aggrecan,	elastin,	fibrillin,	collagen	IV	
Enamelysin	 MMP-20	 Gelatin,	aggrecan	
-	 MMP-21	 Aggrecan	
CA-MMP	 MMP-23	 Gelatin,	casein,	fibronectin	
-	 MMP-27	 -	
Epilysin	 MMP-28	 -	
	
Table	 1.1	 Human	 matrix	 metalloproteases	 (MMPs)	 and	 their	 matrix-associated	
substrates.	
Information	summarised	from	the	findings	of	several	researchers	(Visse	and	Nagase	
2003,	Steffensen	et	al.	2001,	Woessner	1991,	Nagase	et	al.	2006).	
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1.2.4 Matrix	metalloproteinases	and	physiological	tissue	repair	
MMPs	 play	 a	 role	 in	 physiological	 wound	 repair	 as	 early	 as	 the	 first	 phase	 of	
haemostasis	 and	 inflammation.	 Infiltrating	 neutrophils	 at	 the	 wound	 site	 release	
MMP-8	 (neutrophil	 collagenase),	 which	 is	 thought	 to	 be	 essential	 in	 physiological	
wound	 repair	 by	 regulating	 the	 inflammatory	 response	 (Gutiérrez-Fernández	 et	 al.	
2007).	MMP-8	plays	a	role	in	neutrophil	migration	through	collagen	degradation	and	
the	 production	 of	 the	 chemotactic	 peptide	 Pro-Gly-Pro	 in	 a	 murine	 model	 of	
inflammation	 (Lin	 et	 al.	 2008).	 Furthermore,	 the	 isolation	 of	 equine	
polymorphonuclear	neutrophils	 (PMNs)	 from	peripheral	blood	have	been	shown	to	
be	a	strong	source	of	MMP-9	(Clegg	et	al.	1997).	
There	is	an	abundance	of	evidence	that	demonstrates	the	release	of	growth	factors	
from	 the	 ECM	 by	 a	 variety	 of	MMPs.	 For	 instance,	MMP-2	 (gelatinase	 A),	MMP-3	
(stromelysin-1)	and	MMP-7	(matrilysin-1),	have	been	shown	to	cleave	a	decorin-TGF-
β1	 complex	 into	 several	 fragments,	 releasing	 TGF-β1	 in	 vitro	 (Imai	 et	 al.	 1997).	
Further	work	 in	this	area	revealed	that	the	release	of	TGF-β1	complexes	from	ECM	
occurred	 by	 the	 degradation	 of	 latent	 TGF-β	 by	 membrane	 type	 1	 matrix	
metalloprotease	 (MT1-MMP)	 (Tatti	 et	 al.	 2008).	 Belotti	 and	 colleagues	 (2003)	
discovered	a	positive	correlation	with	the	amount	of	MMP-9	(pro-enzyme	and	active	
enzyme)	and	MMP-2	(pro-enzyme)	and	the	release	of	the	angiogenic	growth	factor	
vascular	 endothelial	 growth	 factor	 (VEGF)	 in	 a	 human-derived	 ovarian	 carcinoma	
xenograft	mouse	model.	The	authors	 then	determined	 that	MMP-9	and	 to	a	 lesser	
extent	MMP-2,	 increased	 levels	 of	 VEGF	 in	 the	 human	 ovarian	 carcinoma	 cell	 line	
SKOV3	 in	 vitro,	 leading	 to	 endothelial	 cell	motility.	 This	 cell	motility	was	 then	 fully	
inhibited	by	the	VEGF	inhibitor	SU5416	(Belotti	et	al.	2003).		
A	 study	 by	 Salo	 and	 colleagues	 (1994)	 demonstrated	 a	 role	 for	 MMP-9	 in	
keratinocyte	migration	and	granulation	tissue	formation	in	an	experimental	model	of	
human	oral	mucosa	wounding.	The	authors	showed	strong	MMP-9	expression	in	the	
basal	layer	of	the	migrating	epithelial	sheet	and	granulation	tissue	up	to	7	days	post-
wounding	 and	 a	 high	 expression	 of	MMP-9	 in	 the	wound	 fluid	 of	 2	 and	 4	 day-old	
secretions	 post-wounding.	 The	 expression	 of	 MMP-2	 remained	 constant	 in	
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fibroblasts	alone	(Salo	et	al.	1994).	Subsequent	studies	by	a	different	research	group	
in	 1998	 supported	 the	 involvement	 of	 MMP-9	 in	 re-epithelialisation,	 but	 also	
demonstrated	collagenase	and	stromelysins-1	and	-2	in	populations	of	keratinocytes	
at	the	migrating	wound	edge	(Madlener	et	al.	1998).		
Various	 mouse	 studies	 have	 demonstrated	 the	 importance	 of	 MMPs	 and	 other	
proteases	in	wound	closure.	Plasminogen,	a	serine	protease,	was	first	demonstrated	
to	 play	 a	 role	 in	wound	 healing	when	wound	 closure	was	 significantly	 impaired	 in	
plasminogen	 deficient	mice	 (Rømer	 et	 al.	 1996).	 Lund	 and	 co-workers	 (1999)	 then	
went	on	 to	 show	 the	effects	 of	 the	metalloprotease	 inhibitor	 galardin	 in	wounded	
plasminogen-deficient	 mice,	 which	 resulted	 in	 delayed	 wound	 closure,	
demonstrating	 the	 overlapping	 functionality	 of	 MMPs	 and	 plasminogen	 in	 wound	
healing	(Lund	et	al.	1999).		
	
1.2.5 Protease	levels	in	chronic	wounds	
Several	studies	have	recorded	elevated	MMP	levels	in	the	wound	fluid	and	tissues	of	
chronic	wounds.	Yager	and	colleagues	(1996)	detected	10	to	25-fold	increases	in	the	
gelatinases	MMP-2	and	MMP-9	 in	 the	wound	 fluid	of	patients	with	pressure	ulcers	
when	 compared	 to	 healing	 wounds.	 Furthermore,	 collagenase	 was	 significantly	
increased	in	pressure	ulcers	compared	to	acute	surgical	wounds	(Yager	et	al.	1996).	
The	collagenase	MMP-8	(neutrophil	collagenase)	has	also	been	shown	to	be	one	of	
the	 predominant	 MMPs	 in	 both	 normal,	 healing	 wounds	 and	 non-healing	 chronic	
ulcers,	 with	 active	 forms	 of	MMP-8	 almost	 exclusively	 present	 in	 chronic	wounds.	
Furthermore,	reduced	levels	of	the	inhibitor	TIMP-1	in	chronic	wounds	and	elevated	
MMP-8	 has	 also	 been	 recorded	 (Nwomeh	 et	 al.	 1999),	 demonstrating	MMP:TIMP	
imbalances.	Liu	and	colleagues	(2009)	showed	an	inverse	correlation	between	MMP-
9	and	MMP9:	TIMP-1	ratio	to	healing	rates	in	the	patients	with	diabetic	foot	ulcers,	
with	 the	 authors	 stating	 that	 increases	 in	 MMP-9	 could	 be	 used	 to	 predict	 poor	
wound	healing	(Liu	et	al.	2009).	Furthermore,	various	levels	of	the	pro-enzyme	state	
of	 the	 gelatinases	MMP-2	 and	MMP-9	 have	 been	 detected	 in	 the	 wound	 fluid	 of	
patients	with	chronic	venous	leg	ulcers.	In	addition,	the	active	enzyme	form	of	MMP-
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9	was	highly	expressed	in	wound	fluid	compared	to	wound	tissues	(Moor	et	al.	2009).	
Proteomic	analysis	of	wound	fluid	from	normal	healing	wounds	and	chronic	leg	ulcer	
wounds	 in	diabetic	patients	revealed	188	differentially	expressed	proteins	between	
the	two	wound	types	with	regards	to	controlling	inflammation,	angiogenesis	and	cell	
motility.	Of	those	differentially	expressed	proteins,	more	specifically	MMPs	and	their	
inhibitors,	MMP-1,	MMP-2	 and	MMP-8	were	 shown	 to	 be	 up-regulated	 in	 chronic	
wounds.	Furthermore,	more	frequent	identification	of	peptides	from	the	pro-peptide	
activation	region	of	MMP-2	and	MMP-9	were	discovered	in	chronic	wounds	(Krisp	et	
al.	2013).		
	
1.3 Infection,	Biofilms	and	Wound	Healing		
There	are	thought	to	be	four	states	in	which	the	presence	of	bacteria	within	a	wound	
may	be	observed.	 The	 first	 state	 is	 the	 contamination	of	 the	wound	area	with	 the	
presence	 of	 non-proliferating	 bacteria	 on	 the	 superficial	 tissues.	 At	 this	 stage,	 this	
contamination	 is	not	thought	to	elicit	a	host	 immune	response	and	does	not	affect	
wound	closure.	The	second	state,	bacterial	colonisation,	involves	the	contamination	
of	the	wound	area	with	proliferating	bacteria,	giving	rise	to	the	adherence	of	bacteria	
to	superficial	tissues	and	the	formation	of	colonies.	The	presence	of	non-viable	tissue	
within	the	wound	provides	an	ideal	environment	for	bacteria.	At	this	stage,	bacterial	
colonisation	 is	 not	 thought	 to	 cause	 a	 host	 immune	 response	 or	 affect	 wound	
closure.	 The	 third	 state	 is	 ‘critical	 colonisation’	 and	 is	 a	 term	 coined	 to	 describe	 a	
delay	 in	wound	 healing	without	 clinical	 signs	 of	 inflammation.	 Here,	 bacteria	 have	
not	managed	to	invade	local	tissues,	however	they	are	thought	to	secrete	toxins	and	
virulence	 factors	 that	 impair	wound	closure	without	eliciting	an	 immune	 response.	
Critical	 colonisation	 is	 considered	 to	 be	 the	 point	 at	 which	 the	 wound	 can	 either	
improve	 following	appropriate	 treatment,	 remain	 in	a	 critical	 colonisation	 state,	or	
deteriorate	to	clinical	infection	(White	and	Cutting	2006).	However	it	is	important	to	
note	that	critical	colonisation	is	indeed,	a	theory.	The	final	state	is	known	as	bacterial	
infection	 and	 is	 characterised	 by	 the	 presence	 of	 proliferating	 bacteria	 that	 have	
invaded	 viable	 tissues	 and	 therefore	 initiate	 an	 immune	 response.	 Clinical	
	 37	
characteristics	 of	 bacterial	 infection	 include,	 tissue	 redness	 (erythema),	 pain,	 heat,	
swelling	 and	 excessive	 exudate	 at	 the	 site.	 This	 type	 of	 bacterial	 infection	 is	
considered	 to	 impede	 wound	 closure	 via	 several	 mechanisms	 including	 increased	
host	protease	and	pro-inflammatory	cytokine	production	and	increased	competition	
for	oxygen	and	nutrients	between	both	host	cells	and	bacteria	(Ovington	2003).	
	
1.3.1 Biofilms	
Microbial	biofilms	were	recognised	as	early	as	the	1970’s	with	the	first	observations	
describing	natural	populations	of	bacteria	encased	in	a	self-produced	fibrous	matrix	
within	 the	 slime	 located	on	 the	 surface	of	mountain	 streams	 (Geesey	 et	 al.	 1977).	
Biofilms	 can	 be	 described	 as	 communities	 of	 microorganisms	 that	 can	 attach	 to	
either	abiotic	(non-living	surfaces	such	as	metallic	implants)	or	biotic	surfaces	(living	
surfaces	 such	 as	 human	 skin)	 or	 to	 each	 other,	 surrounding	 themselves	 in	
extracellular	polysaccharide	substances	(EPS).		
	
1.3.2 Biofilm	development	and	intercellular	communication	
The	development	of	a	biofilm	on	a	surface	is	thought	to	comprise	of	several	different	
stages	 involving	 reversible	 and	 irreversible	 attachment,	 colonisation	 and	 dispersal	
(see	 Figure	 1.3).	 The	 physiological	 processes	 of	 a	 biofilm	 such	 as	 the	 secretion	 of	
virulence	 factors	 or	 motility	 of	 individual	 microorganisms,	 is	 controlled	 by	
intercellular	 communication	 known	 as	 quorum	 sensing.	 Bacteria	 within	 the	
developing	 biofilm	 release	 chemical	 signals	 known	 as	 autoinducers,	 which	 are	
constitutively	 released	 from	 bacteria,	 therefore	 as	 the	 biofilm	 grows,	 the	
concentration	 of	 autoinducers	 increases.	 As	 the	 concentration	 of	 autoinducers	
reaches	 a	 critical	 threshold,	 a	 change	 in	 gene	 expression	 occurs,	 resulting	 in	 a	
physiological	response,	such	as	the	release	of	virulence	factors	(Lindsay	and	Von	Holy	
2006,	 Mangwani	 et	 al.	 2012).	 Both	 Gram-negative	 and	 Gram-positive	 bacteria	
secrete	 autoinducers.	 In	 brief,	 Gram-negative	 bacteria	 secrete	 acyl-homoserine	
lactones	 and	 Gram-positive	 bacteria	 release	 oligo-peptide	 molecules	 (Lindsay	 and	
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Von	Holy	2006).	 The	Gram-negative	bacterium	P.	aeruginosa	has	been	 reported	 to	
secrete	 the	 quorum	 sensing	 molecule	 N-(3-oxo-dodecanoyl)-L-homoserine,	 which	
has	 been	 shown	 to	 enhance	 P.	 aeruginosa	 biofilm	 virulence	 and	 repress	 host	
immune	responses	(Driscoll	et	al.	2007).	Indeed,	P.	aeruginosa	has	been	implicated	in	
a	 number	 of	 infectious	 diseases	 including	 chronic	 lung	 infections	 such	 as	 cystic	
fibrosis,	thus	research	into	the	viability	of	targeting	these	quorum	sensing	molecules	
for	 drug	 development	 using	 quorum	 sensing	 inhibitors,	 has	 gained	 precedence	
(Hentzer	et	al.	2003).	
	
1.3.3 Biofilm	recalcitrance	
Biofilms	are	thought	to	be	responsible	for	a	plethora	of	chronic	 infections	including	
chronic	 lung	 infections,	 periodontitis,	 endocarditis,	 osteomyelitis	 and	 chronic	
wounds	(Singh	et	al.	2000,	Distel	et	al.	2002,	Gristina	et	al.	1985a,	James	et	al.	2008,	
Mohamed	et	al.	2004).	Furthermore,	biofilms	have	been	associated	with	the	use	of	
biomaterials,	 implants	 and	 devices,	 from	 urinary	 catheters,	 intravenous	 lines	 and	
prosthetics,	which	can	ultimately	lead	to	systemic	infection.	The	presence	of	biofilms	
in	 the	 healthcare	 setting	was	 recognised	 as	 a	 potential	 impact	 to	 health	 from	 the	
mid-1980’s	when	microorganisms	encased	 in	an	extracellular	matrix	on	the	sutures	
of	 surgical	 wounds	 were	 identified	 (Gristina	 et	 al.	 1985b).	 Subsequent	 to	 this,	 it	
appeared	 that	 bacteria	 growing	 within	 the	 biofilm	 state	 were	 more	 resistant	 to	
antibiotics	 and	 that	 biomaterial	 substrata	 acted	 as	 sites	 of	 colonisation	 and	
potentially	facilitated	bacterial	virulence	(Gristina	et	al.	1987).		
There	are	many	 theories	 involving	 the	potential	mechanisms	by	which	biofilms	are	
considered	 able	 to	 confer	 resistance.	 It	 is	 thought	 that	 the	 presence	 of	 EPS	 that	
encases	the	microorganisms,	results	in	the	incomplete	penetration	of	antimicrobials	
through	 the	 surface	 layers	 of	 the	 biofilm	 (Francolini	 and	 Donelli	 2010).	 Another	
theory	involves	the	slow	growth	rate	within	areas	of	the	biofilm	with	reduced	oxygen	
and	nutrients,	which	 is	 thought	 to	hamper	 the	actions	of	many	antimicrobials	 that	
require	 a	 certain	 degree	 of	 cellular	 metabolic	 activity	 in	 order	 to	 function	 (Hall-
Stoodley	 et	 al.	 2004).	 Phenotypic	 variants	 that	 are	 considered	 to	 demonstrate	 a	
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highly	 resistant	 phenotype	 when	 compared	 to	 other	 microorganisms	 within	 the	
biofilm,	commonly	referred	to	as	'persister	cells’,	confer	resistance	within	the	biofilm	
due	to	their	slow	rate	of	growth.	Although	these	persister	cells	lack	the	genetic	traits	
that	 resemble	 that	 of	 antibiotic	 resistance,	 they	 show	 high	 levels	 of	 multi-drug	
tolerance.	 (Hall-Stoodley	 et	 al.	 2004,	 Spoering	 and	 Lewis	 2001,	 Lewis	 2008,	 Lewis	
2010,	 Percival	 et	 al.	 2011a).
		 	
	 41	
	
Figure	1.3	Schematic	representation	of	biofilm	development	within	a	human	wound.	
I:	Bacteria,	either	present	on	the	skin	or	contamination	from	an	external	source,	reversibly	attach	to	areas	of	slough	or	dead	tissue.	II:	Bacteria	
on	the	surface	of	the	wound	proliferate	and	become	irreversibly	attached	through	the	use	of	bacterial	appendages	that	anchor	the	bacteria	to	
the	tissue.	III:	Colonisation	occurs	when	attached	bacteria	proliferate	and	produce	extracellular	polymeric	substances	(EPS),	which	is	thought	to	
protect	the	bacteria	from	external	disruption.	IV:	The	mature	biofilm,	surrounded	in	EPS,	is	resistant	to	antimicrobial	therapy.	The	release	of	
virulence	factors	helps	protect	 from	a	host	 immune	response.	Parts	of	the	mature	biofilm	can	break	away	from	the	main	biofilm,	a	process	
known	as	dispersal.	Ultimately	 the	dispersal	of	bacteria	 from	the	biofilm	can	 lead	 to	 the	dissemination,	whereby	 these	bacteria	attach	and	
colonise	new	sites,	perpetuating	infection.	
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1.3.4 Evidence	of	biofilms	in	chronic	wounds	
The	 investigation	 of	 biofilm-infected	 chronic	 wounds	 is	 an	 area	 of	 research	 that	
remains	under	much	scrutiny	and	controversy.	Probable	reasoning	behind	this	could	
be	due	to	various	chronic	wound	models;	the	way	in	which	biofilms	are	grown	in	 in	
vitro	and	in	vivo	models	and	the	diversity	of	chronic	wound	sub-types.		
The	 most	 commonly	 isolated	 bacteria	 in	 human	 chronic	 wounds	 include	
Staphylococcus	aureus	(93.5%),	Enterococcus	faecalis	(71.1%),	P.	aeruginosa	(52.2%)	
and	 coagulase	 negative	 Staphylococci	 (CoNS)	 (45.7%)	 (Gjødsbøl	 et	 al.	 2006).	Other	
research	 groups	 have	 extended	 this	 research	 in	 an	 attempt	 to	 gain	 a	 more	
comprehensive	understanding	of	 the	microbial	profile	of	wounds.	The	technique	of	
16S	 rDNA	 amplification	 followed	 by	 pyrosequencing,	 denaturing	 gradient	 gel	
electrophoresis	 (DGGE)	 and	 full	 ribosome	 shotgun	 sequencing	 has	 been	 used	 to	
determine	the	major	microbial	populations	in	diabetic	foot	ulcers,	venous	leg	ulcers	
and	 pressure	 ulcers,	 whereby	 the	 most	 common	 wound	 isolates	 included	
Staphylococcus,	 Pseudomonas,	 Peptoniphilus,	 Enterobacter,	 Stenotrophomonas,	
Finegoldia	and	Serratia	spp	(Dowd	et	al.	2008).	However	it	is	interesting	to	note	that	
the	 population	 profile	 of	 each	 type	 of	 chronic	wound	 varied,	with	 pressure	 ulcers	
housing	more	obligate	anaerobes	(62%)	than	both	diabetic	and	venous	ulcers	(Dowd	
et	 al.	 2008).	 Further	 research	 has	 shown	 Streptococcus,	 Corynebacterium,	
Staphylococcus,	 and	 Pseudomonas	 spp.	 to	 be	 among	 the	 most	 common	 primary	
genera	 of	 bacteria	 isolated	 from	 the	 pressure	 ulcers	 of	 49	 patients,	 which	 were	
identified	using	bacterial	tag-encoded	FLX	amplicon	pyrosequencing	(bTEFAP)	(Smith	
et	al.	2010).		
The	presence	of	microorganisms	within	wounds	has	been	recognised	for	some	time;	
however	the	detection	and	identification	of	the	microorganisms	within	a	biofilm	was	
under	 researched.	 In	order	 to	 investigate	 this	aspect	 further,	 James	and	colleagues	
examined	for	the	presence	of	biofilms	in	both	acute	and	chronic	wounds,	using	both	
scanning	 electron	microscopy	 (SEM)	 and	 polymerase	 chain	 reaction	 (PCR)	 coupled	
with	 DGGE.	 They	 discovered	 a	 significant	 difference	 in	 the	 presence	 of	 biofilms	
between	 chronic	 and	 acute	 wounds,	 with	 60%	 of	 chronic	 wounds	 containing	 a	
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biofilm	when	compared	to	just	6%	in	acute	wounds	(p<0.001).	Furthermore,	PCR	and	
DGGE	 revealed	 that	 these	 biofilms	 were	 polymicrobial	 (James	 et	 al.	 2008).	 The	
presence	of	biofilms	in	chronic	wounds	has	also	been	detected	using	peptide	nucleic	
acid-based	fluorescence	 in	situ	hybridisation	(PNA-FISH),	ultimately	determining	the	
structural	 organisation	 of	 bacteria	 within	 a	 chronic	 wound.	 The	 aggregation	 of	
bacteria	 into	microcolonies	within	an	alginate	matrix	with	very	 few	planktonic	cells	
has	been	observed	within	chronic	wounds	(Kirketerp-Møller	et	al.	2008).	In	addition,	
a	lack	of	correlation	between	the	bacterial	species	identified	using	traditional	culture	
techniques	 and	 PNA-FISH	 has	 been	 highlighted,	 with	 wound	 colonisation	 results	
showing	 >60%	 S.	 aureus	 and	 <30%	P.	 aeruginosa	 using	 culture	methods,	 and	 only	
15%	S.	aureus	and	70%	P.	aeruginosa	using	PNA-FISH	(Kirketerp-Møller	et	al.	2008).	
This	emphasises	the	importance	of	using	not	only	traditional	culture	techniques,	but	
also	molecular	methods,	in	order	to	achieve	an	accurate	microbial	identification	and	
profiling	of	a	wound.	
	
1.3.5 Biofilms	and	host	immune	responses	
A	great	deal	of	research	has	been	dedicated	to	understanding	host	immunity	in	the	
control	 and	 tolerance	of	both	 commensal	 and	pathogenic	microorganisms.	Despite	
this,	a	large	portion	of	this	research	has	been	focussed	upon	invading	bacteria	within	
the	 single	 cell,	 planktonic	 state.	 It	 is	 now	 generally	 thought	 that	 the	 growth	 of	
microorganisms	in	both	environmental	and	clinical	settings	is	within	the	biofilm	form.	
Thus	 research	 into	 the	 host	 immune	 response	 toward	 microorganisms	 within	 a	
biofilm	has	gained	precedence.		
The	host’s	immune	responses	do	indeed	respond	to	the	presence	of	biofilms	and	has	
been	 associated	 with	 the	 infiltration	 of	 neutrophils	 to	 the	 wound	 site	 in	 human	
chronic	venous	leg	ulcers.	Furthermore,	the	number	of	neutrophils	in	chronic	venous	
leg	 ulcer	 biopsies	 containing	 P.	 aeruginosa	 was	 significantly	 higher	 than	 biopsies	
containing	S.	aureus	(Fazli	et	al.	2011).	Lactoferrin,	a	component	of	innate	immunity	
that	 is	abundant	 in	surface	secretions,	was	shown	to	stimulate	twitching,	a	form	of	
bacterial	motility,	 in	P.	aeruginosa	PA01,	effectively	preventing	biofilm	formation	 in	
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vitro	 (Singh	 et	 al.	 2002).	 Cellular	 components	 of	 host	 immunity	 are	 not	 always	
effective	 in	 the	 prevention	 of	 biofilm	 formation.	 For	 example,	 the	 yeast	 Candida	
albicans	has	demonstrated	successful	biofilm	formation	in	the	presence	of	peripheral	
blood	mononuclear	 cells	 (PBMCs)	 in	 an	 cytokine-rich	 environment	 (Chandra	 et	 al.	
2007).	 Furthermore,	 the	 presence	 of	 polymorphonuclear	 leukocytes	 (PMNs)	 has	
been	 shown	 to	 enhance	P.	 aeruginosa	 biofilm	 formation	 and	development	 in	 vitro	
through	 the	deposition	of	 neutrophil-derived	polymers,	 actin	 and	DNA,	 acting	 as	 a	
scaffold	for	microbial	colonisation	and	biofilm	formation	(Walker	et	al.	2005).		
Biofilms	 have	 also	 demonstrated	 the	 ability	 to	 evade	 host	 immune	 responses.	 For	
instance,	the	EPS	matrix	of	P.	aeruginosa	biofilms	has	been	shown	to	protect	against	
interferon-γ-(IFN-γ)-mediated	macrophage	 killing	 (Leid	 et	 al.	 2005).	 Additionally,	P.	
aeruginosa	 biofilms	 have	 been	 shown	 to	 escape	 PMN-mediated	 phagocytosis	
through	 the	 secretion	 of	 a	 quorum	 sensing-regulated	 rhamnolipid,	 which	 effects	
PMN	cell	migration	and	causes	the	rapid,	necrotic	killing	of	PMNs	in	vitro	and	in	vivo	
(Jensen	 et	 al.	 2007).	 A	 study	 by	 Thurlow	 and	 colleagues	 (2011)	 investigated	 the	
innate	immune	responses	directed	towards	a	S.	aureus	biofilm	in	a	mouse	model	of	
catheter-associated	biofilm	infection.	The	latter	researchers	found	that	the	presence	
of	 the	biofilm	did	not	 elicit	 a	 response	 from	pattern	 recognition	 receptors	 such	 as	
Toll-like	 receptors	 (TLRs).	 Instead,	 significant	 reductions	 in	 the	 cytokines	 and	
chemokines	 IL-1β,	 tumour	 necrosis	 factor-alpha	 (TNF-α),	 CXCL2	 and	 CCL2,	 and	
reduced	macrophage	infiltration	into	the	biofilms	were	observed.	In	vitro	co-culture	
of	macrophages	and	S.	aureus	biofilms	showed	a	limited	phagocytosis	response	from	
macrophages,	 indicative	 of	 alternatively	 activated	 M2	 macrophages,	 a	 more	
reparative	 phenotype	 when	 compared	 to	 the	 pro-inflammatory	 phenotype	 of	 M1	
macrophages	 (Thurlow	et	 al.	 2011).	 The	 accumulation	of	 evidence	 to	 support	 host	
immune	evasion	by	microbial	biofilms	could	be	a	conduit	to	disease	pathogenesis	in	
an	immuno-compromised	host.	
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1.3.6 Effect	of	biofilms	on	host	protease	expression	
There	is	very	little	data	on	the	effect	of	biofilms	on	host-protease	expression	as	most	
in	vitro	and	in	vivo	studies	that	have	been	undertaken	focus	on	bacterial	infection	in	
the	 planktonic	 form.	 In	 a	mouse	model	 of	P.	 aeruginosa-related	 corneal	 infection,	
there	 was	 a	 marked	 induction	 of	 MT-MMP-4,	 -5	 and	 -6	 (Dong	 et	 al.	 2001).	
Burkholderia	 cenocepacia	 infection	 of	 an	 in	 vitro	monolayer	 of	 lung	 epithelial	 cells	
resulted	in	the	up-regulation	of	MMP-2	and	MMP-9	genes	and	caused	an	increase	in	
the	 secretion	 of	 active	MMP-9	 protein.	 This	 increase	 in	 active	MMP-9	 resulted	 in	
delayed	 wound	 closure	 in	 lung	 epithelial	 cells	 in	 vitro,	 which	 was	 reversed	 in	 the	
presence	of	a	MMP-9-specific	inhibitor	(Wright	et	al.	2011).		
The	 importance	 of	 investigating	 bacteria	 in	 planktonic	 and	 biofilm	 form	 in	 chronic	
wound	pathogenesis	has	been	recognised.	Kirker	and	colleagues	(2012)	investigated	
the	 effect	 of	 methicillin-resistant	 S.	 aureus	 (MRSA)	 planktonic-	 and	 biofilm-
conditioned	 medium	 on	 human	 dermal	 fibroblasts	 (HDFs)	 in	 a	 monolayer	 scratch	
wound	model.	Planktonic-conditioned	medium	(PCM)	induced	an	increase	in	IL-6,	IL-
8,	VEGF,	 TGF-β1,	MMP-1	and	MMP-3,	whereas	 treatment	with	biofilm-conditioned	
medium	(BCM)	had	a	greater	effect	on	the	release	of	TNF-α	when	compared	to	PCM	
and	 a	 suppression	 of	MMP-3	when	 compared	 to	 controls	 (Kirker	 et	 al.	 2012).	 This	
study	 highlighted	 the	 differences	 in	 the	 soluble	 factors	 released	 by	 S.	 aureus	 in	
planktonic	 and	biofilm	 form	and	 that	 these	 two	different	 physiological	 states	 elicit	
differential	effects	on	the	production	of	growth	factors,	cytokines	and	MMPs	in	host	
cells.	Given	that	MMPs	have	been	shown	to	be	up-regulated	in	chronic	wounds,	the	
suppression	 of	 MMP-3	 is	 unexpected	 and	 unexplained;	 therefore	 further	
investigation	into	the	regulation	of	MMPs	in	response	to	biofilms	is	warranted.	
	
1.4 Bacterial	proteases	
Bacterial	 proteases	 encompass	 a	 large	 and	 diverse	 group	 of	 proteases	 that	 are	
ubiquitously	produced	by	all	microorganisms	and	possess	varying	physiological	and	
biochemical	 functions	 (Schaechter	 2009).	 The	 intracellular	 expression	 and	
extracellular	 secretion	 of	 proteases	 in	 both	 Gram-positive	 and	 Gram-negative	
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bacteria	are	fundamental	contributors	to	infection	through	the	turnover	of	unfolded	
proteins	 in	 the	 host	 environment	 and	 the	 proteolysis	 of	 regulatory	 proteins	 upon	
environmental	stimuli.	The	main	 intracellular	conserved	proteases	 include	Lon,	Clp,	
High	 temperature	 requirement	 A	 (HtrA)	 and	 FtsH.	 The	 biological	 functions	 of	
intracellular	 bacterial	 proteases	 and	 their	 role	 in	 infection	 has	 been	 extensively	
studied	 and	 reviewed	 elsewhere;	 the	 reader	 is	 directed	 to	 an	 excellent	 review	 by	
Ingmer	 and	 Brøndsted	 for	 a	more	 in-depth	 account	 (Ingmer	 and	 Brøndsted	 2009).	
This	 section	of	 the	 introduction	shall	discuss	what	 is	known	about	 the	extracellular	
secreted	 proteases	 from	 the	 bacteria	 most	 commonly	 associated	 with	 infected	
chronic	 wounds,	 more	 specifically	 S.	 aureus	 and	 P.	 aeruginosa.	 Many	 species	 of	
bacteria	are	able	to	produce	and	secrete	proteases,	which	can	be	toxins	or	virulence	
factors,	whilst	others	may	have	a	more	central	 role	 in	 the	degradation	of	proteins.	
Similar	 to	 proteases	 produced	 in	 humans,	 bacterial-derived	 proteases	 can	 also	 be	
categorised	into	metallo-,	serine,	aspartic	and	threonine	proteases.		
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Figure	1.4	Schematic	domain	architecture	of	the	major	secreted	proteases	of		(A)	P.	
aeruginosa	and	(B)	S.	aureus.	
Abbreviations	include:	amino	acids	(aa),	elastase	A	(LasA),	elastase	B	(LasB),	alkaline	
protease	 (AprA),	 staphophain	 A	 (ScpA),	 staphopain	 B	 (SspB)	 and	 staphylococcal	
serine	protease	(SspA).	
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1.4.1 Extracellular	metalloproteases	secreted	by	P.	aeruginosa		
The	MEROPS	peptidase	database	contains	information	of	a	plethora	of	P.	aeruginosa	
strains,	 with	 fully	 sequenced	 genomes	 for	 14	 strains,	 one	 of	 those	 including	 the	
commonly	 used	 laboratory	 strain	 P.	 aeruginosa	 PA01	 (Rawlings	 et	 al.	 2012).	 P.	
aeruginosa	PA01	contains	5572	genes	 in	 its	genome,	of	which	166	are	 identified	as	
proteases.	 Of	 these	 proteases,	 the	 main	 proteases	 families	 include	 62	 serine-
proteases,	45	metallo-proteases,	8	cysteine-proteases	and	3	aspartic	proteases.	The	
most	 common	 P.	 aeruginosa-derived	 metalloproteases	 that	 have	 been	 shown	 to	
interact	with	the	host	during	infection	include	elastase	B	(LasB),	elastase	A	(LasA)	and	
alkaline	protease	(AprA)	(see	Table	1.2	and	Figure	1.4).		
	
1.4.2 P.	aeruginosa	secreted	proteases:	Molecular	structure	and	synthesis	
Elastase	 B	 (LasB)	 is	 a	 metalloprotease	 that	 is	 produced	 within	 the	 cell	 in	 a	 pre-
proenzyme	 form,	 consisting	 of	 two	 pro-peptide	 domains	 and	 a	 third	 catalytic	
domain.	 The	 first	 23	 amino	 acids	 on	 the	 N-terminal	 codes	 for	 the	 signal	 peptide,	
which	directs	 the	 translocation	of	 the	pro-enzyme	across	 the	 inner	membrane	 into	
the	periplasm	via	 the	 secretory	 system.	 This	 process	 results	 in	 the	 cleavage	of	 the	
signal	 peptide.	 The	 unfolded,	 inactive	 pro-enzyme	 is	 then	 folded	 into	 its	 mature,	
active	form	by	the	pro-peptide	domains,	which	act	as	a	chaperone	to	assist	correct	
protein	 folding.	 The	mature	 LasB	 is	 then	 translocated	 across	 the	 outer	membrane	
and	the	pro-peptide	domain	that	has	an	inhibitory	effect	on	the	mature	elastase	B,	is	
auto-catalytically	cleaved	and	is	degraded	in	the	extracellular	environment	(Rawlings	
et	al.	2012,	Hoge	et	al.	2010).		
Elastase	A	(LasA)	is	the	most	abundantly	secreted	metalloprotease	of	P.	aeruginosa,	
containing	a	31	amino	acid	coding	N-terminal	signal	peptide,	a	pro-peptide	domain	
and	 a	 catalytic	 domain.	 The	 synthesis	 and	 secretion	 of	 LasA	 in	 its	mature	 form	 is	
similar	to	that	of	LasB.	However	pro-peptide	cleavage	is	not	auto-catalytic;	instead	it	
is	cleaved	by	other	proteases	produced	by	P.	aeruginosa	(Hoge	et	al.	2010).		
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Alkaline	 protease	 (AprA)	 is	 a	 secreted	metalloprotease,	 which	 in	 its	 inactive	 form,	
contains	a	single	catalytic	domain	and	a	C-terminal	signal	peptide.	In	contrast	to	LasA	
and	LasB,	an	alternative	pathway	controls	 the	synthesis	and	secretion	of	AprA.	The	
genetic	locus	associated	with	the	synthesis	and	secretion	of	AprA	contains	five	open	
reading	frames	that	encode	for	AprA	itself	(aprA),	a	protease	inhibitor	(aprl)	and	the	
three	proteins	aprD,	aprE	and	aprF,	which	are	involved	in	the	translocation	of	AprA	
across	the	inner	and	outer	membrane	of	the	cell	(Duong	et	al.	1992).	
		
1.4.3 P.	aeruginosa-derived	proteases	in	disease	pathogenesis	
The	extracellular	proteases	that	are	produced	by	P.	aeruginosa	have	been	implicated	
in	 a	 range	 of	 pathologies.	 The	 pathophysiology	 of	 corneal	 ulcers	 for	 instance,	 has	
been	 characterised	 as	 the	 breakdown	 of	 extracellular	 matrix,	 and	 indeed,	 P.	
aeruginosa–derived	 extracellular	 proteases	 have	 been	 implicated	 in	 the	
development	of	corneal	ulcers.	Matsumoto	and	colleagues	showed	that	the	presence	
of	 P.	 aeruginosa	 599A	 strain,	 isolated	 from	 a	 vitamin	 A-deficient	 rat	 eye,	 and	 P.	
aeruginosa-RPS,	 isolated	 from	human	corneal	ulcer,	 resulted	 in	 the	cleavage	of	 the	
pro-MMP-2	 to	 release	 the	 active	 MMP-2	 from	 human	 corneal	 fibroblasts.	 The	
authors	stated	that	the	cleavage	of	pro-MMP-2	might	have	been	due	to	the	presence	
of	53kDa,	70kDa	and	110kDa	proteases,	and	53kDa	extracellular	proteases	from	the	
P.	 aeruginosa-RPS	 and	 P.	 aeruginosa	 599A	 strain	 respectively	 (Matsumoto	 et	 al.	
1993).	 P.	 aeruginosa	 is	 a	 common	 bacterial	 pathogen	 identified	 in	 cystic	 fibrosis	
sufferers.	There	is	evidence	to	suggest	that	bacterial	serine	proteases	secreted	by	P.	
aeruginosa	may	affect	the	concentration	of	mucins	within	the	mucus	in	the	airways	
of	 patients	 with	 cystic	 fibrosis.	 Henke	 and	 colleagues	 reported	 a	 significant	
association	with	low	mucin	concentration	and	P.	aeruginosa	infection	and	increased	
degradation	of	mucins	 in	P.	aeruginosa-infected	mucus.	To	test	the	hypothesis	that	
P.	aeruginosa-derived	proteases	degrade	mucins,	healthy	mucus	was	incubated	with	
synthetic	human	neutrophil	elastase	(HNE)	and	Pseudomonas	LasB.	This	resulted	in	a	
significant	 degradation	 of	 mucins	 by	 the	 synthetic	 Pseudomonas	 LasB,	 which	 was	
comparable	 to	 degradation	 by	 HNE.	 Furthermore,	 the	 incubation	 of	 cystic	 fibrosis	
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sputum	 with	 the	 serine-protease	 inhibitors	 diisopropyl	 fluorophosphates	 (DFP),	
phenylmethylsulfonyl	 fluoride	 (PMSF)	 and	 1-chloro-3-tosylamido-7-amino-2-
heptanone	HCl	 (TLCK),	 significantly	 reduced	mucin	 degradation	when	 compared	 to	
inhibitors	of	cysteine	and	metallo-proteases	(Henke	et	al.	2011).	
In	 the	 context	 of	 chronic	 wounds,	 there	 is	 some	 evidence	 to	 suggest	 that	 P.	
aeruginosa-derived	metalloproteases	may	contribute	to	the	pathogenesis	of	chronic	
wounds.	 One	 of	 the	 first	 research	 papers	 to	 acknowledge	 protease-producing	
bacteria	 in	 chronic	wounds	was	published	 in	2001,	whereby	P.	aeruginosa	 isolated	
from	chronic	leg	ulcers	showed	varying	levels	of	P.	aeruginosa	elastase,	AprA	and	an	
unidentified	 100kDa	 protease	 (Schmidtchen	 et	 al.	 2001).	 Wysocki	 and	 colleagues	
identified	 18	 different	 bacterial	 species	 in	 chronic	 venous	 leg	 ulcers	 (10	 Gram-
positive	 and	 8	 Gram-negative)	 that	 displayed	 proteolytic	 activity.	 This	 proteolytic	
activity	 was	 not	 found	 to	 be	 consistent	 in	 any	 of	 these	 species	 after	 repeated	
isolation	(Wysocki	et	al.	2012).	However	it	is	important	to	note	that	in	this	study,	no	
quantitative	 data	 were	 presented	 to	 determine	 the	 varying	 levels	 of	 protease	
production	 between	 species,	 nor	was	 there	 an	 attempt	 to	 identify	 these	 bacterial	
proteases.	 Another	 study	 by	 Wildeboer	 and	 colleagues	 sought	 to	 determine	 a	
correlation	 between	 protease	 activity	 and	 bacterial	 load	 in	 chronic	 wounds	 using	
fluorescent-labelled	peptide	substrates.	Although	there	was	no	correlation	between	
most	 species	 identified	 in	 the	wound	and	protease	activity,	 the	 signal	detection	of	
two	 substrates	 strongly	 correlated	 with	 P.	 aeruginosa	 numbers	 (Wildeboer	 et	 al.	
2012).	 This	 study	highlighted	 a	potential	 use	of	 these	 substrates	 as	 the	basis	 for	 a	
diagnostic	tool	in	the	identification	of	P.	aeruginosa	colonisation	in	chronic	wounds.	
	
1.4.4 Extracellular	proteases	secreted	by	S.	aureus	
The	MEROPS	peptidase	database	contains	fully	sequenced	genomes	for	154	different	
subspecies	 and	 strains	 of	 S.	 aureus	 (Rawlings	 et	 al.	 2012).	 In	 general,	 S.	 aureus	
produce	 499	 proteases,	 of	 which	 the	 major	 protease	 groups	 consist	 of	 75	 serine	
proteases,	 169	metalloproteases,	 84	 cysteine	 proteases	 and	 13	 aspartic	 proteases	
respectively.	 The	 most	 commonly	 secreted	 proteases	 from	 S.	 aureus	 include	 the	
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metalloprotease	 aureolysin,	 the	 staphylococcal	 serine	 protease	 or	 Glutamyl	
peptidase	I	(SspA)	and	the	cysteine	proteases	staphopain	A	(ScpA)	and	staphopain	B	
(SspB)	(see	Table	1.2).		
	
1.4.5 S.	aureus	secreted	proteases:	Molecular	structure	and	synthesis	
In	 its	 inactive	 form,	 the	metalloprotease	 aureolysin	 consists	 of	 a	 27	 amino	 acid	N-
terminal	 signal	 peptide,	 a	 pro-peptide	 domain	 and	 a	 catalytic	 domain.	 Glutamyl	
peptidase	 I	 or	 SspA	 serine	 protease	 contains	 a	 29	 amino	 acid	 N-terminal	 signal	
peptide,	 pro-peptide	 doman	 and	 catalytic	 domain	 and	 is	 activated	 through	 its	
proteolytic	cleavage	by	aureolysin.	The	cysteine	protease	ScpA	contains	a	25	amino	
acid	N-terminal	 signal	 peptide,	 a	 pro-peptide	 domain	 and	 a	 catalytic	 domain	 in	 its	
inactive	 form.	 Post-translational	 modification	 of	 the	 ScpA	 protease	 into	 its	 active	
form	 is	most	 likely	 through	 auto-catalytic	 processing.	 Similarly	 in	 its	 inactive	 form,	
the	 SspB	 protease	 has	 an	 N-terminal	 signal	 peptide	 (36	 amino	 acids	 long),	 a	 pro-
peptide	 domain	 and	 a	 catalytic	 domain.	 Upon	 secretion,	 the	 pro-enzyme	 is	
proteolytically	cleaved	by	SspA	(Rawlings	et	al.	2012).	
	
1.4.6 S.	aureus-derived	extracellular	proteases	in	disease	pathogenesis	
S.	aureus	extracellular	proteases	have	been	associated	with	virulence	and	persistent	
infection.	 Links	 between	 specific	 S.	 aureus-derived	 extracellular	 proteases	 and	
various	 types	 of	 infection	 has	 not	 received	 much	 attention.	 However	 a	 study	 by	
Zdzalik	 and	 co-workers	 investigated	 the	 prevalent	 S.	 aureus	 extracellular	 protease	
genes	derived	from	cases	of	wound	infection,	pneumonia,	sepsis,	cystic	fibrosis,	skin	
infection	and	bone	infection	to	name	a	few	(Zdzalik	et	al.	2012).	In	this	study	they	did	
not	 determine	 any	 correlation	 in	 gene	 expression	 patterns	 with	 specific	 types	 of	
infection,	however	they	do	state	that	most	of	the	S.	aureus	proteases	 investigated,	
are	expressed	and	secreted	in	the	course	of	infection.		
In	 order	 for	 a	 pathogen	 to	 successfully	 invade	 the	 host	 and	 cause	 persistent	
infection,	 the	 pathogen	must	 be	 able	 to	 evade	 host	 immune	 responses.	 S.	 aureus	
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expresses	 and	 secretes	 proteases	 that	 have	 been	 shown	 to	 target	 components	 of	
host	 immunity	 such	 as	 the	 complement	 system.	 For	 example,	 the	 S.	 aureus	
metalloprotease	aureolysin	 targets	 components	of	 the	 immune	system	to	 facilitate	
immune	evasion.	Laarman	and	colleagues	showed	that	the	S.	aureus	aureolysin	could	
effectively	prevent	complement-mediated	phagocytosis	through	the	cleavage	of	the	
C3	 protein	 complex	 (Laarman	 et	 al.	 2011).	 S.	 aureus	 cysteine	 proteases	 have	 also	
been	 implicated	 in	 the	 cleavage	 of	 a	 major	 protein	 in	 pulmonary	 surfactant,	
pulmonary	 surfactant	 protein	 A,	 which	 has	 been	 linked	 to	 a	 reduction	 in	 innate	
immune	 responses	 against	 lung	 infection	 such	 as	 neutrophil-driven	 phagocytosis	
(Kantyka	et	al.	2013).	
	
1.5 Current	Treatment	Strategies	for	Chronic	Wounds	
The	 treatment	 of	 chronic	wounds	 depends	 on	 the	 type	 of	 chronic	wound	 and	 the	
severity	 of	 the	 wound.	 For	 example,	 pressure	 ulcers,	 in	 part,	 can	 arise	 from	
persistent	 mechanical	 pressure	 in	 those	 who	 have	 limited	 mobility	 and	 therefore	
using	the	technique	of	repositioning	can	help	prevent	the	progression	of	this	type	of	
wound.	 Other	 treatment	 strategies	 such	 as	 negative	 pressure	 therapy	 (NPT),	
nutritional	 therapy	 and	 debridement	 are	 also	 used	 in	 the	 treatment	 of	 chronic	
wounds	(see	Table	1.3).	However	for	all	chronic	wounds,	the	use	of	wound	dressings	
is	 an	 integral	 part	 of	 wound	 care	 and	 can	 help	manage	 excessive	 exudate	 and	 in	
some	 cases	 bacterial	 bioburden.	 A	 variety	 of	 wound	 dressings	 are	 used	 in	 the	
treatment	of	chronic	wounds	(see	Table	1.4).	Many	of	these	dressings	focus	on	the	
absorption	 of	 excessive	 wound	 exudate,	 whilst	 others	 combine	 absorptive	 and	
antimicrobial	 properties	 through	 the	 incorporation	 of	 ionic	 silver	 (Percival	 et	 al.	
2011b).	With	regards	 to	 the	regulation	of	excessive	MMPs	observed	within	chronic	
wounds,	 highly	 absorptive	 dressings	 and	 absorptive	 dressings	 with	 incorporated	
substrates	such	as	collagen,	have	been	shown	to	aid	the	sequestration	of	MMPs	but	
also	Clostridium	histolyticum	bacterial	collagenase	(Metzmacher	et	al.	2007).		
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1.6 Prospective	Treatment	Strategies		
Potential	 future	therapies	to	treat	chronic	wounds	are	on	the	horizon,	with	both	 in	
vitro	and	 in	 vivo	 research	developing	new	 technologies	 to	 target	biofilms,	 showing	
promising	results.	
	
1.6.1 Anti-biofilm	technologies	
With	 hypotheses	 surrounding	 the	 pathogenesis	 of	 chronic	 wounds	 relating	 to	 the	
involvement	of	biofilms,	much	 research	 is	now	 taking	place	 to	 identify	 compounds	
with	 ‘anti-biofilm’	 or	 biofilm-disrupting	 properties.	 Although	 there	 is	 a	 plethora	 of	
claims	towards	the	anti-biofilm	properties	of	many	agents	such	as	xylitol,	lactoferrin	
and	ethylenediaminetetraacetic	 acid	 (EDTA)	 in	 vitro,	 the	evidence	 for	 their	efficacy	
within	 in	 vivo	models	 is	 currently	 lacking	 (Wolcott	 and	Rhoads	2008,	Ammons	and	
Copié	 2013).	Nevertheless,	 the	development	 and	potential	 use	of	 small	molecules,	
bioactive	 molecules	 and	 enzymes	 provide	 promising	 opportunities	 for	 biofilm	
management	in	chronic	wounds.	Gawande	and	colleagues	demonstrated	the	efficacy	
of	 a	 novel,	 naturally	 occurring	 enzyme-based	 gel	 on	 chronic	 wound–associated	
microorganisms	 (Gawande	 et	 al.	 2014).	 Dispersin-B®	 -KSL-W	 gel	 containing	 the	
Aggregatibacter	 actinomycetemcomitans-derived	 enzyme	 Dispersin-B®,	 inhibits	
biofilm	 formation	 and	 disperses	 pre-formed	 biofilms.	 This	 gel	 showed	 both	
antimicrobial	and	anti-biofilm	activity	by	significantly	reducing	log	counts	in	chronic-
wound	 associated	 MRSA,	 S.	 epidermidis,	 CoNS,	 Acinetobacter	 baumannii	 and	
Klebsiella	pneumoniae	 (Gawande	et	al.	2014).	Despite	this,	the	dispersal	of	biofilms	
will	 ultimately	 lead	 to	 parts	 of	 the	 biofilm	 colonising	 new	 sites,	 resulting	 in	 the	
spread	 of	 infection.	 Therefore	 it	 is	 important	 that	 such	 technologies	 that	 aim	 to	
disrupt	biofilm	are	combined	with	antimicrobials.	
	
1.6.2 Quorum	sensing	disruption	and	inhibitors	
Quorum	sensing	within	bacterial	biofilms	is	associated	with	biofilm	development	and	
enhanced	 virulence,	 making	 it	 an	 intriguing	 target	 for	 pharmacological	 action	
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(Hentzer	et	al.	2003).	The	proposed	targets	in	the	quorum	sensing	system	include	the	
signal	 generator,	 the	 quorum-sensing	 molecule	 and	 the	 signal	 receptor.	 In	 many	
cases,	 it	 is	 the	 signal	 receptor	 that	 is	 targeted	by	using	molecules	 that	block	 these	
receptors	 and	 disrupt	 signalling	 pathways	 (Rasmussen	 and	 Givskov	 2006).	
Christensen	and	colleagues	showed	that	P.	aeruginosa	biofilms	 in	an	 in	vivo	mouse	
model	 could	 be	 disrupted	 by	 the	 use	 of	 the	 antibiotic	 tobramycin	 and	 several	
quorum-sensing	molecules	including	furanone	and	horseradish	juice	extract.	Synergy	
was	 seen	 between	 both	 treatments	 and	 the	 presence	 of	 quorum	 sensing	 inhibitor	
molecules,	 increased	 the	 susceptibility	 of	 the	 P.	 aeruginosa	 biofilm	 to	 tobramycin	
(Christensen	et	al.	2012).	 In	the	context	of	chronic	wounds,	Schierle	and	colleagues	
demonstrated	reduced	epithelialisation	in	a	murine	chronic	wound	animal	model	in	
the	presence	of	S.	aureus	and	S.	epidermidis	biofilm.	Furthermore,	the	 introduction	
of	 the	quorum	 sensing	 disruptor	 RNAIII	 inhibiting	 peptide	 significantly	 restored	 re-
epithelialisation	 when	 compared	 to	 the	 antibiotic	 oxacilin,	 due	 to	 reduced	
quantifiable	 bacterial	 burden.	 In	 addition,	 the	 staphylococcal	 biofilm	 signalling-
associated	gene,	TRAP,	appeared	to	play	an	important	role	in	the	reduction	of	wound	
closure,	which	was	 demonstrated	 by	 a	weak	 effect	 on	 re-epithelialisation	 in	 TRAP-	
bacterial	mutants	(Schierle	et	al.	2009).		
	
1.6.3 Photodynamic	therapy	(PDT)	
Photodynamic	 therapy	 (PDT)	 is	 the	 application	 of	 a	 photoactive	 dye	 coupled	 with	
irradiation	 that	 brings	 about	 microbial	 cell	 death	 in	 the	 presence	 of	 oxygen.	 The	
anmicrobial	effect	of	PDT	has	been	well	documented.	The	efficacy	of	this	treatment	
in	the	eradication	of	biofilms	has	been	investigated	 in	vitro	and	 in	vivo.	Di	Poto	and	
colleagues	investigated	the	action	of	PDT	and	antibiotic	treatment	on	the	eradication	
of	S.	aureus	biofilms	 in	vitro,	which	resulted	in	a	significant	inactivation	of	S.	aureus	
and	 when	 combined	 with	 the	 antibiotic	 vancomycin,	 showed	 an	 almost	 complete	
eradication	of	the	bacteria	(Di	Poto	et	al.	2009).	A	small	body	of	work	exists	for	the	
treatment	of	biofilm-infected	wounds	in	animal	models.	The	use	of	PDT	has	shown	a	
98%	reduction	in	Escherichia	coli	in	excisional	wounds	of	mice	(Hamblin	et	al.	2002).	
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Further	to	this,	S.	aureus-infected	leg	wounds	in	mice	were	successfully	treated	using	
PDT,	 resulting	 in	complete	eradication	of	S.	aureus	 in	 three	of	 five	mice	 (Gad	et	al.	
2004).	 In	 humans,	 the	 treatment	 of	 two	 autoimmune	 ulcers	 in	 an	 Italian	 patient	
using	PDT	resulted	in	significant	wound	closure	from	4.0cm	to	1.8cm	diameter.	Given	
that	 these	 ulcers	 were	 previously	 shown	 to	 be	 highly	 recalcitrant	 to	 systemic	
antibiotics	and	the	application	of	wound	dressings;	 it	 is	 thought	that	the	successful	
use	of	PDT	could	be	through	such	mechanisms	as	enhanced	keratinocyte	migration,	
immunomodulatory	activity	and	antimicrobial	effectiveness	(Motta	and	Monti	2007).	
PDT	 has	 been	 shown	 to	 significantly	 reduce	 bacterial	 load	 and	 complete	 wound	
closure	in	50%	of	patients	with	chronic	leg	ulcers	in	a	phase	IIa,	randomized,	blinded	
and	single	treatment	study	(Morley	et	al.	2013).	The	use	of	PDT	to	reduce	bacterial	
burden	 and	 encourage	 wound	 healing	 in	 chronic	 wounds	 is	 a	 promising	 potential	
therapy	(Percival	et	al.	2014).	
	
1.6.4 Bacterial	proteases	as	therapeutic	targets	
The	 therapeutic	 targeting	 of	 proteases	 by	 pharmacologically	 attractive	 compounds	
has	 been	 successfully	 used	 in	 the	 treatment	 of	 many	 diseases,	 including	
hypertension,	human	 immunodeficiency	virus	 (HIV)	and	hepatitis	C	virus	 (HCV).	For	
instance,	pharmacologically	approved	serine	protease	inhibitor	boceprevir	(Victrelis;	
Merck)	 reversibly	 binds	 to	 and	 inhibits	 the	 HCV	 non-structural	 3	 (NS3)	 active	 site,	
preventing	 viral	 replication	 and	 thus	 sustaining	 the	 virologic	 response	 in	 patients	
with	previously	untreated,	chronic	HCV	infection	(Venkatraman	2012,	Poordad	et	al.	
2011).		
The	 pharmacological	 targeting	 of	 bacterial	 proteases	 in	 the	 context	 of	 bacterial	
infection	has	not	been	fully	exploited.	Yet	many	of	the	secreted	bacterial	proteases	
are	 involved	 in	 bacterial	 virulence	 or	 growth	 and	 therefore	 the	 inhibition	 of	 these	
proteases	may	disrupt	biofilm	 formation	or	 increase	susceptibility	 to	antimicrobials	
(Kaman	 et	 al.	 2014).	 In	 the	 context	 of	 chronic	 wound-associated	 bacteria,	 P.	
aeruginosa	LasB	protease	has	been	investigated	as	a	target	of	protease	inhibition.	A	
novel	 and	 potent	 inhibitor	 of	 LasB,	 N-mercaptoacetyl-Phe-Tyr-amide,	 has	 been	
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developed	and	shown	to	reduce	P.	aeruginosa	biofilm	growth,	and	when	combined	
with	 additional	 antimicrobials	 such	 as	 ciprofloxacin	 and	 gentamycin,	 can	 fully	
eradicate	the	biofilm	in	vitro	(Cathcart	et	al.	2011).	Similarly,	the	deletion	of	LasB	in	
P.	aeruginosa	PA01,	referred	to	as	a	Lasb	deletion	mutant	strain,	has	been	shown	to	
exhibit	 decreased	 bacterial	 attachment	 and	 microcolony	 formation.	 However	
microcolony	 formation	 in	 the	 LasB	 deletion	 mutants	 was	 restored	 following	
exogenous	 rhamnolipid	 supplementation,	 therefore	 it	 was	 hypothesised	 that	 LasB	
may	promote	biofilm	formation	through	rhamnolipid-mediated	regulation	(Yu	et	al.	
2014).	The	inhibition	of	other	bacterial	proteases	however	may	not	necessarily	result	
in	the	disruption	of	the	biofilm.	Research	by	Loughran	and	colleagues	identified	that	
S.	 aureus	 aureolysin,	 and	 to	 a	 lesser	 extent,	 the	proteases	 ScpA	and	SspB,	 actually	
promote	 the	 dispersal	 of	 S.	 aureus	 biofilms	 (Loughran	 et	 al.	 2014).
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Table	 1.2	 The	 major	 extracellular	 proteases	 associated	 with	 P.	 aeruginosa	 and	 S.	 aureus,	 their	 substrates	 specificities	 and	 associated	
biological	processes.	
Abbreviations	include:	extracellular	matrix	(ECM),	matrix	metalloprotease	(MMP)	and	collagen	(col).	
Organism	 Bacterial	
protease	
MEROPS	
family	
Protease		 Substrate	 Associated	process	 References	
P.	
aeruginosa	
Elastase	A	
(LasA)	
	
M23	 Metallo-	 Fibrinogen,	elastin	 ECM	destruction	 (Morihara	et	al.	1965,	Rawlings	
et	al.	2012)	
Elastase	B		
(Las	B)	
M4	 Metallo-	 Elastin,	col-III,	col-IV,	MMP-
1/MMP-9	(pro-enzyme),	
elastase	B	
	
ECM	destruction,	MMP	
proteolysis,	autoproteolytic	
processing	
(Rawlings	et	al.	2012,	Okamoto	
et	al.	1997)	
Alkaline	
protease	(AprA)	
M10	 Metallo-	 Fibrinogen,	gelatin,	casein,	
haemoglobin,	cytokines	
	
Complement	inactivation,	
host	immune	evasion	
(Rawlings	et	al.	2012,	Barrett	et	
al.	2012,	Parmely	et	al.	1990)	
Protease	IV	 S1	 Serine-	 Plasminogen,	fibrinogen,	
complement	protein	C3	
	
Complement	inactivation	 (Engel	et	al.	1998,	Rawlings	et	
al.	2012)	
S.	aureus	 Aureolysin	 M4	 Metallo-	 Plasminogen,	complement	
protein	C3	
Complement	inactivation	 (Rawlings	et	al.	2012,	Laarman	
et	al.	2011,	Massimi	et	al.	2002)	
	
Staphopain	A	
(ScpA)	
	
C47	 Cysteine-	 Elastin	
	
ECM	destruction	 (Rawlings	et	al.	2012)	
Staphopain	B	
(SspB)	
C47	 Cysteine-	 Fibrinogen,	fibronectin,	elastin	
	
ECM	destruction,	
complement	inactivation	
(Rawlings	et	al.	2012,	Massimi	
et	al.	2002)	
Staphylococcal	
serine	protease	
(SspA)	
S1	 Serine-	 Actin,	collagenase,	IgG1	heavy	
chain,	serum	albumin,	
vimentin,	casein	
Host	immune	evasion,	ECM	
degradation	
(Rawlings	et	al.	2012,	Massimi	
et	al.	2002,	Ryan	et	al.	2008)	
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Table	 1.3	 Commonly	 used	 treatment	 options	 for	 chronic	 wounds.
Treatment	 Description	 Reference	
Negative	 pressure	
therapy	 (NPT)	 or	
vacuum-assisted	closure	
NPT,	whereby	 a	 vacuum	 is	 applied	 to	 a	 sealed	wound	 dressing,	 is	 a	method	 that	 has	
been	 shown	 to	 increase	blood	 flow	and	 reduce	oedema,	promoting	 granulation	 tissue	
formation	 and	 wound	 closure.	 There	 is	 conflicting	 evidence	 for	 the	 management	 of	
microbial	bioburden.	
	
(Levine	 et	 al.	 2013,	
Argenta	 and	 Morykwas	
1997,	 Mouës	 et	 al.	
2011)	
Repositioning	 Particular	method	used	in	the	management	of	pressure	ulcers.	Patients	are	repositioned	
to	 reduce	mechanical	 stress	on	 the	chronic	wound.	For	 instance,	adjusting	 the	patient	
with	 a	 30°	 tilt,	 three-hourly	 per	 night	 has	 been	 shown	 to	 reduce	 the	 incidence	 of	
pressure	ulcers	in	the	elderly.	
	
(Moore	et	al.	2011)	
Debridement	 A	 method	 used	 to	 remove	 non-viable	 tissue	 or	 infected	 tissue	 to	 promote	 the	
development	of	healthy	tissue.	Methods	of	debridement:	
Biological	 -	 Larvae	 or	 maggots	 used	 to	 remove	 necrotic	 tissue;	 Autolytic	 -	 Naturally	
occurring	enzymes	breakdown	dead	tissue;	Chemical	-	Use	of	chemical	compounds	such	
as	 hypochlorite;	 Enzymatic	 –	 Use	 of	 enzymes	 such	 as	 collagenase	 and	 papain;	
Mechanical	-	Mechanical	debridement	encompasses	a	variety	implements	from	the	use	
of	wound	dressings	to	the	surgical	removal	of	dead	or	contaminated	tissue.	
	
(Dryburgh	 et	 al.	 2007,	
Wolcott	et	al.	2009)	
Nutritional	therapy	 A	 change	 in	 the	 patient	 diet	 can	 be	 administered	 if	malnutrition	 is	 suspected.	 Studies	
have	shown	that	a	higher	calorie	intake	can	reduce	wound	size.	
	
(Ohura	et	al.	2011)	
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Table	1.4	Commonly	used	wound	dressings	and	associated	antimicrobial	incorporations	in	the	management	of	chronic	wounds.	
Information	taken	from	several	sources	(Lipsky	and	Hoey	2009,	Mandal	and	Mandal	2011,	Percival	et	al.	2011b,	Zahedi	et	al.	2010).	
Dressing	 Description	
Alginate	 Dressings	composed	from	seaweed	extract.	Highly	absorbent	and	used	for	excessive	amounts	of	wound	
exudate.		 	
Foam	 An	inert	material	with	absorptiv 	capacity	and	usually	mad 	from	polyurethane.	
Hydrocolloid	
	
Dressing	contains	microgranules	made	from	either	natural	or	synthetic	polymers	such	as	gelatin,	pectin	
or	carboxymethylcellulose.	The	microgranules	change	to	a	gel-like	state	upon	the	absorption	of	wound	
exudate.	
Hydrofiber	 An	absorptive	fiber	dressing	that	combines	with	wound	exudate	to	transform	into	a	hydrophilic	gel.	
Hydrogel	 A	water-based	or	glycerine-based	hydrophilic	polymer	dressing.	The	dressing	has	absorptive	properties	
but	can	also	release	water	into	dry,	de-hydrated	wounds.		
Transparent	film	 A	membrane-like	film	composed	of	polyurethane	and	polyethylene	and	coated	with	an	acrylic	adhesive.		
	
Antimicrobial	 Description	
Chlorexidine	 Antimicrobial	activity	again	Gram-positive	and	Gram-negative	bacteria.	
Medical-grade	honey	 Natural,	non-toxic	antimicrobial.		
Silver	 Used	for	 its	broad-spectrum	anmicrobial	activity,	 it	can	be	used	topically	or	 is	quite	often	incorporated	
into	composite	wound	dressings.	
Sodium	hypochlorite	 Antimicrobial	activity	against	fungi,	viruses	and	vegetative	bacteria.	
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1.7 Research	Aims	
The	 first	 research	 aim	 is	 to	 assess	 the	 proteolytic	 activity	 of	 P.	 aeruginosa	 and	 S.	
aureus	 isolated	 from	 equine	 and	 human	 chronic	 wounds	 and	 determine	 whether	
there	is	a	difference	in	proteolytic	activity	between	the	planktonic	and	biofilm	form	
of	these	isolates.	The	second	research	aim	will	then	focus	on	the	effect	of	planktonic-
conditioned	 medium	 (PCM)	 and	 biofilm-conditioned	 medium	 (BCM)	 from	 equine	
clinical	 isolates	 on	 the	 in	 vitro	 wound	 closure	 of	 normal	 fibroblasts	 (NFs)	 isolated	
from	 uninjured	 equine	 lower	 limb	 skin	 and	 granulation	 tissue	 fibroblasts	 (GTFs)	
cultured	 from	 equine	 chronic	 wound	 granulation	 tissue.	 The	 technique	 of	
zymography	will	be	utilised	 to	determine	 the	 release	of	host-derived	MMPs	 in	 this	
wound	model.	In	order	to	gain	a	better	understanding	of	how	infection	affects	MMP	
expression	 in	 host	 tissues,	 both	 normal	 skin	 and	 chronic	wound	 granulation	 tissue	
from	 horse	 lower	 limbs	 will	 be	 assessed	 histologically	 for	 the	 presence	 of	
microorganisms	within	a	biofilm,	and	the	corresponding	expression	of	MMPs	in	the	
surrounding	tissue.		
The	 next	 aim	 will	 then	 address	 the	 effect	 of	 PCM	 and	 BCM	 from	 human	 chronic	
wound-derived	 isolates	on	 the	 in	 vitro	wound	 closure	of	human	dermal	 fibroblasts	
(HDFs)	and	human	epidermal	keratinocytes	(HEKs).	As	with	the	equine	model,	host-
MMP	 expression	 in	 response	 to	 PCM	 and	 BCM	 will	 be	 assessed.	 In	 addition,	 the	
generation	of	an	in	vitro	3-dimensional	keratinocyte-fibroblast	co-culture	model	will	
be	developed,	and	wound	repair	observed	in	response	to	microbial	bioburden.	
I	 hypothesise	 that	 clinically	 derived	 isolates	 from	 both	 equine	 and	 human	 chronic	
wounds	 will	 secrete	 high	 levels	 of	 proteases.	 Furthermore,	 I	 believe	 that	 the	
presence	 of	 S.	 aureus	 and	P.	 aeruginosa	 biofilms,	 but	 not	 planktonic	 bacteria,	will	
reduce	wound	closure	in	equine	and	human	models	in	vitro	and	will	elicit	the	release	
of	host-derived	proteases.	 In	addition	I	postulate	that	the	identification	of	bacterial	
biofilms	 in	 the	 chronic	 wound	 granulation	 tissue	 of	 horses	 will	 correlate	 with	 a	
change	in	local	MMP	expression	in	surrounding	tissues.		
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2 Materials	and	Methods	
	
2.1 Chemicals	and	Reagents	
All	 chemicals	and	 reagents	were	purchased	 from	Sigma	Aldrich	 (Dorset,	UK)	unless	
otherwise	stated.	
	
2.2 Ethical	Approval	
Approval	 for	 the	 isolation	of	 equine-derived	bacteria	was	 carried	out	 in	 a	previous	
study	 at	 the	 University	 of	 Liverpool	 and	 informed	 consent	was	 obtained	 from	 the	
owners	of	the	animals	that	participated	in	the	study	(Westgate	et	al.	2011).	Human	
chronic-wound	 derived	 bacteria	 were	 a	 kind	 gift	 of	 Professor	 David	 Williams	 of	
Cardiff	University	and	ethical	approval	for	the	isolation	of	these	microorganisms	was	
granted	under	their	institution.	
Approval	for	the	harvest	of	equine	skin	from	cadavers	and	equine	granulation	tissue	
following	 routine	 debridement	 for	 the	 isolation	 of	 fibroblasts	 was	 granted	 by	 the	
Ethics	Committee,	University	of	Liverpool	and	informed	consent	was	obtained	from	
the	owners	of	the	animals	participating	in	this	study.	
		
2.3 Microbiology	
2.3.1 Equine-derived	Microorganisms	
Equine-derived	 microorganisms	 were	 obtained	 from	 the	 University	 of	 Liverpool	
relating	 to	 the	 research	 undertaken	 by	Westgate	 and	 colleagues	 (Westgate	 et	 al.	
2011).	Briefly,	bacterial	sampling	in	the	form	of	a	swabbing	technique	was	performed	
on	 both	 acute	 and	 chronic	 equine	 wounds.	 Wound	 type	 was	 determined	 by	 the	
attending	 veterinary	 surgeon,	 whereby	 acute	 wounds	 were	 seen	 to	 progress	 at	 a	
normal	rate	and	chronic	wounds	either	showed	little	signs	of	healing	or	the	presence	
of	bright	red	colouration,	discharge,	malodour	and	exuberant	granulation	tissue.	The	
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various	microorganisms	sampled	from	the	wounds	were	identified	using	a	variety	of	
microbiological	 techniques,	 including	 selective	 agars,	 Gram-staining	 and	 tests	 to	
identify	 the	 production	 of	 oxidase,	 catalase	 and	 coagulase.	 All	 identified	
microorganisms	were	stored	at	-80°C	in	Microbank™	vials	with	cryopreservative	and	
green-colour	beads	(Pro-lab	Diagnostics,	Cheshire	UK).	
	
2.3.2 Human-derived	Microorganisms	
Human	chronic	wound-derived	bacterial	 isolates	were	a	kind	gift	of	Professor	David	
Williams	of	Cardiff	University.	The	isolation	of	these	bacterial	isolates	was	approved	
by	 a	 local	 research	 ethics	 committee	 and	 after	 informed	 consent	 was	 taken	 from	
patients	 attending	 the	Wound	Healing	 Research	Unit,	 University	Hospital	 of	Wales	
(Cardiff,	 UK).	 Microbiological	 methods	 such	 as	 selective	 agars,	 Gram-staining	 and	
tests	 to	 identify	 the	 release	 of	 oxidase	 and	 catalase	 were	 used	 to	 identify	 the	
microorganisms.		
	
2.3.3 Microbiological	Culture	
Prior	 to	 use,	microorganisms	were	 stored	 on	Microbank™	 green	 colour	 beads	 at	 -
80°C	 before	 inoculating	 onto	 Mueller	 Hinton	 Agar	 (MHA)	 (Lab	 M,	 Bury,	 UK)	 and	
incubating	 overnight	 at	 37°C.	 Following	 incubation,	 a	 loop	 of	 bacteria	 was	
transferred	 to	 Mueller	 Hinton	 Broth	 (MHB)	 (Lab	 M),	 Dulbecco’s	 Modified	 Eagle	
Medium	 (DMEM)	 or	 EpiLife	 (Life	 Technologies,	 Paisley,	 UK)	 to	 obtain	 planktonic-
conditioned	medium	 (PCM)	 and	biofilm-conditioned	medium	 (BCM)	 (see	2.3.4	 and	
2.3.5).	 In	 general	 and	 for	 this	 study,	 the	 term	 planktonic	was	 defined	 as	 bacterial	
cells	 that	 are	 grown	 in	 a	 free-floating,	 single-cell	 state.	 The	 term	 biofilm	 was	
described	as	bacterial	cells	that	are	attached	to	a	surface	and	each	other,	and	grow	
as	a	community	of	cells	within	a	self-synthesised	matrix.	Growth	curves	of	bacteria	
within	 a	 planktonic	 state	 was	 performed	 by	 inoculating	 MHB	 with	 the	 chosen	
microorganism	 and	 recording	 the	 absorbance	 of	 the	 inoculum	 at	 a	 range	 of	 time	
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points	from	0-72	hours	using	the	Thermo	Scientific	Multiscan	FC	plate-reader	(Fisher	
Scientific,	Loughborough,	UK)	at	a	wavelength	of	600nm.		
	
2.3.4 Bacterial	planktonic-conditioned	medium	(PCM)	
In	order	to	obtain	planktonic-conditioned	medium	(PCM),	a	loop	of	freshly	cultured	
bacteria	 on	MHA	 was	 used	 to	 inoculate	 either	 MHB,	 DMEM	without	 phenol	 (Life	
Technologies,	 Paisley,	 UK)	 containing	 10%	 Foetal	 Bovine	 Serum	 (FBS),	 2mM	 L-
glutamine	 (Life	 Technologies,	 Paisley,	 UK),	 10mM	 N-2-hydroxyethylpiperazine-N-2-
ethane	 sulfonic	 acid	 (HEPES)	 (Life	 Technologies,	 Paisley,	 UK)	 and	 0.5μg/ml	
Fungizone®Amphotericin	 B	 (Life	 Technologies,	 Paisley,	 UK)	 or	 Epilife	 medium	
containing	 human	 keratinocyte	 growth	 supplement	 (HKGS)	 (Life	 Technologies,	
Paisley,	UK)	before	incubating	overnight	at	37°C.	This	specific	preparation	of	DMEM	
is	referred	to	as	‘DMEM	(without	antibiotics)’	throughout	this	thesis.	Addtionally,	this	
preparation	of	Epilife	 is	referred	to	as	 ‘EpiLife	(without	antibiotics)’	 throughout	this	
thesis.	 Bacterial	 suspensions	 were	 diluted	 with	 either	 MHB	 or	 DMEM	 (without	
antibiotics)	to	approximately	109	colony	forming	units/ml,	which	was	determined	by	
measuring	the	optical	density	 (OD)	of	 the	suspension	to	0.4OD	at	600nm	using	the	
Cecil	CE	2040	spectrophotometer	 (Cambridge,	UK).	Once	diluted,	suspensions	were	
cultured	for	24	hours	before	being	centrifuged	at	11,000	x	g	at	4°C	for	10	minutes	in	
order	to	pellet	the	bacteria.	Supernatants	were	obtained	and	sterile	filtered	using	a	
Whatman	 0.2µm	 syringe	 filter	 (Whatman	 Anodisc,	 Scientific	 Laboratory	 Supplies,	
Yorkshire,	UK).	Conditioned-medium	was	stored	at	-20°C	until	further	use.	PCM	was	
used	for	either	the	scratch	wound	assays	or	general	protease	activity	assays.	 In	the	
scratch	wound	assays,	PCM	was	diluted	1:1	with	DMEM	(without	antibiotics).	
	
2.3.5 Bacterial	biofilm-conditioned	medium	(BCM)	
For	biofilm-conditioned	medium	(BCM),	a	 loop	of	 freshly	cultured	bacteria	on	MHA	
was	 used	 to	 inoculate	 DMEM	 (without	 antibiotics)	 before	 incubating	 overnight	 at	
37°C.	Cultures	were	then	diluted	to	a	concentration	of	106	colony	forming	units/ml,	
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which	was	 determined	 by	 using	 the	 Cecil	 CE	 2040	 spectrophotometer.	Membrane	
filter	 discs	 of	 0.2µm	 pore	 size	 (Whatman	 Anodisc,	 Scientific	 Laboratory	 Supplies,	
Yorkshire,	UK)	were	sterilised	using	ultraviolet	 light	exposure	for	30	minutes	before	
transferring	 the	 discs	 to	MHA	 plates.	 Forty	microliters	 of	 the	 bacterial	 suspension	
was	 added	 to	 the	 filter	 disc.	 The	MHA	plates	 containing	 the	 inoculated	 filter	 discs	
were	 incubated	 for	 72	 hours	 at	 37°C	 in	 humidified	 conditions	 (see	 Figure	 2.1).	
Following	 incubation,	 the	 discs	 were	 transferred	 to	 a	 Deep-Well	 plate	 (BD	
Biosciences,	 Oxford,	 UK).	 The	 wells	 of	 the	 plate	 were	 filled	 with	 8ml	 of	 MHB	 or	
DMEM	(without	antibiotics),	allowing	the	medium	to	touch	the	base	of	the	filter	disc.	
The	 Deep-Well	 plate	 containing	 the	 72-hour	 biofilm	 was	 incubated	 at	 37°C	 in	
humidified	conditions	for	24	hours.	The	conditioned-medium	was	collected	after	24	
hours	and	centrifuged	at	11,000	x	g	at	4°C	for	10	minutes.	Supernatants	were	then	
sterile-filtered	 (0.2	 µm)	 before	 being	 stored	 at	 -20°C	 until	 needed	 for	 further	 use.	
BCM	was	 used	 in	 either	 scratch	 or	 general	 protease	 activity	 assays.	 In	 the	 scratch	
wound	assays,	BCM	was	diluted	1:1	with	DMEM	(without	antibiotics).	
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Figure	 2.1	 Representative	 image	 of	 a	 72-hour	 human-derived	 clinical	 strain	 of	P.	
aeruginosa	grown	as	a	biofilm.	
The	characteristic	yellow/green	P.	aeruginosa	biofilm	(b)	can	be	seen	on	the	surface	
of	 the	membrane	 filter	 disc	 (a).	Mueller	Hinton	Agar	 (MHA)	 (c)	was	pigmented	 (d)	
from	products	released	from	P.	aeruginosa,	indicating	exchange	of	nutrients	and	by-
products	through	the	membrane	filter	surface.		
	
2.3.6 Crystal	Violet	Biofilm	Forming	Assay	
To	 assess	 the	 biofilm	 forming	 potential	 of	 bacterial	 isolates,	 bacteria	was	 cultured	
overnight	in	MHB	at	37°C	and	diluted	to	108	colony	forming	units/ml.	Two-hundred	
microliters	 of	 the	 bacterial	 suspension	 in	MHB	 was	 added	 to	 a	 96-well	 microtitre	
plate	before	covering	the	plate	with	a	96-peg	lid.	The	plate	was	incubated	for	either	
24,	 48	 or	 72	 hours	 at	 37°C	 with	 gentle	 shaking	 of	 125rpm,	 allowing	 the	 bacteria	
within	 the	 suspension	 to	attach	 to	 the	pegs	 (see	Figure	2.2).	 Following	 incubation,	
the	 pegs	 were	 removed	 from	 the	 bacterial	 suspension	 and	 were	 washed	 twice	 in	
phosphate	 buffered	 saline	 (PBS)	 and	 allowed	 to	 air-dry.	 The	 pegs	 were	 then	
incubated	in	a	0.5%	crystal	violet	solution	for	15	minutes	at	room	temperature.	The	
pegs	were	rinsed	with	distilled	water,	removing	any	excess	crystal	violet	that	had	not	
specifically	 stained	 adherent	 bacterial	 cells.	 Excess	 distilled	 water	 was	 removed	
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before	air-drying	the	pegs.	The	pegs	were	then	immersed	in	200μl	of	30%	acetic	acid	
for	15	minutes,	in	a	96-well	format,	which	solubilises	the	crystal	violet	stain.	The	pegs	
were	removed	from	the	96-well	plate	and	the	absorbance	of	each	well	was	read	on	a	
Thermo	Scientific	Multiscan	FC	plate	reader	(Fisher	Scientific,	Loughborough,	UK)	at	a	
wavelength	of	 550nm.	High	 absorbance	 values	 (strong	 crystal	 violet	 staining)	were	
indicative	of	strong	biofilm	formation	due	to	a	greater	number	of	adhered	bacteria	to	
the	 pegs.	 Similarly,	 low	 absorbance	 values	 and	 visually	weak	 crystal	 violet	 staining	
corresponded	to	poor	biofilm	forming	potential.	
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Figure	2.2	Schematic	representation	of	biofilm	formation	on	pegs.	
(A)	 Microorganisms	 suspended	 in	 culture	 medium	 were	 added	 to	 the	 wells	 of	 a	
microtiter	 plate.	 (B)	 A	microtiter	 lid	 containing	 plastic	 pegs	was	 used	 to	 cover	 the	
plate,	 resulting	 in	 the	 submersion	 of	 the	 pegs	 into	 the	 microbial	 suspension.	 (C)	
Following	 incubation,	 the	 pegs	 were	 removed	 from	 the	 plate	 and	 washed.	
Microorganisms	 that	 were	 attached	 to	 the	 surface	 of	 the	 peg	 were	 termed	 a	
‘biofilm’.		
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2.4 Biofilm-disrupting	technology	study	
The	wound	care	company,	and	funders	of	this	PhD,	Advanced	Medical	Solutions	Plc	
identified	 three	 potential	 biofilm-disrupting	 technologies,	 which	 were	 tested	 on	
three	skin-	and	wound-related	microorganisms,	P.	aeruginosa	ATCC	9027,	S.	aureus	
ATCC	6538	and	Candida	albicans	ATCC	10321	(CultiLoops®,	Remel,	Thermo	Scientific,	
US).	 The	 three	 potential	 biofilm-disrupting	 technologies	 included	 a	 chelating	 agent	
and	 two	 surfactants,	 surfactant	 A	 and	 surfactant	 B.	 The	 aim	 of	 this	 study	 was	 to	
identify	 whether	 these	 technologies	 could	 disrupt	 biofilms	when	 combined	with	 a	
commercially	 available	 polymer	 antimicrobial.	 More	 specifically,	 the	 minimum	
biocidal	 concentration	 (MBC)	 and	 minimum	 biofilm	 eradication	 concentration	
(MBEC)	 was	 determined.	 MBC	 was	 defined	 as	 the	 minimum	 concentration	 of	
antimicrobial	that	eradicates	the	growth	of	the	dispersed,	planktonic	cells	 from	the	
biofilm.	 MBEC	 was	 defined	 as	 the	 minimum	 concentration	 of	 antimicrobial	 that	
eradicates	the	biofilm.	
	
2.4.1 Preparation	of	the	biofilm-disrupting	technologies		
Dilutions	of	all	biofilm-disrupting	technologies	were	prepared	using	PBS.	Stock	
solutions	of	each	biofilm-disrupting	technology	were	prepared,	filter	sterilised	
(0.2μm)	and	serially	diluted	in	a	96-well	plate	format	(see	Figure	2.3).	The	first	
column	of	wells	A1-H1	contained	sterile	MHB	only	to	serve	as	no-growth	controls,	
whilst	the	last	column	of	wells	A12-H12	contained	MHB	for	growth	controls.	The	
highest	concentration	of	biofilm-disrupting	technology	was	added	to	the	wells	A11-
H11	and	was	serially	diluted	in	PBS	across	the	plate,	with	the	lowest	concentration	of	
biofilm-disrupting	technology	in	wells	A3-H3.	The	highest	concentration	of	polymer	
antimicrobial	was	then	added	to	wells	H2-H11	and	serially	diluted	in	PBS	up	the	
plate,	whereby	the	lowest	concentration	of	polymer	antimicrobial	was	in	wells	B2-
B11.	The	resulting	volume	of	each	well	in	the	treatment	plate	was	100μl;	therefore	
each	well	containing	the	treatment,	was	diluted	further	by	adding	a	100μl	of	MHB.	
The	checkerboard-style	method	allowed	the	determination	of	MBC	and	MBEC	of	
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microorganisms	after	treatment	with	a	variety	of	concentrations	of	both	biofilm-
disrupting	technology	and	the	polymer	antimicrobial	in	combination	and	alone.				
	
	
	
	
	
Figure	2.3	Treatment	plate	set-up	containing	serial	dilutions	of	the	anti-biofilm	
technology	and	polymer	antimicrobial.	
	
	
2.4.2 Determination	of	MBC	and	MBEC	
Prior	 to	 use,	microorganisms	were	 stored	 on	Microbank™	 green	 colour	 beads	 at	 -
80°C	 before	 inoculating	 onto	 MHA	 and	 incubating	 overnight	 at	 37°C.	 Following	
incubation,	 a	 loop	 of	 bacteria	was	 transferred	 to	MHB	 and	 incubated	 overnight	 at	
37°C.	The	microbial	suspension	was	then	diluted	to	108	colony	forming	units/ml	and	
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a	volume	of	180μl	was	transferred	the	wells	of	a	96-well	plate.	The	plate	was	then	
covered	with	a	96-peg	 lid	and	 incubated	 in	a	shaking	 incubator	(125rpm)	for	either	
24,	48	or	72	hours	at	37°C.	Biofilms	grown	on	pegs	for	24,	48	or	72	hours	were	then	
gently	 washed	 once	 in	 PBS	 before	 being	 transferred	 to	 the	 respective	 treatment	
plate	and	placed	in	a	shaking	incubator	(125rpm)	for	24	hours	at	37°C.	The	96-peg	lid	
was	 subsequently	 removed	 from	 the	 treatment	 plate	 and	 transferred	 to	 a	 plate	
containing	PBS	(wash	step).	Each	well	of	the	treatment	plate	was	then	transferred	to	
individual	MHA	 plates	 and	 incubated	 at	 37°C	 in	 order	 to	 detect	microbial	 growth,	
which	subsequently	allowed	the	determination	of	the	MBC.	The	96-peg	lid	was	then	
removed	from	PBS	and	transferred	to	a	new	96-well	plate	containing	200μl	of	sterile	
MHB	per	well.	The	plate	was	then	transferred	to	the	Q-Series	sonic	bath	(Ultrawave,	
Cardiff,	UK)	and	sonicated	for	20	to	30	minutes	to	remove	adherent	microorganisms	
from	the	pegs.	The	peg	lid	was	finally	removed	and	discarded.	The	contents	of	each	
well	 was	 transferred	 to	 individual	 MHA	 plates	 and	 incubated	 at	 37°C	 in	 order	 to	
detect	 microbial	 growth,	 which	 subsequently	 allowed	 the	 determination	 of	 the	
MBEC.	For	no-growth	controls,	wells	were	filled	with	180μl	of	MHB	without	bacteria.	
	
2.5 Scanning	Electron	Microscopy	
Bacterial	 biofilms	 grown	 on	 membrane	 filter	 discs	 were	 visualised	 using	 scanning	
electron	microscopy	 (SEM).	 Stock	 solutions	 of	 25%	 gluteraldehyde	were	 diluted	 in	
PBS	 to	a	2.5%	working	concentration.	Bacteria	grown	for	72	hours	were	washed	 in	
PBS	to	remove	non-adherent	cells	and	fixed	in	2.5%	gluteraldehyde	for	90	minutes	at	
room	 temperature.	 Gluteraldehyde	 fixative	 was	 removed	 and	 the	 biofilms	 were	
washed	twice	in	PBS.	Biofilms	were	dehydrated	in	a	series	of	ethanol	concentrations	
ranging	from	50%	to	100%.	Following	dehydration	the	samples	were	sputter-coated	
using	 a	 Polaron	 E5100	 sputter-coater	 with	 a	 gold/palladium	 target.	 Once	 coated,	
membrane	 filters	 containing	 the	bacterial	 biofilms	were	attached	 to	25mm	x	6mm	
aluminium	 stubs	 (Agar	 Scientific,	 Essex,	 UK)	 using	 two-sided	 sticky	 tape.	 Biofilms	
were	 imaged	 using	 the	 Hitachi	 TM3000	 tabletop	 microscope	 (Daresbury	
Laboratories,	Cheshire,	UK).	
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2.6 Non-specific	Protease	Assays	
2.6.1 Milk-Casein	Agar		
Milk-casein	 agar	 was	 used	 to	 assess	 the	 proteolytic	 activity	 of	 equine	 PCM	 at	 a	
preliminary	 level	 (see	 Appendix	 I).	 Milk-casein	 agar	 was	 prepared	 by	 adding	 25g	
skimmed	milk	 powder	 (BD,	Oxford,	UK),	 2.5g	 casein	 (BDH,	 VWR,	 Lutterworth,	UK),	
used	for	casein	nutritional	experiments,	1.25g	yeast	extract	(Oxoid,	Basingstoke,	UK),	
0.5g	D-glucose	(BDH,	Oxford,	UK)	and	6.25g	Number	1	agar	(LabM	Bury,	UK)	to	500ml	
distilled	 water.	 The	 agar	 was	 autoclaved,	 poured	 into	 petri	 dishes	 (approximately	
30ml	per	plate)	and	allowed	to	cool	until	set.	Milk-casein	agar	plates	were	dried	in	an	
oven	to	remove	excess	moisture	before	creating	two	8mm	wells	in	the	agar,	of	equal	
distance	 apart,	 using	 a	 sterile	 punch	 biopsy.	 One	 hundred	 microlitres	 of	 bacterial	
supernatant	was	added	to	the	first	well	followed	by	100µl	of	MHB	in	the	second	to	
act	 as	a	negative	growth	and	protease	activity	 control.	 This	was	 repeated	 for	each	
bacterial	 supernatant	before	 incubating	 the	plates	 at	 37°C	 for	 24	or	 48	hours.	 The	
experiment	was	performed	three	times	using	triplicate	PCM.	Plates	were	checked	for	
proteolytic	activity	(zones	of	clearance)	and	measured	at	24	hours	and	48	hours	(see	
Figure	2.4).	The	negative	control	 (MHB)	was	not	expected	to	show	signs	of	activity	
with	 the	 milk-casein	 agar.	 If	 activity	 was	 present	 it	 was	 assumed	 that	 there	 was	
contamination	of	the	MHB	and	the	experiment	was	repeated	with	new	PCM.		
	
	
Page	74	of	253	
	
	
Figure	2.4	Zones	of	clearance	in	milk-casein	agar.	
Images	of	P.	aeruginosa	 planktonic-conditioned	medium	 (PCM)	protease	activity	 in	
milk-casein	 agar	 at	 24-	 (A)	 and	 48-hours	 (B)	 Black	 arrows	 indicate	 the	 zones	 of	
clearance	whereby	the	casein	has	been	degraded	by	proteases	in	the	P.	aeruginosa	
PCM.	 Images	 contain	 the	 abbreviations:	 Mueller	 Hinton	 broth	 (MHB),	 phosphate	
buffered	saline	(PBS).	
	
	
2.6.2 Azo-Casein	Assay	
To	measure	 the	 general	 protease	 activity	 of	 PCM	 and	 BCM,	 an	 assay	 utilising	 the	
chromogenic	 substrate	Azo-casein,	 a	non-specific	protease	 substrate	 conjugated	 to	
an	azo-dye,	was	performed.	Briefly,	Azo-casein	solution	was	made	by	dissolving	Azo-
casein	 in	 distilled	 water	 to	 a	 concentration	 of	 5mg/ml.	 Fresh	 Azo-casein	 was	
prepared	 for	every	new	assay.	Blank	 samples	were	made	using	50µl	medium,	50µl	
Azo-casein	 solution	 and	 500µl	 PBS.	 Test	 samples	 were	made	 using	 50µl	 bacterial-
conditioned	 medium,	 50µl	 Azo-casein	 solution	 and	 500µl	 PBS.	 All	 samples	 were	
tested	 in	duplicate	and	 incubated	overnight	at	37°C.	Following	 incubation,	600µl	of	
ice	cold	5%	trichloroacetic	acid	(TCA)	was	added	to	each	sample	and	incubated	on	ice	
for	 30	 minutes.	 All	 of	 the	 samples	 were	 centrifuged	 at	 11,000	 x	 g	 at	 4°C	 for	 10	
minutes.	After	centrifugation,	200µl	of	each	sample	supernatant	was	transferred	to	a	
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96-well	 plate	 before	 reading	 the	 absorbance	 on	 a	 Thermo	 Scientific	 Multiscan	 FC	
plate	 reader	 at	 a	 wavelength	 of	 405nm.	 Absorbance	 values	 for	 duplicate	 blank	
samples	were	 subtracted	 from	 test	 samples	 to	 give	 ‘blank	 subtraction	 values’.	 The	
average	of	the	blank	subtraction	values	was	calculated.		
	
2.6.3 Azocoll	Assay	
To	further	assess	the	general	proteolytic	activity	of	PCM	and	BCM,	an	assay	using	a	
different	non-specific	substrate	named	Azocoll,	a	chromogenic	azo	dye-impregnated	
collagen,	 was	 performed	 (see	 Figure	 2.5).	 Azocoll	 solution	 was	 made	 by	 adding	
Azocoll	to	a	buffer	containing	0.05M	Tris-Hydrochloride	(Tris-Hcl)	and	1mM	calcium	
chloride	(CaCl2),	at	a	concentration	of	5mg/ml.	Fresh	Azocoll	solution	was	prepared	
for	each	new	assay.	Blank	samples	consisted	of	50µl	buffer	and	90µl	Azocoll	solution.	
Test	 samples	 were	 made	 using	 50µl	 bacterial-conditioned	medium	 (PCM	 or	 BCM)	
and	90µl	Azocoll	solution.	All	samples	were	run	in	duplicate	per	assay	and	all	assays	
repeated	 three	 times	 using	 triplicate	 bacterial-conditioned	medium.	 Samples	were	
incubated	in	a	shaker	(200rpm)	overnight	at	37°C.	Following	incubation,	all	samples	
were	 centrifuged	 at	 10,000	 x	 g	 for	 8	 minutes	 at	 4°C.	 Sample	 supernatants	 were	
transferred	 to	 a	 96-well	 plate	 and	 the	 absorbance	 read	 at	 550nm	 on	 a	 Thermo	
Scientific	Multiscan	FC	plate	reader.	Absorbance	values	for	duplicate	blank	samples	
were	subtracted	from	test	samples	to	give	‘blank	subtraction	values’.	Averages	of	all	
blank	subtraction	values	were	taken	of	all	duplicate	test	samples.		
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Figure	2.5	Azocoll	assay	
Image	shows	a	microtiter	plate	with	wells	containing	bacterial-conditioned	medium	
and	the	Azocoll	 solution	after	 incubation	at	37°C.	The	presence	of	proteases	 in	 the	
bacterial-conditioned	medium	causes	the	hydrolysis	of	the	collagen	substrate,	which	
releases	the	azo-dye.	Black	arrows	indicate	strong	proteolytic	activity,	which	appears	
a	 dark	 red	 colour.	 Red	 arrows	 indicate	 weak	 proteolytic	 activity,	 which	 appears	
clear/pale	pink	in	colour.	
	
2.7 Gel	Electrophoresis	
2.7.1 Substrate	Zymography	
A	 Miniprotean	 II	 gel	 system	 (Bio-Rad,	 Hemel	 Hempstead,	 UK)	 was	 employed	 for	
zymography	gels.	Samples	were	prepared	1:1:3	bacterial-conditioned	medium	(PCM	
or	BCM)	 :	Laemmli	sample	buffer	 (Bio-Rad,	Hemel	Hempstead,	UK)	 :	distilled	water	
and	incubated	at	37°C	for	1	hour.	A	resolving	gel	was	prepared	using	30%	acrylamide	
stock	(Severn	Biotech	Limited,	Kidderminster,	UK)	resolving	buffer	(1.5M	Tris-Hcl,	pH	
8.8),	1%	gelatin	solution	(EIA	grade	reagent	gelatin)	(Bio-Rad,	Hemel	Hempstead,	UK)	
or	 1%	 collagen	 solution	 (Type	 I	 from	 rat	 tail),	 distilled	water,	 20%	 sodium	dodecyl	
sulfate	(SDS),	ammonium	persulfate	(APS)	and	tetramethylethylenediamine	(TEMED).	
The	0.25%	gelatin	and	7.5%	polyacrylamide	gel	was	cast	into	1mm	thick	glass	plates.	
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A	small	volume	of	isobutanol	was	laid	over	the	gel	to	produce	a	level	surface.	Once	
the	gel	was	set	the	isobutanol	was	washed	away	with	distilled	water	and	the	stacking	
gel	was	cast.	A	4%	stacking	gel	was	produced	using	30%	acrylamide	stock,	stacking	
buffer	 (0.5M	 Tris-Hcl,	 pH	 6.8),	 distilled	 water,	 SDS,	 APS	 and	 TEMED.	 Once	 the	
stacking	gel	was	added	to	the	plates,	a	10-well	comb	was	 inserted	and	the	gel	was	
allowed	to	set.	Once	set,	the	comb	was	removed	and	the	plates	were	transferred	to	
a	gel	running	tank	and	filled	with	running	buffer	(concentrated	10x	–	18g	Tris	base,	
86.4g	Glycine,	6g	SDS	and	made	up	to	600ml	with	distilled	water	–	diluted	1:10	for	
1x).	Incubated	samples	were	loaded	at	a	volume	of	20µl	per	well.	Gel	electrophoresis	
occurred	at	a	constant	200V	until	the	sample	bands	were	run	off	the	bottom	of	the	
gel.	The	gel	was	then	transferred	to	2.5%	Triton-X	100	for	one	hour	to	remove	traces	
of	 the	 SDS.	 Following	 incubation	 the	 gel	was	washed	 thoroughly	 in	 distilled	water	
before	 being	 placed	 in	 1x	 refolding	 buffer	 (concentrated	 10x	 –	 6.05g	 Tris-base,	
11.68g	 sodium	 chloride,	 5.50g	 calcium	 chloride,	 670µl	 Brij,	 pH	 7.6)	 and	 incubated	
overnight	 at	 37°C.	 Following	 incubation,	 the	 gel	 was	 removed	 from	 the	 refolding	
buffer	and	stained	in	0.5%	Coomassie	Brilliant	Blue	G250	for	40	minutes.	Stained	gels	
were	de-stained	 in	a	de-staining	solution	 (150ml	methanol,	35ml	glacial	acetic	acid	
and	 315ml	 distilled	 water),	 changing	 the	 de-stain	 solution	 every	 15	 minutes	 until	
clear	 bands	 were	 visible	 on	 a	 blue	 background.	 Following	 de-staining,	 bands	
representing	 enzymatic	 activity	 were	 present	 as	 clear	 bands	 on	 a	 dark	 blue	
background.	To	determine	an	approximate	molecular	weight	for	the	protease	bands,	
7μl	 of	Novex®	 Sharp	 Pre-stained	Protein	 Standards	 (Life	 Technologies,	 Paisley,	UK)	
were	 loaded	 onto	 all	 gels.	 Gels	 were	 visualised	 on	 the	 Syngene	 Gene	 genius	 Bio-
imaging	system	using	GeneSnap	software.	
	
2.7.2 Inhibitor	Studies	
Protease	 class	 was	 determined	 using	 inhibitors	 for	 cysteine,	 metallo	 and	 serine	
proteases.	Zymograms	were	 inhibited	with	10mM	N-ethylmalemide	(NEM),	100mM	
EDTA,	50mM	Benzamidine	hydrochloride	hydrate	and	incubated	in	normal	refolding	
buffer	as	a	control	and	refolding	buffer	supplemented	with	the	inhibitor.	Gels	were	
Page	78	of	253	
	
stained	in	0.5%	Coomassie	Brilliant	Blue	G250	for	40	minutes	as	previously	described	
(see	2.7.1).		
	
2.7.3 SDS	PAGE	
A	 15%	 Acrylamide	 gel	 (resolving	 gel)	 was	 made	 and	 cast	 using	 7.5ml	 30%	
acrylamide/bis-acrylamide,	3.5ml	distilled	water,	3.75ml	resolving	buffer	(1.5M	Tris-
HCL,	pH8.8),	150µl	10%	SDS,	75µl	10%	APS	and	10µl	TEMED.	Once	the	gel	was	added	
to	 the	 1mm	 glass	 plates,	 a	 small	 amount	 of	 isobutanol	 was	 added	 to	 the	 gel	 to	
provide	an	even	surface.	Once	the	gel	had	set,	the	isobutanol	was	removed	and	the	
gel	was	washed	with	distilled	water.	A	stacking	gel	was	made	and	cast	using	0.67ml	
acrylamide/bis-acrylamide,	 3ml	 distilled	 water,	 1.25ml	 stacking	 buffer	 (0.5M	 Tris-
HCL,	pH	6.8),	50µl	10%	SDS,	50µl	10%	APS	and	20µl	TEMED	before	inserting	a	10-well	
comb.	Test	samples	were	prepared	by	diluting	bacterial-conditioned	medium	in	1:1	
in	 2x	 Laemmli	 sample	 buffer	 (Bio-Rad,	 Hemel	 Hempstead,	 UK)	 containing	
dithiothreitol	(DTT)	and	heated	for	10	minutes	at	100°C.	When	the	gels	were	set,	the	
comb	was	 removed	 and	 the	wells	washed	 thoroughly	 in	 distilled	water.	Gels	were	
transferred	 to	 the	 gel	 tank	 and	 filled	 with	 NuPAGE	 MES	 SDS	 running	 buffer	 (Life	
Technologies,	Paisley,	UK)		(1x)	before	loading	the	samples	into	the	wells	of	the	gel	at	
20µl	per	well.		A	Novex	Sharp	Unstained	Protein	Standard	(Life	Technologies,	Paisley,	
UK)	 (7µl)	 was	 added	 to	 one	 of	 the	 wells	 to	 determine	 the	 molecular	 weight	 of	
proteins	 within	 the	 samples.	 Electrophoresis	 occurred	 at	 150V	 until	 the	 dye	 front	
reached	the	bottom	of	the	gel.	The	gels	were	removed	and	placed	in	0.5%	Coomassie	
Brilliant	G250	overnight	 at	 room	 temperature.	 Following	 incubation,	 the	 gels	were	
de-stained	in	150ml	methanol,	35ml	glacial	acetic	acid	and	315ml	of	distilled	water,	
until	blue	bands	appeared	against	a	clear	background.		
	
2.8 Ammonium	Sulfate	Precipitation	and	Partial	Purification	of	Proteins	
Initially,	to	assess	at	which	percentage	of	Ammonium	Sulfate	solid	(AS)	was	needed	
to	precipitate	the	target	protease(s),	15-70%	AS	was	tested	and	it	was	subsequently	
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found	 that	 55%	 AS	was	 sufficient	 to	 precipitate	 the	 target	 protease(s).	 Depending	
upon	the	working	temperature	and	volume	of	the	protein	solution,	the	amount	of	AS	
solid	to	be	added	to	the	protein	solution	can	be	calculated	from	an	AS	precipitation	
table.	 In	 brief,	 BCM	was	 transferred	 to	 a	 50ml	 glass	 beaker	 on	 ice.	 AS	was	 added	
slowly	to	the	BCM	whilst	gently	mixing	so	that	the	solution	didn’t	become	unevenly	
saturated	with	AS.	After	the	addition	of	AS	to	the	BCM,	the	solution	was	allowed	to	
equilibrate	for	20	minutes	on	ice.	The	solution	was	then	transferred	to	a	centrifuge	
tube	 centrifuged	at	10,000	 x	 g	 for	15	minutes	at	4°C.	After	 centrifugation,	 a	pellet	
was	 observed,	 which	 contained	 the	 AS	 and	 the	 precipitated	 protein	 fraction.	 The	
supernatant	was	removed	and	the	pellet	was	re-suspended	 in	PBS	 (10%	of	starting	
volume).	The	re-suspended	pellet	was	then	transferred	to	dialysis	tubing	and	placed	
in	PBS	overnight	 at	 4°C	 to	 remove	 the	AS.	 The	protein	 concentration,	 content	 and	
proteolytic	activity	of	the	solution	was	then	assessed	using	the	BCA	assay,	SDS-PAGE,	
non-specific	 proteases	 assay	 and	 zymography.	 This	 solution	 was	 referred	 to	 as	 a	
partially	 purified	 protease.	 Partially	 purified	 protease	 was	 obtained	 from	 three	 P.	
aeruginosa	 biological	 replicates	 (P1097,	 P1140	 and	 P1145).	 These	 proteases	 were	
then	used	 in	 the	human	adult	dermal	 fibroblast	 (HDF)	 and	human	adult	 epidermal	
keratinocyte	(HEK)	scratch	wound	assays	(see	2.13).	
	
2.9 BCA	Assay	and	Sample	Protein	Quantification.	
The	 detection	 and	 quantification	 of	 total	 protein	 in	 the	 partially	 purified	 protease	
solution	was	performed	using	the	Pierce®	BCA	Protein	Assay	Kit	(Fisher	Scientific	UK	
Ltd,	 Loughborough,	 UK)	 to	 the	manufacturer’s	 instructions.	 Bovine	 serum	 albumin	
(BSA)	was	diluted	in	PBS	to	create	BSA	standard	concentrations	between	0mg/ml	to	
2mg/ml.	The	partially	purified	protease	sample	was	diluted	in	BCA	working	reagent.	
BSA	 standards	 and	 test	 samples	 were	 performed	 in	 duplicate.	 The	 assay	 was	
incubated	 for	 30	minutes	 at	 37°C	 before	 the	 absorbance	was	 read	on	 the	 Thermo	
Scientific	Multiscan	FC	plate	reader	at	a	wavelength	of	570nm.	Average	absorbance	
values	 of	 the	 BSA	 standards	 were	 plotted	 against	 the	 known	 concentration	 to	
produce	 a	 standard	 curve.	 The	 equation	 of	 the	 standard	 curve	 was	 used	 to	
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determine	the	concentration	of	protein	per	sample	based	on	the	average	absorbance	
values.	 Protein	 concentration	 of	 the	 partially	 purified	 protease	 was	 expressed	 as	
mg/ml.		
	
2.10 Cell	Culture	
2.10.1 Equine	fibroblasts	
Equine	normal	 fibroblasts	 (NFs)	were	obtained	from	cadavers	 (see	Figure	2.6).	Hair	
was	 removed	 using	 hair	 clippers	 and	 the	 surface	 of	 the	 skin	 was	 washed	 with	
Hibiscrub	 (containing	 4%	 Chlorhexidine	 Gluconate)	 (MediSupplies,	 Poole,	 UK)	 to	
remove	 any	microorganisms	 that	may	 have	 caused	 infections	 in	 subsequent	 tissue	
culture.	 A	 small	 section	 of	 the	 skin	 was	 removed	 and	 dissected	 into	 small	 pieces	
(approximately	 2mm	 x	 2mm)	 using	 a	 scalpel	 and	washed	 in	 HBSS.	 The	 tissue	was	
then	added	to	a	25cm2	tissue	culture	flask	containing	DMEM	(with	phenol	red)	(Life	
Technologies,	 Paisley,	 UK)	 supplemented	with	 100	 units/ml	 penicillin-streptomycin	
(Life	 Technologies,	 Paisley,	 UK),	 0.5μg/ml	 Fungizone®Amphotericin	 B	 (Life	
Technologies,	 Paisley,	 UK),	 10mM	 HEPES	 (Life	 Technologies,	 Paisley,	 UK)	 and	 10%	
FBS.	This	formulation	of	DMEM	culture	medium	used	to	culture	mammalian	cells	 is	
referred	 to	 as	 DMEM	 (complete)	 throughout	 this	 thesis.	 For	 the	 initial	 culture	 of	
equine	 tissue,	DMEM	 (complete)	 contained	 an	 additional	 10ng/ml	 gentamicin	 (Life	
Technologies,	Paisley,	UK).	The	tissue	was	 incubated	 in	humidified	conditions	 in	5%	
CO2	at	37°C	for	5	days	before	changing	the	medium.	Following	this	 incubation	step,	
the	tissue	culture	flask	was	microscopically	checked	on	a	daily	basis	for	the	presence	
of	 adherent	 fibroblasts.	 When	 adherent	 fibroblasts	 were	 observed,	 the	 tissue	
explants	 were	 removed	 and	 fibroblasts	 were	 cultured	 to	 90%	 confluence	 before	
passage.	 Adherent	 cells	 were	 removed	 from	 the	 tissue	 culture	 flask	 using	 0.05%	
Trypsin/EDTA	 (Life	 Technologies,	 Paisley,	UK).	 The	monolayer	was	washed	 twice	 in	
Hanks	 balanced	 salt	 solution	 (HBSS)	 without	 calcium	 and	 magnesium	 (Life	
Technologies,	Paisley,	UK)	before	adding	Trypsin/EDTA	to	the	tissue	culture	flask	(just	
enough	to	coat	the	cells)	and	incubating	at	37°C	for	5	minutes.	Once	lifted	from	the	
flask,	 the	 cells	 were	 centrifuged	 at	 1000	 x	 g	 for	 4	 minutes	 and	 re-suspended	 in	
Page	81	of	253	
	
DMEM	 (complete).	 Fibroblasts	 from	 three	 donors	 were	 used	 for	 scratch	 assays.	
Equine	 normal	 fibroblasts	 were	 used	 in	 experiments	 between	 passages	 three	 and	
five.		
Equine	granulation	tissue	fibroblasts	(GTFs)	were	obtained	from	chronic	wounds	that	
were	 being	 debrided	 as	 part	 of	 routine	 clinical	 treatment	 to	 remove	 excessive	
granulation	tissue.	This	 involved	sharp	dissection	and	removal	of	granulation	tissue	
raised	 above	 the	 level	 of	 the	 epithelial	 margin.	 The	 debrided	 tissue	 was	 treated	
similarly	to	normal	skin,	as	described	above,	for	fibroblast	isolation.	After	five	days	in	
culture,	 the	 medium	 was	 changed,	 explants	 removed	 and	 GTFs	 were	 cultured	 to	
approximately	 90%	 confluence	 before	 being	 sub-cultured	 and	 used	 for	 scratch	
wound	assays.	Three	donors	were	used	for	the	scratch	wound	assays	and	GTFs	were	
used	between	passages	three	and	five.	
	
	
Figure	 2.6	 Schematic	 representation	 of	 the	 collection	 of	 equine	 tissue	 for	 tissue	
culture.	
Normal	 skin	 from	 the	 lower	 leg	 of	 cadavers	 or	 granulation	 tissue	 from	 chronic	
wounds	 located	on	 the	 lower	 leg	was	obtained	using	a	 scalpel.	Tissue	was	cut	 into	
2mm	 x	 2mm	 pieces	 and	 transferred	 to	 a	 tissue	 culture	 flask	 containing	 DMEM	
supplemented	 with	 penicillin-streptomycin,	 Fungizone®Amphotericin	 B,	 HEPES	 and	
FBS.	The	tissue	pieces	were	cultured	for	5	days	in	5%	CO2	at	37°C	before	changing	the	
culture	medium.	Following	 incubation	culture	medium	was	changed	and	fibroblasts	
that	had	migrated	out	of	the	tissue	could	be	identified	microscopically.	
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2.10.2 Adult	human	dermal	fibroblasts	(HDFs)	
Adult	human	dermal	fibroblasts	(HDFs)	(Life	Technologies,	Paisley,	UK)	were	cultured	
in	DMEM	(with	phenol	red)	(Life	Technologies,	Paisley,	UK)	supplemented	with	10%	
FBS,	 100	 units/ml	 penicillin-streptomycin	 (Life	 Technologies,	 Paisley,	 UK),	 0.5μg/ml	
Fungizone®Amphotericin	B	(Life	Technologies,	Paisley,	UK)	and	10mM	HEPES	buffer	
(Life	 Technologies,	 Paisley,	 UK),	 also	 referred	 to	 as	 DMEM	 (complete).	 Cells	 were	
cultured	 until	 approximately	 90%	 confluence	 before	 passage.	 HDFs	 were	 used	 in	
scratch	wounds	and	to	create	the	dermal	layer	of	the	skin	construct.	HDFs	cells	were	
used	between	passages	four	and	seven.	
	
2.10.3 Adult	human	epidermal	keratinocytes	(HEKs)	
Adult	 human	 epidermal	 keratinocytes	 (HEKs)	 (Life	 Technologies,	 Paisley,	 UK)	 were	
cultured	 in	 EpiLife	 medium	 (Life	 Technologies,	 Paisley,	 UK)	 supplemented	 with	
human	keratinocyte	growth	supplement	(HKGS),	100	units/ml	penicillin-streptomycin	
(Life	 Technologies,	 Paisley,	 UK),	 0.5μg/ml	 Fungizone®Amphotericin	 B	 (Life	
Technologies,	Paisley,	UK).	HEKs	were	cultured	until	80%	confluence	before	passage.	
HEKs	were	used	 to	 create	 the	 epithelial	 layer	 of	 the	 skin	 construct	 and	were	used	
between	 passages	 three	 and	 six.	 All	 of	 the	 cells	 used	 in	 the	 skin	 constructs	 were	
cultured	in	humidified	conditions	with	5%	CO2	at	37°C.			
	
2.11 MMP-2	isolation		
To	provide	a	positive	control	for	substrate	zymography	and	also	to	assess	the	efficacy	
of	 MMP	 sequestration	 by	 a	 variety	 of	 wound	 dressings	 (see	 method	 2.11	 and	
Appendix	II),	the	isolation	and	purification	of	MMP-2	from	equine	normal	fibroblasts	
(NFs)	was	carried	out.	The	isolation	of	NFs	was	carried	out	as	described	earlier	in	this	
chapter	 (see	2.9.1).	NFs	were	cultured	 in	T175	 tissue	culture	 flasks	 for	 the	optimal	
volume	 of	 crude	 MMP-2.	 When	 the	 NFs	 were	 approximately	 90-95%	 confluent,	
DMEM	(complete)	was	 removed	 from	the	 flask	and	 the	cells	were	washed	 in	HBSS	
(without	calcium	and	magnesium)	 in	order	 to	remove	traces	of	FBS.	The	cells	were	
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then	treated	with	serum-free	DMEM	containing	100	units/ml	penicillin-streptomycin,	
0.5μg/ml	 Fungizone®Amphotericin	 B	 and	 10mM	 HEPES	 buffer	 (approximately	 30-
35ml	 in	 a	 T175	 tissue	 culture	 flask)	 and	 incubated	 in	 5%	 CO2	 at	 37°C	 for	 5	 days.	
Following	 incubation,	 the	NF-conditioned	medium	was	collected	and	centrifuged	at	
1000	x	g	for	4	minutes	to	remove	cells.	The	NFs	that	remained	in	the	tissue	culture	
flask	 were	 disposed	 of.	 Conditioned	 medium	 containing	 crude-MMP-2	 was	 then	
stored	at	-20°C	until	ready	for	enzyme	purification.		
	
2.11.1 MMP-2	purification	using	gelatin	sepharose	chromatography	
The	 gelatin	 sepharose	 chromatography	 column	 was	 prepared	 by	 placing	 a	 small	
amount	of	glass	wool	in	the	bottom	of	a	20ml	syringe	(without	needle)	before	adding	
5ml	 of	 gelatin	 sepharose	 (GE	Healthcare,	 Little	 Chalfont,	UK)	 to	 the	 surface	 of	 the	
wool.	The	column	was	washed	twice	 in	equilibration	buffer	 (0.05M	Tris	Base,	0.5M	
NaCl2,	0.005M	CaCl2,	0.05%	Brij,	0.02%	sodium	azide,	pH	7.6)	before	adding	the	cell	
supernatant	 (crude	 MMP-2)	 to	 the	 column	 and	 allowing	 the	 supernatant	 to	 pass	
through	the	column	into	a	collection	tube.	The	collected	supernatant	was	discarded.	
The	column	was	washed	four	times	using	the	equilibration	buffer	(5ml	each	wash).	At	
this	stage,	the	MMP-2	was	bound	to	the	gelatin	sepharose.	The	MMP-2	protease	was	
then	eluted	from	the	column	using	10ml	of	10%	DMSO	in	80%	elution	buffer	(0.05M	
Tris	HCl,	1M	NaCl2,	0.005M	CaCl2,	0.05%	Brij,	0.02%	sodium	azide,	pH	7.6),	which	was	
collected	 in	 15ml	 centrifuge	 tubes.	 The	 eluted	 MMP-2	 was	 then	 transferred	 to	
dialysis	tubing,	which	was	incubated	in	MMP	dialysis	buffer	(0.05M	Tris	HCl,	0.005M	
CaCl2,	 0.05%	 Brij	 35,	 0.02%	 sodium	 azide,	 pH	 7.6)	 at	 4°C	 overnight.	 Post-dialysis,	
MMP-2	was	stored	 in	aliquots	at	 -20°C	until	needed.	The	gelatin	sepharose	column	
was	washed	 four	 times	 in	 equilibration	 buffer	 (5ml	 each	wash)	 before	 adding	 5ml	
equilibration	 buffer	 to	 the	 column	 and	 storing	 at	 4°C	 in	 a	 sealed	 bag	 to	 prevent	
dehydration.	
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2.12 Wound	dressing	studies:	Sequestration	of	MMP-2	
It	 was	 proposed	 by	 Advanced	Medical	 Solutions	 Plc	 to	 test	 the	 efficacy	 of	 several	
wound	dressings	to	sequester	proteases,	specifically	MMP-2.	As	the	overall	focus	of	
this	thesis	concerned	bacterial	biofilms	and	their	extracellular	proteases,	the	results	
of	this	study	can	be	found	in	Appendix	II	of	this	thesis.	In	brief,	0.01g	of	each	dressing	
sample	was	 individually	 incubated	with	250µl	of	purified	MMP-2,	 in	a	12-well	plate	
format,	 for	 1,	 3,	 6,	 24	 or	 48	 hours	 at	 37°C.	 After	 the	 specified	 incubation	 period,	
500µl	of	 sterile	PBS	was	added	to	 the	dressings	and	the	supernatant	was	collected	
and	stored	at	-20°C	until	further	use.	Samples	were	then	assessed	for	MMP-2	activity	
using	substrate	zymography	(see	method	2.7.1).	
	
2.13 Scratch	wound	assay	
The	in	vitro	scratch	wound	model	is	a	commonly	used	model	to	assess	cell	migration	
and	wound	closure	due	to	its	simplicity,	reproducibility	and	cost	effectiveness	(Liang	
et	al.	2007).	Therefore	this	model	was	used	to	assess	the	wound	closure	of	various	
cell	types	in	response	to	bacterial-conditioned	medium.	Furthermore	the	model	was	
used	to	assess	the	release	of	host	proteases	and	in	the	case	of	HDFs,	the	expression	
of	MMP-1,	-2,	-9,	-13	and	collagen-I	at	a	transcriptional	level	in	response	to	bacterial-
conditioned	medium.	HEKs,	HDFs,	NFs	or	GTFs	were	 seeded	 into	6-well	plates	at	a	
cell	density	of	1	x	105	 cells/ml	 in	EpiLife	or	DMEM	(complete).	Viable	cell	numbers	
were	 determined	 using	 trypan	 blue	 exclusion	 dye.	 Cells	 were	 cultured	 until	 95%	
confluence	 before	 creating	 a	 scratch	 using	 a	 sterile	 100µl	 pipette	 tip.	 Cells	 were	
washed	 using	 PBS	 to	 remove	 cell	 debris	 caused	 from	 the	 scratch.	 Bacterial-
conditioned	medium,	 both	 PCM	 and	 BCM,	 were	 diluted	 1:1	 with	 DMEM	 (without	
antibiotics).	 Two	millilitres	of	 the	diluted	bacterial-conditioned	medium	was	 added	
per	 well.	 Both	 untreated	 unscratched	 and	 scratched	monolayers	 were	 included	 in	
this	 assay	 as	 controls.	 The	 treated	 and	 untreated	 cells	 were	 incubated	 in	
atmospheric,	humidified	conditions	at	37°C	with	5%	CO2	for	48	hours	(see	Figure	2.7).	
Images	of	the	scratch	area	were	taken	at	0,	24	and	48	hours.	To	ensure	images	were	
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taken	 in	 the	same	place	each	time,	a	 line	was	drawn	on	the	underside	of	 the	dish,	
perpendicular	to	the	scratch.	Images	were	taken	using	the	Nikon	Eclipse	microscope	
(Melville,	USA)	using	x10	magnification.	Aliquots	of	media	(100	µl)	were	taken	from	
each	well	at	0,	24	and	48	hours	to	determine	the	presence	of	proteases	using	gelatin	
zymography.	 At	 48	 hours,	 the	 cells	 were	 lysed	 in	 1	 ml	 of	 TriZol	 reagent	 (Life	
Technologies,	 Paisley,	UK)	per	well	 and	 stored	at	 -80°C	 in	preparation	 for	 qRT-PCR	
(see	2.16).	
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Figure	2.7	Schematic	representation	of	the	in	vitro	scratch	wound	assay.	
	(A)	A	single	scratch	 in	the	monolayer	of	cells	was	performed	using	a	100μl	pipette	
tip.	The	resulting	cell-free	area,	indicated	by	the	blue	dotted	line,	was	termed	as	the	
‘scratch	 area’.	 (B)	 The	 scratch	 cell	 monolayer	 was	 imaged	 at	 24-hour	 intervals	 to	
assess	 the	 scratch	area	and	 the	potential	movement	of	 cells	 into	 the	 scratch	area.	
The	movement	 of	 cells	 into	 the	 scratch	 area	 was	 thought	 to	 be	 due	 to	migration	
and/or	proliferation	and	was	termed	‘wound	closure’.		
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2.13.1 Analysis	of	the	scratch	wound	area	using	ImageJ	software	
To	measure	the	scratch	area,	 images	of	a	scratch	wound	that	were	taken	at	0-,	24-	
and	 48-hour	 intervals	 were	 opened,	 in	 a	 consecutive	 manner,	 in	 ImageJ.	 These	
images	were	then	stacked	into	one	file	(Image-->Stacks-->Images	to	Stack)	and	then	
converted	 to	 an	 “8-bit”	 image	 before	 saving	 the	 file.	 The	 saved	 file	with	 all	 three	
images	 of	 the	 scratch	 wound	 at	 0,	 24	 and	 48	 hours	 was	 then	 defined	 (Process--
>Sharpen	and	Process-->	Find	Edges)	and	the	threshold	was	adjusted	to	produce	a	
black	 and	white	 image	 (Image-->Adjust-->Threshold),	 which	 allowed	 for	 a	 suitable	
contrast	 between	 cells	 and	 the	 blank	 scratch	 area.	 The	 image	 was	 defined	 again	
(Process-->	Find	Edges)	before	using	the	Wand	(tracing)	tool	to	outline	the	scratch	
area	 (shown	 by	 a	 yellow	 line).	 The	 area	was	 then	measured	 (Analyse-->Measure),	
which	 appeared	 in	 a	 summary	 window.	 Measurements	 of	 the	 scratch	 area	 were	
taken	 of	 0-,	 24-,	 and	 48-hour	 images,	 for	 all	 treatment	 conditions.	Wound	 closure	
was	 determined	 as	 percentage	 closure	 (%),	 which	 was	 subsequently	 calculated	 as	
follows:	
	
	
	
	
2.14 Cell	Viability	Assay	
The	 cell	 viability	 of	 HEKs	 and	HDFs	was	 quantified	 using	 PrestoBlue™	 Cell	 Viability	
Reagent	Protocol	(Life	Technologies,	Paisley,	UK).	Cells	were	seeded	into	the	wells	of	
a	 microtiter	 plate	 at	 a	 cell	 density	 of	 1	 x	 104	 cells	 per	 well	 and	 were	 cultured	 in	
DMEM	(complete)	or	EpiLife	overnight,	or	until	95%	confluency	was	reached.	Culture	
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medium	was	 then	 removed	and	 a	 scratch	was	 created,	 as	with	 the	 scratch	wound	
assay,	 however	 with	 a	 10μl	 pipette	 tip.	 The	 cells	 were	 washed	 with	 PBS	 before	
adding	either	100μl	of	control	medium	(either	DMEM	complete	or	EpiLife)	or	treating	
the	cells	with	100μl	of	bacterial-conditioned	medium	per	well.	To	assess	cell	viability,	
treatments	were	removed	from	the	cells	before	briefly	washing	the	cells	in	PBS	and	
adding	90μl	of	control	medium	(either	DMEM	complete	or	EpiLife)	to	the	cells.	The	
PrestoBlue™	 reagent	 was	 then	 added	 to	 each	 well	 (10μl)	 and	 incubated	 for	 30	
minutes	 at	 37°C.	 The	 fluorescence	 of	 each	well	 was	 then	 read	 (excitation	 525nm)	
using	 the	 GloMax®-Multi+	Microplate	Multimode	 Reader	 with	 Instinct®	 (Promega,	
Southhampton,	 UK).	 The	 PrestoBlue™	 reagent	 was	 discarded	 and	 the	 cells	 were	
washed	 with	 PBS	 before	 replacing	 the	 control	 and	 bacterial-conditioned	 medium	
treatments	and	further	incubating.	Cell	viability	was	measured	at	4-,	24-	and	48-hour	
time	points.	Each	treatment	was	performed	in	duplicate.	Average	fluorescence	units	
were	plotted	against	each	experimental	setting	(E.g.	Control,	P.	aeruginosa	PCM)	at	
each	of	the	various	time	points.	
	
2.15 3D	Keratinocyte-Fibroblast	Co-culture	Model	
2.15.1 Creating	the	fibroblast	dermal	layer	
To	create	the	dermal	layer	of	the	skin	construct,	HDFs	were	grown	in	a	fibrin	matrix.	
Human	fibrinogen	(depleted	of	plasminogen,	von	Willebrand	factor	and	fibronectin)	
(Enzyme	Research	 Laboratories,	 Swansea,	UK)	was	diluted	 in	PBS	with	 calcium	and	
magnesium	 to	 a	 concentration	 of	 4	 mg/ml.	 The	 fibrin	 gel	 was	 created	 by	 mixing	
2.1ml	 of	 the	 fibrinogen	 solution	 with	 157μl	 PBS	 and	 265μl	 of	 a	 3	 x	 105	 cells/ml	
suspension	 of	 HDFs.	 Bovine	 thrombin	 was	 diluted	 in	 a	 0.1%	 BSA	 solution	 to	 a	
concentration	 of	 5	 units/ml	 before	 adding	 107μl	 of	 thrombin	 to	 the	 fibrinogen	
suspension.	The	HDF-containing	solution	was	added	to	a	Corning	24mm	cell	culture	
insert	with	a	3μm	pore	size	and	polyester	membrane	(Scientific	Laboratory	Supplies,	
East	Riding	of	Yorkshire,	UK),	where	it	was	left	to	polymerise.	The	fibroblast-fibrin	gel	
was	 submersed	 in	 3ml	 of	 DMEM	 containing	 10%	 FBS,	 100	 units/ml	 penicillin-
streptomycin	 (Life	 Technologies,	 Paisley,	 UK),	 0.5μg/ml	 Fungizone®Amphotericin	 B	
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(Life	Technologies,	Paisley,	UK)	and	10mM	HEPES	buffer	 (Life	Technologies,	Paisley,	
UK)	and	 incubated	 in	atmospheric,	humidified	conditions	with	5%	CO2	at	37°C.	The	
fibroblasts	were	incubated	for	6-7	days	before	adding	the	keratinocytes.		The	culture	
medium	was	changed	daily.	
	
2.15.2 Creating	the	keratinocyte	epidermis	
The	fibroblast	dermal	layer	was	washed	in	PBS	without	calcium	and	magnesium	three	
times	 to	 remove	 traces	 of	 the	 DMEM	 culture	medium	 before	 adding	 the	 HEKs.	 A	
keratinocyte	cell	density	of	1	x	106	cells	was	added	to	the	top	of	the	fibroblast	dermal	
layer	 and	 then	 submerged	 in	 EpiLife	 medium	 (Life	 Technologies,	 Paisley,	 UK)	
containing	HKGS	(Life	Technologies,	Paisley,	UK),	100units/ml	penicillin-streptomycin	
(Life	 Technologies,	 Paisley,	 UK),	 0.5μg/ml	 Fungizone®Amphotericin	 B	 (Life	
Technologies,	 Paisley,	UK)	 and	 200	 units/ml	 of	 the	 protease	 inhibitor	 aprotinin	 for	
approximately	2-3	days,	or	until	the	HEKs	formed	a	confluent	layer.	EpiLife	medium	
was	changed	twice	daily.	
When	the	HEKs	formed	a	confluent	layer,	the	skin	construct	was	raised	above	the	air	
liquid	interface,	 leaving	part	of	the	dermal	 layer	submersed	in	culture	medium	(see	
Figure	2.8).	At	this	point	the	culture	medium	was	changed	to	a	3:1	mixture	of	DMEM	
(with	 phenol	 red)	 (Life	 Technologies,	 Paisley,	 UK)	 and	 Ham’s	 F12	 medium	 (Life	
Technologies,	 Paisley,	 UK)	 and	 was	 supplemented	 with	 100	 units/ml	 penicillin-
streptomycin	 (Life	 Technologies,	 Paisley,	 UK),	 5μg/ml	 human	 transferrin,	 10ng/ml	
epidermal	growth	factor	(EGF),	200	units/ml	aprotinin,	400ng/ml	hydrocortisone,	1.8	
x	 10-4M	 adenine,	 5μg/ml	 insulin,	 50μg/ml	 L-ascorbic	 acid	 and	 2	 x	 10-7M	 triiodo-L-
thyronine	 sodium	 salt.	 The	 culture	 medium	 was	 changed	 twice	 daily	 for	 10	 days	
before	 transferring	 the	 cell	 culture	 insert	 to	 a	 Deep-Well	 plate	 (BD	 Biosciences,	
Oxford,	UK)	and	adding	3:1	DMEM	and	Ham’s	F12	medium	without	the	addition	of	
antibiotics	and	aprotinin.	The	constructs	were	cultured	for	a	further	4	days	with	daily	
changes	 of	 medium,	 before	 being	 treated	 with	 bacterial-conditioned	medium	 and	
fixed	for	immunohistochemistry	(see	2.17).		
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Figure	2.8	Schematic	of	the	3-dimensional	co-culture	human	skin	model.	
Human	dermal	fibroblasts	(HDFs)	were	suspended	in	a	fibrinogen-thrombin	solution,	
before	 adding	 the	 fibroblast-containing	 solution	 to	 the	 cell	 culture	 insert	 and	
allowing	 for	 the	 solution	 to	 set.	The	cell	 culture	 insert	 containing	 the	 fibroblasts	 in	
the	fibrin	gel	matrix	was	suspended	in	supplemented	DMEM	culture	medium	for	6-7	
days.	The	 fibroblast-fibrin	gel	was	 termed	the	 ‘dermal	 layer’.	The	dermal	 layer	was	
washed	 before	 adding	 human	 epidermal	 keratinocytes	 (HEKs)	 to	 the	 top	 of	 the	
surface.	 The	 keratinocytes	were	 cultured	 in	 EpiLife	medium	 until	 confluent	 before	
then	raising	the	keratinocytes	above	the	air-liquid	interface	and	continuing	to	culture	
for	a	further	14	days.	The	keratinocyte	 layer	was	termed	the	‘epidermal	 layer’.	The	
skin	model	was	then	removed	from	culture	and	immersed	in	10%	formalin	fixative	in	
preparation	for	histological	analysis.	
	
	
2.16 Quantitative-RTPCR	
2.16.1 RNA	Extraction	
Cells	 in	monolayer	 culture	were	washed	 in	 PBS	 before	 1ml	 of	 TRIzol	 reagent	 (Life	
Technologies,	 Paisley,	 UK)	 was	 added	 to	 each	 6-well	 plate.	 The	 suspension	 was	
carefully	mixed	 by	 pipetting	 to	 lyse	 the	 cells	 before	 transferring	 to	 an	 RNase-free	
centrifuge	tube	and	storing	at	-80°C	until	needed	for	RNA	extraction.	
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Frozen	samples	were	incubated	at	room	temperature	for	15	minutes	to	allow	for	the	
dissociation	 of	 the	 nucleoprotein	 complex,	 before	 adding	 200μl	 of	 chloroform	 to	
each	 sample.	 Samples	 were	 vortexed	 and	 incubated	 at	 room	 temperature	 for	 10	
minutes	before	centrifugation	at	12,000	x	g	for	15	minutes	at	4°C.	The	upper,	clear,	
aqueous	 phase	 of	 the	 sample	 was	 transferred	 to	 a	 clean	 centrifuge	 tube,	 being	
careful	not	to	take	up	any	of	the	interphase	layer.	Isopropanol	(500μl)	was	added	to	
each	 sample	 and	 incubated	 at	 room	 temperature	 for	 10	 minutes	 before	
centrifugation	at	12,000	x	g	 for	10	minutes	at	4°C.	One	ml	of	75%	molecular	grade	
ethanol	made	up	with	0.1%	Diethyl	Pyrocarbonate	 (DEPC)	water	was	added	 to	 the	
samples	and	gently	mixed.	The	samples	were	then	transferred	to	a	RNeasy	Mini	spin	
column	and	 collection	 tube,	 part	 of	 the	RNeasy	Mini	 Kit	 (Qiagen,	Manchester,	UK)	
before	 centrifugation	 at	 8000	 x	 g	 for	 15	 seconds.	 The	 flow-through	was	 discarded	
and	350μl	of	Buffer	RW1	was	added	to	the	RNeasy	column	before	centrifugation	for	
15	seconds	at	8000	x	g.	Flow-through	was	discarded	before	adding	10μl	of	DNase	I	
stock	 solution	 (Qiagen,	 Manchester,	 UK)	 and	 70μl	 Buffer	 RDD	 to	 the	 column	
membrane	 and	 incubating	 at	 room	 temperature	 for	 15	 mins.	 Incubation	 was	
followed	 by	 another	 Buffer	 RW1	wash	 step.	 Buffer	 RPE	 (500μl)	 was	 added	 to	 the	
column	and	 centrifuged	 for	 15	 seconds	 at	 8000	 x	 g	before	 repeating	 this	 step	and	
extending	centrifugation	to	2	minutes	at	8000	x	g.	The	column	membrane	was	dried	
through	centrifugation	of	the	spin	column	with	a	new	collection	tube,	at	11,000	x	g.	
RNA	was	obtained	by	adding	30μl	of	RNase-free	water	to	the	membrane	followed	by	
centrifugation	for	1	minute	at	8000	x	g.	RNA	concentration	was	calculated	using	the	
Thermo	 Scientific	 Nanodrop®	 ND-1000	 spectrophotometer	 (Fisher	 Scientific,	
Loughborough,	UK).	
	
2.16.2 cDNA	Synthesis	
cDNA	 was	 prepared	 by	 adding	 1μg	 of	 RNA	 to	 1μl	 of	 Random	 Primers	 (Promega,	
Southampton,	UK)	which	was	made	up	to	a	volume	of	13.4μl	with	0.1%	DEPC	water.	
Samples	 were	 heated	 to	 70°C	 for	 5	 minutes	 in	 a	 PCR	 thermo-cycler	 (Applied	
Biosystems®,	2720,	Life	Technologies,	Paisley,	UK)	before	adding	5μl	of	5X	Moloney	
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Murine	 Leukemia	 Virus	 Reverse	 Transcriptase	 (M-MLV	 RT)	 Buffer	 (Promega,	
Southampton,	UK),	1.25μl	dATP	(10mM)	(Promega,	Southampton,	UK),	1.25μl	dCTP	
(10mM)	(Promega,	Southampton,	UK),	1.25μl	dTTP	(10mM)	(Promega,	Southampton,	
UK),	 1.25μl	 dGTP	 (10mM)	 (Promega,	 Southampton,	 UK),	 0.6μl	 RNasin®	 Plus	 RNase	
Inhibitor	 (Promega,	Southampton,	UK)	and	1μl	M-MLV	RT	(Promega,	Southampton,	
UK)	 to	 each	 sample.	 Samples	 were	 heated	 for	 60	minutes	 at	 37°C,	 followed	 by	 5	
minutes	 at	 95°C.	 cDNA	 concentration	was	 determined	 using	 the	 Thermo	 Scientific	
Nanodrop®	ND-1000	(Fisher	Scientific,	Loughborough,	UK).		
	
2.16.3 Quantitative	Reverse	Transcriptase	Polymerase	chain	Reaction	(qRT-PCR)	
Primers	for	human	MMP-1,	MMP-2,	MMP-9,	MMP-13	and	Collagen-I	(see	Table	2.1)	
were	 used	 to	 assess	 regulation	 at	 a	 transcriptional	 level.	 The	 housekeeping	 gene	
glyceraldehyde	 3-phophate	 dehydrogenase	 (GAPDH)	 was	 used	 as	 a	 control	 to	
normalise	quantitative	gene	expression	data.	Reaction	mix	was	prepared	using	12.5μl	
GoTaq®	qPCR	master	mix	and	CXR	reference	dye	(Promega,	Southampton,	UK),	2.5μl	
forward	and	reverse	primers	and	5μl	nuclease-free	water	per	sample.	A	total	of	5μl	
of	 cDNA	per	 sample	was	 added	 to	 each	well	 of	 a	 96-well	MicroAmp®	 Fast	Optical	
Reaction	Plate	(Applied	Biosystems®,	Life	Technologies,	Paisley,	UK)	followed	by	20μl	
of	the	reaction	mix.	Nuclease-free	water	(Promega,	Southampton,	UK)	was	used	as	a	
negative	control.	All	samples	were	performed	in	duplicate	per	assay.		
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Target	
(Human)	
Forward	Sequence	(5’-->3’)	 Reverse	Sequence	(5-->3’)	
MMP-1	 CTGGCCACAACTGCCAAATG	 CTGTCCCTGAACAGCCCAGTACTTA	
MMP-2	 AGGGCACATCCTATGACAGC	 CCTTCTGAGTTCCCACCAAC	
MMP-9	 CAGAGATGCGTGGAGAGTCGAAA	 GGCAAAGGCGTCGTCAATCA	
MMP-13	 TCCCAGGAATTGGTGATAAAGTAGA	 CTGGCATGACGCGAACAATA	
Collagen-I	 CAGCCGCTTCACCTACAGC	 TTTTGTATTCAATCACTGTCTTGCC	
	
Table	2.1	Primer	sequences.	
Primers	were	stored	at	 -20°C	and	diluted	to	3μM	in	nuclease-free	water	 (Promega,	
Southampton,	UK).		
	
	
2.17 Histology	and	Immunohistochemistry	
Immunohistochemistry	was	performed	on	equine	normal	skin	(n=8),	chronic	wound-
derived	granulation	tissue	(n=8)	and	the	3D	co-culture	skin	model	(see	2.12),	which	
was	 performed	 as	 part	 of	 a	 service	 provided	 by	 the	 on-site	 Veterinary	 Pathology	
Department.	 All	 tissue	 samples	 were	 fixed	 in	 10%	 neutral-buffered	 formalin	 for	 a	
minimum	 of	 24	 hours.	 Fixed	 samples	 were	 processed	 in	 a	 series	 of	 ethanol	
dehydration	 steps,	 a	 clearing	 xylene	 step	 to	 displace	 residual	 ethanol	 and	 remove	
fats,	 and	 then	 finally	 infiltrated	 with	 paraffin	 wax.	 Following	 processing,	 samples	
were	 embedded	 in	 paraffin	 wax	 blocks	 and	 sectioned	 (4-6	 micron	 sections)	 onto	
slides.	 Routine	 haematoxylin	 and	 eosin	 stains	were	 performed	on	 all	 specimens.	 A	
Gram	stain	for	normal	and	chronic	equine	tissue	samples	was	performed	to	identify	
any	presence	of	bacteria	within	the	tissue.	
For	 immunohistochemistry	 staining,	 unstained	 sections	 were	 mounted	 onto	 slides	
coated	with	poly-L-lysine.	Sections	were	deparaffinised	in	xylene	for	5	minutes,	three	
times.	 The	 re-hydration	 of	 sections	 was	 performed	 by	 immersing	 the	 slides	 three	
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times	100%	ethanol	for	3	minutes,	twice	in	95%	ethanol	for	3	minutes,	twice	in	80%	
ethanol	for	3	minutes	and	then	rinsing	slides	in	distilled	water	for	5	minutes.	Sections	
were	blocked	in	10%	goat	serum	in	PBS	for	1	hour	at	25°C	in	a	humidified	chamber.	
Excess	blocking	solution	was	removed	and	100μl	of	primary	antibody,	diluted	in	1%	
goat	serum	in	PBS,	(Goat	anti-rabbit	MMP-2:	1	in	200,	Goat	anti-rabbit	MMP-9:	1	in	
200,	 Goat	 anti-rabbit	 MMP-13:	 1	 in	 100)	 was	 added	 to	 the	 slide	 and	 incubated	
overnight	at	4°C	in	a	humidified	chamber.	Excess	primary	antibody	was	removed	and	
the	 slides	 were	 washed	 three	 times	 in	 PBS	 for	 5	 minutes	 each	 wash.	 Diluted	
secondary	antibody	was	added	 to	 the	 slides	and	 incubated	 for	1	hour	at	25°C	 in	 a	
humidified	chamber.	Slides	were	washed	four	times	in	PBS	for	5	minutes	each	wash	
before	adding	a	colour	developer.	Slides	were	washed	in	PBS	an	additional	four	times	
for	5	minutes	each	wash	before	a	final	wash	in	distilled	water	for	one	minute.	Slides	
were	dehydrated	 in	80%	ethanol	 for	one	minute,	95%	ethanol	 for	one	minute	and	
100%	 ethanol	 for	 one	 minute.	 Each	 ethanol	 step	 was	 repeated	 in	 fresh	 ethanol.	
Slides	were	washed	in	xylene	three	times	for	one	minute	each	wash.	Coverslips	were	
applied	to	the	slides	using	mounting	medium.	Stained	sections	were	visualised	using	
the	Nikon	80i	Eclipse	advanced	research	microscope.	
	
2.18 Statistical	Analysis	
Statistical	 analysis	 of	 data	 from	 the	 non-specific	 protease	 assays,	 scratch	 wound	
assays,	 cell	 viability	 assays,	 quantitative	 RT-PCR	 data	 and	 crystal	 violet	 assays	was	
performed	 using	 Graphpad	 Prism®	 Version	 6.0.	 Specifically,	 data	 from	 the	 non-
specific	protease	assays	and	quantitative	RT-PCR	was	statistically	analysed	using	the	
Kruskal-Wallis	 non-parametric	 analysis	 of	 variants	 (ANOVA)	with	 a	 Dunn’s	multiple	
comparison	 test.	Data	 from	 the	 scratch	wound	assay	 and	 cell	 viability	 assays	were	
assessed	 using	 a	 two-way	 ANOVA	 with	 a	 Tukey’s	 multiple	 comparisons	 test.	 The	
analysis	 of	 ammonium	 sulfate	 fractions	using	 the	non-specific	 protease	 assays	was	
statistically	assessed	using	Freidman’s	non-parametric	ANOVA	with	a	Dunn’s	multiple	
comparison	test.		
	 	
Page	95	of	253	
	
CHAPTER	3:	
Results	 I:	 The	 Proteolytic	 Activity	 of	 Bacteria	
Isolated	from	Acute	and	Chronic	Equine	Wounds	
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3 Results	I:	The	Proteolytic	Activity	of	Bacteria	Isolated	from	Acute	and	Chronic	
Equine	Wounds	
	
3.1 Introduction	
The	 detrimental	 aspects	 of	 bacterial	 infection	 in	 human	 wounds	 have	 long	 been	
recognised	 and	 their	 control	 is	 crucial	 for	wound	management.	 However	 it	 is	 now	
thought	that	the	presence	of	biofilms,	complex	communities	of	microorganisms	that	
reside	 in	 a	 self-synthesised	matrix,	 are	 responsible	 for	 the	development	of	 chronic	
outcomes	 in	 many	 wounds	 in	 humans	 (James	 et	 al.	 2008).	 In	 human	 medicine,	
biofilms	 are	 a	 great	 burden	 on	 healthcare	 establishments	 due	 to	 their	 association	
with	 antibiotic	 resistance.	 Medical	 biofilms,	 as	 they	 are	 referred	 to,	 have	 been	
detected	on	indwelling	medical	devices	such	as	catheters	and	implant	materials,	and	
have	been	associated	with	septicaemia,	osteomyelitis	and	periodontitis	 (Gristina	et	
al.	1985a,	Singhai	et	al.	2012,	Distel	et	al.	2002,	Mohamed	et	al.	2004).		
In	 terms	 of	 veterinary	 medicine,	 biofilms,	 particularly	 in	 the	 context	 of	 chronic	
wounds,	are	greatly	under-researched.	Indeed,	the	development	of	chronic	wounds	
is	 prevalent	 in	 horses.	 Horse	 wounds	 can	 be	 categorised	 as	 either	 surgical	 or	
traumatic,	 and	 then	 further	 diagnosis	 of	 the	 healing	 status	 of	 the	 wound	 can	 be	
described	as	acute	or	chronic	(Westgate	et	al.	2011).	Traumatic	wounds	in	horses	can	
arise	from	the	horse’s	immediate	environment	such	as	damaged	fencing,	kick	injuries	
or	activities	such	as	cross-country	jumping	and	racing.	Surgical	wounds,	as	the	name	
suggests,	occur	as	a	 result	of	 invasive	surgery.	Both	 traumatic	and	surgical	wounds	
can	 show	 signs	 of	 delayed	 healing	 due	 to	 factors	 such	 as	 ischemia,	 the	 horse’s	
nutritional	state,	wound	pH	and	wound	location	(Westgate	et	al.	2010).	Equine	distal	
limb	 wounds,	 are	 notoriously	 difficult	 to	 heal	 when	 compared	 to	 wounds	 on	 the	
proximal	 limb,	 or	 main	 body,	 which	 has	 been	 described	 in	 ponies.	 This	 is	
predominantly	due	to	a	greater	deal	of	wound	retraction	in	the	limbs	than	the	main	
trunk	of	the	body	(Jacobs	et	al.	1984).	
Due	 to	 the	 nature	 of	 the	 environment	 where	 horses	 reside,	 they	 are	 exposed	 to	
many	 environmental	 pathogens	 and	 therefore	 there	 is	 an	 obvious	 risk	 of	 infection	
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and	 biofilm	 formation	 in	 lower	 limb	 wounds,	 potentially	 delaying	 wound	 closure	
further.	However	this	is	yet	to	be	fully	investigated	in	equine	wounds.	Cochrane	and	
colleagues	 identified	 small	 clusters	or	 aggregates	of	 bacteria	 in	 skin	biopsies	 taken	
from	equine	wounds,	which	demonstrated	the	presence	of	biofilms	in	horse	wounds	
for	the	first	time.	This	study	identified	Pseudomonas	aeruginosa	and	Staphylococcus	
epidermidis	to	be	the	most	common	isolates	from	the	equine	wound	(Cochrane	et	al.	
2009).	 Westgate	 and	 co-workers	 identified	 Gram-positive	 and	 Gram-negative	
bacterial	aggregates	in	61.5%	(8	of	13)	equine	wounds,	with	the	predominant	species	
in	these	wounds	being	P.	aeruginosa	and	Enterococcus	faecium,	and	Staphylococcus	
being	 the	most	 commonly	 isolated	 genus	 (Westgate	 et	 al.	 2011).	 A	 study	 into	 the	
presence	 of	 biofilms	 on	 the	 surgical	 sutures	 of	 wounds	 in	 cats,	 dogs	 and	 horses,	
identified	 Gram-positive	 biofilms	 using	 staining	 techniques	 and	 microscopy.	
However,	of	the	91	tissue	samples	examined,	only	two	contained	bacterial	colonies	
resembling	 a	 biofilm	 from	 canine	 tissue	 (König	 et	 al.	 2014).	 These	 results	 do	 not	
support	the	findings	of	Westgate	and	colleagues	and	also	in	human	studies,	whereby	
it	was	shown	that	approximately	60%	of	chronic	wounds	contained	a	biofilm	(James	
et	 al.	 2008).	Although	König	and	 colleagues	assessed	 samples	 from	 tissue	 that	had	
been	 categorised	 as	 having	 inflammation,	 it	 is	 still	 unclear	 as	 to	 whether	 this	
presence	of	inflammation	was	in	an	acute	or	chronic	setting.	Whilst	the	identification	
of	 equine	 wound-derived	 biofilms	 has	 been	 achieved	 microscopically	 in	 these	
studies,	the	clinical	assessment	and	diagnosis	of	biofilms	in	equine	wounds	relies	on	
the	 identification	 of	 a	 thick,	 shiny	 and	 slimy	 layer	 on	 the	 surface	 of	 the	 wound	
(Westgate	et	al.	2010).	Although	there	is	evidence	to	suggest	that	the	biofilm	resides	
in	this	 layer	of	slime	(Cochrane	et	al.	2009)	histological	evidence	from	the	research	
discussed,	has	shown	bacterial	biofilms	that	reside	deep	within	the	tissue.		
It	 has	 been	 demonstrated	 that	 there	 is	 an	 imbalance	 of	 matrix	 metalloproteases	
(MMPs)	and	their	 inhibitors,	tissue	inhibitors	of	metalloproteases	(TIMPs)	in	human	
chronic	wounds,	 and	wound	 fluid	 has	 shown	 to	 have	 a	 significant	 up-regulation	 in	
MMPs	 (Yager	 et	 al.	 1996).	 A	 similar	 theory	 has	 been	 proposed	 in	 the	 context	 of	
equine	chronic	wounds	(Clutterbuck	et	al.	2010),	although	there	is	a	lack	of	relevant	
research	 studies.	 Nevertheless,	 if	 equine	 chronic	 wounds	 also	 share	 a	 similar	
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dysregulation	 in	 the	 proteolytic	 environment	 of	 the	 wound,	 it	 is	 important	 to	
consider	 the	 contribution	 of	 bacterial	 proteases.	 Indeed,	 bacterial	 proteases	 have	
been	implicated	in	human	pathologies,	including	chronic	lung	infections,	whereby	P.	
aeruginosa	 elastase	 B	 (LasB)	 has	 been	 shown	 to	 degrade	 airway	 mucins,	 an	
important	component	of	the	mucus	barrier	defence	against	microorganisms	(Henke	
et	al.	2011).	In	equine	pathology,	the	Bacillus-derived	metalloprotease,	thermolysin,	
has	 been	 shown	 to	 play	 a	 role	 in	 the	 lamellar	 explant	 separation	 and	 host	 MMP	
activation	in	an	ex	vivo	model	of	equine	laminitis	(Mungall	et	al.	2001).	
As	of	yet,	there	appears	to	be	no	evidence	of	proteolytic	activity	in	bacterial	isolates	
taken	from	equine	chronic	wounds.	It	was	therefore	the	aim	of	this	chapter	to	assess	
the	 proteolytic	 activity	 of	 P.	 aeruginosa	 and	 S.	 aureus	 isolated	 from	 acute	 and	
chronic	wounds	of	the	horse.		
	
3.2 Methods	
The	 bacterial	 isolates	 used	 in	 this	 chapter	 were	 derived	 from	 equine	 acute	 and	
chronic	 wounds,	 including	 limb	 wounds	 and	 surgical	 wounds	 (see	 Table	 3.1),	 and	
were	isolated	and	identified	as	part	of	a	previous	study	at	the	University	of	Liverpool	
(Westgate	 et	 al.	 2011).	 For	 a	 detailed	 description	 of	 the	 methods	 used	 in	 this	
chapter,	 the	 reader	 is	 directed	 to	 Chapter	 2	 of	 this	 thesis	 (2.3	Microbiology,	 2.3.6	
Crystal	 Violet	 Biofilm	 Forming	 Assay,	 2.5	 Scanning	 Electron	 microscopy,	 2.6	 Non-
specific	Protease	Assays,	2.7	Gel	Electrophoresis	and	2.18	Statistical	Analysis).	
	
3.3 Results	
3.3.1 Growth	 curve	 analysis	 and	 biofilm	 forming	 potential	 of	 equine	 acute	 and	
chronic	wound-derived	P.	aeruginosa	and	S.	aureus	
Growth	curves	of	S.	aureus	and	P.	aeruginosa	 isolates	from	both	acute	and	chronic	
wounds	of	the	horse	(see	Table	3.1)	were	taken	to	assess	their	cell	proliferation	over	
a	period	of	time.	Growth	curves	within	this	experiment	were	performed	in	a	96-well	
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plate	 format,	whereby	 the	 absorbance	 of	 each	well	was	measured	 at	 several	 time	
points	 over	 a	 72-hour	 period.	 S.	 aureus	 isolates	 followed	 similar	 growth	 curve	
profiles	to	each	other,	with	most	isolates	entering	the	exponential	phase	between	0	
and	 16	 hours	 (see	 Figure	 3.1,	 A).	 Beyond	 this	 time	 frame,	 the	 S.	 aureus	 isolates	
appeared	to	stay	within	the	stationary	phase	up	to	72	hours.	Two	out	of	the	seven,	
‘Mgg’	and	 ‘Gj’,	S.	aureus	 isolates	showed	a	higher	amount	of	proliferation	than	the	
other	isolates.	Similarly,	the	P.	aeruginosa	 isolates	all	followed	similar	growth	curve	
profiles	 to	 each	other,	with	 ‘Ha14’	 and	 ‘Ba19’	 showing	 a	 slightly	 higher	 amount	of	
proliferation	 than	 other	 isolates	 (see	 Figure	 3.1,	 B).	 Most	 of	 the	 P.	 aeruginosa	
isolates	entered	the	exponential	phase	of	growth	between	0	and	12	hours,	however	
both	 ‘Ha14’	 and	 ‘Ba19’	 reached	 20	 hours	 before	 exponential	 growth	 reached	 a	
plateau.	 P.	 aeruginosa	 isolates	 entered	 the	 stationary	 phase	 between	 12	 and	 32	
hours	 respectively,	 before	 a	 decline	 in	 the	 growth	 curves	was	 seen,	 indicating	 cell	
death.	No	growth	was	detected	in	the	DMEM	control	throughout	the	duration	of	the	
experiment	(see	Figure	3.1,	A	and	B).	
The	next	experiment	 tested	 the	ability	of	 each	S.	 aureus	 and	P.	aeruginosa	 clinical	
isolate	 to	 form	 a	 biofilm	 on	 plastic	 pegs	 within	 a	 96-well	 plate,	 as	 described	 in	
Chapter	2	of	this	thesis.	Within	this	experiment,	the	equine	wound-derived	isolates	
were	 cultured	 in	 the	 assay	 for	 72	 hours	 before	 assessing	 biofilm-formation	 on	 the	
pegs.	Crystal	violet	was	used	to	stain	the	biofilms	before	solubilisation,	whereby	the	
denser	 the	 biofilm,	 the	 stronger	 the	 intensity	 of	 the	 dye.	 The	 majority	 of	 P.	
aeruginosa	 isolates	 displayed	 strong	 biofilm	 forming	 potential,	 shown	 by	 the	 high	
absorbance	values	from	the	crystal	violet	staining	(see	Figure	3.2,	A).	Variability	was	
seen	between	P.	aeruginosa	 isolates,	with	 isolates	 such	as	 ‘Ma3’	and	 ‘Mt’	 showing	
relatively	weak	biofilm	formation.	S.	aureus	isolates	showed	particularly	weak	biofilm	
formation	with	 negative	 absorbance	 values	 for	 the	majority	 of	 isolates	 (see	Figure	
3.2,	B).		
Scanning	electron	microscopy	of	S.	 aureus	 and	P.	 aeruginosa	 grown	as	biofilms	on	
membrane	filter	discs	also	support	 the	crystal	violet	 findings.	The	spherical	cocci	S.	
aureus	appeared	scattered	with	the	occasional	presence	of	small	clusters,	indicative	
of	biofilm	formation	(see	Figure	3.3,	A	and	B).	However	whilst	clustering	amongst	S.	
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aureus	was	seen,	 the	surface	of	 the	membrane	filter	was	still	visible.	P.	aeruginosa	
however,	 formed	dense	 layers,	with	the	rod-like	morphology	of	 the	bacteria	barely	
visible	on	the	surface	of	the	biofilm.	P.	aeruginosa	appeared	to	be	surrounded	by	a	
extracellular	 polymeric	 substances	 (EPS),	 thus	 making	 it	 more	 difficult	 to	 see	 the	
morphology	of	the	bacteria	(see	Figure	3.3,	C	and	D).	
	
	
	
	
	
	
	
	
	
	
	
	
Table	3.1	Origin	of	equine	bacterial	isolates.	
P.	aeruginosa	(n=7)	and	S.	aureus	(n=7)	were	isolated	and	identified	from	traumatic	
(T)	and	surgical	(S)	equine	wounds,	which	were	classified	as	either	acute	or	chronic.	
These	 isolates	 were	 obtained	 from	 a	 previous	 study	 held	 at	 the	 University	 of	
Liverpool	by	Westgate	and	colleagues	(Westgate	et	al.	2011).	
	
Isolate	Code	 Type	 of	 Wound	
(Acute/Chronic)	
Wound	Origin	
Staphylococcus	aureus	
Gj	 Acute	 S	
Kc	 Acute	 T	
Ke	 Chronic	 T	
Lb	 Chronic	 T	
Mgg	 Chronic	 T	
Tg	 Chronic	 T	
Wi	 Normal	Equine	Skin	 -	
Pseudomonas	aeruginosa	
Ba19	 Chronic	 T	
Ca1	 Chronic	 T	
Ha14	 Chronic	 T	
Ia7	 Chronic	 T	
Ma1	 Chronic	 T	
Ma3	 Chronic	 T	
Mt	 Acute	 S	
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Figure	 3.1	Growth	 curves	 of	 equine-derived	S.	 aureus	 and	P.	 aeruginosa	over	 72	
hours.	
S.	 aureus	 (n=7)	 (A)	 and	 P.	 aeruginosa	 (n=7)	 (B)	 clinical	 isolates	 were	 individually	
seeded	into	a	96-well	plate	and	incubated	for	72	hours,	whereby	the	absorbance	of	
each	well	 containing	 the	 isolate	was	measured	every	4	hours.	Dulbecco’s	Modified	
Eagle’s	medium	(DMEM)	was	used	as	a	negative	(no	growth)	control.	The	assay	was	
repeated	three	times	and	the	average	absorbance	values	obtained	and	used	to	plot	
the	growth	curves.	
	
0 20 40 60 80
0.0
0.2
0.4
0.6
0.8
Time+(Hours)
Av
er
ag
e+
ab
so
rb
an
ce
+a
t+6
00
nm DMEM
Gj
Kc
Ke
Lb
Mgg
Tg
Wi
A
0 20 40 60 80
0.0
0.2
0.4
0.6
Time+(Hours)
Av
er
ag
e+
ab
so
rb
an
ce
+a
t+6
00
nm
DMEM
Ba19
Ca1
Ha14
Ia7
Ma3
B
Ma1
Mt
Page	102	of	253	
	
	
	
Figure	3.2	Biofilm	forming	potential	of	equine-derived	clinical	isolates	using	crystal	
violet.	
P.	aeruginosa	isolates	(n=7)	(A)	and	S.	aureus	isolates	(n=7)	(B)	were	incubated	for	72	
hours	before	being	 stained	with	 crystal	 violet,	 solubilised	and	absorbance	 readings	
recorded	 at	 a	 wavelength	 of	 550nm.	 Mueller	 Hinton	 broth	 (MHB)	 was	 used	 as	 a	
negative	control.	The	experiment	was	repeated	three	times	before	taking	an	average	
of	the	absorbance	values.	Error	bars	represent	standard	deviation.	
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Figure	 3.3	 Scanning	 electron	 microscopy	 (SEM)	 of	 72-hour	 biofilms	 grown	 on	
membrane	filter	discs.	
Images	 represent	S.	 aureus	 ‘Tg’	 at	 x5000	 (A)	 and	 x20,000	 (B)	magnification	 and	P.	
aeruginosa	 ‘Ba19’	 at	 x5000	 (C)	 and	 x12,000	 (D)	 magnification.	 Both	 isolates	 were	
grown	 on	membrane	 filters	 for	 72	 hours	 before	 being	washed	 in	 PBS	 and	 fixed	 in	
2.5%	gluteraldehyde	and	dehydrated	in	ethanol.	Images	were	taken	using	the	Hitachi	
TM300	 tabletop	 scanning	 electron	 microscope.	 Black	 arrows	 indicate	 evidence	 of	
bacterial	clustering	and	the	red	arrow	shows	the	membrane	filter	surface.	
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3.3.2 Proteolytic	activity	of	equine	acute	and	chronic	wound-derived	P.	aeruginosa	
and	S.	aureus	in	planktonic	and	biofilm	form		
To	 assess	 the	 general	 proteolytic	 activity	 of	 the	 equine-derived	 S.	 aureus	 and	 P.	
aeruginosa	 planktonic-	 and	 biofilm-conditioned	 medium	 (PCM	 and	 BCM),	 the	
substrates	 Azo-casein	 and	 Azocoll	 were	 used.	 The	 Azo-casein	 assay	 revealed	 low	
levels	 of	 proteolytic	 activity	 in	 S.	 aureus	 PCM	 and	 BCM	 (see	 Figure	 3.4).	 No	
differences	 in	proteolytic	activity	were	 recorded	between	S.	aureus	PCM	and	BCM.	
On	 the	 other	 hand,	 both	 P.	 aeruginosa	 PCM	 and	 BCM	 showed	 high	 levels	 of	
proteolytic	 activity,	 with	 P.	 aeruginosa	 PCM	 and	 BCM	 showing	 significantly	 higher	
activity	 than	 S.	 aureus	 PCM	 and	 BCM,	 respectively	 (P	 <0.01	 and	 P	 <0.05).	 No	
differences	 in	 proteolytic	 activity	 were	 recorded	 between	 P.	 aeruginosa	 PCM	 and	
BCM.	Similarly	the	Azocoll	assay	revealed	low	levels	of	activity	in	S.	aureus	PCM	and	
BCM,	 with	 no	 significant	 difference	 between	 PCM	 and	 BCM	 (see	 Figure	 3.5).	 P.	
aeruginosa	PCM	and	BCM	showed	high	levels	of	protease	activity,	with	P.	aeruginosa	
PCM	 showing	 higher	 activity	 than	 S.	 aureus	 PCM	 (P	 <0.01).	 Although	 proteolytic	
activity	 appeared	higher	 in	P.	 aeruginosa	 BCM	 than	S.	 aureus	 BCM,	no	 statistically	
significant	differences	were	determined.	
In	 order	 to	 determine	 whether	 the	 high	 proteolytic	 activity	 seen	 in	 P.	 aeruginosa	
PCM	and	BCM,	was	 in	part,	due	 to	 the	presence	of	metalloproteases,	all	bacterial-
conditioned	 medium	 was	 run	 on	 gelatin	 zymograms.	 Zymography	 revealed	 the	
presence	of	a	52kDa	protease,	to	varying	degrees	of	intensity	in	most	P.	aeruginosa	
PCM	samples	(see	Figure	3.6,	A).	This	52kDa	protease	did	not	appear	in	the	PCM	of	
the	isolate	‘Mt’.	Furthermore,	there	were	no	differences	noted	in	the	intensity	of	the	
proteolytic	bands	between	P.	aeruginosa	PCM	and	BCM	(see	Figure	3.6,	B),	although	
this	was	not	semi-quantifiably	measured.	The	presence	of	proteolytic	bands	was	not	
detected	in	S.	aureus	PCM	and	BCM	(data	not	shown).	In	order	to	determine	which	
of	 the	major	 groups	 of	 proteases	 this	 52kDa	 protease	 belonged	 to,	 P.	 aeruginosa	
PCM	 was	 run	 on	 several	 gelatin	 zymograms	 and	 either	 incubated	 with	 a	 serine	
protease	inhibitor	(Benzamidine	hydrochloride	hydrate),	a	metalloprotease	inhibitor	
(EDTA)	 or	 a	 cysteine	 protease	 inhibitor	 (N-ethylmaleimide	 or	 NEM).	 The	 use	 of	
100mM	 EDTA	 inhibited	 the	 equine	 fibroblast-derived	 MMP-2	 positive	 control	 but	
Page	105	of	253	
	
failed	 to	 inhibit	 the	 P.	 aeruginosa-derived	 protease	 bands.	 Furthermore,	 50mM	
Benzamidine	hydrochloride	hydrate	and	10mM	NEM	did	not	have	an	inhibitory	effect	
on	 the	 52kDa	 bands	 when	 compared	 to	 the	 bands	 incubated	 in	 normal	 refolding	
buffer	(see	Figure	3.6,	A).	
	
	
Figure	3.4	The	non-specific	proteolytic	activity	of	planktonic	and	biofilm	S.	aureus-	
and	P.	aeruginosa-conditioned	medium	using	the	Azo-casein	assay.	
Data	 from	the	biological	 replicates	were	combined	 in	order	 to	assess	 the	statistical	
difference	 between	 clinical	 S.	 aureus	 (n=7)	 and	 P.	 aeruginosa	 (n=7).	 All	 biological	
replicates	in	the	assay	were	run	in	duplicate.	Error	bars	represent	standard	deviation.	
Statistical	 analysis	was	performed	using	 the	Kruskal-Wallis	 non-parametric	ANOVA,	
with	Dunn’s	multiple	comparison	test;	*P	<	0.05,	**P	<	0.01.	Abbreviations	 include	
planktonic-conditioned	medium	(PCM)	and	biofilm-conditioned	medium	(BCM).	
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Figure	3.5	The	non-specific	proteolytic	activity	of	planktonic	and	biofilm	S.	aureus-	
and	P.	aeruginosa-conditioned	medium	using	the	Azocoll	assay.	
Data	 from	the	biological	 replicates	were	combined	 in	order	 to	assess	 the	statistical	
difference	 between	 clinical	 S.	 aureus	 (n=7)	 and	 P.	 aeruginosa	 (n=7).	 All	 biological	
replicates	in	the	assay	were	run	in	duplicate.	Error	bars	represent	standard	deviation.	
Statistical	 analysis	was	performed	using	 the	Kruskal-Wallis	 non-parametric	ANOVA,	
with	Dunn’s	multiple	 comparison	 test;	*P	<	0.01.	Abbreviations	 include	planktonic-
conditioned	medium	(PCM)	and	biofilm-conditioned	medium	(BCM).	
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Figure	 3.6	 The	 detection	 and	 inhibition	 of	 equine	 wound-derived	 P.	 aeruginosa	
proteases.	
P.	aeruginosa	PCM	was	run	on	0.25%	gelatin	and	7.5%	poly-acrylamide	zymograms	
(A).	Lanes	2-8	represents	the	PCM	of	equine	isolates	BA19,	Ca1,	Ha14,	Ia7,	Ma1,	Ma3	
and	Mt	respectively.	Lane	1	shows	the	MMP-2	positive	control,	isolated	from	equine	
fibroblasts.	Zymograms	were	incubated	with	either	untreated	buffer,	100mM	EDTA-
treated	buffer,	50mM	benzamidine-treated	buffer	or	10mM	NEM-treated	buffer.	P.	
aeruginosa	 PCM	 and	 BCM	were	 run	 on	 a	 gelatin	 zymogram	 for	 comparison	 in	 the	
abundance	 of	 the	 protease	 (B).	Molecular	weight	 is	 displayed	 in	 kilodaltons	 (kDa).	
Protease	 activity	 is	 shown	 as	 a	 white	 band	 against	 a	 Coomassie	 blue-stained	
background.	 Experiments	 were	 performed	 using	 all	 biological	 replicates	 of	 P.	
aeruginosa	 (n=	 7)	 and	 were	 repeated	 three	 times.	 Abbreviations	 include	
Ethylenediaminetetraacetic	 acid	 (EDTA),	 N-ethlymaleamide	 (NEM),	 planktonic-
conditioned	medium	(PCM)	and	biofilm-conditioned	medium	(BCM).	
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3.3.3 Identification	 of	 equine-derived	 P.	 aeruginosa	 protease	 using	 mass	
spectrometry	
In	 order	 to	 identify	 the	 P.	 aeruginosa-derived	 protease	 of	 approximately	 52kDa,	
three	biological	replicates	of	P.	aeruginosa	PCM	(Ba19,	Ca1	and	Ma1)	were	run	on	a	
gelatin	zymogram.	The	zymogram	was	stained	to	visualise	the	protease	band	before	
the	bands	were	cut	out	of	the	gel	and	used	for	mass	spectrometric	analysis.	For	the	
control,	Mueller	Hinton	broth	(MHB)	was	run	on	the	same	zymogram	and	a	sample	
of	the	equivalent	molecular	weight	as	the	P.	aeruginosa	52kDa	protease	was	cut	out	
and	 used	 for	 mass	 spectrometric	 analysis	 (carried	 out	 by	 the	 University	 of	
Manchester).	Data	in	the	form	of	amino	acid	sequences	in	the	protease	sample	were	
entered	 into	 the	Mascot	 search	 engine	 against	 the	 SwissProt	 database	 under	 the	
‘Eubacteria’	 taxonomy	 in	 order	 to	 identify	 potential	 bacterial-derived	proteases.	 In	
this	experiment,	 I	 focused	on	proteins	 identified	by	 the	Mascot	 search	engine	 that	
shared	significant	identity	or	shared	homology	(P	<0.05)	to	the	peptide	sequence	in	
the	protease	 sample.	Therefore,	 although	each	 sample	 received	protein	 ‘hits’,	only	
the	results	that	were	deemed	significant	by	Mascot	were	assessed.	Results	from	the	
Mascot	search	showed	that	all	biological	replicates	of	the	protease	received	at	least	
one	protein	hit,	 however	 the	 results	 for	 each	protease	 sample,	 differed	 from	each	
other	(see	Table	3.2).	The	sample	‘Ca1’	had	four	protein	hits,	however	these	proteins	
were	also	detected	 in	 the	control	 sample.	Protease	samples	 ‘Ba19’	and	 ‘Ma1’	each	
had	one	protein	hit	that	were	not	detected	in	the	control	sample.	The	85kDa	protein	
DNA	translocase	ftsK	was	detected	in	‘Ma1’	and	was	shown	to	be	associated	with	the	
bacterium	 Xanthomonas	 axonopodis	 pv.	 For	 ‘Ba19’,	 a	 35kDa	 protein	 named	 S-
adenosyl-L-methionine-dependent	 methyltransferase	 mraW,	 associated	 with	 the	
bacterium	Alkaliphilus	 oremlandii	was	 detected.	 Unfortunately,	 the	 protein	 results	
for	all	three	protease	samples	showed	varying	molecular	weights	dissimilar	from	the	
initial	52kDa	P.	aeruginosa-derived	protease.	Furthermore,	there	was	no	evidence	of	
P.	aeruginosa-derived	proteins/proteases.		
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Table	3.2	Mass	spectrometric	identification	of	the	proteins	in	equine	wound-derived	P.	aeruginosa	protease	samples.	
The	table	shows	a	 list	of	proteins	that	have	been	found	to	significantly	share	 identity	or	extensive	homology	with	the	peptides	within	three	
biological	 replicates	 (n=3)	 of	 the	 previously	 identified	P.	 aeruginosa	 protease	 sample	 (P	 <0.05).	 For	 the	 control,	MHB	was	 run	on	 a	 gelatin	
zymogram	and	a	sample	of	the	same	molecular	weight	as	the	P.	aeruginosa-derived	protease	was	cut	out	of	the	gel	for	mass	spectrometric	
analysis.		Peptide	sequence	data	was	entered	into	the	Mascot	search	engine	to	identify	proteins	from	the	SwissProt	database	under	Eubacteria	
taxonomy.	 Bacteria	 associated	 with	 the	 identified	 protein,	 according	 to	 the	 Mascot	 search	 is	 listed	 in	 the	 table.	 Peptide	 sequences	 are	
represented	as	one-letter	symbol	amino	acids,	whereby	K=	Lysine,	T=	Threonine,	A=	Alanine,	D=	Aspartic	acid,	N=	Asparagine,	P=	Proline,	R=	
Arginine,	 L=	 Leucine,	 G=	 Glycine,	 V=	 Valine	 and	 I=	 Isoleucine.
Protein	description	 Associated	bacteria	 Protein	Mass	
(daltons)	
Peptide	sequence	
identified	
Presence	in	
sample	
Presence	in	
control	sample	
DNA	translocase	ftsK	 Xanthomonas	axonopodis	pv	
	
84,992	 KTAAADNPRR	 Ma1	 No	
Protein	nrdI		 Klebsiella	pneumonia	
	
15,387	 LGLPAVR	 Ca1	 	 yes	
Exodeoxyribonuclease	 V	 beta	
chain		
Mycobacterium	tuberculosis	 119,106	 LGLPGLR	 Ca1	 yes	
Lipid-A-disaccharide	synthase		 Ralstonia	solanacearum	
	
42,579	 LGLPLGR	 Ca1	 yes	
DNA	polymerase	I		
	
Bacillus	subtilis	 99,030	 IGLPVVK	
	
Ca1	 yes	
S-adenosyl-L-methionine-
dependent	 methyltransferase	
mraW		
	
Alkaliphilus	oremlandii	 35,303	 RAIPKGAR	
	
Ba19	 No	
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3.4 Discussion	
The	 involvement	 of	 bacterial	 proteases	 in	 equine	wounds	 has	 not	 previously	 been	
investigated.	 For	 the	 first	 time,	 this	 study	 identifies	 the	 presence	 of	 proteolytic	
activity	 from	bacteria	 isolated	 from	both	acute	and	chronic	equine	wounds	using	a	
combination	of	basic	enzymatic	assays	and	substrate	zymography.	More	specifically,	
P.	aeruginosa	isolates	were	shown	to	secrete	a	52kDa	protease.	Unfortunately	at	this	
stage	of	 the	 investigations,	 there	 is	no	definitive	answer	as	 to	 the	 identification	of	
this	 protease.	 Based	 on	 the	 approximate	 molecular	 weight	 of	 this	 P.	 aeruginosa-
derived	protease,	the	literature	suggests	that	the	52kDa	band	is	that	of	P.	aeruginosa	
alkaline	protease	(AprA).	As	discussed	in	chapter	1	of	this	thesis,	P.	aeruginosa	AprA	
is	a	metalloprotease	and	a	known	virulence	factor	secreted	by	P.	aeruginosa.	A	study	
by	Caballero	and	colleagues,	whereby	six	various	in	vitro	assays	were	used	to	assess	
the	major	P.	aeruginosa	proteases,	demonstrated	P.	aeruginosa	AprA	at	a	molecular	
weight	of	56kDa	 in	gelatin	and	casein	 zymography	 (Caballero	et	al.	 2001).	Another	
study	 compared	 the	 protease	 profiles	 of	 the	 P.	 aeruginosa	 reference	 strain	 ATCC	
27853	and	 two	clinical	 strains	of	P.	aeruginosa,	which	displayed	different	protease	
profiles	 in	 zymography	 depending	 on	 the	 strain	 and	 growth	 medium	 used.	 More	
specifically,	AprA	was	only	detected	using	gelatin	zymography	in	the	strains	grown	in	
minimal	 M9	 culture	 medium	 but	 not	 Luria-Bertani	 (LB)	 broth,	 with	 a	 molecular	
weight	 of	 52kDa	 (Andrejko	 et	 al.	 2013).	Nevertheless,	many	 studies	 have	 reported	
the	inhibition	of	metalloproteases	and	indeed,	AprA,	with	the	chelator	EDTA,	which	
deactivates	 metalloproteases	 by	 sequestering	 zinc	 ions	 (Caballero	 et	 al.	 2001,	
Twining	et	al.	1993).	However	within	this	chapter,	100mM	EDTA,	failed	to	inhibit	the	
52kDa	 P.	 aeruginosa-derived	 protease,	 despite	 successfully	 inhibiting	 the	 MMP-2	
positive	control.	The	reason	for	this	remains	unknown;	however	there	is	a	possibility	
that	 the	 52kDa	 protease	 secreted	 from	 equine-derived	 P.	 aeruginosa	may	 display	
EDTA	 resistance.	 An	 example	 of	 EDTA	 resistance	 in	 bacterial	metalloproteases	 has	
been	recorded	in	Xenorhabdus,	whereby	it	was	hypothesised	that	the	zinc	ion	within	
the	 metalloproteases	 may	 be	 tightly	 bound,	 making	 the	 protease	 inaccessible	 to	
EDTA	 inhibition	 (Massaoud	 et	 al.	 2011).	 Mass	 spectrometric	 analysis	 of	 the	 P.	
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aeruginosa-derived	 protease	 was	 based	 on	 a	 sample	 that	 was	 extracted	 from	 a	
gelatin	 zymogram.	While	 zymography	works	 in	 the	 same	manner	 as	 an	 SDS-PAGE,	
whereby	the	proteins	of	a	particular	sample	are	separated	through	the	gel	according	
to	 size	 under	 the	 influence	 of	 a	 current,	 a	 zymogram	 contains	 a	 substrate,	 and	
therefore	any	proteases	that	have	been	separated,	effectively	digest	the	substrate	in	
the	 surrounding	 gel.	 Therefore	 any	 bands	 visualised	 upon	 staining	 the	 gel	 are	
amplified,	unlike	the	neat	bands	that	are	visualised	in	an	SDS-PAGE	gel,	resulting	in	a	
less	accurate	isolation	of	the	protease	when	excising	bands	for	mass	spectrometry.	
The	S.	aureus	isolates	in	this	study	showed	little	proteolytic	activity	in	planktonic	and	
biofilm	form.	Indeed,	S.	aureus	do	produce	extracellular	proteases	that	play	a	role	in	
bacterial	virulence,	such	as	the	metalloprotease	aureolysin,	the	serine	protease	SspA	
and	 the	 cysteine	 protease	 SspB,	 as	 mentioned	 in	 Chapter	 1	 of	 this	 thesis.	 Other	
studies	 have	 identified	 these	 particular	 S.	 aureus-derived	 extracellular	 proteases	
using	 gelatin	 zymography	 (Shaw	 et	 al.	 2004),	 however	 the	 detection	 of	 these	
proteases	may	be	strain-dependant.	
There	are	 limitations	 to	 the	work	presented	 in	 this	chapter.	 It	 is	 important	 to	note	
that	the	method	used	to	obtain	BCM	is	based	upon	a	laboratory	model	of	a	biofilm,	
and	indeed,	like	many	 in	vitro	models,	results	obtained	are	only	indications	of	what	
may	occur	in	vivo.	For	instance,	the	thickness	of	the	biofilm	observed	in	this	model	is	
unlikely	 to	 be	 observed	 in	 an	 equine	 chronic	 wound,	 due	 to	 the	 external	
environment	and	host	immune	responses	towards	the	biofilm.	In	addition	to	this,	the	
levels	of	proteolytic	activity	 from	P.	aeruginosa	may	differ	when	these	bacteria	are	
within	the	wound.	This	could	be	potentially	due	to	the	influence	of	external	factors	
such	as	nutrient	availability,	host-derived	factors	or	surrounding	microorganisms.		
	
3.4.1 Future	directions		
The	incorporation	of	these	biofilms	into	an	in	vitro	equine	wound	healing	model	will	
also	reveal	 the	effect	of	 the	soluble	 factors	released	by	biofilms	on	wound	closure.	
More	specifically,	it	would	be	interesting	to	investigate	how	both	the	PCM	and	BCM	
from	this	chapter	affects	 fibroblast	migration	and	proliferation,	given	the	excessive	
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production	of	granulation	tissue	seen	in	many	chronic	equine	wounds.	Following	this,	
one	would	 be	 able	 to	 determine	 how	host	 proteases	 are	 regulated	 in	 response	 to	
these	 external	 stimuli,	 in	 order	 to	 create	 a	more	 complete	 picture	 of	 how	 equine	
tissue	responds	to	bacterial	infection	within	a	wound.	To	then	assess	whether	the	P.	
aeruginosa-derived	 exogenous	 protease	 highlighted	 in	 this	 chapter	 contributes	 to	
the	development	of	 chronic	equine	wounds,	 future	work	would	aim	 to	 isolate	and	
identify	this	protease.	In	doing	so,	it	would	determine	how	this	protease	is	regulated	
within	a	biofilm	subject	to	an	environment	similar	to	that	of	the	wound	site.	Further	
work	would	then	focus	on	whether	this	protease	impedes	wound	closure.		
	
3.4.2 Key	points	
In	summary,	P.	aeruginosa	isolated	from	acute	and	chronic	equine	wounds	displayed	
high	 levels	 of	 proteolytic	 activity,	 which	 was	 identified	 through	 the	 use	 of	 non-
specific	 protease	 activity	 assays.	P.	 aeruginosa	 in	 planktonic	 and	 biofilm	 form	was	
shown	to	release	a	52kDa	protease,	detected	in	gelatin	zymography,	which	was	not	
inhibited	by	broad	spectrum	protease	inhibitors.	The	subsequent	attempt	to	identify	
this	 protease	 through	 the	 method	 of	 mass	 spectrometric	 analysis	 resulted	 in	
ambiguous	results.	Thus,	the	identification	of	this	protease	remains	unknown.	
S.	aureus	isolates	in	both	planktonic	and	biofilm	form	showed	little	protease	activity	
and	there	was	an	absence	of	detectable	proteases	using	zymography.	
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4 Results	II:	The	effect	of	equine	wound-derived	bacteria	on	the	wound	closure	
and	protease	production	of	normal	and	chronic	wound-derived	fibroblasts	
	
4.1 Introduction	
In	 the	 aim	 of	 understanding	 how	 biofilms	 prevent	 wound	 closure,	 many	 in	 vivo	
models	 of	 biofilm-infected	 chronic	 wounds	 have	 been	 developed.	 For	 example,	 a	
model	 using	 wounded	 New	 Zealand	 rabbit	 ears	 has	 shown	 sustained	 low	 grade	
inflammation,	 decreased	 granulation	 tissue	 formation	 and	 reduced	 re-
epithelialisation	 in	 the	presence	of	S.	 aureus	 biofilms	 (Gurjala	 et	 al.	 2011).	 Though	
not	 all	 biofilm-infected	 wound	 models	 have	 resulted	 in	 impaired	 wound	 healing.	
Kanno	and	colleagues	infected	full	thickness	wounds	with	P.	aeruginosa	biofilm	in	a	
murine	model.	The	authors	visualised	biofilm	presence	on	the	wounds	at	as	early	as	
8	 hours	 however	 there	were	 no	 differences	 in	 epithelialisation	when	 compared	 to	
uninfected	controls	(Kanno	et	al.	2010).	However,	it	has	been	proposed	that	equine	
models	could	be	a	more	physiologically	relevant	model	(Theoret	and	Wilmink	2013).	
There	is	a	natural	occurrence	of	chronic	wounds	within	the	horse	due	to	the	nature	
of	 the	environment	 that	 the	horse	 resides,	but	also,	wounds	 to	 the	 limb	are	often	
deemed	difficult	to	heal	due	to	the	high	tension	(tightness	of	the	skin)	and	increased	
risk	 of	 infection	 (Jacobs	 et	 al.	 1984).	 Furthermore,	 unlike	 wound	 healing	 in	 the	
mouse,	 which	 predominantly	 relies	 on	 wound	 contraction	 rather	 than	
epithelialisation,	 wound	 healing	 in	 the	 horse	 is	 driven	 more	 by	 epithelialisation,	
drawing	 parallels	 to	 human	 wound	 repair.	 The	 clinical	 characteristics	 of	 equine	
chronic	 wounds	 shares	 similarities	 to	 those	 in	 human,	 with	 frequent	 signs	 of	
persistent	 inflammation	 and	 exudate.	 However	 a	 distinct	 characteristic	 of	 chronic	
wounds	 on	 horse	 limbs	 is	 the	 exuberant	 production	 of	 granulation	 tissue	 that	
requires	 regular	 debridement.	 In	 human	 hard-to-heal	 chronic	 wounds,	 there	 is	 a	
suboptimal	 production	 of	 granulation	 tissue	 in	many	 cases,	 potentially	 due	 to	 the	
high	proteolytic	environment	(Nunan	et	al.	2014).	However	similarities	can	be	drawn	
to	 human	 fibroproliferative	 disorders	 such	 as	 keloids,	 where	 excessive	 scar	 tissue	
formation	 is	 present.	 For	 example,	 Theoret	 and	 colleagues	 using	 histological	
techniques	 to	 compare	 equine	 granulation	 tissue	 and	 human	 keloid	 tissue,	 found	
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similarities	in	dermal	thickened	collagen	fibres	and	increased	numbers	of	fibroblasts,	
however	 there	were	also	differences	 identified	 in	 inflammatory	cell	 types	between	
these	tissues	(Theoret	et	al.	2013).	Furthermore,	significant	differences	in	fibroblasts	
isolated	 from	normal	healthy	equine	 tissue	and	equine	 chronic	wounds	have	been	
noted.	 Cochrane	 and	 colleagues	 identified	 morphological	 differences	 between	
normal	 fibroblasts	 (NFs)	 and	 chronic	 granulation	 tissue	 fibroblasts	 (GTFs),	whereby	
NFs	 appear	 spindle-like	 and	 GTFs	 were	 spread-out	 and	 cuboidal	 in	 appearance	
(Cochrane	et	al.	1996).	Furthermore,	the	proliferation	rates	of	GTFs	were	determined	
significantly	lower	than	NFs	after	20	day	in	culture	(P	<0.01).		
Host	 proteases	 have	 been	 extensively	 studied	 in	 terms	 of	 their	 role	 in	 the	
mammalian	 wound	 healing	 process.	 Although	 it	 is	 known	 that	 in	 human	 chronic	
wounds,	 there	 is	 an	 imbalance	 in	 matrix	 metalloproteases	 (MMPs)	 and	 their	
inhibitors,	 tissue	 inhibitors	of	metalloproteases	 (TIMPs),	 there	 is	 little	 research	 into	
the	expression	and	regulation	of	MMPs	in	horse	wounds.	When	referring	to	equine	
chronic	wounds,	many	reviews	simply	draw	parallels	to	the	exaggerated	proteolytic	
environment	of	human	chronic	wounds	(Clutterbuck	et	al.	2010),	although	this	may	
not	be	the	case.		
As	mentioned	 previously,	 bacterial	 biofilms	 have	 been	 identified	 in	 equine	wound	
tissue	(Westgate	et	al.	2011,	Cochrane	et	al.	2009).	It	has	been	determined,	for	the	
first	time,	in	Chapter	3	of	this	thesis,	that	P.	aeruginosa	isolated	from	equine	chronic	
wounds	display	high	levels	of	proteolytic	activity.	However,	though	the	presence	of	a	
biofilm	 within	 an	 open	 wound	 is	 understandable,	 particularly	 considering	 the	
surrounding	 environment	 of	 a	 horse,	 it	 remains	 to	 be	 answered	 whether	 these	
biofilms	 directly	 affect	 wound	 closure.	 Furthermore,	 it	 remains	 unknown	whether	
the	presence	of	 bacterial	 biofilms	within	 the	wound,	 affects	 the	 secretion	of	 host-
derived	 proteases.	 Indeed,	 it	 has	 been	 documented	 that	 bacteria	 and	 the	 purified	
bacterial	 protease	 thermolysin,	 caused	 the	 activation	 of	 host	MMP-2	 and	MMP-9,	
leading	 to	 lamellar	 explant	 separation	 in	 an	equine	 laminitis	model	 (Mungall	 et	 al.	
2001).	
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The	aim	of	this	study	was	to	assess	in	vitro	wound	closure	of	equine	fibroblasts	from	
normal	skin	and	chronic	wound	granulation	tissue,	in	response	to	treatment	with	S.	
aureus	 and	 P.	 aeruginosa	 planktonic-conditioned	 medium	 (PCM)	 and	 biofilm-
conditioned	medium	(BCM),	and	assess	the	secretion	of	host	proteases	under	these	
experimental	 conditions.	 Furthermore,	 the	 overall	 expression	 of	 MMPs	 in	 equine	
skin	 and	 chronic	 wound-derived	 granulation	 tissue	 was	 investigated	 using	
immunohistochemistry	 to	 determine	 whether	 the	 presence	 of	 biofilms	 in	 equine	
chronic	wounds	affected	the	overall	expression	of	MMPs.	
	
4.2 Methods	
For	a	detailed	description	of	the	methods	used	in	this	chapter,	the	reader	is	directed	
to	 Chapter	 2	 of	 this	 thesis	 (2.3	 Microbiology,	 2.7	 Gel	 Electrophoresis,	 2.10	 Cell	
Culture,	2.13	Scratch	Wound	Assay,	2.17	Histology	and	 Immunohistochemistry	and	
2.18	Statistical	Analysis).	
	
4.3 Results	
4.3.1 Scratch	closure	of	equine	normal	and	granulation	tissue	fibroblasts	(NFs	and	
GTFs)	 in	 response	 to	 P.	 aeruginosa	 and	 S.	 aureus	 planktonic-	 and	 biofilm-
conditioned	medium		
Upon	 culturing	 fibroblasts	 from	 normal	 equine	 skin	 and	 chronic	 wound-derived	
granulation	tissue,	differences	in	cell	morphology	were	identified.	Normal	fibroblasts	
(NFs)	 appeared	 elongated	 and	 spindle-like	 in	 shape,	 whereas	 granulation	 tissue	
fibroblasts	 (GTFs)	 appeared	 cuboidal	 in	 shape	and	 in	 some	cases,	 particularly	 after	
treatment	with	bacterial-conditioned	medium,	appeared	 stellate	 (see	Figure	4.1,	A	
and	B).	
NF’s	 were	 cultured	 and	 seeded	 into	 a	 6-well	 plate	 format	 to	 perform	 an	 in	 vitro	
scratch	 assay.	 Cultures	 were	 either	 cultured	 normally	 in	 DMEM	 (complete)	
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(untreated	control)	or	 treated	 in	a	1:1	dilution	of	either	S.	aureus	or	P.	aeruginosa	
PCM	and	BCM.	The	untreated	scratch	controls	showed	complete	closure	at	72	hours	
(see	Figure	4.2,	A).	There	was	no	significant	reduction	in	percentage	wound	closure	
in	NFs	treated	with	S.	aureus	PCM	(49.1%	±	24.8%)	and	BCM	(67.5%	±	15.6%)	after	72	
hours	when	compared	 to	 the	untreated	scratch	control	 (97.4%	±	3.6%)	 (see	Figure	
4.3).	 After	 48	 hours,	 NFs	 treated	 with	 P.	 aeruginosa	 PCM	 and	 BCM	 showed	 a	
significant	 reduction	 in	 percentage	 closure	 (-48.3%	 ±	 40.4%	 and	 -17.8%	 ±	 63.0%)	
when	compared	to	the	control	(78.5%	±	11.4%)	(P	<0.05	and	P	<0.0001	respectively)	
with	 BCM	 causing	 a	 significant	 reduction	 in	 closure	 when	 compared	 with	 PCM	 (P	
<0.0001).	 Furthermore	 a	 significant	 reduction	 in	 closure	 was	 detected	 in	 P.	
aeruginosa	PCM	treated	cultures	in	comparison	with	S.	aureus	PCM	(36.5%	±	14.4%)	
treated	 cultures	 at	 48	 hours	 (P	 <0.0001).	 After	 72	 hours,	 significant	 differences	 in	
percentage	closure	were	still	seen	in	NFs	treated	with	P.	aeruginosa	PCM	and	BCM	(-
64.7%	 ±	 29.2%	 and	 -17.7%	 ±	 63.0%)	 when	 compared	 with	 the	 untreated	 scratch	
control	 (P	 <0.0001).	 Furthermore	 differences	 in	 closure	 were	 noted	 between	 S.	
aureus	 and	 P.	 aeruginosa	 PCM	 (P	 <0.0001),	 S.	 aureus	 and	 P.	 aeruginosa	 BCM	 (P	
<0.0001)	and	P.	aeruginosa	PCM	and	BCM	(P	<0.01).		
The	 assessment	 of	 scratch	 closure	 in	 fibroblasts	 isolated	 from	 chronic	 wound	
granulation	tissue,	also	referred	to	 in	this	chapter	as	 ‘granulation	tissue	fibroblasts’	
or	‘GTFs’,	showed	complete	scratch	wound	closure	after	48	hours,	unlike	NFs,	which	
took	72	hours	to	reach	complete	closure	(see	Figure	4.2,	B).	Control	GTF	scratches	in	
DMEM	(complete)	showed	an	average	percentage	closure	of	77.2%	±	7.9%	after	24	
hours	 and	 99.5%	±	 0.9%	 closure	 after	 48	 hours	 (see	Figure	 4.4).	 After	 24	 hours	 in	
culture,	 cells	 treated	with	 S.	 aureus	 PCM	 showed	 55.6%	 ±	 11.1%	 closure	 that	was	
significantly	 reduced	when	 compared	 to	 the	untreated	 control	 (P	 <0.05).	S.	 aureus	
BCM-treated	 cells	 showed	 a	 89.0%	 ±	 7.8%	 closure	 after	 24	 hours,	 which	 was	
significantly	higher	than	percentage	wound	closure	in	S.	aureus	PCM-	treated	cells	(P	
<0.0001).	 Furthermore,	 GTFs	 treated	 with	 P.	 aeruginosa	 PCM	 and	 BCM	 showed	
significant	 reduction	 in	 scratch	 closure	 (12.8%	 ±	 8.1%	 and	 37.6%	 ±	 10.3%	
respectively)	when	 compared	with	 the	 control	 (P	 <0.0001)	 and	when	 compared	 to	
each	 other	 (P	 <0.001).	 At	 48	 hours,	 cells	 treated	 with	 S.	 aureus	 PCM	 and	 BCM	
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reached	93.6%	±	9.2%	and	99.9%	±	0.1%	closure,	comparable	to	the	control.	Scratch	
closure	 of	 P.	 aeruginosa	 PCM-	 and	 BCM-treated	 cells	 was	 greatly	 reduced	 when	
compared	to	the	control	with	an	average	percentage	closure	of	13.2%	±	10.5%	and	
16.3%	±	21.2%	(P	<0.0001).	
	
	
Figure	 4.1	 Representative	 images	 of	 equine	 normal	 skin	 fibroblasts	 and	 chronic	
wound	granulation	tissue	fibroblasts.	
Normal	fibroblasts	(NFs)	(A)	were	isolated	from	the	intact	skin	of	equine	lower	legs	
obtained	from	the	abattoir.	Granulation	tissue	fibroblasts	(GTFs)	were	isolated	from	
the	granulation	tissue	of	equine	chronic	 lower	 limb	wounds	 following	debridement	
for	clinical	purposes.	Skin	and	tissue	samples	were	gently	cleaned	and	cut	into	2mm	x	
2mm	 pieces	 before	 culturing	 the	 tissue	 in	 supplemented	 cell	 culture	 medium.	
Fibroblasts	could	be	visualised	after	5	days	in	culture.	Images	were	taken	at	passage	
2	 of	 cell	 culture	 at	 x10	 magnification.	 Scale	 bar	 represents	 100μm.
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Figure	4.2	Representative	 images	of	(A)	normal	fibroblast	(NF)	and	(B)	granulation	tissue	fibroblast	(GTF)	scratch	wounds	after	treatment	
with	equine	wound-derived	S.	aureus	and	P.	aeruginosa	planktonic-	and	biofilm-conditioned	medium.	
Abbreviations	 include	 planktonic-conditioned	 medium	 (PCM)	 and	 biofilm-conditioned	 medium	 (BCM).
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Figure	4.3	Percentage	scratch	wound	closure	of	normal	fibroblasts	(NFs)	in	vitro.	
Results	are	shown	for	NFs	treated	with	either	S.	aureus	or	P.	aeruginosa	planktonic-
conditioned	 medium	 (PCM)	 and	 biofilm-conditioned	 medium	 (BCM).	 Results	
represent	the	mean	values	±	standard	deviation	(biological	replicates:	S.	aureus	n=7	
and	P.	aeruginosa	n=7,	technical	replicates	n=3).	NFs	were	used	between	passage	3	
and	5.	Statistical	analysis	was	performed	using	two-way	analysis	of	variants	(ANOVA)	
with	 Tukey’s	 multiple	 comparisons	 test.	 Statistical	 significance	 is	 indicated	 as	 *P	
<0.05	and	**P	<0.0001	when	compared	with	the	control	group.	
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Figure	 4.4	 Percentage	 scratch	 wound	 closure	 of	 granulation	 tissue	 fibroblasts	
(GTFs)	in	vitro.	
Results	are	shown	for	GTFs	treated	with	either	S.	aureus	or	P.	aeruginosa	planktonic-
conditioned	 medium	 (PCM)	 and	 biofilm-conditioned	 medium	 (BCM).	 Results	
represent	the	mean	values	±	standard	deviation	(biological	replicates:	S.	aureus	n=7	
and	P.	aeruginosa	n=7,	technical	replicates	n=3).	NFs	were	used	between	passage	3	
and	5.	Statistical	analysis	was	performed	using	two-way	analysis	of	variants	(ANOVA)	
with	 Tukey’s	 multiple	 comparisons	 test.	 Statistical	 significance	 is	 indicated	 as	 *P	
<0.05	and	**P	<0.0001	when	compared	with	the	control	group.		
	
	
4.3.2 Secretion	of	equine	fibroblast	matrix	metalloproteases	(MMPs)	in	response	to	
S.	 aureus	 and	 P.	 aeruginosa	 planktonic-conditioned	 medium	 (PCM)	 and	
biofilm-conditioned	medium	(BCM)	
In	 order	 to	 determine	 whether	 the	 treatment	 of	 equine	 fibroblasts	 taken	 from	
normal	 skin	 and	 chronic	 wound	 granulation	 tissue,	 secrete	 proteases	 into	 their	
surrounding	medium	following	incubation	with	S.	aureus	and	P.	aeruginosa	PCM	and	
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BCM,	 conditioned	 medium	 samples	 from	 the	 in	 vitro	 scratch	 assay	 were	 run	 on	
gelatin	 zymograms.	 Controls	 included	 DMEM	 culture	 medium	 alone	 and	 the	
conditioned	medium	from	untreated	scratches.	S.	aureus	and	P.	aeruginosa	PCM	and	
BCM	alone	were	also	 run	on	 the	 zymogram	 to	determine	 the	proteases	 that	were	
bacterial-derived.	 Proteolytic	 bands	 of	 approximately	 80kDa	 and	 60kDa	 were	
detected	in	the	DMEM	and	untreated	NF	and	GTF	scratch	controls	(see	Figure	4.5,	A	
and	Figure	4.6,	A).	 Interestingly,	 the	80kDa	band	was	not	present	 in	P.	aeruginosa	
PCM	and	BCM	alone	and	P.	aeruginosa	PCM-	and	BCM-treated	NFs	and	GTFs.		
The	bacterial-conditioned	medium	used	in	the	NF	scratch	assay	showed	only	a	60kDa	
protease	 band	 (see	 Figure	 4.5,	 A).	 Interestingly,	 the	 conditioned	 medium	 of	 NFs	
treated	with	P.	 aeruginosa	PCM	 showed	 the	 presence	 of	 an	 approximately	 57kDa	
protease	band	at	48	and	72	hours.	The	57kDa	protease	band	was	also	detected	in	the	
conditioned	medium	 of	 NFs	 treated	 with	 P.	 aeruginosa	 BCM	 at	 48	 and	 72	 hours,	
however	an	additional	protease	band	of	approximately	38kDa	was	also	detected	at	
48	 and	 72	 hours	 (see	 Figure	 4.5,	 A).	 To	 see	 whether	 the	 proteolytic	 bands	 were	
metalloproteases,	the	zymograms	were	inhibited	with	EDTA	(see	Figure	4.5,	B).	The	
80kDa,	 60kDa	 and	38kDa	protease	bands	were	 successfully	 inhibited,	 however	 the	
62kDa	protease	present	in	P.	aeruginosa	BCM	alone	and	P.	aeruginosa	BCM-treated	
NF	conditioned	medium	remained	uninhibited	(see	Figure	4.5,	B).	
Zymography	of	P.	 aeruginosa	 PCM	and	BCM	alone,	 used	 in	 the	GTF	 scratch	 assay,	
showed	the	presence	of	a	62kDa	band	but	also	the	presence	of	the	52kDa	bacterial-
derived	 band,	 previously	 identified	 in	 Chapter	 3	 of	 this	 thesis.	 However	 another	
bacterial-derived	band	of	approximately	42kDa	was	present,	as	shown	by	the	red	box	
in	 Figure	 4.6,	A.	 Furthermore,	 upon	 treating	 the	 zymograms	with	 EDTA,	 all	 bands	
were	 inhibited	 except	 for	 the	 bacterial-derived	 52kDa	 and	 42kDa	 protease	 bands	
(See	Figure	4.6,	B).	The	treatment	of	GTFs	with	P.	aeruginosa	PCM	and	BCM	did	not	
elicit	the	release	of	host-derived	proteases.	
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Figure	4.5	Representative	zymography	of	supernatants	from	the	normal	fibroblast	
(NF)	scratch	wound	assay	following	P.	aeruginosa	PCM	and	BCM	treatment.	
Supernatants	from	P.	aeruginosa	PCM-	and	BCM-treated	cells	after	24	and	48	hours	
were	 run	 on	 gelatin	 zymograms,	 which	 were	 either	 untreated	 (A)	 or	 inhibited	 for	
metalloproteases	 using	 100mM	EDTA	 (B).	 Controls	 include	DMEM	 culture	medium	
alone	 and	 an	 untreated	 scratch	 control.	 The	 red	 arrows	 indicate	 the	 presence	 of	
proteases	that	are	of	interest	and	the	black	arrows	indicate	the	loss	of	protease	band	
post-treatment.	 Gelatin	 zymography	 of	 all	 supernatants	 from	 P.	 aeruginosa	 PCM-	
and	BCM-treated	cells	were	run	and	repeated	twice	(technical	replicates,	n=2).	
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Figure	 4.6	 Representative	 zymography	 of	 supernatants	 from	 granulation	 tissue	
fibroblast	 (GTF)	 scratch	 wound	 assay	 following	 P.	 aeruginosa	 PCM	 and	 BCM	
treatment.	
Supernatants	from	P.	aeruginosa	PCM-	and	BCM-treated	cells	after	24	and	48	hours	
were	 run	 on	 gelatin	 zymograms,	 which	 were	 either	 untreated	 (A)	 or	 inhibited	 for	
metalloproteases	 using	 100mM	EDTA	 (B).	 Controls	 include	DMEM	 culture	medium	
alone	and	an	untreated	scratch	control.	The	red	box	indicates	point	of	interest.	The	
red	 arrows	 indicate	 the	 presence	 of	 proteases	 that	 are	 of	 interest	 and	 the	 black	
arrows	indicate	the	loss	of	protease	band	post-treatment.		Gelatin	zymography	of	all	
supernatants	from	P.	aeruginosa	PCM-	and	BCM-treated	cells	were	run	and	repeated	
twice	(technical	replicates,	n=2).		
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4.3.3 The	expression	of	matrix	metalloproteases	(MMPs)	in	equine	normal	skin	and	
chronic	wound	granulation	tissue		
Normal	tissue	obtained	from	the	 lower	 leg	of	horse	was	stained	with	haematoxylin	
and	 eosin	 (H&E)	 to	 reveal	 a	 distinct	 epidermal	 layer	 whereby	 the	 basal	 cell	 layer	
(stratum	basale),	stratum	spinosum	and	the	stratum	coreum	were	easily	identifiable.	
The	dermis	of	the	normal	skin	was	composed	of	a	network	of	collagen	fibres,	which	
could	 be	 seen	 as	 pale	 pink	 using	 H&E	 staining	 or	 blue	 using	 Masson’s	 trichrome	
staining.	Furthermore,	the	dermis	contained	hair	follicles,	shown	by	the	right-facing	
arrows	(see	Figure	4.7),	which	were	seen	as	hollow	circular	structures	surrounded	by	
an	 epithelial	 layer.	 Sebaceous	 glands	 were	 identified	 near	 to	 the	 base	 of	 the	 hair	
follicles	 (see	 Figure	 4.7,	 A	 and	 C).	 Histological	 assessment	 of	 equine	 granulation	
tissue	taken	from	chronic	wounds	showed	a	complete	absence	of	an	epidermal	layer	
at	the	wound	edge	and	a	 large	 inflammatory	cell	 infiltrate,	which	was	 identified	by	
the	 presence	 of	 blue/purple	 nuclei.	 In	 addition,	 there	 appeared	 to	 be	 numerous	
‘pockets’	of	 red	staining	present	 in	 the	granulation	tissue,	which	are	 thought	 to	be	
the	presence	of	red	blood	cells.	Masson’s	trichrome	staining	showed	the	presence	of	
collagen	(pale	blue),	however	the	staining	was	not	as	strong	as	the	collagen	staining	
in	 normal	 skin	 and	 there	 was	 a	 distinct	 lack	 of	 collagen	 fibre	 organisation.	 The	
presence	 of	 hair	 follicles	 and	 sebaceous	 glands	 were	 not	 detected	 in	 granulation	
tissue	(see	Figure	4.7,	B	and	D).		
Normal	 skin	 and	 granulation	 tissue	were	 treated	with	 a	Gram	 stain	 to	 identify	 the	
presence	of	microorganisms	within	the	tissue	(see	Figure	4.8,	B	and	C).	Infected	lung	
tissue	 was	 used	 as	 a	 positive	 control	 (provided	 by	 Veterinary	 histopathology	
laboratory,	 University	 of	 Liverpool),	 clearly	 showing	 clusters	 of	 Gram-positive	
bacteria	 (black)	 (see	Figure	4.8,	A).	 As	 expected,	 the	presence	of	Gram-positive	or	
Gram-negative	 bacteria	was	 not	 detected	 in	 normal	 skin.	 However	 after	 thorough	
microscopic	examination,	the	presence	of	bacteria	in	any	chronic	wound	granulation	
tissue	 samples	were	not	detected	either,	 contrary	 to	 the	 findings	of	Westgate	and	
co-workers	(Westgate	et	al.	2011).	
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MMP-2	 antibody	 staining	 of	 normal	 skin	 showed	 strong	 positive	 staining	 in	 the	
epidermal	layer,	specifically	the	basal	cell	layer	and	the	stratum	spinosum,	but	also,	
to	a	lesser	extent,	in	the	epithelial	layer	surrounding	the	hair	follicles.	Slight	positive	
staining	was	seen	in	MMP-2-negtive	control,	particularly	 in	some	of	the	cells	of	the	
basal	 layer	 and	 epithelium	 surrounding	 the	 hair	 follicles.	 The	 dermal	 layer	 of	 the	
normal	skin	showed	faint	MMP-2	positive	staining	that	was	comparable	in	intensity	
to	 the	 positive-control	 stained	 tissue	 (see	 Figure	 4.9,	A,	C	 and	E).	MMP-2	 staining	
was	 similar	 in	 all	 normal	 skin	 samples	 assessed.	 Chronic	wound	 granulation	 tissue	
showed	faint	MMP-2-positive	staining	throughout	the	tissue	when	compared	to	the	
controls,	however	strong	staining	was	identified	in	an	irregular	manner,	adjacent	to	
the	wound	edge,	although	this	was	not	seen	in	all	samples	(see	Figure	4.9,	B	and	D).	
Similarly,	 normal	 skin	 sections	 stained	 with	 an	 MMP-9	 antibody	 showed	 strong	
staining	in	the	basal	cell	layer	and	stratum	spinosum	of	the	epidermal	layer	and	the	
epithelium	 surrounding	 the	 hair	 follicles	 and	 sebaceous	 glands,	 which	 was	
comparable	 to	 the	MMP-9-positive	control.	The	collagen	 fibres	of	 the	dermal	 layer	
were	not	positive	for	MMP-9	and	were	comparable	to	the	MMP-9	negative	control	
(see	 Figure	 4.10,	 A,	 C	 and	 E).	 Chronic	 wound	 granulation	 tissue	 samples	 showed	
MMP-9	 positivity	 ubiquitously	 throughout	 the	 tissue	 when	 compared	 with	 the	
negatively	 stained	 control	 section	 (see	 Figure	 4.10,	 B	 and	 D).	 MMP-13-positive	
staining	was	observed	in	the	epidermal	layer	of	normal	skin,	with	particularly	strong	
staining	in	the	stratum	granulosum,	the	layer	of	the	epidermis	directly	beneath	the	
stratum	corneum,	when	compared	with	the	negatively	stained	control.	Furthermore,	
whilst	 MMP-13	 staining	 was	 detected	 throughout	 the	 dermal	 layer,	 particularly	
strong	 staining	 was	 seen	 in	 the	 epithelium	 surrounding	 the	 hair	 follicles	 and	 the	
sebaceous	glands	 (see	Figure	4.11,	A,	C	 and	E).	 In	 chronic	wound	 tissue,	MMP-13-
positive	 staining	was	 ubiquitous	when	 compared	 to	 the	 negatively	 stained	 control	
section,	however	the	intensity	of	staining	was	not	as	strong	as	the	MMP-13-positive	
control	 tissue	 (see	 Figure	 4.11,	 B,	 D	 and	 E).
Page	130	of	253	
	
	
	 	
Page	131	of	253	
	
	
Figure	4.7	Comparison	of	 the	basic	histological	 features	of	normal	 equine	 skin	 (A	and	C)	 and	equine	 chronic	wound-derived	 granulation	
tissue	(B	and	D)	stained	with	haematoxylin	and	eosin	(A	and	B)	and	Masson's	trichrome	(C	and	D).	
Black	arrow	indicates	hair	follicle;	vertical	line	highlights	the	epidermal	layer	and	asterisks	(*)	indicate	the	outer	wound	edge.	Images	shown	are	
at	x10	magnification.	Scale	bar	represents	100μm.	Biological	replicates,	n=8.
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Figure	4.8	Gram	staining	of	normal	equine	skin	(B)	and	equine	chronic	wound-derived	granulation	tissue	(C).	
For	 a	 positive	 control,	 chronic	 infected	 lung	 tissue	 (A)	was	 used.	 Black	 left-pointing	 arrows	 indicate	Gram-positive	 bacterial	 colonies;	 black	
right-pointing	 arrow	 indicates	 hair	 follicle;	 vertical	 line	 highlights	 the	 epidermal	 layer	 and	 the	 asterisk	 (*)	 indicates	 the	 outer	wound	 edge.	
Images	 shown	 are	 at	 x10	 magnification.	 Scale	 bar	 represents	 100μm.	 Biological	 replicates,	 n=8.
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Figure	4.9	The	presence	of	matrix	metalloprotease-2	(MMP-2)	in	equine	normal	skin	(A	and	C)	and	chronic	wound-derived	granulation	tissue	
(B	and	D).	
Tissue	from	the	mammary	mass	of	a	cat	was	used	for	MMP-2	positive	control	(E).	Images	(A)	and	(B)	represent	negative	staining	controls.	Black	
right-pointing	arrows	 indicate	hair	 follicles;	 vertical	 line	highlights	 the	epidermal	 layer	and	 the	asterisk	 (*)	 indicates	 the	outer	wound	edge.	
Images	shown	are	at	x10	magnification.	Scale	bar	represents	100μm.	Biological	replicates,	n=8.	
Page	134	of	253	
	
	
Figure	4.10	 The	presence	of	matrix	metalloprotease-9	 (MMP-9)	 in	 equine	normal	 skin	 (A	 and	C)	 and	 chronic	wound-derived	 granulation	
tissue	(B	and	D).	
Tissue	from	the	mammary	mass	of	a	cat	was	used	for	MMP-9	positive	control	(E).	Images	(A)	and	(B)	represent	negative	staining	controls.	Black	
right-pointing	arrows	 indicate	hair	 follicles;	 vertical	 line	highlights	 the	epidermal	 layer	and	 the	asterisk	 (*)	 indicates	 the	outer	wound	edge.	
Images	shown	are	at	x10	magnification.	Scale	bar	represents	100μm.	Biological	replicates,	n=8.	
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Figure	4.11	The	presence	of	matrix	metalloprotease-13	(MMP-13)	in	equine	normal	skin	(A	and	C)	and	chronic	wound-derived	granulation	
tissue	(B	and	D).	
Tissue	from	the	mammary	mass	of	a	cat	was	used	for	MMP-13	positive	control	(E).	Images	(A)	and	(B)	represent	negative	staining	controls.	
Black	right-pointing	arrows	indicate	hair	follicles;	vertical	line	highlights	the	epidermal	layer	and	the	asterisk	(*)	indicates	the	outer	wound	
edge.	Images	shown	are	at	x10	magnification.	Scale	bar	represents	100μm.	Biological	replicates,	n=8.
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4.4 Discussion	
One	 of	 the	 aims	 of	 this	 chapter	 was	 to	 assess	 the	 effect	 of	 bacterial-conditioned	
medium,	 in	planktonic	and	biofilm	form,	on	the	wound	healing	of	NFs	and	GTFs,	to	
understand	 the	 potential	 role	 bacteria	 plays	 in	 equine	 wound	 repair.	 A	 study	 by	
Kirker	 and	 colleagues	 showed	 a	 significant	 decrease	 in	 human	 dermal	 fibroblast	
scratch	 closure	when	 treated	with	methicillin-resistant	 S.	 aureus	 (MRSA)	 PCM	 and	
BCM	 (Kirker	 et	 al.	 2012),	 therefore	 it	 was	 expected	 that	 the	 bacterial-conditioned	
medium	 used	 in	 this	 chapter	 would	 also	 reduce	 scratch	 closure	 in	 equine-derived	
fibroblasts.	 Indeed,	 this	 study	 showed	 a	 significant	 reduction	 in	 NF	 and	 GTF	
percentage	scratch	closure	upon	treatment	with	P.	aeruginosa	PCM	and	BCM.	This	is	
the	first	study	to	demonstrate	the	effect	of	bacterial-conditioned	medium	on	equine	
fibroblast	scratch	closure.		
In	 this	 chapter,	 it	 appeared	 that	NFs	were	much	more	 sensitive	 to	 treatment	with	
bacterial-conditioned	 medium	 than	 the	 GTFs.	 Furthermore,	 NFs	 took	 72	 hours	 to	
reach	over	95%	scratch	closure,	compared	to	GTFs,	which	were	able	to	achieve	this	
closure	 in	 48	 hours.	 The	 differences	 noted	 between	 the	 effects	 of	 bacterial-
conditioned	 medium,	 particularly	 P.	 aeruginosa	 PCM	 and	 BCM,	 on	 NFs	 and	 GTFs	
could	 indicate	 potential	 differential	 effects	 of	 bacterial	 biofilms	 in	 acute	 wounds,	
where	one	may	expect	the	presence	of	normal	fibroblasts,	and	in	granulating	chronic	
wounds,	 where	 the	 presence	 of	 granulation	 tissue	 fibroblasts	 reside.	 Therefore,	
although	it	 is	thought	that	biofilms	may	lead	to	the	development	of	human	chronic	
wounds	(Bjarnsholt	et	al.	2008),	the	presence	of	biofilms	 in	equine	chronic	wounds	
with	 exuberant	 granulation	 tissue,	 may	 not	 have	 a	 significant	 effect	 on	 fibroblast	
migration	and	viability	in	vivo.		
There	are	a	number	of	studies	that	have	investigated	equine	wound	healing,	utilising	
equine	 limb	 fibroblasts	 (normal	 fibroblasts).	 For	 example	 Rose	 investigated	 the	 in	
vitro	 wound	 closure	 rates	 of	 fibroblasts	 isolated	 from	 equine	 oral	 muscosa	 and	
equine	limb	skin	in	response	to	various	growth	factors	(Rose	2012).	The	author	found	
that	 transforming	 growth	 factor	 beta-1	 (TGF-β1),	 platelet-derived	 growth	 factor	
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(PDGF)	 and	 fibroblast	 growth	 factor-2	 (FGF-2)	 had	 differential	 effects	 on	 limb	
fibroblasts	 and	 oral	 mucosa	 fibroblasts,	 potentially	 providing	 an	 insight	 into	 the	
varying	 clinical	 outcomes	 of	 wounding	 in	 these	 different	 regions.	 In	 the	 study	 by	
Rose,	limb	fibroblasts	showed	complete	wound	closure	in	36	hours,	in	contrast	to	the	
72	 hours	 for	NFs	 in	 this	 chapter,	 however	 this	may	 be	 due	 to	 the	 collagen-coated	
surface	 in	 which	 the	 fibroblasts	 were	 able	 to	 migrate	 across.	 Furthermore,	 the	
method	in	which	the	scratch	was	created	in	this	study	differs	to	the	scratch	made	by	
Rose,	where	a	vacuum	suction	and	a	200μl	pipette	tip	were	used	to	make	a	circular	
wound.	 Another	 study,	 reported	 increased	 equine	 dermal	 fibroblast	 migration	 in	
response	 to	mesenchymal	 stromal	 cell	 conditioned	medium,	 in	 an	 in	 vitro	 scratch	
closure	 model	 (Bussche	 et	 al.	 2015),	 however	 these	 cells	 were	 from	 an	 already	
established	 cell	 line.	 The	 isolation	 and	 characterisation	 of	 fibroblasts	 from	 normal	
skin	 and	 the	 granulation	 tissue	 of	 chronic	 wounds	 have	 been	 performed	 before.	
Cochrane	 and	 colleagues	 assessed	 the	morphology	 and	 proliferation	 rates	 of	 both	
NFs	 and	 GTFs	 and	 subsequently	 found	 that	 GTFs	 appeared	 more	 cuboidal	 in	
morphology,	 compared	 to	 the	 spindle-like	 NFs,	 which	 support	 the	 findings	 in	 this	
chapter.	Furthermore,	the	assessment	of	proliferation	in	NFs	and	GTFs	showed	faster	
growth	rates	in	NFs	when	compared	to	GTFs	(Cochrane	et	al.	1996),	although	growth	
rates	were	not	assessed	in	this	chapter.	
In	this	chapter,	zymography	was	used	to	detect	the	presence	of	proteases	in	samples	
of	 the	medium	 taken	at	 varying	 time	points	of	 the	 in	 vitro	 scratch	assays.	 The	aim	
was	 to	 determine	 whether	 equine-derived	 fibroblasts	 from	 normal	 skin	 and	
granulation	tissue	secrete	proteases	in	response	to	the	soluble	products	of	bacteria	
(isolated	from	wounds)	 in	planktonic	and	biofilm	form.	 In	addition	to	the	bacterial-
derived	 proteases	 and	 proteases	 secreted	 by	 the	 fibroblasts	 cultured	 in	 DMEM	
(complete),	 a	 57kDa	 metalloprotease	 was	 secreted	 by	 NFs	 in	 response	 to	 P.	
aeruginosa	PCM	and	BCM,	but	also	a	38kDa	metalloprotease	was	secreted	from	NFs	
treated	with	P.	 aeruginosa	 BCM.	 Based	 on	 the	molecular	weight	 and	 inhibition	 by	
EDTA,	it	is	possible	that	the	57kDa	protease	is	that	of	the	stromelysins,	MMP-3	and	
MMP-10,	which	both	have	a	molecular	weight	of	57kDa	in	their	latent	enzyme	form.	
However	published	molecular	weights	of	MMPs	that	are	run	on	SDS-PAGE	may	not	
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have	 the	 same	 molecular	 weight	 when	 run	 on	 a	 gelatin	 zymogram.	 Therefore	
additional	 studies	 whereby	 known	 MMP-3	 and	 MMP-10	 controls	 are	 run	 on	 the	
same	zymograms	would	help	to	confirm	this.		
Interestingly,	no	additional	and	potentially	host-derived	proteases	were	detected	in	
the	 medium	 of	 GTFs	 treated	 with	 bacterial-conditioned	 medium.	 Given	 the	
characteristic	over-production	of	granulation	tissue	in	chronic	wounds,	these	results	
could	 suggest	 a	 potential	 dampening	 in	 the	 secretion	 of	 MMPs	 from	 granulation	
tissue	 fibroblasts	 in	 the	 context	 of	 the	 complex	 environment	 of	 equine	 chronic	
wounds,	 leading	 to	 an	 overproduction	 of	 extracellular	 matrix	 components	 and	 a	
fibroproliferative	 state.	 However	 research	 into	 keloid-derived	 fibroblasts	 in	 human	
has	shown	an	increase	in	the	secretion	of	active	MMP-2	when	compared	to	a	normal	
skin	 dermal-derived	 fibroblasts	 (Imaizumi	 et	 al.	 2009).	 Though	 the	 use	 of	 gelatin	
zymography	alone	does	not	 allow	 the	 identification	of	 all	MMPs,	 therefore	 further	
investigation	 of	 other	 MMPs	 in	 this	 experimental	 setting	 using	 such	 methods	 as	
enzyme-linked	 immunosorbent	assay	 (ELISA),	may	give	a	better	understanding	 into	
the	protease	secretome.		
An	interesting	observation	was	the	presence	of	two	protease	bands	in	P.	aeruginosa-
conditioned	medium	used	in	the	GTF	scratch	assay,	as	opposed	to	the	single	52kDa	
protease	band	identified	 in	Chapter	3	and	in	the	NF	scratch	assay.	One	explanation	
for	this	is	the	use	of	DMEM	to	obtain	the	PCM	and	BCM.	In	Chapter	3	of	this	thesis,	
bacterial	PCM	and	BCM	were	obtained	using	Mueller	Hinton	broth	(MHB),	a	standard	
microbiological	 growth	medium.	 However	 the	 use	 of	MHB	 on	mammalian	 cells	 in	
culture	caused	cell	death	(data	not	shown),	and	therefore	it	was	decided	that	the	use	
of	mammalian	cell	culture	medium,	in	this	case	DMEM,	would	be	more	appropriate	
to	create	bacterial	PCM	and	BCM	that	could	be	used	to	treat	the	equine	fibroblasts.	
Therefore	 the	 change	 in	 growth	 medium	 could	 have	 affected	 the	 release	 of	
proteases	 from	 P.	 aeruginosa.	 There	 is	 however,	 the	 matter	 of	 differing	 protease	
profiles	 between	 the	 P.	 aeruginosa-conditioned	 medium	 used	 in	 the	 NF	 and	 GTF	
scratch	assay,	whereby	an	additional	band	of	42kDa	was	detected	in	the	GTF	scratch	
assay.	 Indeed,	fresh	batches	of	bacterial-conditioned	medium	were	used	for	the	NF	
and	GTF	 scratch	 assay,	 and	 although	 the	methodology	 for	 obtaining	 the	 bacterial-
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conditioned	medium	remained	the	same	between	batches,	changes	to	the	secretion	
of	bacterial	proteases	may	occur	after	sub-culturing.	
The	assessment	of	normal	equine	skin	and	chronic	wound-derived	granulation	tissue	
using	basic	histology	staining	and	immunohistochemistry	was	performed	in	order	to	
assess	 potential	 differences	 in	 the	 expression	 of	 MMPs	 between	 these	 tissues.	
Furthermore,	 following	 the	 identification	 of	 bacterial	 biofilms	 in	 equine	 chronic	
wounds	(Westgate	et	al.	2011),	I	aimed	to	discover	whether	the	presence	of	bacterial	
biofilms	 in	 granulation	 tissue,	 affected	 the	 expression	 of	 MMPs	 within	 the	
surrounding	tissue.	Surprisingly,	in	all	eight	chronic	wound-derived	granulation	tissue	
samples	examined,	bacterial	biofilms	were	not	identified.	Potential	reasons	as	to	why	
these	findings	do	not	corroborate	the	findings	of	Westgate	and	colleagues	could	be	
due	to	treatment	of	the	horse	prior	to	obtaining	the	samples.	The	criteria	for	chronic	
wound	sampling	in	this	study	included	wounds	that	had	not	been	treated	topically	by	
means	 of	 cleansing	 or	 scrubbing	 the	 wound	 with	 antimicrobials.	 However	 it	 is	
possible	 that	 treatment	with	antibiotics	could	have	occurred,	which	may	affect	 the	
bioburden	of	the	wound.		
Immunohistochemistry	 showed	 MMP-2	 positive	 staining	 was	 near	 to	 the	 wound	
edge	 of	 the	 granulation	 tissue,	 with	 faint	 staining	 in	 the	 surrounding	 tissue.	 A	
significant	up-regulation	in	the	expression	of	MMP-2,	TIMP-1	and	TIMP-2	mRNA	and	
secreted	 TIMP-1	 in	 keloid	 tissue	 and	 hypertrophic	 scars	 has	 been	 recorded	 in	
humans,	 whereby	 the	 ratio	 of	 MMPs:TIMPs	 is	 reduced	 (Ulrich	 et	 al.	 2010).	
Furthermore,	the	expression	of	MMP-2	has	been	shown	to	be	located	in	the	collagen	
bundles	of	human	keloid	tissue	(Imaizumi	et	al.	2009),	which	may	provide	a	possible	
explanation	 for	 this	 localisation.	 Strong	 MMP-9	 staining	 was	 detected	 evenly	
throughout	equine	granulation	tissue,	which	has	also	been	demonstrated	in	human	
tissue.	MMP-9	plays	a	 role	 in	 keratinocyte	migration	 in	 the	wound	healing	process	
and	has	been	shown	to	be	localised	to	the	epithelium	in	the	oral	mucosa,	but	is	also	
strongly	 expressed	 in	 the	 granulation	 tissue	 of	 wounded	 oral	 mucosa	 (Salo	 et	 al.	
1994).		
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MMP-13	 was	 detected	 ubiquitously	 in	 equine	 chronic	 wound-derived	 granulation	
tissue.	MMP-13	has	been	documented	to	regulate	the	growth	of	granulation	tissue,	
which	 has	 been	 demonstrated	 by	 delayed	 myofibroblast	 organisation	 and	
granulation	 tissue	 growth	 in	 MMP-13-/-	 mice	 (Toriseva	 et	 al.	 2012).	 Furthermore,	
MMP-13	has	also	been	associated	with	pathologies	such	as	equine	laminitis	whereby	
evidence	 shows	 an	 up-regulation	 of	 MMP-13	 in	 the	 laminae	 of	 carbohydrate-
overload	laminitis,	suggesting	a	role	for	MMP-13	in	extracellular	matrix	degradation	
(Wang	et	al.	2014).	
	
4.4.1 Limitations	
There	are	of	course	 limitations	 to	 this	 study	 for	example;	 the	mechanism	by	which	
wound	closure	 is	achieved	 in	 this	 study	 is	neither	due	 to	migration	or	proliferation	
alone,	 but	more	 likely	 a	 combination	 of	 both.	 Therefore	 the	 term	 ‘migration’	with	
relation	 to	 fibroblast	wound	 closure	 is	 avoided.	 Studies	 such	 as	 those	of	 Rose	 and	
Bussche	 and	 colleagues,	 as	mentioned	 earlier,	 assess	 fibroblast	migration	 in	 the	 in	
vitro	 scratch	 assay	 only	 after	 the	 incorporation	 of	 mitomycin	 C,	 which	 effectively	
inhibits	mitosis,	 eliminating	 proliferation	 as	 a	 source	 for	wound	 closure.	Albeit	 the	
contribution	of	proliferation	towards	wound	closure	 in	these	studies	were	minimal.	
Furthermore,	the	fibroblasts	isolated	from	normal	equine	skin	and	granulation	tissue	
were	 not	 characterised	 using	 antibodies	 for	 fibroblasts-specific	markers.	 However,	
the	method	used	to	isolate	these	fibroblasts	is	well	published	(Cochrane	et	al.	1996)	
and	contaminating	cells	were	not	observed	throughout	culture.	
It	is	important	to	note	that	the	results	obtained	from	the	use	of	bacterial-conditioned	
medium	 to	 treat	 fibroblasts	 may	 not	 reflect	 the	 outcomes	 of	 using	 planktonic	 of	
biofilm	 bacteria	 directly	 within	 the	 assay.	 Whilst	 the	 soluble	 products	 of	 bacteria	
within	planktonic	and	biofilm	form	clearly	affect	fibroblast	scratch	closure,	this	assay	
does	not	account	for	direct	interactions	between	host	cells	and	bacteria,	nor	does	it	
account	 for	 the	 effects	 of	 host-derived	 soluble	 products	 on	 bacterial	 secretions,	
particular	 extracellular	 proteases.	 Indeed,	 it	 was	 the	 intention	 to	 incorporate	
bacteria	 into	 the	 assay	 by	 means	 of	 a	 0.2μm	 cell	 culture	 insert,	 however	 I	
Page	141	of	253	
	
encountered	many	problems	trying	to	obtain	this	product	as	 it	was	not	available	 in	
most	EU	countries	and	shipping	from	the	US	proved	impossible.	
	
4.4.2 Future	work	
The	 use	 of	 zymography	 in	 this	 chapter	 was	 a	 good	 way	 to	 identify	 host-derived	
secreted	proteases,	however	future	work	would	aim	to	use	more	sensitive	methods	
such	 as	 enzyme-linked	 immunosorbent	 assay	 (ELISA)	 to	 quantitatively	 assess	
secreted	 MMPs.	 Furthermore	 the	 use	 of	 reverse	 transcriptase-polymerase	 chain	
reaction	(RT-PCR)	will	aid	the	understanding	of	protease	gene	expression	within	cells	
treated	with	 bacterial-conditioned	medium.	 Unfortunately	 due	 to	 technical	 issues,	
the	 detection	 of	 TIMPs	 from	equine	 fibroblasts	 using	 reverse	 zymography	was	 not	
possible.	 Given	 the	 characteristic	 excessive	 granulation	 tissue	 formation	 seen	 in	
equine	 chronic	 wounds,	 it	 would	 be	 interesting	 to	 understand	 the	 role	 of	 TIMPs	
within	the	wound.		
Regarding	the	in	vitro	scratch	wound	assay,	future	work	would	aim	to	determine	the	
effect	of	bacterial-conditioned	medium	on	cell	viability	and	proliferation	by	using	cell	
viability	 and	 proliferation	 assays	 such	 as	 PrestoBlue™.	 In	 addition,	 repeating	 these	
studies	on	equine	keratinocytes	may	also	provide	more	information	on	the	effects	of	
bacteria	on	the	re-epithelialisation	of	an	equine	wound.	Advancing	upon	this,	normal	
equine	 skin	 fibroblasts	 and	 equine	 keratinocytes	 could	 be	 used	 to	 create	 a	 3-
dimensional	 co-culture	 skin	 model	 in	 vitro,	 whereby	 wound	 closure	 and	 MMP	
expression	in	the	presence	of	bacterial	biofilms	could	be	assessed	using	histological	
and	immunohistochemistry	techniques.	
	
4.4.3 Key	points	
The	PCM	and	BCM	of	P.	aeruginosa,	but	not	S.	aureus,	isolated	from	equine	wounds,	
caused	 a	 significant	 reduction	 in	 the	 wound	 closure	 of	 NFs	 and	 GTFs	 in	 vitro.	
Furthermore	 it	 appeared	 that	 the	NF	were	much	more	 sensitive	 to	P.	 aeruginosa-
conditioned	medium	than	the	GTFs,	although	 further	experiments	 into	cell	viability	
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needs	to	be	performed.	Conditioned	medium	from	the	 in	vitro	scratch	assays	were	
assessed	 for	 proteases	 using	 gelatin	 zymography.	 The	 conditioned	medium	 of	 NFs	
treated	with	P.	aeruginosa	BCM	contained	57kDa	and	38kDa	metalloproteases	that	
were	 not	 present	 in	 P.	 aeruginosa	 BCM	 alone	 and	 the	 NF	 control	medium.	 There	
appeared	to	be	no	host-derived	proteases	secreted	into	the	conditioned	medium	of	
GTFs	treated	with	bacterial-conditioned	medium.		
Histological	 analysis	of	 chronic	wound-derived	granulation	 tissue	 showed	a	distinct	
lack	of	an	epidermal	layer,	hair	follicles	and	sebaceous	glands	when	compared	with	
normal	equine	skin.	Furthermore,	 there	was	a	 lack	of	collagen	fibre	organisation	 in	
granulation	 tissue.	 Surprisingly,	 the	 presence	 of	 bacterial	 colonies	 in	 granulation	
tissue	samples	was	not	detected.	MMP-9	and	MMP-13	positive	antibody	staining	was	
found	 to	 be	 localised	 in	 the	 epidermis	 and	 the	 epithelial	 cells	 surrounding	 hair	
follicles	 and	 sebaceous	 glands	 in	 normal	 skin,	 whereas	 positive	 staining	 was	
ubiquitous	throughout	the	granulation	tissue.	MMP-2	positive	antibody	staining	was	
localised	to	the	epidermis	 in	normal	skin,	however	whilst	 faint	staining	was	seen	 in	
the	 majority	 of	 granulation	 tissue,	 stronger,	 more	 intense	 MMP-2	 staining	 was	
identified	near	to	the	wound	edge.		
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Chapter	5:		
Results	 III:	 Protease	 activity	 of	 human	 chronic	
wound-derived	bacteria	
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5 Results	III:	Protease	activity	of	human	chronic	wound-derived	bacteria	
	
5.1 Introduction	
Bacterial	 biofilms	 in	wound	healing	 and	 the	management	of	 chronic	wounds	 are	 a	
research	field	that	 is	generating	many	questions.	This	 is	partly	due	to	the	attention	
that	has	been	drawn	to	biofilms	with	regards	to	their	persistence	within	the	host	and	
resistance	to	antimicrobials	within	the	healthcare	setting.	A	popular	example	of	this	
is	 the	 widely	 publicised	 hospital	 ‘super-bug’	 methicillin-resistant	 Staphylococcus	
aureus	(MRSA),	which	is	thought	to	reside	within	a	biofilm,	which	is	a	common	cause	
of	septicaemia	or	bacteraemia	in	a	clinical	setting	(HPA	2012).	Furthermore,	evidence	
of	bacterial	biofilms	on	indwelling	medical	devices	has	been	documented,	such	as	in	
the	case	of	ventilator-associated	pneumonia	(VAP).	Vandecandelaere	and	colleagues	
identified	a	diverse	range	of	microorganisms	 in	biofilm	form	on	endotracheal	tubes	
(ETTs),	from	common	oral-associated	micro-flora	such	as	Acinetobacter,	to	the	more	
clinically	relevant	isolates	including	Pseudomonas	aeruginosa,	Staphylococcus	aureus	
and	Staphylococcus	epidermidis	(Vandecandelaere	et	al.	2012).		
As	 mentioned	 in	 chapter	 1,	 biofilms	 have	 been	 identified	 in	 chronic	 wounds	 of	
humans	 and	 other	 species	 such	 as	 horse	 and	 dog,	 and	 both	 in	 vitro	 and	 in	 vivo	
research	 has	 shown	 that	 the	 presence	 of	 a	 biofilm	 can	 significantly	 delay	 wound	
closure	(Kirker	et	al.	2012,	Gurjala	et	al.	2011)	and	ultimately	retard	wound	healing.	
However,	one	might	question	whether	all	biofilms	are	detrimental	to	wound	healing,	
or	whether	 is	 it	 the	presence	of	biofilms	with	a	predominant	pathogenic	species	of	
microorganism	that	leads	to	impaired	wound	healing.	The	demonstration	of	bacterial	
biofilms	on	sutures	from	both	infected	and	non-infected	wounds	has	highlighted	that	
biofilms	can	indeed	be	present	at	the	wound	site	without	causing	infection	but	that	
there	 is	 a	 difference	 in	 microbial	 profiles	 associated	 with	 clinically	 diagnosed	
infection	and	those	with	no	evidence	of	infection.	Edmiston	and	colleagues	showed	
Corynebacterium	to	be	the	most	commonly	isolated	microorganism	from	the	sutures	
of	non-infected	wounds,	followed	by	Bacillus	spp.	and	S.	epidermidis	(Edmiston	et	al.	
2013).	However	 the	microorganisms	 that	dominated	sutures	 from	 infected	wounds	
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included	 S.	 epidermidis,	 P.	 aeruginosa,	 methicillin-sensitive	 S.	 aureus	 and	 MRSA.	
Although	 there	was	 a	 significant	 difference	 in	 the	 presence	 of	 biofilms	 in	 infected	
wounds	when	compared	to	uninfected	wounds,	66.6%	of	uninfected	wound-derived	
sutures	were	still	positive	for	biofilms.	Research	by	Thomas	Bjarnsholt	and	colleagues	
in	Denmark	have	 advanced	 the	hypothesis	 that	 it	 is	 the	presence	of	P.	 aeruginosa	
biofilms	 that	 prevents	 a	 chronic	 wound	 from	 healing,	 following	 research	 into	 the	
pathogenic	role	of	P.	aerguinosa	in	cystic	fibrosis	(Bjarnsholt	et	al.	2008).	S.	aureus	is	
another	 microorganism	 that	 poses	 a	 potential	 threat	 to	 wound	 healing,	 as	 it	 is	 a	
microorganism	 that	 can	 reside	 asymptomatically	 on	 the	 skin	 of	 approximately	 one	
third	of	human	beings	(Kluytmans	et	al.	1997).	Staphylococcal	infection	on	indwelling	
medical	 devices	 such	 as	 catheters	 is	 a	 common	problem	 in	 the	 healthcare	 setting.	
The	potential	theory	behind	this	complication	identifies	the	lack	of	vascularisation	at	
implantation	 sites,	 which	 impedes	 host	 defences	 against	 colonisation	 (Kiedrowski	
and	Horswill	2011).		
The	 characteristic	 tissue	 degradation	 often	 seen	 in	 chronic,	 non-healing	 wounds	
brought	 about	 the	 theory	of	 a	 potential	 dysregulation	 in	host	 protease	production	
(Velnar	et	al.	2009).	Indeed,	this	theory	was	addressed	and	subsequent	studies	in	the	
1990’s	revealed	significantly	increased	levels	of	specific	MMPs	in	chronic	wound	fluid	
(Wysocki	et	al.	1993,	Nwomeh	et	al.	1999).	More	specifically,	significant	increases	in	
the	 gelatinases	 MMP-2	 and	 MMP-9	 in	 chronic	 wound	 fluid,	 has	 been	 a	 common	
finding	in	a	variety	of	non-healing	chronic	wounds	(Nwomeh	et	al.	1999,	Yager	et	al.	
1996,	Wysocki	et	al.	1993).	In	these	studies,	and	indeed	in	many	studies	investigating	
host	 proteases,	 the	 method	 of	 zymography	 is	 used,	 whereby	 a	 substrate	 is	
incorporated	into	a	polyacrylamide	gel	in	order	to	determine	the	molecular	weight	of	
the	protease	that	degrades	that	particular	substrate	within	the	gel.	This	method	of	
protease	 detection	 is	 not	 specific	 to	 mammalian-derived	 proteases	 and	 is	 also	 a	
method	 used	 to	 identify	 many	 bacterial-derived	 proteases	 (Lantz	 and	 Ciborowski	
1994).	Therefore	with	reference	to	these	earlier	studies,	it	is	interesting	to	consider	
whether	 other	 proteolytic	 enzymes	 found	 in	 chronic	 wound	 fluid	 were	 indeed	
bacterial-derived,	and	thus	contributing	to	the	high	levels	of	proteases	seen	in	many	
chronic	wounds	today.		
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Despite	 the	 already	well-documented	 altered	proteolytic	 environment	of	 a	 chronic	
wound	 and	 the	more	 recent	 implications	 of	 bacterial	 biofilms,	 the	 contribution	 of	
bacterial-derived	 extracellular	 proteases	 in	 chronic	 wounds	 has	 been	 poorly	
researched.	One	only	has	to	enter	‘bacterial	proteases	AND	chronic	wounds’	into	the	
PubMed	search	engine	to	reveal	a	mere	43	results,	of	these,	only	2	primary	research	
papers	 specifically	 address	 bacterial	 proteases	 in	 the	 context	 of	 chronic	 wounds	
(Schmidtchen	 et	 al.	 2001,	Wysocki	 et	 al.	 2012).	 These	 studies	 typically	 assess	 the	
proteolytic	 activity	 of	 bacteria	 grown	 in	 a	 planktonic	 or	 ‘free-floating’	 state.	 For	
example,	Wysocki	and	colleagues	assessed	bacterial	gelatinase	activity	using	gelatin-
agarose	 gel	 in	 which	 they	 diluted	 a	 single	 bacterial	 colony	 in	 HEPES	 buffer	 and	
directly	 incubated	with	 the	 gel	 (Wysocki	 et	 al.	 2012).	 There	 is	 currently	 very	 little	
evidence	of	the	proteolytic	activity	of	human	chronic-wound-derived	bacteria	when	
grown	in	a	biofilm	state.	However,	one	study	touched	upon	this	area	with	respect	to	
antimicrobial	 resistance	 and	 bacterial	 virulence,	 when	 questioning	 whether	 P.	
aeruginosa	protease	production	was	affected	after	antibiotic	treatment.	Here	it	was	
found	that	extracellular	proteases	secreted	from	two	burn	wound-derived	strains	of	
P.	 aeruginosa,	 in	 biofilm	 form,	 secreted	 elastase	 B	 (LasB)	 post-ciprofloxacin	
treatment,	although	total	proteolytic	activity	was	reduced	(Ołdak	and	Trafny	2005).	
Given	 the	 increased	 antimicrobial	 resistance	 of	 bacterial	 biofilms,	 this	 research	
highlighted	the	persistence	and	virulence	of	 those	biofilm-derived	cells	 that	remain	
unaffected	by	antimicrobials.	
Given	 that	 some	 of	 the	 most	 commonly	 isolated	 bacteria	 from	 human	 chronic	
wounds	include	S.	aureus	(93.5%)	and	P.	aeruginosa	(52.2%)	(Gjødsbøl	et	al.	2006),	it	
was	the	objective	of	this	chapter	to	assess	the	proteolytic	activity	of	human	chronic	
wound-derived	 P.	 aeruginosa	 and	 S.	 aureus	 in	 both	 planktonic	 and	 biofilm	 states,	
followed	by	 the	 identification	of	 these	proteases.	More	specifically,	 clinical	 isolates	
were	 used	 to	 produce	 planktonic-conditioned	 medium	 (PCM)	 and	 biofilm-
conditioned	medium	(BCM),	which	were	subjected	to	non-specific	proteases	assays	
in	 order	 to	 assess	 protease	 activity	 and	 zymography	 to	 detect	 proteases	 and	
determine	the	molecular	weight/protease	group.	Based	on	the	findings	in	Chapter	III	
of	this	thesis,	I	hypothesised	that	P.	aeruginosa	in	planktonic	and	biofilm	form	would	
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secrete	 high	 levels	 of	 proteases	 and	 that	 S.	 aureus	 would	 produce	 low	 or	
undetectable	levels	of	proteases.	
	
5.2 Methods	
The	bacterial	isolates	used	in	this	chapter	were	derived	from	human	chronic	wounds,	
including	 leg	 ulcers	 and	 surgical	 wounds	 (see	 Table	 5.1),	 and	were	 obtained	 from	
Professor	David	Williams	of	Cardiff	University,	UK.	Ethical	approval	for	the	collection	
of	these	isolates	from	patients	was	approved	as	part	of	a	separate	research	project	
at	Cardiff	University.	For	a	detailed	description	of	the	methods	used	in	this	chapter,	
the	 reader	 is	 directed	 to	 Chapter	 2	 of	 this	 thesis	 (2.3	 Microbiology,	 2.3.6	 Crystal	
Violet	 Biofilm	 Forming	 Assay,	 2.5	 Scanning	 Electron	 microscopy,	 2.6	 Non-specific	
Protease	 Assays,	 2.7	 Gel	 Electrophoresis,	 2.8	 Ammonium	 Sulfate	 Precipitation	 and	
Partial	Purification	of	Proteins,	2.9	BCA	Assay	and	Sample	Protein	Quantification	and	
2.18	Statistical	Analysis).	
		
5.3 Results	
5.3.1 Growth	curve	analysis	and	biofilm	forming	potential	of	human	chronic	wound-
derived	P.	aeruginosa	and	S.	aureus	
The	growth	curves	 in	this	experiment	were	performed	in	a	96-well	format	whereby	
the	 absorbance	 of	 each	well	was	measured	 at	 several	 time	 points	 (every	 4	 hours)	
over	 a	 72-hour	 period.	 Within	 each	 bacterial	 species,	 both	 P.	 aeruginosa	 and	 S.	
aureus	 isolates	 followed	 similar	 growth	 curve	 profiles.	 However	 two	P.	 aeruginosa	
isolates,	 P1139	 and	 P1145,	 showed	 a	 greater	 amount	 of	 proliferation	 when	
compared	to	the	other	P.	aeruginosa	isolates	(see	Figure	5.1,	A).	All	isolates	entered	
the	 exponential	 phase	 between	 0-hours	 and	 4-hours,	 which	 reached	 its	 peak	
between	 8	 and	 12	 hours.	 After	 this,	 growth	 curves	 for	 all	 isolates	 then	 reached	 a	
plateau	(stationary	phase)	that	was	either	maintained	throughout	the	course	of	the	
experiment,	 which	 was	 seen	 in	 the	 P.	 aeruginosa	 isolates	 (see	 Figure	 5.1,	 A),	 or	
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maintained	for	a	short	time	period	before	a	decline	in	the	growth	curve	(cell	death),	
which	was	seen	more	in	the	S.	aureus	isolates	(see	Figure	5.1,	B).		
Biofilms	are	described	as	communities	of	microorganisms	that	attach	to	a	surface	or	
each	other,	proliferate	and	surround	themselves	in	an	EPS	matrix.	Scanning	electron	
microscopy	(SEM)	is	a	regularly	utilised	method	of	biofilm	identification,	as	it	allows	
for	 the	 identification	 of	 biofilm-specific	 morphology	 and	 the	 spatial	 location	 of	
individual	 cells	at	a	high	 resolution	 (Oates	et	al.	2014).	 In	 this	experiment,	biofilms	
were	grown	on	sterile	0.2μm	membrane	filter	discs	for	72	hours.	Upon	washing	the	
biofilms	prior	to	fixation,	it	was	noted	that	a	large	proportion	of	S.	aureus	was	easily	
washed	 away	 from	 the	 membrane	 filter	 and,	 although	 some	 P.	 aeruginosa	 was	
removed	 from	 the	 membrane	 filter	 upon	 washing,	 the	 P.	 aeruginosa	 biofilm	
remained	relatively	intact.	This	observation	was	substantiated	upon	SEM	imaging	of	
the	 biofilms.	 It	 was	 evident	 that	 clinically	 derived	 P.	 aeruginosa	 formed	 a	 dense	
biofilm,	with	P.	aeruginosa	rods	barely	visible	under	what	was	believed	to	be	an	EPS	
matrix	 (see	 Figure	 5.3,	 B).	 The	 clinical	 S.	 aureus	 showed	 communities	 of	 spherical	
cocci;	however	these	where	scant	when	compared	to	the	thick	biofilm	produced	by	
clinical	P.	aeruginosa	(see	Figure	5.3,	A).	Following	this,	the	biofilm	forming	potential	
of	S.	aureus	and	P.	aeruginosa	isolates	was	evaluated	by	staining	24,	48	and	72	hour	
biofilms	produced	in	a	96-well	peg-lid	plate	format,	with	crystal	violet.	In	this	assay,	
the	 crystal	 violet	 dye,	which	 appears	 dark	 purple	 in	 colour,	 binds	 to	 the	 adherent	
bacteria	before	being	solubilised	and	measured	using	absorbance.	High	absorbance	
values	indicate	high	numbers	of	adherent	bacterial	cells,	due	to	the	intensity	of	dye	
in	the	well,	and	thus	strong	biofilm	formation	(George	2011).	In	a	similar	fashion,	low	
absorbance	 values	 (low	 intensity	 of	 stain	 in	 the	 well)	 indicate	 low	 numbers	 of	
adherent	bacterial	cells,	and	thus	poor	biofilm	formation	(see	Figure	5.2,	C).	 In	this	
study,	the	majority	of	clinical	S.	aureus	isolates	showed	low	biofilm	forming	potential	
which	 did	 not	 significantly	 alter	 between	 24,	 48	 and	 72	 hours.	 However	 some	
anomalies	 with	much	 higher	 biofilm	 forming	 potential	 were	 recorded	 such	 as	 the	
clinical	isolates	S1007,	S1010	and	S1070	(see	Figure	5.2,	A).		
Although	 it	 was	 the	 primary	 aim	 of	 this	 chapter	 to	 assess	 differences	 between	
bacterial	 isolates,	 bacterial	 isolates	were	 taken	 from	a	 variety	 of	wounds	 including	
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chronic	and	surgical	wounds	 (see	Table	5.1).	Therefore	 it	 is	 important	 to	note	 that	
there	 appeared	 to	 be	 no	 correlation	 between	 the	 higher	 biofilm	 forming	 potential	
phenotype	and	 the	wound	type.	There	were	no	significant	differences	 in	 the	mean	
absorbance	 values	 between	 S.	 aureus	 biofilms	 at	 24,	 48	 and	 72	 hours.	 Clinical	 P.	
aeruginosa	 isolates	 showed	 varied	 biofilm	 forming	 potential	 and,	 although	 the	
strongest	 biofilm	 forming	 potential	 appeared	 to	 be	 at	 72	 hours,	 variability	 in	
absorbance	 values	 between	 each	 isolate	 resulted	 in	 no	 significant	 differences	
between	24,	48	and	72-hour	biofilms.		
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Strain	 Isolate	
Code	
Type	of	Wound	 Age	 of	
Patient	
Gender	
P.	aeruginosa	 P1006a	 Leg	ulcer	 56	 F	
P.	aeruginosa	 P1007a	 Leg	ulcer	 85	 F	
P.	aeruginosa	 P1097a	 Surgical	wound	 85	 F	
P.	aeruginosa	 P1102a	 Venous	leg	ulcer	 59	 M	
P.	aeruginosa	 P1120a	 Venous	leg	ulcer	 50	 M	
P.	aeruginosa	 P1126a	 Leg	ulcer	 90	 F	
P.	aeruginosa	 P1131a	 Leg	ulcer	 61	 F	
P.	aeruginosa	 P1134a	 Surgical	wound	 76	 F	
P.	aeruginosa	 P1139a	 Leg	ulcer	 78	 F	
P.	aeruginosa	 P1140a	 Leg	ulcer	 65	 M	
P.	aeruginosa	 P1145a	 Foot	ulcer	 69	 F	
P.	aeruginosa	 P1146a	 Venous	leg	ulcer	 66	 F	
P.	aeruginosa	 P1147a	 Leg	ulcer	 79	 F	
P.	aeruginosa	 P1151a	 Leg	ulcer	 93	 F	
P.	aeruginosa	 P1152a	 Foot	ulcer	 66	 M	
	 	 	 	 	
S.	aureus	 S1002a	 Leg	ulcer	 63	 F	
S.	aureus	 S1003a	 Venous	leg	ulcer	 47	 M	
S.	aureus	 S1006a	 Leg	ulcer	 56	 F	
S.	aureus	 S1007c	 Leg	ulcer	 85	 F	
S.	aureus	 S1010a	 Venous	leg	ulcer	 67	 M	
S.	aureus	 S1012a	 Venous	leg	ulcer	 57	 M	
S.	aureus	 S1014a	 Surgical	wound	 54	 M	
S.	aureus	 S1016	 Venous	leg	ulcer	 60	 F	
S.	aureus	 S1019a	 Venous	leg	ulcer	 76	 F	
S.	aureus	 S1030a	 Surgical	wound	 52	 M	
S.	aureus	 S1059a	 Leg	ulcer	 50	 F	
S.	aureus	 S1060a	 Surgical	wound	 75	 M	
S.	aureus	 S1068a	 Venous	leg	ulcer	 49	 M	
S.	aureus	 S1069a	 Foot	ulcer	 38	 M	
S.	aureus	 S1070a	 Leg	ulcer	 39	 F	
S.	aureus	 S1071b	 Leg	ulcer	 65	 M	
S.	aureus	 S1078a	 Surgical	wound	 52	 F	
S.	aureus	 S1087a	 Leg	ulcer	 81	 M	
S.	aureus	 S1095a	 Leg	ulcer	 72	 F	
	
Table	5.1	Origin	of	human-derived	bacterial	isolates.	
Bacterial	isolates	obtained	from	Cardiff	University).	Abbreviations	include	F	=	Female,	
M	 =	 Male,	 S.	 aureus	 =	 Staphylococcus	 aureus,	 P.	 aeruginosa	 =	 Pseudomonas	
aeruginosa.	 	
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Figure	5.1	Growth	curves	of	P.	aeruginosa	and	S.	aureus	over	72	hours.	
P.	aeruginosa	(A)	and	S.	aureus	(B)	clinical	isolates	were	individually	seeded	into	a	96-
well	 plate	 and	 incubated	 for	 72	 hours,	 whereby	 the	 absorbance	 of	 each	 well	
containing	the	isolate	was	measured	every	4	hours.	Mueller	Hinton	broth	(MHB)	was	
used	 as	 a	 negative	 (no	 growth)	 control.	 The	 assay	 was	 repeated	 three	 times	
(technical	repeats)	and	the	average	absorbance	values	obtained	and	used	to	plot	the	
growth	curves.	
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Figure	5.2	Biofilm	forming	potential	of	human-derived	clinical	isolates	using	crystal	
violet.	
S.	aureus	(A)	isolates	and	P.	aeruginosa	(B)	isolates	were	incubated	for	24,	48	or	72	
hours	before	being	stained	with	crystal	violet,	solubilised	and	read	at	a	wavelength	of	
550nm.	The	crystal	violet	assay	plate	(C)	shows	the	solubilised	crystal	violet	from	72-
hour	 biofilms.	 The	 red	 and	 black	 arrow	 indicates	 strong	 and	weak	 biofilm	 forming	
potential	 respectively.	 Controls	 include	 Mueller	 Hinton	 broth	 (MHB)	 without	
microorganisms	 (negative	 control).	 The	 assay	 was	 repeated	 three	 times	 with	 all	
clinical	isolates.	Error	bars	represent	standard	deviation.	
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Figure	5.3	Scanning	electron	microscopy	(SEM)	of	72-hour	human-derived	bacterial	
biofilms	grown	on	membrane	filter	discs.	
	A.	S.	aureus	and	B.	P.	aeruginosa	were	grown	on	membrane	filter	discs	for	72	hours	
before	 being	 washed	 in	 PBS	 and	 fixed	 in	 2.5%	 gluteraldehyde	 and	 dehydrated	 in	
ethanol.	 Images	 were	 taken	 using	 the	 Hitachi	 TM300	 tabletop	 scanning	 electron	
microscope.	 Magnification	 10,000x.	 Black	 arrow	 indicates	 bacterial	 clustering,	 red	
arrow	shows	the	membrane	filter	surface.	
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5.3.2 Proteolytic	 activity	 of	 human	 chronic	 wound-derived	 P.	 aeruginosa	 and	 S.	
aureus	in	planktonic	and	biofilm	form		
The	 assessment	 of	 proteolytic	 activity	 using	 the	 Azo-casein	 assay	 revealed	 a	
significant	difference	in	the	proteolytic	activity	of	P.	aeruginosa	BCM	when	compared	
with	 P.	 aeruginosa	 PCM	 (P	 ≤	 0.0001),	 which	 produced	 low	 levels	 of	 proteases.	
Furthermore,	significant	differences	were	found	between	P.	aeruginosa	BCM	and	S.	
aureus	BCM	(P	≤	0.05),	with	S.	aureus	showing	equally	low	proteolytic	activity	in	the	
PCM	and	BCM	(see	Figure	5.4).	The	Azocoll	assay	revealed	similar	results	to	the	Azo-
casein	 assay,	 showing	 low	 proteolytic	 activity	 in	 both	 S.	 aureus	 and	P.	 aeruginosa	
PCM.	S.	aureus	BCM	showed	no	increase	in	proteolytic	activity	when	compared	to	S.	
aureus	PCM,	however	a	significant	increase	in	activity	was	recorded	for	P.	aeruginosa	
BCM	when	compared	to	P.	aeruginosa	PCM	(P	≤	0.0001)	and	S.	aureus	BCM	(P	≤	0.05)	
(see	 Figure	 5.5).	 Although	 the	majority	 of	 P.	 aeruginosa	 BCM	 biological	 replicates	
showed	high	proteolytic	activity,	there	was	still	variability	in	activity	across	biological	
replicates	with	some	isolates	showing	lower	activity	than	expected.		
Traditionally,	 collagen	zymography	 is	used	 to	 identify	collagenases	 such	as	MMP-1,	
MMP-9	 and	MMP-13	 (Snoek	 and	Von	den	Hoff	 2005).	However,	 as	 summarised	 in	
chapter	 1	 of	 this	 thesis	 (see	 Table	 1.1),	 a	 wide	 range	 of	 MMP’s	 can	 actively	
breakdown	collagen	as	a	substrate.	Therefore,	in	order	to	determine	what	proteases	
were	being	produced	by	P.	aeruginosa	in	biofilm-form,	BCM	samples	from	all	isolates	
were	subject	to	collagen	zymography.	In	this	experimental	setting,	a	positive	control	
of	equine-derived	MMP-2	was	loaded	on	the	collagen	zymogram,	which	resulted	in	a	
68kDa	pro-enzyme	band	and	a	58kDa	active	band	respectively.	In	addition,	a	DMEM	
culture	medium	control	 sample	was	 loaded	to	represent	 the	medium	by	which	 the	
biofilm	was	suspended.	The	DMEM	control	sample	showed	faint	proteolytic	bands	of	
approximately	 80kDa	 and	 68kDa.	 Interestingly	 the	 clinical	 P.	 aeruginosa	 BCM	
samples	 showed	 strong	 proteolytic	 bands	 at	 approximately	 62kDa	 and	 52kDa.	 The	
presence	of	the	62kDa	band	was	seen	in	the	majority	of	the	BCM	samples,	however	a	
smaller	 number	 of	 isolates	 expressed	 both	 the	 62kDa	 and	 52kDa	 band	
simultaneously	 (see	 Figure	 5.6),	 highlighting	 the	 variability	 of	 proteolytic	 activity	
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between	 the	 various	 clinical	 strains	 of	 P.	 aeruginosa.	 There	 was	 no	 correlation	
between	the	presence	of	the	52kDa	band	and	wound	type.		
In	order	to	assess	which	of	the	major	proteolytic	groups	these	P.	aeruginosa-derived	
proteases	belong	to,	a	clinical	isolate	which	was	shown	to	produce	proteases	was	run	
separately	 on	 a	 collagen	 zymogram	 and	 subsequently	 incubated	 with	 broad	
spectrum	 inhibitors	 of	 either	 metallo-,	 serine	 or	 cysteine	 proteases	 (EDTA,	
benzaminide	hydrochloride	hydrate	and	N-ethylmaleimide	(NEM)).	The	treatment	of	
the	 proteolytic	 bands	 with	 EDTA,	 benzamidine	 and	 NEM	 revealed	 that	 the	
treatments	 were	 ineffective	 in	 the	 inhibition	 of	 the	 proteolytic	 bands	 (see	 Figure	
5.7).	
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Figure	5.4	The	non-specific	proteolytic	activity	of	human-derived	S.	aureus	and	P.	
aeruginosa	clinical	isolates	using	the	Azo-casein	assay.	
Data	 from	the	biological	 replicates	were	combined	 in	order	 to	assess	 the	statistical	
difference	 of	 average	 absorbance	 values	 between	 clinical	 S.	 aureus	 and	 P.	
aeruginosa.	 All	 biological	 replicates	 in	 the	 assay	 were	 run	 in	 duplicate.	 Error	 bars	
represent	 standard	 deviation.	 Statistical	 analysis	was	 performed	 using	 the	 Kruskal-
Wallis	non-parametric	ANOVA,	with	Dunn’s	multiple	comparison	test;	*P	<	0.05,	**P	
<	0.0001.	Abbreviations	 include	planktonic-conditioned	medium	(PCM)	and	biofilm-
conditioned	medium	(BCM).	
	
	
S.#
au
reu
s!P
CM
P.#
ae
rug
ino
sa#
PC
M
S.#
au
reu
s!B
CM
P.#
ae
rug
ino
sa#
BC
M
&0.05
0.00
0.05
0.10
0.15
0.20
Condi0oned!medium
Av
er
ag
e!
Ab
so
rb
an
ce
!a
t!4
05
nm
*
**
Page	158	of	253	
	
	
Figure	5.5	The	non-specific	proteolytic	activity	of	human-derived	S.	aureus	and	P.	
aeruginosa	clinical	isolates	using	the	Azocoll	assay.	
Data	 from	the	biological	 replicates	were	combined	 in	order	 to	assess	 the	statistical	
difference	 of	 average	 absorbance	 values	 between	 clinical	 S.	 aureus	 and	 P.	
aeruginosa.	 All	 biological	 replicates	 in	 the	 assay	 were	 run	 in	 duplicate.	 Error	 bars	
represent	 standard	 deviation.	 Statistical	 analysis	was	 performed	 using	 the	 Kruskal-
Wallis	non-parametric	ANOVA,	with	Dunn’s	multiple	comparison	test;	*P	<	0.05,	**P	
<	0.0001.	Abbreviations	 include	planktonic-conditioned	medium	(PCM)	and	biofilm-
conditioned	medium	(BCM).	
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Figure	 5.6	 Collagen	 zymography	 of	 human-derived	 P.	 aeruginosa	 biofilm-
conditioned	medium	(BCM).	
Lanes	3-9	 (A)	 represent	clinical	 isolates	P1006-P1131	and	 lanes	13-20	(B)	 represent	
clinical	isolates	P1134-P1152	(see	Table	5.1	for	reference).	Lanes	1	and	11	represent	
the	 molecular	 weight	 ladder	 (labelled	 in	 kDa).	 Controls	 include	 equine	 fibroblast-
derived	 MMP-2	 (lanes	 2	 and	 12)	 and	 DMEM	 culture	 medium	 (lane	 10).	 The	
experiment	was	performed	using	all	biological	replicates	of	P.	aeruginosa	(n=15)	and	
was	repeated	three	times.	
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Figure	5.7	The	effect	of	broad-spectrum	protease	 inhibitors	on	human-derived	P.	
aeruginosa	proteases	detected	in	BCM.	
Clinical	 isolate	 P1097	 BCM	 was	 run	 on	 a	 collagen	 zymogram	 before	 cutting	 the	
zymogram	into	sections	containing	the	sample	and	 incubating	 in	either	(A)	Normal,	
untreated	buffer,	(B)	100mM	ethylenediaminetetraacetic	acid	(EDTA)-treated	buffer.	
(C)	 50mM	 benzamidine	 hydrochloride	 hydrate-treated	 buffer	 or	 (D)	 10mM	 N-	
ethylmaleimide	(NEM)-treated	buffer.		
	
	
5.3.3 Partial	protease	purification	of	P.	aeruginosa	extracellular	proteases	
Precipitation	 is	 a	 commonly	 used	method	 in	 the	 recovery	 of	 biomolecules	 such	 as	
proteins	 from	 complex	 protein	 samples.	 In	 this	 chapter,	 ammonium	 sulfate	 (AS)	
((NH4)2SO4)	precipitation	was	used	 in	 the	attempt	 to	purify	 the	bacterial	 proteases	
detected	 in	 zymography.	AS	precipitation	works	by	 interfering	with	 the	hydrophilic	
amino	acid	region	on	the	protein	and	water,	effectively	reducing	the	solubility	of	the	
protein	and	encouraging	hydrophobic	interactions,	leading	to	the	aggregation	of	the	
protein	 from	 solution.	 Proteins	 have	 different	 proportions	 of	 hydrophilic	 regions,	
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thus	making	it	possible	to	separate	particular	proteins	based	on	their	hydrophilicity.	
For	example,	a	protein	with	relatively	 few	hydrophilic	 regions	will	aggregate	at	 low	
concentrations	of	AS	and	a	protein	with	many	hydrophilic	regions	will	need	a	much	
higher	concentration	of	AS	to	precipitate	from	the	solution	(Scopes	1994).		
In	 order	 to	 investigate	 the	 role	 of	 human	 chronic	 wound-derived	 P.	 aeruginosa	
62kDa	 and	 52kDa	 proteases	 in	 wound	 healing,	 partial	 purification	 of	 BCM	 was	
performed	 using	 AS	 precipitation	 followed	 by	 dialysis	 in	 PBS.	 The	 dialysed	 AS	
fractions	were	 then	 subject	 to	 SDS-PAGE	 and	 zymography	 to	 evaluate	 the	 protein	
and	 enzyme	 profile	 of	 each	 fraction.	 The	 MMP-2	 positive	 control	 showed	 clear	
proteolytic	 bands	 at	 approximately	 68kDa	 and	 58kDa.	 	 However	 no	 bands	 were	
detected	in	SDS-PAGE	(see	Figure	5.8;	A	and	C,	 lane	2).	The	DMEM	culture	medium	
control	showed	a	dense	protein	profile	that	was	particularly	saturated	between	the	
molecular	weights	 of	 50-60kDa,	 and	 as	well	 as	 further	 proteolytic	 bands	 at	 60kDa	
and	80kDa	(see	Figure	5.8;	A	and	C,	 lane	3).	 In	all	precipitate	fractions	there	was	a	
62kDa	band	shown	in	the	SDS-PAGE	gels	(see	Figure	5.8;	A	and	B,	lanes	4-8	and	10-
16),	however,	only	the	50%	and	55%	fractions	displayed	62kDa	proteolytic	bands	(see	
Figure	5.8;	C	and	D,	lanes	12	and	13).	In	addition	to	this,	the	50%	and	55%	fractions	
showed	 the	 highest	 protein	 concentrations	 of	 835.1μg/ml	 and	 490.7	 μg/ml	
respectively	(see	Table	5.2).	Furthermore,	in	11	of	12	precipitate	fractions	there	was	
the	 presence	 of	 a	 52kDa	 proteolytic	 band,	 of	 varying	 intensities,	 seen	 in	 collagen	
zymography;	however	it	was	difficult	to	detect	the	presence	of	this	band	using	SDS-
PAGE	 (see	 Figure	 5.8;	 A,	 B,	 C	 and	 D,	 lanes	 4-8	 and	 11-16).	 The	 50%	 and	 55%	
precipitate	 fractions	were	 the	only	 fractions	 containing	both	 the	52kDa	and	62kDa	
proteolytic	 bands	 (see	 Figure	 5.8;	D,	 lanes	 12	 and	 13).	 There	 were	 no	 proteolytic	
bands	evident	in	the	40%	fraction	(see	Figure	5.8;	D,	lane	10).	Following	the	70%	AS	
precipitation	of	 the	BCM,	 the	 remaining	 supernatant	was	 collected	and	 run	on	 the	
SDS-PAGE	gel	and	collagen	zymogram.	It	was	clear	from	zymography	that	the	desired	
proteolytic	bands	were	not	present	in	the	remaining	supernatant	(see	Figure	5.8;	D,	
lane	17).	Additionally,	protein	 fractions	were	 subject	 to	 the	Azo-casein	and	Azocoll	
assays.	The	Azo-casein	assay	revealed	a	significant	level	of	proteolytic	activity	in	the	
50%	protein	fraction	when	compared	to	the	PBS	control	(P	<	0.05)	(see	Figure	5.8,	E).	
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The	 Azocoll	 assay	 showed	 high	 levels	 of	 protease	 activity	 in	 all	 fractions,	 however	
statistical	 analysis	 showed	 the	 50%	 protein	 fraction	 to	 have	 significantly	 high	
protease	activity	when	compared	to	the	PBS	control	(see	Figure	5.8,	F).	Furthermore,	
this	high	protease	activity	appeared	to	reflect	the	high	protein	concentration	in	this	
fraction,	as	determined	by	the	BCA	assay	(see	Table	5.2).	It	was	therefore	concluded	
that	50%	ammonium	sulfate	precipitation	would	be	suitable	to	isolate	the	62kDa	and	
52kDa	proteases	from	human	chronic	wound-orginating	P.	aeruginosa	BCM.	
	
	
Table	 5.2	 Multiple	 protein	 fractions	 of	 P1097	 BCM	 using	 ammonium	 sulfate	
precipitation	 and	 the	 subsequent	 protein	 concentration	 of	 the	 dialysed	 protein	
fractions.	
The	 concentration	 of	 protein	 at	 the	 various	 ammonium	 sulfate	 saturation	
percentages	was	performed	using	 the	BCA	protein	assay.	The	chemical	 formula	 for	
ammonium	sulfate	is	written	as	(NH4)2SO4.	
	
Starting	
volume	(ml)	
Ammonium	 sulfate	
saturation	(%)	
Amount	 of	
(NH4)2SO4	added	(g)	
Protein	concentration	
post-dialysis	(μg/ml)	
11.8	 15	 0.96	 266.8	
11.8	 20	 0.32	 231.2	
11.2	 25	 0.31	 202.1	
10.7	 30	 0.30	 158.4	
10.4	 35	 0.30	 197.3	
9.9	 40	 0.29	 172.8	
9.4	 45	 0.28	 206.8	
9.1	 50	 0.27	 835.1	
8.6	 55	 0.26	 490.7	
8.2	 60	 0.26	 286.0	
8.0	 65	 0.25	 248.7	
7.6	 70	 0.24	 328.7	
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Figure	5.8	Ammonium	sulfate	precipitation	fractions	of	P1097	BCM.	
The	protein	precipitate	fractions	of	P.	aeruginosa	(P1097)	BCM	were	visualised	using	
SDS-PAGE	 (A	 and	B)	 and	 collagen	 zymography	 (C	 and	D).	 Lanes	 1	 and	 9	 represent	
molecular	weight	marker.	Controls	include	equine	fibroblast-derived	MMP-2	(lane	2)	
and	DMEM	culture	medium	(lane	3).	Lanes	4-8	shows	AS	fractions	15,	20,	25,	30	and	
35%	and	lanes	10-16	show	fractions	40,	45,	50,	55,	60,	65	and	70%	respectively.	The	
remaining	 supernatant	 following	 AS	 precipitation	 is	 shown	 in	 lane	 17.	 Subsequent	
protease	 assays	of	 the	AS	precipitation	 fractions	 including	 the	Azo-casein	 assay	 (E)	
and	Azocoll	 assay	 (F)	were	performed.	All	 experiments	were	 repeated	 three	 times.	
Error	 bars	 represent	 standard	 error.	 Statistical	 analysis	 was	 performed	 using	 a	
Freidman	 non-parametric	 analysis	 of	 variants	 (ANOVA),	 with	 Dunn’s	 multiple	
comparison	test	*P	<	0.05.	Abbreviations	include	biofilm-conditioned	medium	(BCM),	
Dulbecco’s	modified	Eagles	medium	(DMEM),	ammonium	sulfate	(AS)	and	phosphate	
buffered	saline	(PBS).	
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5.4 Discussion	
Bacterial	biofilms	are	a	key	area	of	clinical	 interest	 in	 the	developed	world	and	are	
being	 recognised	 as	 an	 important	 area	 of	 wound	 healing	 research	 by	 large	
associations	 such	 as	 the	 European	 wound	 management	 association	 (EWMA)	
(Kirketerp-Møller	et	al.	2011).	Given	the	altered	proteolytic	environment	of	chronic	
wounds,	it	is	important	to	consider	whether	this	is,	in	part,	due	to	the	presence	of	a	
biofilm	or	the	contribution	of	bacterial	proteases	themselves.	Therefore	this	chapter	
aimed	 to	 utilise	 both	 P.	 aeruginosa	 and	 S.	 aureus	 obtained	 from	 human	 chronic	
wounds	 and	 assess	 whether	 these	 isolates	 displayed	 proteolytic	 activity	 in	 both	
planktonic	and	biofilm	states.		
In	this	study,	there	was	a	significant	increase	in	proteases	in	the	P.	aeruginosa	BCM	
when	compared	to	PCM	(see	Figures	5.4	and	5.5),	which	may	provide	evidence	that	
these	extracellular	proteases	could	play	a	role	in	biofilm	formation.	Indeed,	there	is	
existing	 evidence	 to	 suggest	 the	 involvement	 of	 bacterial	 intracellular	 proteases	 in	
biofilm	formation.	Marr	and	colleagues	identified	the	gene	encoding	Lon	protease	to	
be	induced	in	P.	aeruginosa	PA01	after	exposure	to	sub-inhibitory	concentrations	of	
the	 antibiotic	 gentamicin.	 Furthermore,	 Lon	 protease	 mutants	 showed	 reduced	
bacterial	 swimming	 and	 twitching,	 two	 factors	 that	 are	 important	 in	 biofilm	
formation	(Marr	et	al.	2007).	Another	more	recent	study	tested	the	biofilm	forming	
potential	 of	P.	 aeruginosa	 that	 housed	mutations	 in	 the	 protease-related	 proteins	
PfpI,	 ClpS,	 and	 ClpP	 and	 subsequently	 found	 up	 to	 a	 70%	 reduction	 in	 biofilm	
formation	when	 compared	 to	 the	wild-type	 (Fernández	 et	 al.	 2012).	 Research	 into	
the	 involvement	 of	 P.	 aeruginosa	 extracellular	 proteases	 in	 biofilm	 formation	 and	
EPS	 production	 has	 been	 documented.	 The	 over-expression	 of	 the	 P.	 aeruginosa	
extracellular	protease	elastase	B	(LasB)	has	been	shown	to	significantly	affect	biofilm	
architecture,	reduce	alginate	concentration,	increase	hydrophobicity	and	viscosity	of	
EPS,	 and	 increase	 swimming,	 swarming	 and	 twitching	 motility	 of	 P.	 aeruginosa	
mucoid	 strains	 (Tielen	 et	 al.	 2010).	 This	 evidence	 supports	 a	 role	 of	 bacterial	
extracellular	proteases	in	biofilm	formation.	Indeed,	the	crystal	violet	assay	showed	
varying	 levels	 of	 biofilm	 forming	 potential	 in	P.	 aeruginosa.	However	 comparisons	
between	 biofilm	 forming	 potential	 and	 proteolytic	 activity	 were	 not	 made	 in	 this	
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study.	 The	 reason	 for	 this	 is	 due	 to	 the	 difference	 in	 biofilm	models	 used	 for	 the	
crystal	 violet	 assay	 (peg-lid	method)	 and	 to	 obtain	 the	BCM	 (grown	on	membrane	
filters),	 whereby	 these	 biofilms	 were	 grown	 on	 different	 surfaces	 with	 potentially	
different	amounts	of	nutrient	availability.				
P.	aeruginosa	 isolated	 from	chronic	wounds	has	been	shown	to	produce	proteases	
detected	by	zymography,	of	approximately	150kDa	and	50kDa,	which	were	identified	
as	a	multimeric	form	of	P.	aeruginosa	elastase	(33kDa)	and	alkaline	protease	(AprA)	
(50kDa)	 respectively	 (Schmidtchen	 et	 al.	 2001).	 In	 addition,	 the	 zymography	
performed	 in	 the	 latter	 paper	 showed	 the	 presence	 of	 a	 faint	 proteolytic	 band	
around	 64kDa;	 however	 the	 authors	 did	 not	 discuss	 this	 result.	 In	 my	 study,	 P.	
aeruginosa	 proteolytic	 bands	 of	 52kDa	 and	 62kDa	 were	 identified.	 It	 was	 initially	
thought	that	the	52kDa	band	may	have	been	the	metalloprotease	AprA,	however	if	
this	was	the	case,	the	proteolytic	band	should	have	been	inhibited	by	100mM	EDTA,	
a	known	inhibitor	of	metalloproteases.	Instead,	the	100mM	EDTA	treatment	resulted	
in	no	evidence	of	protease	inhibition	(see	Figure	5.7).	Therefore,	at	this	stage	of	the	
research,	 the	 identification	 of	 the	 proteases	 that	 these	 clinical	 strains	 of	 P.	
aeruginosa	are	secreting	remains	unknown.		
	
There	are	limitations	to	this	study,	firstly	regarding	the	biofilm	model	used	to	obtain	
BCM.	Though	it	is	important	that	the	biofilm	is	developed	for	at	least	72	hours,	it	is	in	
an	 artificial	 environment	 and	 the	 thickness	 of	 the	 biofilm	 in	 vitro	 is	 probably	 not	
reflective	 of	 a	 biofilm	 that	 resides	 in	 the	 human	 tissue	 of	 a	 chronic	 wound.	 In	
addition	to	this,	the	proteolytic	activity	that	has	been	documented	in	this	study	may	
differ	 in	 an	 in	 vivo	 setting,	 where	 factors	 such	 as	 nutrient	 availability	 and	 host-
derived	growth	 factors	and	cytokines	may	have	an	effect.	Furthermore,	 in	order	 to	
normalise	the	protease	results	between	PCM	and	BCM,	the	bacterial	cell	numbers	for	
the	preparation	of	PCM	were	diluted	to	similar	bacterial	cell	numbers	of	the	72-hour	
biofilms.	 However	 this	 method	 of	 normalisation	 has	 limitations	 in	 that	 it	 is	 an	
approximate,	 as	 each	 bacterial	 strain	 has	 slightly	 different	 growth	 rates,	 not	 to	
mention	the	growth	rate	of	a	biofilm	slows	as	the	biofilm	matures	(Costerton	et	al.	
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1999).	In	addition,	the	experimental	environment	in	the	production	of	PCM	and	BCM	
differ.	 The	 bacteria	 for	 PCM	 is	 grown	 for	 24	 hours	 in	 nutrient-rich	 conditions,	
however	the	biofilms	are	grown	for	72	hours	on	the	surface	of	membrane	filter	discs	
with	 potentially	 limited	 nutrients	 from	 the	 agar	 beneath	 due	 to	 the	 0.2μm	 pore	
surface	 of	 the	 filter.	 However,	 it	 has	 been	 documented	 that	 nutrient	 depletion	
encourages	biofilm	 formation	as	a	mechanism	 to	 survive	hostile	environments	and	
that	 the	 introduction	 of	 nutrient	 sources	 causes	 a	 reduction	 in	 biofilm	 biomass	
through	dispersal	(O'Toole	et	al.	2000,	Sauer	et	al.	2004).	
	
5.4.1 Future	directions	
In	 this	 study,	 I	have	demonstrated	 that	P.	aeruginosa	 in	biofilm	 form	produce	high	
levels	of	proteases.	This	led	to	the	discovery	of	two	proteolytic	bands	at	52kDa	and	
62kDa	 produced	 by	 some	 of	 the	 isolates.	 Although	 uncertainty	 still	 surrounds	 the	
identification	of	these	bands,	it	would	be	interesting	to	determine	the	effect	of	these	
partially	 purified	 bacterial	 proteases	 on	 wound	 closure,	 in	 order	 to	 determine	
whether	they	may	play	a	role	in	reduced	wound	closure	in	infected	chronic	wounds.	
To	 do	 so,	 initial	 studies	 could	 investigate	 the	 effect	 PCM,	 BCM	 and	 the	 partially	
purified	 bacterial	 proteases	 on	 fibroblast	 and	 keratinocyte	wound	 closure	 in	 an	 in	
vitro	scratch	wound	model.	The	presence	of	MRSA	PCM	and	BCM	on	human	dermal	
fibroblasts	 has	 been	 shown	 to	 reduce	 cellular	 migration	 and	 viability	 in	 vitro.	
Furthermore,	differential	effects	in	MMP	expression	in	human	dermal	fibroblasts	was	
recorded,	 with	MRSA	 PCM	 causing	 an	 increase	 in	MMP-1	 and	MMP-3	 production	
compared	to	MRSA	BCM	(Kirker	et	al.	2012).	Thus,	as	 the	bacterial	 isolates	used	 in	
the	present	study	are	of	chronic	wound	origin	and	not	a	typical	 laboratory	strain,	 it	
would	 be	 interesting	 to	 investigate	 the	 effect	 of	 both	 S.	 aureus	 and	P.	 aeruginosa	
clinical	 isolates,	 in	planktonic	and	biofilm	form	on	the	expression	and	production	of	
host	proteases	in	a	similar	model.	Furthermore,	it	would	be	intriguing	to	determine	
whether	 protease	 expression	 and	 production	 is	 altered	 in	 the	 presence	 of	 the	
partially	 purified	 P.	 aeruginosa-derived	 proteases.	 This	 type	 of	 study	 could	
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potentially	 reveal	whether	 bacterial-derived	 proteases	 play	 a	 role	 in	 imbalances	 in	
MMP	production	observed	in	the	chronic	wound	environment.	
	
5.4.2 Key	points	
In	 summary,	 P.	 aeruginosa	 isolated	 from	 human	 chronic	 wounds	 displayed	 high	
levels	of	proteolytic	activity	when	grown	in	biofilm	form.	However	planktonic	growth	
of	 these	 P.	 aeruginosa	 isolates	 revealed	 little	 or	 no	 proteolytic	 activity.	 Using	
zymographic	analysis,	 two	proteolytic	bands	were	evident	 in	P.	aeruginosa	BCM	at	
52kDa	 and	 62kDa,	 which	 the	 major	 broad-spectrum	 protease	 inhibitors	 failed	 to	
inhibit.	The	identification	of	these	proteases	remains	unknown.	
S.	aureus	isolated	from	human	chronic	wounds	showed	little	evidence	of	proteolytic	
activity	in	both	planktonic	and	biofilm	forms.		
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CHAPTER	6:	
Results	 IV:	 The	 Effect	 of	 S.	 aureus	 and	 P.	
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6 Results	 IV:	The	Effect	of	S.	aureus	and	P.	aeruginosa	Planktonic-	and	Biofilm-
Conditioned	 Medium	 on	 Human	 Dermal	 Fibroblast	 and	 Human	 Epidermal	
Keratinocyte	Wound	Closure	and	Protease	Secretion	In	Vitro		
	
6.1 Introduction	
A	chronic	wound	can	be	defined	as	a	wound	that	is	slow	to	heal	and	that	is	halted	in	
the	 inflammatory	phase	of	 the	wound	healing	process	 (Velnar	et	al.	2009).	Chronic	
wounds	such	as	pressure	ulcers,	venous	 leg	ulcers	and	diabetic	 foot	ulcers,	present	
with	 an	 increased	 infiltration	 of	 neutrophils,	 increased	 levels	 of	 pro-inflammatory	
cytokines	and	an	exaggerated	proteolytic	environment.	There	are	known	host	factors	
that	contribute	to	the	development	of	a	chronic	wound,	such	as	 ischemia,	diabetes	
and	 abnormal	 white	 blood	 cell	 function	 (Guo	 and	 DiPietro	 2010).	 However	 it	 has	
been	proposed	that	it	is	not	these	factors	that	prevent	a	wound	from	healing,	rather	
the	 compromised	 immune	 response	 to	 invading	 bacteria,	 which	 are	 then	 able	 to	
form	 a	 biofilm,	 resulting	 in	 persistent	 inflammation	 (Wolcott	 et	 al.	 2008).	 Clinical	
studies	 and	 in	 vivo	 laboratory	 research	have	 shown	 that	 the	presence	of	 a	 biofilm	
may	be	detrimental	 to	 the	wound	healing	process.	 For	example,	 clinical	 studies	by	
Hurlow	 and	 Bowler	 described	 the	 presence	 of	 a	 slimy	 film,	 distinct	 from	 that	 of	
slough,	 in	wounds	showing	delayed	wound	healing	 (Hurlow	and	Bowler	2009).	This	
theory	is	strengthened	by	work	investigating	the	use	of	photodynamic	therapy	(PDT),	
which	 uses	 irradiation	 coupled	 with	 a	 photoactive	 dye	 resulting	 in	 microbial	 cell	
death,	which	resulted	in	improved	wound	healing.	Morley	and	colleagues	showed	a	
significant	reduction	in	bacterial	load	after	PDT	treatment	in	patients	with	chronic	leg	
ulcers	when	 compared	 to	 the	placebo	 controls	 in	 a	phase	 IIa,	 randomised,	blinded	
and	 single	 treatment	 study	 (Morley	 et	 al.	 2013).	 Results	 showed	 complete	wound	
closure	in	50%	of	patients	that	underwent	PDT	when	compared	to	12%	of	patients	on	
placebo.	Animal	studies	such	as	that	of	Gurjala	and	co-workers,	have	shown	that	the	
presence	 of	 S.	 aureus	 biofilms	 in	 wounded	 New	 Zealand	 rabbit	 ears,	 results	 in	
sustained	 low	 grade	 inflammation,	 decreased	 granulation	 tissue	 formation	 and	
reduced	re-epithelialisation	(Gurjala	et	al.	2011).		
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As	investigated	in	the	previous	chapter,	the	presence	of	bacterial	biofilms	in	chronic	
wounds	 could	 potentially	 contribute	 to	 the	 exaggerated	 proteolytic	 environment	
that	has	been	documented	in	chronic	wounds,	given	the	high	extracellular	protease	
production	 from	 chronic	 wound	 isolates	 such	 as	 P.	 aeruginosa	 (see	 Chapter	 5).	
Whether	 the	 presence	 of	 bacterial	 biofilms	 in	 a	 wound	 promotes	 the	 excessive	
release	of	proteases	 from	host	cells,	has	yet	 to	be	determined.	A	study	by	Twining	
and	colleagues	assessed	the	effect	of	P.	aeruginosa	extracellular	proteases,	elastase	
and	 alkaline	 protease	 (AprA)	 on	 the	 secretion	 of	 proteases	 from	 rabbit	 corneas	
(Twining	 et	 al.	 1993).	 The	 results	 of	 the	 latter	 study	 showed	 that	 P.	 aeruginosa-
derived	extracellular	proteases	could	activate	corneal	proteases,	with	P.	aeruginosa	
elastase	cleaving	a	92kDa	corneal	gelatinase	into	an	active	77kDa	form.	Furthermore	
the	authors	reported	release	of	a	72kDa	gelatinase	and	97kDa	caseinase	in	presence	
of	 the	 P.	 aeruginosa	 virulence	 factor	 exotoxin	 A.	 This	 research	 highlighted	 the	
potential	 interaction	between	host	tissue	and	bacteria	 in	the	release	and	activation	
of	active	proteases	that	can	lead	to	tissue	destruction.	The	effect	of	bacterial	biofilms	
on	 host-protease	 expression	 in	 the	 context	 of	 chronic	 wounds	 has	 not	 been	 fully	
addressed.	 Cell	 types	 such	 as	 dermal	 fibroblasts	 play	 critical	 roles	 in	 all	 aspects	 of	
wound	 repair	 such	 as	wound	 contraction	 and	 extracellular	matrix	 (ECM)	 turnover,	
through	the	production	of	ECM	components	 including	collagen-I	and	the	release	of	
matrix	 metalloproteases	 (MMPs)	 (Bainbridge	 2013).	 Furthermore,	 increases	 in	 the	
expression	of	MMP-2	and	MMP-3	in	fibroblasts	from	human	diabetic	foot	ulcers	has	
been	 documented	 (Wall	 et	 al.	 2003).	 Keratinocytes,	 the	 major	 cell	 type	 in	 the	
epidermis,	 play	 an	 important	 role	 in	 maintaining	 barrier	 function	 against	 invading	
microorganisms.	Failure	to	re-epithelialise	is	a	characteristic	that	is	commonplace	in	
chronic	wounds.	
It	was	therefore	the	aim	of	this	chapter	to	assess	the	effect	of	human	chronic	wound-
derived	 S.	 aureus	 and	 P.	 aeruginosa	 planktonic-conditioned	 medium	 (PCM)	 and	
biofilm-conditioned	medium	 (BCM)	 on	 the	 wound	 closure	 of	 adult	 human	 dermal	
fibroblasts	(HDFs)	and	adult	human	epidermal	keratinocytes	(HEKs).	The	intracellular	
expression	and	extracellular	secretion	of	host-derived	proteases	was	investigated	to	
determine	 whether	 these	 cells	 altered	 the	 secretion	 of	 proteases	 in	 response	 to	
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bacterial-conditioned	 medium.	 This	 chapter	 also	 investigated	 the	 effect	 of	 the	 P.	
aeruginosa-derived	partially	purified	protease,	outlined	in	chapter	5	of	this	thesis,	on	
HDFs	 and	 HEKs	 wound	 closure.	 Finally	 this	 study	 aimed	 to	 assess	 the	 effect	 of	
bacterial-conditioned	medium	on	host	protease	expression	in	a	more	physiologically	
relevant	model,	which	 required	 the	 development	 of	 a	 3-dimensional	 keratinocyte-
fibroblast	 co-culture	 in	 vitro.	 Based	 on	 the	 findings	 in	 previous	 chapters,	 I	
hypothesised	 that	 the	 treatment	 of	 HDFs	 and	 HEKs	 with	 P.	 aeruginosa	 PCM	 and	
BCM,	would	significantly	reduce	wound	closure	in	vitro.	Furthermore,	I	hypothesised	
that	P.	aeruginosa-derived	partially	purified	proteases	would	also	 reduce	HDFs	and	
HEKs	wound	closure.				
	
6.2 Methods	
For	a	detailed	description	of	the	methods	used	in	this	chapter,	the	reader	is	directed	
to	chapter	2	of	this	thesis	(2.3	Microbiology,	2.7	Gel	Electrophoresis,	2.8	Ammonium	
Sulfate	Precipitation	and	Partial	Purification	of	Proteins,	2.9	BCA	Assay	and	Sample	
Protein	 Quantification,	 2.10	 Cell	 Culture,	 2.13	 Scratch	 Wound	 Assay,	 2.14	 Cell	
Viability	Assay,	2.15	3D	Keratinocyte-Fibroblast	Co-culture	Model,	2.16	Quantitative	
RT-PCR,	2.17	Histology	and	Immunohistochemistry	and	2.18	Statistical	Analysis).	
	
6.3 Results	
6.3.1 Human	 dermal	 fibroblast	 (HDF)	 scratch	 closure	 and	 cellular	 viability	 in	
response	 to	 P.	 aeruginosa	 and	 S.	 aureus	 planktonic-conditioned	 medium	
(PCM)	and	biofilm-conditioned	medium	(BCM)	
In	order	 to	determine	whether	chronic	wound-derived	P.	aeruginosa	 and	S.	aureus	
had	any	effect	on	the	wound	closure	of	human	dermal	fibroblasts	(HDFs),	HDFs	were	
treated	with	either	PCM	or	BCM	of	each	bacterial	isolate	in	an	in	vitro	scratch	wound	
assay.	Prior	to	starting	the	experiment,	PCM	and	BCM	were	obtained	as	the	methods	
describe	 in	 Chapter	 2,	 and	 were	 subsequently	 diluted	 1:1	 with	 DMEM	 (without	
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antibiotics)	before	adding	to	the	HDF	scratches.	Images	of	the	scratch	wounds	taken	
at	0,	24	and	48	hours	showed	that	P.	aeruginosa	BCM	greatly	reduced	scratch	closure	
when	compared	to	all	other	treatment	groups	and	 in	some	cases	caused	cell	death	
(see	Figure	6.1).	Neither	S.	aureus	PCM	or	BCM	appeared	to	affect	closure.	Following	
ImageJ	 analysis	 of	 the	 scratch	wounds,	 it	 was	 found	 that	within	 24	 hours,	 control	
scratches	 (treated	 with	 DMEM	 complete)	 were	 59.8%	 ±	 13.8%	 closed,	 while	 P.	
aeruginosa	 PCM	 and	 BCM	 were	 49.1%	 ±	 16.8%	 and	 26.6%	 ±	 17.2%	 closed	
respectively,	 with	 P.	 aeruginosa	 BCM-treated	 scratches	 showing	 a	 significant	
reduction	 in	 closure	when	 compared	 to	 control	 and	P.	 aeruginosa	 PCM	 (P	 <0.001)	
(see	Figure	6.2).	After	48	hours,	control	scratches	were	93.7%	±	5.5%	closed,	which	
was	comparable	to	scratches	treated	with	S.	aureus	PCM	that	showed	95.0%	±	6.9%	
closure.	 In	contrast,	 scratches	 treated	with	P.	aeruginosa	BCM	showed	significantly	
reduced	 closure	 (40.1%	 ±	 20.4%)	 at	 48	 hours	 (P	 <	 0.0001)	 when	 compared	 with	
control,	P.	aeruginosa	PCM	and	S.	aureus	BCM.	A	reduction	in	closure	was	seen	after	
48	hours	for	scratches	treated	with	P.	aeruginosa	PCM	(79.4%	±	21.3%),	which	was	
significant	when	compared	to	S.	aureus	PCM	(P	<0.01).	
Given	 that	 percentage	 scratch	 closure	 was	 significantly	 reduced	 by	 P.	 aeruginosa	
BCM	at	24	and	48	hours	(see	Figure	6.1	and	Figure	6.2),	the	PrestoBlue™	cell	viability	
reagent	was	employed	to	test	whether	there	was	a	reduction	in	the	viability	of	these	
cells	in	response	to	the	bacterial-conditioned	medium	(see	Figure	6.3).	After	4	hours	
treatment	 with	 bacterial-conditioned	 medium,	 no	 significant	 changes	 in	 viability	
between	control	scratches	and	the	treatment	groups	were	recorded.	Similarly,	after	
24	 hours,	 HDFs	 treated	 with	 bacterial-conditioned	 medium	 did	 not	 show	 any	
significant	 reduction	 in	 viability	 when	 compared	 with	 the	 control,	 although	
differences	 between	 treatment	 groups	 were	 recorded.	 There	 was	 a	 significant	
reduction	in	the	viability	of	cells	treated	with	S.	aureus	BCM	when	compared	with	S.	
aureus	 PCM	and	P.	aeruginosa	BCM-treated	cells	 showed	a	 significant	 reduction	 in	
viability	when	compared	to	S.	aureus	BCM	(P	<0.0001).	After	48	hours	of	treatment	
the	viability	of	HDFs	treated	with	S.	aureus	and	P.	aeruginosa	BCM	was	significantly	
lower	 than	 that	 of	 the	 control	 (P	 <0.01	 and	 P	 <0.0001	 respectively),	 with	 P.	
aeruginosa	 BCM	 treatment	 causing	 the	 greatest	 reduction	 in	 cell	 viability.	 The	
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reduced	viability	seen	in	P.	aeruginosa	BCM-treated	cells	was	significantly	lower	than	
other	treatment	groups	including	P.	aeruginosa	PCM	and	S.	aureus	BCM	(P	<0.0001).	
Furthermore	S.	aureus	BCM	treated	cells	showed	a	greater	reduction	in	viability	than	
S.	aureus	PCM	(P	<0.0001).		
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Figure	 6.1	 Representative	 images	 of	 scratch	 wounds	 after	 treatment	 with	 human	 chronic	 wound-derived	 S.	 aureus	 and	 P.	 aeruginosa	
planktonic-	and	biofilm-conditioned	medium.	
Monolayer	cultures	of	adult	human	dermal	 fibroblasts	 (HDFs)	were	scratched	before	adding	either	control	medium	or	bacterial-conditioned	
medium.	Images	of	the	scratch	area	were	then	taken	at	0,	24	and	48	hours,	post-treatment,	using	the	Nikon	Eclipse	microscope.	Yellow	lines	
outline	 the	 scratch	 wound	 area.	 Abbreviations	 include	 planktonic-conditioned	 medium	 (PCM)	 and	 biofilm-conditioned	 medium	 (BCM).
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Figure	 6.2	 Percentage	 scratch	 wound	 closure	 of	 adult	 human	 dermal	 fibroblasts	
(HDFs)	in	vitro.	
Results	are	shown	for	HDFs	treated	with	either	S.	aureus	or	P.	aeruginosa	planktonic-
conditioned	 medium	 (PCM)	 and	 biofilm-conditioned	 medium	 (BCM).	 Results	
represent	the	mean	values	±	standard	deviation	(biological	replicates:	S.	aureus	n=19	
and	P.	aeruginosa	n=15,	technical	replicates	n=2).	Statistical	analysis	was	performed	
using	two-way	analysis	of	variants	(ANOVA)	with	Tukey’s	multiple	comparisons	test.	
Statistical	 significance	 is	 indicated	 as	 *P	 <0.001	 and	 **P	 <0.0001	 when	 compared	
with	the	control	group.	
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Figure	6.3	Cell	viability	of	adult	human	dermal	fibroblasts	(HDFs)	using	PrestoBlue™	
in	vitro.	
Results	are	shown	as	relative	fluorescence	values	whereby	HDFs	were	exposed	to	S.	
aureus	 and	 P.	 aeruginosa	 planktonic-conditoned	 medium	 (PCM)	 and	 biofilm-
conditioned	 medium	 (BCM)	 over	 48	 hours.	 Results	 represent	 the	 mean	 values	 ±	
standard	 deviation	 (biological	 replicates:	 S.	 aureus	 n=19	 and	 P.	 aeruginosa	 n=15,	
technical	replicates	n=2).Statistical	analysis	was	performed	using	two-way	analysis	
of	variants	(ANOVA)	with	Tukey’s	multiple	comparisons	test.	Statistical	significance	is	
indicated	as	*P	<0.01	and	**P	<0.0001	when	compared	with	the	control	group.	
	
	
6.3.2 Secretion	 and	 expression	 of	 adult	 human	 dermal	 fibroblast	 (HDFs)	 matrix	
metalloproteases	 (MMPs)	 in	 response	 to	 P.	 aeruginosa	 and	 S.	 aureus	
planktonic-conditioned	 medium	 (PCM)	 and	 biofilm-conditioned	 medium	
(BCM)	
To	 establish	 whether	 the	 presence	 of	 S.	 aureus	 and	 P.	 aeruginosa	 bacterial-
conditioned	 medium	 had	 any	 affect	 on	 the	 secretion	 of	 active	 host-derived	
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proteases,	gelatin	zymography	was	used	to	assess	the	supernatant	from	the	in	vitro	
scratch	 assay	 at	 24	 and	 48	 hours	 (see	 Figure	 6.4).	 Control	 supernatants,	 including	
DMEM	 culture	 medium	 alone,	 untreated	 no-scratch	 control	 (NSC)	 and	 untreated	
scratch	control,	all	contained	two	proteases	of	approximately	60kDa	and	80kDa	(see	
Figure	 6.4,	 A).	 When	 evaluating	 the	 supernatants	 from	 scratches	 treated	 with	 P.	
aeruginosa	PCM,	zymography	showed	an	increase	in	the	intensity	of	the	60kDa	band	
at	24	hours	and	again	at	48	hours	when	compared	to	the	P.	aeruginosa	PCM	alone.	
Furthermore,	 the	 presence	 of	 the	 80kDa	 protease	 remained	 unchanged	 in	 the	 P.	
aeruginosa	PCM-treated	cell	supernatants.	Supernatants	treated	with	P.	aeruginosa	
BCM	 showed	 the	 presence	 of	 the	 bacterial-derived	 62kDa	 protease,	 which	 was	
identified	 in	 the	 previous	 chapter.	 Interestingly,	 at	 both	 24	 and	 48	 hours	 of	
treatment	 with	 the	 P.	 aeruginosa	 BCM,	 the	 appearance	 of	 an	 additional	 protease	
band	of	approximately	56kDa	was	noted	(see	red	arrow,	Figure	6.4,	A).	Additionally	
the	80kDa	protease	was	not	observed	 in	either	P.	aeruginosa	BCM	alone,	or	 in	 the	
24-	and	48-hour	scratch	supernatants	(see	black	arrow,	Figure	6.4,	A).	To	determine	
whether	 the	 additional	 protease,	 seen	 in	 the	 BCM-treated	 cell	 supernatants,	
belonged	to	the	metalloprotease	group,	the	zymograms	were	inhibited	with	100mM	
EDTA	 (see	 Figure	 6.4,	 B).	 The	 results	 showed	 a	 complete	 inhibition	 of	 the	 56kDa	
protease	and	the	proteases	identified	in	the	control	and	PCM	supernatants,	and	was	
therefore	undetectable	on	the	zymograms.	However,	as	shown	 in	Chapter	5	of	this	
thesis,	the	P.	aeruginosa-derived	62kDa	protease	in	the	BCM	supernatants	remained	
uninhibited	 by	 the	 EDTA	 treatment	 and	 was	 therefore	 still	 observed	 on	 the	
zymograms.	The	treatment	of	HDFs	with	S.	aureus	PCM	and	BCM	caused	a	change	in	
the	intensity	of	the	60kDa	band	after	48	hours	in	the	scratch	assay	(see	Figure	6.5).	
Furthermore,	 the	 80kDa	 was	 faint	 but	 present	 in	 all	 samples.	 All	 protease	 bands	
detected	 by	 gelatin	 zymography	were	 completely	 inhibited	 by	 100mM	 EDTA	 (data	
not	 shown).	 The	 presence	 of	 any	 further	 proteases	 within	 the	 supernatant	 of	 S.	
aureus	PCM-	and	BCM-treated	HDFs	were	not	detected.	
The	 expression	 of	 MMPs	 in	 HDFs	 at	 a	 transcriptional	 level	 was	 assessed	 using	
quantitative	reverse	transcriptase	polymerase	chain	reaction	(RT-PCR)	to	determine	
whether	any	significant	changes	 in	MMP	mRNA	expression	occurred	after	48	hours	
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treatment	with	bacterial-conditioned	medium	 in	 the	scratch	assay	 (see	Figure	6.6).	
More	specifically,	the	collagenases	MMP-1	and	MMP-13	and	gelatinases	MMP-2	and	
MMP-9	were	 investigated.	 Furthermore,	 expression	 of	 the	major	 substrate	 for	 the	
collagenases	 (and	 also	 the	 gelatinases),	 collagen-I,	 was	 tested.	 The	 validity	 of	 the	
expression	data	for	MMP-9	and	MMP-13	were	considered	unreliable	given	high	delta	
Ct	values	of	approximately	30	(data	not	shown)	and	therefore	were	not	presented	in	
this	 chapter.	 The	 reason	 for	 unreliable	 expression	 data	 could	 be	 due	 to	 a	 lack	 of	
expression	of	MMP-9	and	MMP-13	in	HDFs.	The	expression	of	collagen-I	in	HDFs	was	
significantly	reduced	in	cells	treated	with	P.	aeruginosa	BCM	when	compared	to	the	
untreated	scratch	control	(P	<0.05).	When	evaluating	the	MMP-1	expression	data,	a	
significantly	 higher	 expression	 of	 MMP-1	 in	 cells	 treated	 with	 P.	 aeruginosa	 PCM	
when	 compared	 to	 S.	 aureus	 PCM	 (P	 <0.01)	 was	 found.	 MMP-2	 expression	 in	 all	
treatment	groups	remained	relatively	constant	with	the	untreated	scratch	control.	In	
all	 expression	 data,	 there	were	 large	 error	 bars	 indicating	 variability	 in	 the	 results	
obtained	between	each	biological	replicate	in	their	respective	treatment	groups.		
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Figure	 6.4	 Representative	 zymography	 of	 supernatants	 from	 the	 HDFs	 scratch	
wound	assay	following	P.	aeruginosa	PCM	and	BCM	treatment.	
Supernatants	from	P.	aeruginosa	PCM-	and	BCM-treated	cells	after	24	and	48	hours	
were	 run	 on	 gelatin	 zymograms,	 which	 were	 either	 untreated	 (A)	 or	 inhibited	 for	
metalloproteases	 using	 100mM	EDTA	 (B).	 Controls	 include	DMEM	 culture	medium	
alone,	 untreated	 no-scratch	 control	 and	 untreated	 scratch	 control.	 Red	 and	 black	
arrows	represent	points	of	interest,	discussed	in	the	text.	Gelatin	zymography	of	all	
supernatants	from	P.	aeruginosa	PCM-	and	BCM-treated	cells	were	run	and	repeated	
twice	 (technical	 replicates,	 n=2).	 This	 zymogram	 is	 representative	 of	 HDFs	 treated	
with	P.	aeruginosa	P1126	clinical	isolate.	The	molecular	weight	is	in	kilodaltons	(kDa).	
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Abbreviations	 include	 Dulbecco’s	 modified	 Eagles	 medium	 (DMEM),	 no-scratch	
control	 (NSC),	 planktonic-conditioned	 medium	 (PCM)	 and	 biofilm-conditioned	
medium	(BCM).	
	
	
	
Figure	 6.5	 Representative	 zymography	 of	 supernatants	 from	 HDF	 scratch	 wound	
assay	following	S.	aureus	PCM	and	BCM	treatment.	
Supernatants	from	S.	aureus	PCM-	and	BCM-treated	cells	after	48	hours	were	run	on	
gelatin	 zymograms.	 Controls	 include	 DMEM	 culture	 medium	 alone,	 untreated	 no-
scratch	 control	 and	 untreated	 scratch	 control.	 Gelatin	 zymography	 of	 all	
supernatants	 from	 S.	 aureus	 PCM-	 and	 BCM-treated	 cells	 were	 run	 and	 repeated	
twice	 (technical	 replicates,	 n=2).	 The	 molecular	 weight	 is	 in	 kilodaltons	 (kDa).	
Abbreviations	 include	 Dulbecco’s	 modified	 Eagles	 medium	 (DMEM),	 no-scratch	
control	 (NSC),	 planktonic-conditioned	 medium	 (PCM)	 and	 biofilm-conditioned	
medium	(BCM).	
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Figure	6.6	The	expression	of	MMPs	and	collagen-I	using	quantitative	RT-PCR.	
Results	 represent	 the	 mean	 values	 ±	 standard	 deviation	 (biological	 replicates	 for	
each	species	n=6,	technical	replicates	n=2).Statistical	analysis	was	performed	using	
the	non-parametric	Kruskal-Wallis	with	Dunn’s	multiple	comparisons	test.	Statistical	
significance	is	indicated	as	*P	<0.05	and	**P	<0.01.		Abbreviations	include	no-scratch	
control	(NSC),	matrix	metalloprotease	(MMP),	planktonic-conditioned	medium	(PCM)	
and	biofilm-conditioned	medium	(BCM).	
	
	
6.3.3 The	 effect	 of	 P.	 aeruginosa	 and	 S.	 aureus	 planktonic-conditioned	 medium	
(PCM)	 and	 biofilm-conditioned	 medium	 (BCM)	 on	 adult	 human	 epidermal	
keratinocytes	(HEKs)	
Scratch	assays	using	HEKs	were	performed	in	the	same	manner	as	that	of	the	HDFs	
scratch	assays,	to	determine	whether	S.	aureus	and	P.	aeruginosa	PCM	and	BCM	had	
similar	 effects	 on	wound	 closure	 and	 cell	 viability.	 Images	 of	 scratch	 closure	were	
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taken	 at	 0,	 24	 and	 48	 hours	 and	 were	 analysed	 using	 ImageJ	 software.	 After	 24	
hours,	the	untreated	scratch	control	cells	showed	25.4%	±	12.1%	closure,	with	cells	
treated	with	S.	aureus	 PCM	and	BCM	showing	mixed	outcomes	between	biological	
replicates	with	 49.4%	 ±	 46.4%	 and	 11.1%	 ±	 45.3%	 closure	 respectively	 (see	 Figure	
6.7).	Cells	treated	with	P.	aeruginosa	PCM	and	BCM	after	24	hours	showed	-15.0%	±	
132.2%	and	-36.7%	±	56.9%	closure.	After	48	hours	the	untreated	control	cells	had	
reached	83.0%	±	7.6%	closure,	however	cells	 treated	with	S.	aureus	PCM	and	BCM	
continued	 to	 have	 profound	 effects	 on	 closure	with	 percentage	 values	 of	 29.3%	 ±	
107.7%	 and	 -17.4%	 ±	 85.3%.	 Similarly,	 most	 scratches	 treated	 with	 P.	 aeruginosa	
PCM	and	BCM	resulted	in	cell	detachment,	giving	percentage	closure	values	of	1.9%	
±	99.0%	and	-95.8%	±	53.6%.	There	were	huge	variability	in	these	results;	however,	
statistical	 analysis	 revealed	 that	 P.	 aeruginosa	 BCM	 significantly	 reduced	 wound	
closure	when	compared	to	the	untreated	control	(P	<0.01)	and	cells	treated	with	P.	
aeruginosa	PCM	(P	<0.05).	
It	was	clear	from	scratch	wound	analysis,	that	all	bacterial-conditioned	medium	had	
a	great	effect	on	not	only	HEKs	scratch	closure,	but	also	the	viability	of	the	cells,	with	
the	majority	 of	 cells	 treated	 with	 P.	 aeruginosa-conditioned	medium	 showing	 cell	
death.	 Therefore	 the	 cell	 viability	 of	 untreated	 HEKs	 and	 HEKs	 treated	 with	 the	
bacterial-conditioned	 medium	 were	 assessed.	 Results	 showed	 a	 large	 amount	 of	
variability	 in	 the	 viability	 of	 HEKs	 in	 all	 treatment	 groups	 after	 24	 and	 48	 hours	
(demonstrated	by	standard	deviation	error	bars),	which	reflected	the	variability	seen	
in	the	scratch	closure	results	(see	Figure	6.8).	At	4	hours	post-treatment	there	were	
no	differences	in	cells	treated	with	bacterial-conditioned	medium	when	compared	to	
the	 untreated	 control.	 After	 24	 hours,	 there	 were	 significant	 reductions	 in	
keratinocyte	viability	upon	treatment	with	S.	aureus	BCM	(P	<0.05)	and	P.	aeruginosa	
BCM	(P	<0.01)	when	compared	to	the	untreated	control.	After	48	hours,	only	HEKs	
treated	 with	 P.	 aeruginosa	 BCM	 showed	 a	 significantly	 lower	 viability	 when	
compared	to	the	untreated	control	(P	<0.05).		
Due	to	the	obvious	cell	death	observed	in	many	of	the	treatment	groups	in	the	HEKs	
scratch	 assays,	 zymography	of	 the	 scratch	 assay	 supernatants	 and	quantitative	RT-
PCR	was	not	performed.	
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Figure	 6.7	 Percentage	 scratch	 wound	 closure	 of	 adult	 human	 epidermal	
keratinocytes	(HEKs)	in	vitro.		
Results	are	shown	for	HEKs	treated	with	either	S.	aureus	or	P.	aeruginosa	planktonic-
conditioned	 medium	 (PCM)	 and	 biofilm-conditioned	 medium	 (BCM).	 Results	
represent	the	mean	values	±	standard	deviation	(biological	replicates:	S.	aureus	n=19	
and	P.	aeruginosa	n=15,	technical	replicates	n=2).	Statistical	analysis	was	performed	
using	two-way	analysis	of	variants	(ANOVA)	with	Tukey’s	multiple	comparisons	test.	
Statistical	 significance	 is	 indicated	 as	 *P	 <0.01	 when	 compared	 with	 the	 control	
group.	
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Figure	6.8	Adult	human	epidermal	keratinocyte	(HEK)	viability	following	bacterial-
conditioned	medium	treatment	using	PrestoBlue™.	
Results	are	shown	as	relative	fluorescence	values	whereby	HEKs	were	exposed	to	S.	
aureus	 and	 P.	 aeruginosa	 planktonic-conditoned	 medium	 (PCM)	 and	 biofilm-
conditioned	 medium	 (BCM)	 over	 48	 hours.	 Results	 represent	 the	 mean	 values	 ±	
standard	 deviation	 (biological	 replicates:	 S.	 aureus	 n=19	 and	 P.	 aeruginosa	 n=15,	
technical	replicates	n=2).	Statistical	analysis	was	performed	using	two-way	analysis	of	
variants	 (ANOVA)	with	 Tukey’s	multiple	 comparisons	 test.	 Statistical	 significance	 is	
indicated	 as	 *P	 <0.05	 and	 **P	 <0.01	 when	 compared	 with	 the	 untreated	 control	
group.	
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determine	 their	effect	on	HDFs	and	HEKs	scratch	closure	and	cell	 viability.	Both	50	
μg/ml	and	100	μg/ml	of	the	partially	purified	protease	(isolated	from	human	chronic	
wound-originating	P.	aeruginosa	P1097,	P1140,	P1145	BCM)	had	no	significant	effect	
on	scratch	closure	in	HDFs	(see	Figure	6.9).	The	cellular	viability	of	HDFs	was	tested	
and	 there	 was	 a	 significant	 reduction	 in	 viability	 after	 48	 hours	 exposure	 to	 100	
μg/ml	of	the	partially	purified	proteases	(P	<0.01)	(see	Figure	6.10).	Given	that	both	
PCM	 and	 BCM	 of	 both	 S.	 aureus	 and	 P.	 aeruginosa	 had	 a	 greater	 effect	 on	
keratinocyte	 scratch	 wound	 closure	 than	 HDFs	 wound	 closure,	 the	 effect	 of	 the	
partially	 purified	 proteases	 on	 keratinocyte	 scratch	 closure	 was	 tested.	 After	 24	
hours,	a	significant	reduction	in	closure	of	-120.2%	±	103.4	was	seen	after	treatment	
with	100	μg/ml	of	the	partially	purified	proteases	(P	<0.05)	(see	Figure	6.11).	After	48	
hours	 both	 50	 μg/ml	 and	 100	 μg/ml	 of	 the	 partially	 purified	 proteases	 caused	 a	
statistically	significant	reduction	in	closure	of	-112.9%	±	119.7%	and	-151%	±	57.3%	
respectively	 (P	 <0.01).	 Treatment	 with	 the	 partially	 purified	 proteases	 also	 had	 a	
greater	effect	on	 cell	 viability	 in	 the	keratinocytes	 than	 fibroblasts.	After	24	hours,	
there	 was	 a	 significant	 reduction	 in	 keratinocyte	 viability	 with	 50	 μg/ml	 and	 100	
μg/ml	of	the	partially	purified	protease	when	compared	to	the	untreated	control	(P	
<0.0001).	After	48	hours,	keratinocyte	viability	remained	significantly	lower	than	the	
untreated	control	(P	<0.001)	(see	Figure	6.12).		
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Figure	 6.9	 Percentage	 scratch	 wound	 closure	 of	 adult	 human	 dermal	 fibroblasts	
(HDFs)	after	treatment	with	P.	aeruginosa-derived	partially	purified	proteases.	
Results	 represent	 mean	 values	 ±	 standard	 deviation	 (biological	 replicates:	 n=3,	
technical	 replicates	 n=2).	 There	 was	 no	 statistically	 significant	 difference	 in	 the	
percentage	scratch	wound	closure	between	HDFs	treated	with	the	partially	purified	
proteases	and	HDFs	treated	with	control	(DMEM	complete)	medium	alone.	
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Figure	6.10	Cell	viability	of	adult	human	dermal	fibroblasts	(HDFs)	after	treatment	
with	P.	aeruginosa-derived	partially	purified	proteases,	using	PrestonBlue™.	
Results	show	two	treatment	groups,	whereby	HDFs	were	treated	with	50	μg/ml	and	
100	μg/ml	P.	aeruginosa-derived	protease	and	the	control	group	whereby	HDFs	were	
treated	 with	 DMEM	 complete.	 Results	 represent	 the	 mean	 values	 ±	 standard	
deviation	(biological	replicates	n=3,	technical	replicates	n=2).Statistical	analysis	was	
performed	 using	 two-way	 analysis	 of	 variants	 (ANOVA)	 with	 Tukey’s	 multiple	
comparisons	 test.	 Statistical	 significance	 is	 indicated	 as	 *P	 <	 0.01	when	 compared	
with	the	control	group.	
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Figure	 6.11	 Percentage	 scratch	 wound	 closure	 of	 adult	 human	 epidermal	
keratinocytes	 (HEKs)	after	 treatment	with	P.	aeruginosa-derived	partially	purified	
proteases.	
Results	 represent	 mean	 values	 ±	 standard	 deviation	 (biological	 replicates:	 n=3,	
technical	replicates:	n=2).	Statistical	analysis	was	performed	using	two-way	analysis	
of	variants	(ANOVA)	with	Tukey’s	multiple	comparisons	test.	Statistical	significance	is	
indicated	as	*P	<0.05	and	**P	<0.01	when	compared	with	the	control	group.	
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Figure	 6.12	 Cell	 viability	 of	 adult	 human	 epidermal	 keratinocytes	 (HEKs)	 after	
treatment	 with	 P.	 aeruginosa-derived	 partially	 purified	 proteases,	 using	
PrestoBlue™.	
Results	 show	 two	 treatment	 groups,	where	HEKs	were	 treated	with	 50	 μg/ml	 and	
100	 μg/ml	 P.	 aeruginosa-derived	 protease.	 Results	 represent	 the	 mean	 values	 ±	
standard	 deviation	 (biological	 replicates	 n=3,	 technical	 replicates	 n=2). Statistical	
analysis	 was	 performed	 using	 two-way	 analysis	 of	 variants	 (ANOVA)	 with	 Tukey’s	
multiple	comparisons	test.	Statistical	significance	is	indicated	as	*P	<	0.001	and	**P	
<0.0001	when	compared	with	the	control	group.	
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continued	 to	 be	 cultured	 before	 fixing	 and	 assessing	 the	 preliminary	 model	
histologically.	Haematoxylin	 and	 eosin	 (H&E)	 staining	 revealed	 a	 thick	 keratinocyte	
layer	that	was	dense	in	cell	nuclei	(see	Figure	6.13,	A).	The	dermal	layer	was	faintly	
stained,	with	few	identifiable	fibroblasts	(see	Figure	6.13,	B).	Despite	this,	a	distinct	
layer	 between	 the	 adhered	 keratinocytes	 and	 the	 fibroblast	 dermal	 layer	 was	
observed,	which	was	proposed	to	be	the	formation	of	the	basement	membrane	(see	
Figure	 6.13,	 C).	 Unfortunately,	 it	 was	 not	 possible	 to	 develop	 this	 model	 further	
planned	attempts	at	this	model	due	to	difficulties	with	the	culturing	and	viability	of	
HEKs	on	the	dermal	layer	construct.	
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Figure	6.13	 Images	of	 a	 3-dimensional	human	epidermal	 keratinocyte	 (HEKs)	 and	
human	dermal	fibroblast	(HDFs)	in	vitro	co-culture	model.	
The	 co-culture	 skin	model	 was	 assessed	 histologically	 using	 the	 haematoxylin	 and	
eosin	 stain.	 The	 co-culture	 model	 contained	 an	 epidermal	 keratinocyte	 layer	 (A),	
fibroblast	 dermal	 layer	 (B)	 and	 basement	membrane	 (C).	 A	 yellow	 arrow	 indicates	
the	 nuclei	 of	 the	 keratinocytes	 and	 fibroblasts	 are	 indicated	 using	 a	 black	 arrow.	
Images	of	the	histology	sections	were	taken	at	x10,	x20	and	x40	respectively.	
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6.4 Discussion	
It	was	the	aim	of	this	chapter	to	assess	the	effect	of	several	human	chronic-wound-
derived	S.	aureus	and	P.	aeruginosa	 isolates,	on	fibroblast	and	keratinocyte	scratch	
wound	 closure	 and	 cell	 viability.	 My	 study	 identified	 that	 P.	 aeruginosa	 BCM	
significantly	affected	HDF	scratch	closure	and	cell	viability,	whereas	other	treatment	
conditions	 such	 as	S.	 aureus	 PCM	and	BCM	and	P.	 aeruginosa	 PCM	had	 less	 of	 an	
effect.		
Methicillin-resistant	 S.	 aureus	 (MRSA)	 PCM	 and	 BCM	 has	 been	 shown	 to	 cause	 a	
significant	 reduction	 in	 the	 migration	 of	 human	 dermal	 fibroblasts	 (Kirker	 et	 al.	
2012).	 However	 S.	 aureus-conditioned	 medium	 had	 little	 effect	 on	 HDFs	 wound	
closure	 in	 this	 chapter.	A	possible	explanation	 could	be	due	 to	 the	 fact	 that	 the	S.	
aureus	 strains	 used	 in	 this	 chapter	were	methicillin-sensitive	 and	 therefore	 do	 not	
secrete	 the	 same	 soluble	 products	 that	 impede	 fibroblast	 migration.	 Indeed,	
differences	 between	 methicillin-sensitive	 S.	 aureus	 and	 MRSA,	 with	 regards	 to	
secreted	 virulence	 factors,	 has	 been	 reported	 (Schlievert	 et	 al.	 2010).	 However	 a	
recent	study	by	Souza	and	colleagues	assessed	the	genes	associated	with	virulence	in	
methicillin-sensitive	S.	aureus	and	MRSA	isolated	from	the	surrounding	environment	
and	from	equipment	 in	a	hospital,	and	found	no	significant	differences	 in	virulence	
factors,	biofilm	formation	or	cytokine	production	(Souza	et	al.	2014).		
When	 repeating	 the	 scratch	 wound	 experiments	 using	 HEKs,	 it	 appeared	 that	 the	
HEKs	 were	 much	 more	 sensitive	 to	 bacterial-conditioned	 medium,	 to	 varying	
degrees,	when	compared	to	the	HDFs.	In	vitro	studies	by	Kirker	and	colleagues	have	
previously	 demonstrated	 the	 detrimental	 properties	 of	 the	 soluble	 products	 of	
chronic	 wound-associated	 bacterial	 PCM	 and	 BCM	 on	 human	 epidermal	
keratinocytes.	 In	 the	 latter	 study,	 they	 found	 that	 the	 presence	 of	 PCM	and	 BCM,	
from	a	single	chronic	wound-derived	S.	aureus	 isolate,	significantly	 reduced	normal	
human	 keratinocyte	 scratch	 closure	 and	 that	 S.	 aureus	 BCM	 significantly	 reduced	
keratinocyte	 viability	 and	 increased	 apoptosis	 when	 compared	 to	 S.	 aureus	 PCM	
(Kirker	 et	 al.	 2009).	 Whilst	 this	 work	 emphasised	 the	 impact	 of	 biofilm-infected	
chronic	wounds	in	terms	of	tissue	destruction	and	reduced	keratinocyte	migration,	it	
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was	based	upon	the	conditioned	medium	of	a	single	wound-derived	isolate.	With	this	
in	 mind,	 an	 interesting	 finding	 in	 the	 work	 presented	 in	 this	 thesis	 was	 the	 large	
variability	 in	 the	 effects	 of	 these	 clinical	 isolates	 on	 scratch	 closure.	 For	 instance,	
although	the	majority	of	P.	aeruginosa	BCM	caused	a	significant	reduction	in	wound	
closure	in	HDFs,	BCM	from	a	few	isolates	appeared	to	have	little	effect	on	cells	in	the	
scratch	wound	assay	(data	not	shown).		
It	 has	 been	 proposed	 that	 bacterial	 biofilms	 within	 a	 wound	 are	 the	 reason	 for	
increases	 in	 host	 proteases	 and	 therefore	 this	 proteolytic	 activity	 is	 indicative	 of	 a	
biofilm	 (Wolcott	 et	 al.	 2008).	 The	mechanism	 behind	 a	 biofilm-related	 increase	 in	
host	 proteases	 is	 currently	 unknown.	 In	 this	 chapter,	 it	 has	 been	 shown	 that	 P.	
aeruginosa	BCM,	but	not	PCM,	elicits	 the	release	of	a	56kDa	metalloprotease	 from	
dermal	 fibroblasts.	 The	 soluble	 products	 of	 dermal	 fibroblasts	 treated	 with	MRSA	
PCM	and	BCM	was	assessed	for	MMPs,	growth	factors	and	cytokines	using	ELISA	and	
subsequently	 showed	 a	 significant	 increase	 in	 MMP-1	 and	 MMP-3	 secreted	 from	
MRSA	PCM-treated	fibroblasts,	whereas	MRSA	BCM-treated	fibroblasts	appeared	to	
suppress	MMP-3	activity	(Kirker	et	al.	2012).	It	was	unclear	as	to	whether	this	study	
explored	other	MMPs.	Regarding	the	data	in	this	chapter,	an	interesting	observation	
was	 that	 of	 the	 80kDa	 band	 detected	 in	 all	 controls	 and	 the	 P.	 aeruginosa	 PCM-
treated	 supernatants,	 but	 not	 the	 P.	 aeruginosa	 BCM-treated	 supernatants.	 As	
outlined	 previously	 in	 this	 chapter,	 the	 soluble	 products	 of	 P.	 aeruginosa	 can	
effectively	cleave	other	proteases	(Twining	et	al.	1993).	Therefore	it	 is	possible	that	
the	 soluble	 products	 present	 in	 P.	 aeruginosa	 BCM,	 but	 not	 PCM,	 cleaved	 or	
potentially	 degraded	 this	 protease.	 I	 propose	 that	 the	 detection	 of	 the	 56kDa	
protease	 in	 the	 P.	 aeruginosa	 BCM	 treatment	 group	 is	 a	 product	 of	 the	 HDFs	 in	
response	to	the	bacterial-conditioned	medium.	However,	an	alternative	explanation	
could	be	that	soluble	products	released	by	the	HDFs	were	able	to	cleave	the	bacterial	
protease	to	release	an	active	56kDa	protease	that	could	be	successfully	inhibited	by	
EDTA.	Indeed,	the	P.	aeruginosa-derived	bacterial	protease	was	still	observed	in	the	
EDTA-treated	 zymogram	 (see	 Figure	 6.4,	 B),	 however	 the	 bands	 appeared	 slightly	
faint	 when	 compared	 to	 P.	 aeruginosa	 BCM	 alone,	 which	 may	 indicate	 potential	
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interactions	between	 the	bacterial	protease	and	 the	 soluble	products	of	HDFs	 (see	
Figure	6.4,	A).		
An	 interesting	 finding	 in	 this	 chapter	 was	 the	 effect	 of	 the	 P.	 aeruginosa-derived	
partially	 purified	 proteases	 on	 HDFs	 and	 HEKs.	 This	 protease	 preparation	 using	
ammonium	 sulfate	 precipitation	 followed	 by	 dialysis,	 was	 referred	 to	 as	 ‘partially	
purified’	as	there	is	more	than	one	bacterial	protease	(62kDa	and	52kDa).	The	use	of	
SDS-PAGE	has	shown	additional	proteins	in	this	preparation,	however	due	to	its	high	
protease	activity	and	the	presence	of	protease	bands	in	zymography	(see	Chapter	5,	
Figure	 5.8),	 it	 was	 used	 to	 investigate	 its	 effects	 on	 wound	 closure.	 It	 was	 clear	
throughout	 the	entirety	of	 this	 project	 that	 the	 fibroblasts	were	more	 robust	 than	
the	keratinocytes	in	culture,	therefore	it	is	not	entirely	surprising	that	the	HEKs	were	
more	 sensitive	 to	 the	 partially	 purified	 proteases	 than	 the	 HDFs.	 However	
considering	this,	I	hypothesise	that	these	proteases	released	by	the	biofilm	within	a	
chronic	wound	may	 reduce	 keratinocyte	 viability	 and	prevent	migration	 across	 the	
wound,	but	 that	 these	proteases	do	not	effect	dermal	 fibroblast	migration.	Rather,	
other	soluble	factors,	possibly	known	P.	aeruginosa	virulence	factors,	may	play	more	
of	a	role	in	fibroblast	migration	and	viability	in	biofilm-infected	chronic	wounds.		
Whilst	the	use	of	monolayer	scratch	wounds	can	give	a	basic	understanding	of	how	a	
single	 cell	 type	 may	 regulate	 the	 secretion	 of	 MMPs	 in	 response	 to	 bacterial-
conditioned	medium,	they	simply	do	not	mimic	the	complexity	of	human	skin.	It	has	
been	shown	that	the	assessment	of	wound	healing	in	3-D	fibroblast-keratinocyte	skin	
equivalent	models	 is	 comparable	 to	 that	 of	 wound	 healing	 in	mice	 (Maione	 et	 al.	
2014).	It	was	therefore	an	important	aim	within	this	chapter	to	develop	a	3-D	human	
keratinocyte	 and	 fibroblast	 co-culture	 skin	 model	 that	 would	 serve	 as	 a	 more	
physiologically	relevant	model	compared	to	that	of	single	cell-type	monolayers.	The	
development	 of	 this	 model	 was	 based	 upon	 the	 model	 published	 previously,	
whereby	fibroblasts	were	cultured	in	a	3-D	fibrin	gel	matrix,	followed	by	the	culture	
of	keratinocytes	on	the	surface,	 to	effectively	reproduce	the	epidermal	and	dermal	
layer	 of	 the	 skin	 (Holland	et	 al.	 2008).	Using	 this	model,	 I	 had	planned	 to	 test	 the	
effects	 of	 bacterial-conditioned	 medium,	 P.	 aeruginosa-derived	 partially	 purified	
proteases	and	low	cell	numbers	of	bacteria	on	unwounded	and	wounded	skin,	on	the	
Page	198	of	253	
	
expression	of	MMPs	 in	 the	epidermal	and	dermal	 layers.	A	preliminary	experiment	
developing	 this	 model	 resulted	 in	 a	 particularly	 acellular	 dermal	 layer.	 Therefore,	
further	attempts	were	made	to	increase	the	seeding	density	of	fibroblasts	in	the	3-D	
fibrin	matrix,	which	 resulted	 in	 contraction	 of	 the	 fibrin	 gel	 in	 culture	 (images	 not	
shown).	However	due	 to	difficulties	with	keratinocyte	cell	 culture	on	 the	 fibrin	gel,	
further	attempts	at	the	skin	model	were	not	progressed.	Unfortunately	it	is	unknown	
whether	the	encountered	technical	issues	were	due	to	the	keratinocytes	themselves	
or	an	incompatibility	with	the	fibrin	matrix.	Although	collagen	matrices	have	always	
been	 the	 preferred	 scaffold	 of	 choice	 in	 these	 skin	 equivalent	models,	 it	 has	 been	
known	 for	 some	 time	 that	 fibrin	 helps	 to	 promote	 keratinocyte	 migration	 and	
differentiation	 (Geer	 and	 Andreadis	 2003).	 Furthermore	 Holland	 and	 colleagues	
successfully	 cultured	 this	 fibrin-containing	 skin	 equivalent	 for	 subsequent	 testing;	
however	 they	 used	 epidermal	 keratinocytes	 from	 neonatal	 foreskin	 rather	 than	
keratinocytes	from	adult	epidermis,	as	seen	in	this	chapter.		
	
6.4.1 Limitations	
It	is	important	to	note	that	the	effects	of	bacterial-conditioned	medium	on	cells	may	
not	reflect	the	potential	effects	of	a	biofilm	incorporated	into	the	scratch	assay.	This	
could	 be	 due	 to	 the	 fact	 that	 the	 PCM	 and	 BCM	 are	 produced	 in	 an	 isolated	
environment	 whereby	 factors	 affecting	 the	 bacterial	 growth	 include	 temperature,	
nutrient	 availability	 and	 oxygen.	 Such	 factors	 such	 as	 host	 cell-derived	 growth	
factors,	cytokines,	and	proteases	are	not	present	 in	this	artificial	 laboratory	setting.	
Therefore	 it	 is	 logical	 to	consider	that	these	factors	may	have	an	 impact	on	biofilm	
growth	 and	 maturity,	 and	 in	 particular,	 the	 release	 of	 soluble	 factors	 such	 as	
extracellular	 bacterial	 proteases	 and	 other	 virulence	 factors.	 It	 was	 indeed	 the	
intention	 of	 this	 particular	 study,	 to	 incorporate	 biofilms	 into	 the	 assay,	 however	
there	was	a	 lack	of	availability	 in	0.2μm	cell	culture	 inserts	 in	 the	UK,	and	shipping	
from	 other	 countries	 from	 particular	 manufacturers	 was	 difficult	 and	 delayed.	 An	
alternative	option	to	combat	this	was	to	grow	the	biofilm	on	the	0.2μm	membrane	
filter	before	suspending	it	 in	a	BD	deep-well	plate,	whereby	the	cells	were	adhered	
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to	the	bottom	of	the	well.	However	due	to	the	nature	of	experiment	set-up,	involving	
the	movement	 of	 the	 experiment	 to	 image	 cells	 and	 collect	medium,	 there	was	 a	
high	 rate	of	 contamination	of	 the	culture	medium,	which	caused	cell	death.	 It	was	
also	observed	that	the	biofilm,	once	suspended	on	the	surface	of	the	medium	in	the	
BD	 deep-well	 plate,	 became	 unstable,	 with	 bacteria	 contaminating	 the	 culture	
medium	in	the	well.	Therefore	it	was	decided	to	produce	BCM	without	the	presence	
of	 fibroblasts	 or	 keratinocytes	 in	 the	 well,	 with	 the	 intention	 to	 then	 treat	 cells	
separately.		
	
6.4.2 Future	Directions	
Work	performed	in	this	chapter	involved	investigations	into	whether	the	expression	
of	specific	MMPs	at	a	transcriptional	level	was	altered	after	treatment	with	bacterial-
conditioned	medium.	 This	 initial	work	 indicated	 that	 the	 expression	 of	 the	MMPs’	
under	investigation	was	not	significantly	altered.	These	results	perhaps	indicate	that	
to	focus	solely	on	the	expression	of	MMPs	could	be	misleading,	and	that	the	use	of	
techniques	such	as	ELISA	and	substrate	zymography,	which	focus	on	the	detection	of	
the	 secreted	 active	 protease,	 is	 more	 appropriate.	 Therefore,	 future	 work	 should	
investigate	 the	 levels	 of	 active	 host-derived	 MMPs	 in	 response	 to	 bacterial-
conditioned	 medium	 in	 a	 more	 quantitative	 manner,	 possibly	 through	 the	 use	 of	
ELISA.	Unfortunately	 in	 this	study,	 the	use	of	 reverse	zymography	to	 identify	 tissue	
inhibitors	of	metalloproteases	 (TIMPs)	was	not	possible	due	to	technical	difficulties	
and	therefore	future	work	would	also	aim	to	assess	the	presence	of	secreted	TIMPs	
from	both	fibroblasts	and	keratinocytes	 in	the	scratch	assay.	 It	would	also	be	more	
physiologically	 relevant	 to	 study	 bacterial-induced	 protease	 release	 from	
keratinocytes	 and	 fibroblasts	 taken	 from	 human	 chronic	 wounds	 (as	 done	 for	 the	
equine	studies	in	Chapter	4	of	this	thesis).	
An	 important	observation	 in	 the	 results	 obtained	 from	 the	work	performed	 in	 this	
chapter	 is	 the	variability	between	 the	clinical	 isolates	and	 their	effect	on	HDFs	and	
HEKs.	 In	particular	 it	was	noted	that	although	the	majority	of	bacterial-conditioned	
medium	had	detrimental	effects	on	HEKs	scratch	wound	closure	and	viability,	not	all	
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conditioned	medium	from	these	isolates	had	this	effect.	However,	as	the	results	are	
presented	 as	 a	 mean	 of	 the	 biological	 replicates,	 it	 is	 easy	 to	 overlook	 these	
anomalies.	Questions	 do	 arise	 as	 to	why	 the	 secreted	 products	 of	 these	 particular	
strains	 of	 bacteria	 do	 not	 have	 the	 same	 effect	 on	 cells	 as	 the	 majority	 of	 the	
isolates.	Therefore	it	would	be	interesting	to	investigate	the	effect	of	factors	such	as	
the	 host	 wound	 environment	 in	 which	 the	 bacterial	 strain	 was	 isolated	 and	 the	
treatment	strategies	that	were	undertaken	at	the	time	of	isolation,	for	example	the	
use	of	antibiotics.	It	is	possible	that	these	factors	may	play	a	role	in	the	virulence	of	
these	 bacteria,	 which	 has	 a	 lasting	 effect	 that	 is	 continued	 through	 to	 laboratory	
culture.		
	
6.4.3 Key	Points	
The	major	 findings	 within	 this	 chapter	 include	 the	 significant	 reduction	 in	 scratch	
wound	 closure	 and	 cell	 viability	 of	 fibroblasts	 after	 treatment	 with	 the	 BCM	 of	
human	chronic	wound-derived	P.	aeruginosa.	Furthermore,	keratinocytes	appeared	
much	 more	 sensitive	 to	 bacterial-conditioned	 medium,	 with	 varying	 effects	 on	
scratch	 closure	 and	 keratinocyte	 viability.	 Zymography	 revealed	 the	 release	 of	 a	
56kDa	metalloprotease	 from	HDFs	 after	P.	 aeruginosa	 BCM	 treatment,	 which	was	
not	 detected	 in	 P.	 aeruginosa	 BCM	 or	 untreated	 fibroblast-conditioned	 medium	
alone.	The	expression	of	fibroblast	MMP-1	and	MMP-2	at	a	transcriptional	level	did	
not	significantly	alter	when	compared	to	the	untreated	control.	However	there	was	a	
significant	 decrease	 in	 the	 expression	 of	 collagen-I	 after	 treatment	 with	 P.	
aeruginosa	BCM.	The	partially	purified	P.	aeruginosa-derived	proteases	did	not	cause	
any	significant	reduction	in	fibroblast	scratch	closure,	however	100μg	of	the	partially	
purified	 protease	 caused	 a	 significant	 reduction	 in	 fibroblast	 viability	 at	 48	 hours.	
Interestingly,	the	P.	aeruginosa-derived	partially	purified	proteases	had	a	significant	
effect	on	HEKs	scratch	closure	and	cellular	viability,	which	would	suggest	that	there	is	
a	detrimental	effect	of	bacterial	proteases	on	keratinocyte	migration	and	cell	viability	
in	chronic	wounds.	
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Chapter	7:	Conclusions	and	Perspectives	
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7 Conclusions	and	Perspectives	
The	 cellular	 and	molecular	mechanisms	 of	 physiological	 wound	 healing	 have	 been	
well	 researched,	however	 there	 still	 remains	a	 clear	 lack	of	understanding	 into	 the	
pathological	 mechanisms	 behind	 hard-to-heal	 chronic	 wounds.	 Theories	 exploring	
chronic	wound	pathology	 include	the	 increased	secretion	of	host-derived	proteases	
and	 the	 presence	 of	 bacterial	 biofilms	 within	 the	 wound	 (Bjarnsholt	 et	 al.	 2008,	
Wysocki	et	al.	1993).	There	are	a	plethora	of	advanced	technology	wound	dressings	
and	 techniques	 such	 as	 debridement	 and	 antibiotic	 therapy	 that	 are	 used	 in	 the	
attempt	 to	 control	 wound	 exudate	 and	microbial	 bioburden.	 Despite	 this,	 chronic	
wounds	still	 remain	an	economic	burden	and	health	concern.	Wound	management	
appears	to	adopt	a	‘one-fits-all’	approach,	with	no	clear	strategy	employed	by	health	
organisations.	 One	 reason	 for	 this	 could	 be	 due	 to	 the	 lack	 of	 point-of-care	 tests	
available	 that	may	 help	 decide	 the	 course	 of	 treatment	 for	 individual	 patients.	 In	
order	 to	 address	 this	 issue,	 research	 must	 be	 focussed	 on	 understanding	 the	
dynamics	of	the	chronic	wound.	The	research	in	this	thesis	focuses	on	understanding	
the	 potential	 role	 of	 bacterial	 biofilms	 and	 bacterial	 proteases	 in	 chronic	 wound	
pathology	in	horse	and	human.	
Due	to	the	clinically	characteristic	proteolytic	environment	of	human	chronic	wounds	
and	the	presence	of	bacterial	biofilms	in	both	human	and	equine	chronic	wounds,	I	
hypothesised	 that	 bacteria	 within	 these	 wounds	 contribute	 to	 an	 exaggerated	
proteolytic	 environment	 through	 the	 secretion	 of	 extracellular	 bacterial	 proteases	
and	that	both	bacteria	(in	planktonic	and	biofilm	form)	and	bacterial	proteases	may	
affect	wound	closure.	Therefore	the	main	objective	of	this	thesis	was	to	evaluate	the	
proteolytic	 activity	 of	 bacteria	 isolated	 from	equine	 and	human	 chronic	wounds	 in	
planktonic	and	biofilm	form,	and	determine	whether	these	bacteria	reduced	wound	
healing	and	affected	fibroblast	protease	secretion	in	vitro.		
	
The	 data	 presented	 in	 this	 thesis	 strongly	 supports	 the	 theory	 that	 bacteria,	
particularly	 P.	 aeruginosa	 in	 biofilm	 form,	 contribute	 to	 the	 protease-rich	
environment	in	human	chronic	wounds.	Furthermore,	it	is	likely	that	the	presence	of	
a	bacterial	biofilm	contributes	to	the	release	of	proteases	from	resident	fibroblasts	in	
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human	chronic	wounds	 (see	Figure	7.1).	 The	 reader	 is	directed	 to	Table	7.1	 for	an	
overview	of	all	bacterial-	and	fibroblast-derived	proteases	identified	in	this	thesis.		
The	 exaggerated	 protease-rich	 environment	 subsequently	 leads	 to	 the	 excessive	
degradation	 of	 extracellular	 matrix	 (ECM)	 components	 and	 potentially	 provides	
additional	 nutrients	 for	 a	 developing	 biofilm.	 Indeed,	 a	 proteomic	 analysis	 of	
catheter-associated	 biofilm	 has	 shown	 the	 release	 of	 P.	 aeruginosa-derived	
proteases,	 which	 are	 not	 only	 thought	 to	 play	 a	 role	 as	 virulence	 factors	 in	 the	
evasion	of	host	immune	responses	but	also	play	a	role	in	nutrient	acquisition	through	
amino	 acid	 metabolism	 (Lassek	 et	 al.	 2015).	 Interesting	 findings	 relating	 to	 this	
concept	 include	 the	 significant	 difference	 in	 protease	 activity	 between	 human-
derived	 P.	 aeruginosa	 in	 planktonic	 and	 biofilm	 form	 (see	 Figure	 7.2)	 and	 the	
presence	of	a	secreted	protease	that	could	only	be	detected	in	biofilm	cultures.	Few	
studies	have	focussed	on	biofilm-specific	secreted	proteases.	According	to	a	study	by	
Whiteley	and	colleagues,	there	are	a	small	but	significant	percentage	of	differentially	
expressed	 genes	 in	 planktonic	 and	 biofilm	 P.	 aeruginosa	 (Whiteley	 et	 al.	 2001).	 A	
laboratory	 strain	 of	 P.	 aeruginosa	 has	 been	 shown	 to	 secrete	 a	 25kDa	
metalloprotease	 named	Mep72,	which	 is	 only	 secreted	 from	 the	 biofilm	 form	 and	
not	 planktonic	 cells	 (Passmore	 et	 al.	 2015).	 Future	work	 would	 aim	 to	 investigate	
whether	 the	 secretion	 of	 these	 proteases	 are	 linked	 to	 the	 development	 of	 P.	
aeruginosa	 biofilms	 in	 chronic	wounds.	 If	 indeed	 they	are,	 it	may	be	 interesting	 to	
consider	this	mechanism	as	a	therapeutic	target,	possibly	for	the	development	of	a	
diagnostic	point-of-care	test	that	indicates	the	presence	of	a	biofilm	within	a	wound.	
Alternatively,	 this	 protease	 could	 be	 pharmacologically	 targeted	 to	 disrupt	 biofilm	
formation	in	chronic	wounds.		
The	 bacterial-derived	 extracellular	 proteases	 detected	 in	 human-derived	 P.	
aeruginosa	 BCM	 were	 partially	 purified,	 however	 the	 results	 in	 Chapter	 6	 of	 this	
thesis	 show	 that	 these	proteases	did	not	 significantly	 affect	 in-vitro	human	dermal	
fibroblast	 (HDF)	 wound	 closure.	 Although	 the	 bacterial-derived	 proteases	 did	
significantly	reduce	human	epidermal	keratinocyte	(HEK)	wound	closure,	which	may	
suggest	 a	 potential	 role	 for	 bacterial	 proteases	 in	 the	 prevention	 of	 re-
epithelialisation,	these	results	should	be	approached	with	caution.	In	vitro	culture	of	
the	 HEKs	 was	 problematic	 throughout	 this	 study	 due	 to	 cell	 death	 and	 a	 lack	 of	
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cellular	proliferation,	despite	obtaining	several	different	batches	of	these	cells	from	
the	 company	 from	which	 they	were	 purchased.	 Thus,	more	 research	 is	 needed	 to	
elucidate	 the	 effects	 of	 bacterial	 proteases	 on	 keratinocyte	 wound	 closure	 by	
assessing	other	available	keratinocytes	such	as	 that	of	a	neonatal	origin,	which	are	
considered	more	 robust	 in	culture.	 Investigating	 the	 role	of	 this	bacterial	protease,	
for	example,	as	a	virulence	 factor	 in	evading	host	 immune	responses,	would	be	an	
essential	focus	of	future	work.	
	
	
	
Figure	7.1	Representation	of	the	potential	sources	of	protease	release,	which	may	
contribute	to	the	exaggerated	proteolytic	environment	of	human	chronic	wounds.	
It	is	hypothesised	that	bacterial	biofilms,	particularly	P.	aeruginosa,	contribute	to	the	
excessive	production	of	proteases	in	chronic	wound	pathology	through	the	release	of	
extracellular	 bacterial	 proteases.	 Furthermore	 the	 presence	 of	 a	 P.	 aeruginosa	
biofilm	within	the	wound	may	induce	the	release	of	matrix	metalloproteases	(MMPs)	
from	 resident	 dermal	 fibroblasts.	 It	 is	 unknown	 whether	 fibroblast-derived	MMPs	
effect	 the	 production	 of	 extracellular	 bacterial-derived	 proteases	 (indicated	 by	
dashed	grey	arrow).	
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Figure	7.2	A	comparison	between	the	proteolytic	activity	of	human	and	equine	P.	
aeruginosa	clinical	isolates	in	the	Azocoll	assay.	
Abbreviations	 include	 planktonic-conditioned	 medium	 (PCM),	 biofilm-conditioned	
medium	(BCM),	human	(h)	and	equine	(eq).	Error	bars	represent	standard	deviation.	
Statistical	 analysis	 was	 performed	 using	 the	 Kruskal-Wallis	 non-parametric	 ANOVA	
with	a	Dunn’s	multiple	comparison	test.	Statistical	significance	 is	represented	as	*P	
<0.01;	**P		<0.0001.	
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	 Detected	proteases	
Source	of	bacteria	 P.	aeruginosa-derived
	 	
Fibroblast	(host)-derived	
Equine	chronic	wounds	 62kDa,	52kDa,	42kDa	 57kDa,	38kDa	
Human	chronic	wounds	 62kDa,	52kDa	 56kDa	
	
Table	7.1	An	overview	of	the	bacterial-	and	fibroblast-derived	proteases	detected	
within	the	study.	
Dulbecco’s	 modified	 Eagle’s	 medium	 (DMEM)	 was	 used	 to	 obtain	 bacterial-	 and	
fibroblast-derived	conditioned	medium.	Proteases	were	either	detected	using	gelatin	
or	collagen	zymography.	Molecular	weights	were	estimated	using	a	molecular	weight	
marker.		
	
	
	
As	mentioned	 previously	within	 this	 thesis,	 the	 study	 of	 equine	 chronic	wounds	 is	
gaining	precedent	due	 to	 the	parallels	 that	 can	be	drawn	 to	human	skin	disorders,	
particularly	 fibroproliferative	 disorders.	 In	 the	 context	 of	 equine	 chronic	 wounds,	
whereby	 exuberant	 granulation	 tissue	 is	 present,	 it	 is	 unclear	 whether	 there	 is	 a	
protease-rich	environment	similar	to	that	diagnosed	in	human	chronic	wounds.	The	
available	 literature	 merely	 draws	 assumptions	 based	 on	 the	 clinical	 findings	 in	
human	 chronic	 wounds.	 Therefore	 it	 must	 be	 acknowledged	 that	 the	 clinical	
characteristics	 of	 equine	 and	 human	wounds	 do	 differ,	 with	 equine	wounds	 often	
presenting	with	exuberant	granulation	tissue	unlike	human	chronic	wounds.		
Whilst	the	findings	in	this	thesis	show	that	equine-derived	P.	aeruginosa	secrete	high	
levels	of	extracellular	proteases	in	planktonic	and	biofilm	form,	these	proteases	may	
not	effect	the	production	of	granulation	tissue.	Granulation	tissue	fibroblasts	(GTFs)	
showed	faster	wound	closure	and	appeared	to	be	more	resilient	towards	the	effects	
of	bacterial-conditioned	medium	compared	to	the	normal	fibroblasts	(NFs).	Although	
the	presence	of	P.	aeruginosa	BCM	still	caused	a	significant	reduction	in	GTF	wound	
closure,	these	observations	may	indicate	that	GTFs	within	equine	chronic	wounds	are	
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better	at	withstanding	the	soluble	products	released	by	the	biofilm.	Further	studies	
into	 the	 effects	 of	 biofilms	 on	 the	 proliferative	 capacity	 and	 viability	 may	 help	 to	
clarify	this.	The	presence	of	P.	aeruginosa	 in	biofilm	form	also	elicited	the	secretion	
of	proteases	from	NFs	but	not	from	GTFs.	In	light	of	this,	future	work	would	involve	
the	investigation	of	tissue	inhibitors	of	metalloproteases	(TIMPs)	released	from	NFs	
and	GTFs	and	other	detectable	bacterial-derived	inhibitors	may	help	gain	insight	into	
overall	proteases	imbalances	in	equine	chronic	wounds.		
	
When	 reflecting	 upon	 the	 equine	 and	 human	 data	 as	 a	 whole,	 the	 discovery	 that	
human-derived	 P.	 aeruginosa	 in	 planktonic	 form	 produce	 low	 levels	 of	 protease	
activity	 was	 indeed	 a	 surprise,	 considering	 the	 high	 levels	 secreted	 by	 planktonic	
equine-derived	P.	aeruginosa	(see	Figure	7.2).	Whilst	variations	in	proteolytic	activity	
between	varying	strains	 is	 to	be	expected,	 it	still	unearths	the	question	of	whether	
there	 is	 a	 relationship	between	 the	 environment	 from	which	 the	 isolate	originates	
and	 its	 protease	 activity.	 Horses	 are	 exposed	 to	 a	 plethora	 of	 environmental	
microbes,	 which	 may	 have	 an	 effect	 on	 the	 protease	 profile	 of	 these	 individual	
isolates.	 Very	 few	 studies	 have	 addressed	 this	 issue	 of	mixed	 species	 biofilms	 and	
how	the	bacterial	secretome	differs	within	this	environment.	One	study	by	Purschke	
and	 colleagues	 identified	 a	 uniquely	 expressed	 collection	 of	 proteins	 specific	 to	P.	
aeruginosa	 and	Candida	albicans	 in	 a	mixed	 species	biofilm	 (Purschke	et	 al.	 2012).	
More	specifically,	they	determined	that	the	bacterial	secretome	was	less	diverse	in	a	
mixed-species	 biofilm,	 however	 P.	 aeruginosa-derived	 proteins	 relating	 to	 iron-
acquisition	(a	process	that	is	thought	to	be	necessary	for	biofilm	formation),	such	as	
pyoverdine,	was	significantly	increased	in	mixed-species	biofilms.	Interestingly,	mass	
spectrometry	 results	also	 showed	a	decrease	 in	detected	P.	aeruginosa	AprA,	 LasA	
and	LasB	proteases	 in	mixed-species	biofilms	(Purschke	et	al.	2012).	 Indeed,	one	of	
the	 limitations	 of	 the	 research	 within	 this	 thesis	 is	 the	 determination	 of	 the	
proteolytic	 activity	 of	 the	 bacterial	 isolates	 in	 an	 artificial	 environment,	 whereby	
individual	 species	 lack	 interactions	with	other	microorganisms	 that	may	have	been	
present	within	the	wound.	It	would	be	interesting	to	investigate	further	with	mixed	
species	biofilms,	P.	aeruginosa	and	S.	aureus,	to	determine	how	protease	secretion	is	
affected,	providing	more	clinically	relevant	data.		
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Similarities	 in	 the	proteases	detected	 in	equine-	and	human-derived	P.	aeruginosa-
conditioned	medium	and	the	medium	from	P.	aeruginosa-treated	fibroblasts	can	be	
seen	 (see	 Table	 7.1).	 Both	 equine-	 and	 human-derived	 P.	 aeruginosa	 secreted	 a	
62kDa	 and	 52kDa	 proteases	 (respectively	 with	 variation	 between	 biological	
replicates).	Furthermore	it	can	be	argued	that	equine	and	human	fibroblasts	secrete	
the	same	protease	in	response	to	the	P.	aeruginosa	biofilm,	with	proteases	of	57kDa	
and	 56kDa	 detected,	 respectively.	 A	 notable	 observation	 in	 the	 detection	 of	 both	
equine-	 and	 human-derived	 bacterial	 proteases	 was	 the	 resistance	 of	 these	
proteases	 to	 broad-spectrum	 inhibitors.	 Unfortunately	 due	 to	 this	 and	 a	 lack	 of	
conclusive	 mass	 spectrometry	 data	 (Chapter	 3),	 it	 was	 difficult	 to	 determine	 the	
identification	 of	 these	 proteases.	 Nevertheless,	 if	 the	 inhibition	 of	 extracellular	
bacterial	 proteases	 were	 to	 be	 considered	 as	 a	 target	 to	 discourage	 biofilm	
development,	the	potential	resistance	of	these	proteases	to	protease	inhibitors	may	
prove	problematic.		
	
To	 conclude,	 the	 role	of	P.	 aeruginosa	 biofilms	and	 their	 extracellular	proteases	 in	
equine	chronic	wound	pathology	remains	undetermined.	Whilst	this	is	the	first	study	
to	 demonstrate	 high	 levels	 of	 extracellular	 proteases	 in	 the	 planktonic	 and	biofilm	
forms	 of	 equine-derived	 P.	 aeruginosa,	 it	 is	 difficult	 to	 relate	 the	 clinical	
characteristics	 of	 equine	wounds	with	 this	 bacterial	 physiology.	Understanding	 the	
role	of	protease	inhibitors	such	as	TIMPs	in	equine	chronic	wounds	may	be	of	great	
clinical	significance.	Nevertheless,	 the	results	within	this	thesis	do	help	to	elucidate	
the	detrimental	impact	of	P.	aeruginosa	biofilms	in	human	chronic	wound	pathology,	
with	high	levels	of	secreted	proteases	from	these	biofilms	and	the	presence	of	these	
biofilms	relating	to	the	secretion	of	host-derived	proteases,	thus	contributing	to	an	
exaggerated	proteolytic	environment.	For	the	first	time,	this	research	has	shown	the	
presence	of	a	62kDa	and	52kDa	P.	aeruginosa	protease	that	appears	to	be	specific	to	
biofilm	forms	and	not	planktonic	forms.	However	further	research	needs	to	be	done	
in	 order	 to	 understand	 the	 role	 of	 this	 specific	 P.	 aeruginosa	 protease	 in	 the	
development	of	the	biofilm	and	the	pathogenesis	of	human	chronic	wounds.	
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Appendix	 I:	 Protease	 activity	 in	 equine	 P.	 aeruginosa	 planktonic-
conditioned	medium	(PCM)	using	milk-casein	agar		
	
	
	
Figure	 I	 A	 Protease	 activity	 of	 equine	 chronic	 wound-derived	 P.	 aeruginosa	 using	
milk-casein	agar.	P.	aeruginosa	planktonic-conditioned	medium	(PCM)	was	added	to	
milk-casein	agar	and	 incubated	at	37°C.	Zones	of	clearance	 in	milk-casein	agar	was	
measured	 at	 24-	 and	 48-hours.	 Error	 bars	 represent	 standard	 deviation.	 The	
experiment	was	repeated	three	times	(n=3).	
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Appendix	 II:	 The	 Sequestration	 of	 MMP-2	 using	 a	 Novel	 Natural	 Fibre	
Dressing	and	the	Assessment	of	Potential	Biofilm-Disrupting	Technologies	
In	Vitro	-	Work	proposed	by	Advanced	Medical	Solutions	Plc	
	
Introduction	
Since	 the	 identification	 of	 elevated	 proteases	 in	 chronic	 wounds	 (Wysocki	 et	 al.	
1993),	wound	care	has	been	directed	toward	the	management	of	excessive	chronic	
wound	fluid	 in	order	 to	control	 the	destructive	action	of	potential	 tissue-degrading	
MMPs.	 For	 instance,	 diagnostic	 tools	 such	 as	 WOUNDCHEK™	 Protease	 status	
(WOUNDCHEK™	 Laboratories,	 UK),	 a	 novel	 point	 of	 care	 test	 to	 detect	 elevated	
protease	 activity	 in	 hard-to-heal	 chronic	 wounds,	 has	 been	 developed	 to	 create	 a	
more	 targeted	 approach	 to	wound	management.	 	 Furthermore,	 a	 range	 of	wound	
dressings	 with	 high-absorption	 qualities	 are	 used	 to	 control	 MMP-rich	 wound	
exudate.	 As	 mentioned	 in	 Chapter	 1	 of	 this	 thesis,	 materials	 such	 as	 alginates,	
hydrofiber,	 foam,	 hydrogel	 and	 hydrocolloid,	 all	 possess	 absorptive	 properties	 and	
are	 commonly	 used	materials	 for	 wound	 dressings.	 Dressings	 incorporated	 with	 a	
substrate	 such	 as	 collagen,	 have	 also	 been	 designed	 to	 provide	 an	 additional	
substrate	for	excess	MMP’s,	as	well	as	for	bacterial	collagenases	that	have	also	been	
detected	within	wounds	(Metzmacher	et	al.	2007).	In	addition	there	has	been	much	
attention	 surrounding	 biofilms	 and	 chronic	 wound	 pathology	 and	 subsequently,	
wound	 care	 companies	 have	 developed	 wound	 care	 products	 with	 not	 only	 high	
absorptive	properties,	but	also	antimicrobial	 technology.	A	good	example	of	 this	 is	
wound	 dressings	 incorporated	 with	 silver,	 which	 have	 been	 shown	 to	 reduce	
bacterial	numbers	in	chronic	wound-associated	bacteria,	with	a	low	risk	of	microbial	
silver	 resistance	 (Percival	 et	 al.	 2007,	 Percival	 et	 al.	 2008).	 The	 use	 of	 silver	
nanoparticle	 technology	 is	 also	 being	 investigated	 and	 has	 been	 shown	 to	 reduce	
bacterial	 cell	 numbers	 in	 an	 in	 vitro	Pseudomonas	 aeruginosa	 biofilm	model,	 and,	
with	 human	 fibroblast	 biocompatibility,	 is	 thought	 to	 be	 able	 to	 reduce	microbial	
load	 and	 improve	 wound	 closure	 in	 chronic	 wounds	 (Velázquez-Velázquez	 et	 al.	
2014).	Manuka	honey	in	wound	management	has	also	shown	promising	results,	with	
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significant	evidence	of	wound	healing	 in	methicillin-resistant	Staphylococcus	aureus	
(MRSA)	 infected	 wounds	 that	 have	 been	 managed	 with	 Manuka	 honey	 dressings	
(Visavadia	et	al.	2008).	 Some	 research	groups	have	 focussed	on	developing	wound	
dressings	 that	 can	 control	 both	 elevated	 MMPs	 and	 control	 wound	 bioburden.	
Adhirajan	 and	 colleagues	 developed	 a	 novel	 biomaterial	 consisting	 of	 an	 MMP	
inhibitor,	2,3-dihydroxybenzoic	acid,	and	gelatin	microsphere	conjugate,	loaded	with	
the	antmicrobial	doxycycline	and	incorporated	into	a	collagen	scaffold	(Adhirajan	et	
al.	 2009).	 This	 novel	 biomaterial	 effectively	 reduced	MMP-2	 and	MMP-9	 released	
from	 diabetic	 wound	 tissues,	 displayed	 biocompatibility	 with	 human	 dermal	
fibroblasts	 in	vitro	and	demonstrated	biocidal	activity	against	S.	aureus,	Escherichia	
coli,	Klebsiella	pneumoniae	and	P.	aeruginosa	laboratory	strains.	
This	chapter	aims	to	assess	the	MMP	sequestration	of	a	novel	natural	fibre	dressing	
produced	 by	 Advanced	 Medical	 Solutions	 Plc	 (project	 funder)	 in	 comparison	 with	
commercially	 available	 wound	 dressings,	 including	 a	 collagen-substrate	 dressing.	
These	dressings	will	be	tested	for	their	efficacy	in	the	absorption	of	MMP-2,	shown	
to	be	upregulated	 in	human	chronic	wounds,	 in	 vitro,	which	will	be	assessed	using	
gelatin	 zymography.	 This	 chapter	 also	 aims	 to	 assess	 potential	 biofilm	 disrupting	
technologies	against	P.	aeruginosa,	S.	aureus	and	Candida	albicans	biofilms	 in	vitro,	
in	 order	 to	 determine	 their	 antimicrobial	 efficacy	 for	 incorporation	 into	 wound	
dressings.	More	specifically,	the	technologies	to	be	tested	include	a	chelating	agent,	
a	commercial	used	polymer	antimicrobial,	non-ionic	surfactants	and	a	commercially	
available	pre-blended	antimicrobial.	
	
Materials	and	Methods	
For	a	detailed	description	of	the	materials	and	methods	used	in	this	chapter,	please	
refer	 to	 Chapter	 2	 of	 this	 thesis	 (2.4	 Biofilm-disrupting	 technologies	 study,	 2.11	
MMP-2	 isolation,	 2.12	 Wound	 dressing	 studies:	 Sequestration	 of	 MMP-2,	 2.18	
Statistical	analysis).	
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Results	
Sequestration	of	pro-MMP-2	and	active	MMP-2	by	wound	dressings	
The	ability	of	wound	dressings	to	sequester	secreted	host-derived	proteases	that	are	
present	 in	 the	 wound	 environment	 could	 prove	 advantageous	 in	 wound	
management	 by	 reducing	 protease-related	 local	 tissue	 degradation.	 Therefore,	 the	
ability	of	a	dressing	to	sequester	MMP-2	was	tested	in	several	commercially	available	
wound	 dressings,	 including	 a	 hydrofibre	 dressing,	 an	 alginate	 dressing,	 collagen	
substrate	 dressing	 and	 hydrocolloid	 dressing.	 In	 addition,	 a	 novel,	 natural	 fibre	
prototype	 wound	 dressing,	 manufactured	 by	 Advanced	 Medical	 Solutions	 Plc	 was	
also	tested.	
After	 1	 hour,	 the	 collagen-substrate	 dressing	 caused	 a	 significant	 reduction	 in	
detectable	pro-MMP-2	and	active	MMP-2	(P	<0.001	and	P	<0.05)	respectively,	with	
values	of	3.4%	±	2.3%	(standard	deviation)	and	32.1%	±	6.2%	when	compared	with	
the	MMP-2	 control	 (100%)	 (see	 Figure	 II-A).	 Furthermore,	 the	 novel	 natural	 fibre	
dressing	 caused	 a	 reduction	 in	 detectable	 pro-MMP-2	 to	 17.8%	 ±	 9.1%	 and	 active	
MMP-2	 to	 32.7%	 ±	 27.9%	 (P	 <0.01	 and	 P	 <0.05)	 and	 hydrofibre	 dressing	 caused	 a	
significant	reduction	in	pro-MMP-2	to	27.2%	±	10.6%	(P	<0.01)	but	not	active	MMP-
2.	 The	 alginate	 and	 hydrocolloid	 dressing	 did	 not	 significantly	 reduce	 detectable	
MMP-	 2	 in	 pro-enzyme	 and	 active	 forms	 after	 1-hour	 incubation.	 After	 3	 hours	
incubation,	pro-MMP-2	and	active	MMP-2	bands	were	undetectable	after	incubation	
with	the	collagen-substrate	dressing	with	values	of	9.5%	±	9.7%	and	9.1%	±	6.7%	(P	
<0.001)	respectively.	The	novel	natural	fibre	dressing	also	caused	a	reduction	in	pro-
MMP-2	 and	 active	 MMP-2,	 with	 values	 of	 12.2%	 ±	 10.1%	 and	 17.3%	 ±	 13.5%	 (P	
<0.001	 and	 P	 <0.01)	 respectively.	 The	 hydrofibre	 and	 alginate	 dressings	 caused	 a	
significant	reduction	in	pro-MMP-2	to	8.7%	±	7.6%	and	26.0%	±	16.0%	(P	<0.001	and	
P	<0.01),	with	hydrofibre	reducing	active	MMP-2	to	5.2%	±	1.8%	(P	<0.001)	but	the	
alginate	 dressing	 having	 no	 significant	 effect	 on	 detectable	 active	MMP-2.	 After	 6	
hours,	 hydrofibre,	 the	 novel	 natural	 fibre	 dressing,	 the	 collagen-substrate	 dressing	
and	 the	 alginate	 dressing	 significantly	 reduced	 detectable	 pro-MMP-2	 to	 6.3%	 ±	
2.4%,	10.9%	±	0.6%,	6.4%	±	2.9%	(P	<0.001)	and	25.5%	±	8.0%	(P	<0.01)	respectively.	
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Similarly,	 the	 hydrofibre,	 the	 novel	 natural	 fibre	 dressing,	 the	 collagen-substrate	
dressing	 and	 the	 alginate	 dressing	 significantly	 reduced	 active	 MMP-2	 to	 4.4%	 ±	
2.6%,	 2.2%	±	 1.3%,	 4.8%	±	 4.1%	 (P	 <0.001)	 and	14.2%	±	 10.7%	 (P	 <0.01).	 After	 24	
hours,	 the	 efficacy	 of	 the	 hydrofibre	 and	 alginate	 dressings	 to	 reduce	 detectable	
MMP-2,	appeared	to	diminish,	however	percentage	values	still	showed	a	significant	
reduction	 in	 pro-MMP-2	 to	 10.4%	 ±	 7.8%	 and	 10.7%	 ±	 3.6%	 (P	 <0.001)	 and	 a	
significant	reduction	in	active	MMP-2	to	2.6%	±	0.9%	and	9.8%	±	6.1%	(P	<0.001).	The	
collagen-substrate	dressing	continued	to	maintain	low	levels	of	pro-MMP	and	active	
MMP-2,	with	values	of	2.5%	±	2.7%	and	1.9%	±	2.0%	(P	<0.001).	The	novel	natural	
fibre	dressing	also	maintain	reduced	detectable	pro-MMP-2	levels	of	2.8%	±	2.0%	(P	
<0.001)	 and	 active	 MMP-2	 of	 14.3%	 ±	 4.1%	 (P	 <0.01).	 After	 48	 hours,	 sustained	
reductions,	to	varying	degrees,	in	pro-MMP-2	and	active	MMP-2	was	detected	in	the	
hydrofibre	dressing	[25.3%	±	11.7%	(P	<0.05)	and	4.6%	±	2.3%	(P	<0.01)],	the	alginate	
dressing	 [7.0%	±	4.7%	and	8.3%	±	8.7%	 (P	<0.01)],	 the	novel	natural	 fibre	dressing	
[2.2%	 ±	 0.1%	 (P	 <0.01)	 and	 22.8%	 ±	 8.6%	 (P	 <0.05)]	 and	 the	 collagen-substrate	
dressing	 [4.8%	 ±	 1.5%	 and	 0.6%	 ±	 0.1%	 (P	 <0.01)].	 The	 hydrocolloid	 dressing	 was	
ineffective	 in	 the	 sequestration	 of	MMP-2	 and	 showed	 no	 significant	 reduction	 in	
pro-MMP-2	and	active	MMP-2	at	all	 time	points	of	 the	experiment.	There	were	no	
significant	differences	between	the	collagen-substrate	dressing	and	the	novel	natural	
fibre	dressing.	
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Figure	II-A	Sequestration	of	pro-MMP-2	and	active	MMP-2.		
Purified	 equine	 fibroblast-derived	 MMP-2	 was	 incubated	 with	 0.1g	 of	 wound	
dressing	for	1,	3,	6,	24	or	48	hours	at	37°C,	before	washing	the	dressings	in	PBS	and	
testing	 the	 supernatant	 for	 MMP-2	 activity	 using	 gelatin	 zymography.	 Images	 of	
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gelatin	 zymograms	 showing	 MMP-2	 activity	 following	 incubation	 with	 wound	
dressing	 was	 taken	 using	 the	 Syngene	 gel	 doc	 (A)	 and	 pro-MMP-2	 (B)	 and	 active	
MMP-2	band	 intensity	 (C)	was	measured	using	GeneTools	 image	analysis	 software.	
Lane	1	represents	MMP-2	alone.	Lanes	2-6	represent	the	hydrofibre,	alginate,	novel	
natural	fibre	dressing,	the	collagen-substrate	and	hydrocolloid	dressings	respectively.	
Values	are	presented	as	percentage	 (%)	whereby	MMP-2	alone	 is	100%.	Error	bars	
represent	 standard	 deviation.	 Statistical	 analysis	 was	 performed	 using	 a	 two-way	
analysis	 of	 variants	 (ANOVA)	 with	 a	 Tukey’s	 multiple	 comparisons	 test.	 Statistical	
significance	is	represented	as	+P	<0.05,	*P	<0.01	and	#P	<0.001	when	compared	with	
the	MMP-2	control.	The	experiment	was	repeated	three	times	(n=3).	
	
	
Biofilm	 forming	 potential	 of	 Staphylococcus	 aureus	 ATCC	 9538,	 Pseudomonas	
aeruginosa	ATCC	9027	and	Candida	albicans	ATCC	10231		
The	 in	 vitro	 crystal	 violet	 assay	 was	 used	 to	 test	 the	 biofilm	 forming	 potential	 of	
Staphylococcus	aureus	ATCC	9538,	Pseudomonas	aeruginosa	ATCC	9027	and	Candida	
albicans	ATCC	10231	at	24,	48	and	72	hours.	Following	crystal	violet	staining,	it	was	
clear	 that	 both	 P.	 aeruginosa	 and	 S.	 aureus	 formed	 dense	 biofilms	 in	 vitro	 when	
compared	with	C.	albicans	whereby	 crystal	 violet	 staining	appeared	 very	 faint	 (see	
Figure	II-B).	Upon	solubilisation	of	crystal	violet-stained	biofilms	the	absorbance	was	
measured	and	it	was	determined	that	high	absorbance	values	were	represented	high	
biofilm	 forming	 potential,	 due	 to	 the	 greater	 amount	 of	 solubilised	 crystal	 violet.	
Equally,	 low	 absorbance	 values	 represent	 low	 biofilm	 forming	 potential.	 Results	
showed	significantly	higher	biofilm	forming	potential	for	S.	aureus	and	P.	aeruginosa	
when	compared	with	C.	albicans	at	24,	48	and	72	hours	 (P	<0.0001).	No	significant	
difference	 in	 biofilm	 forming	 potential	 between	 S.	 aureus	 and	P.	 aeruginosa	 were	
detected	at	24	and	72	hours.	However,	S.	aureus	showed	significantly	higher	biofilm	
forming	potential	than	P.	aeruginosa	at	48	hours	(P	<0.0001)	(see	Figure	II-C).	
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Figure	II-B	Representative	images	of	biofilms	stained	with	crystal	violet.		
P.	aeruginosa,	C.	albicans	and	S.	aureus	were	grown	 in	a	96-well	plate	with	peg-lid	
for	24-,	48-	and	72-hours.	After	incubation,	biofilm	growth	on	the	pegs	was	assessed	
using	0.5%	crystal	 violet	 stain.	Pegs	were	 removed	 from	 the	 lid	 for	 the	purpose	of	
obtaining	images	only.	
	
	
C.#albicans#! S.#aureus#P.#aeruginosa##
T24!
T48!
T72!
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Figure	 III-C	 Biofilm	 forming	 potential	 of	 S.	 aureus,	 P.	 aeruginosa	 and	 C.	 albicans	
biofilms	using	crystal	violet.		
Untreated	24-,	48-	and	72-hour	biofilms	were	stained	with	0.5%	crystal	violet	for	15	
minutes	 before	 biofilms	 were	 washed	 in	 tap	 water.	 Biofilms	 were	 air-dried	 and	
solubilised	 in	30%	acetic	acid.	The	absorbance	of	each	sample	was	 read	at	570nm.	
Statistical	analysis	was	performed	using	two-way	analysis	of	variants	(ANOVA)	with	a	
Tukey’s	 multiple	 comparisons	 test.	 Statistical	 significance	 is	 represented	 as	 *P	
<0.0001.	Error	bars	represent	standard	deviation.	The	experiment	was	repeated	six	
times	(n=6).	
	
	
MIC	 and	 MBEC	 values	 of	 a	 chelating	 agent,	 surfactant	 A,	 surfactant	 B,	 polymer	
antimicrobial	and	commercial	pre-blended	antimicrobial	on	24	hour	biofilms	
In	 this	 section	 of	 the	 chapter,	 potential	 biofilm-disrupting	 technologies	 including	 a	
chelating	 agent,	 surfactants	 A	 and	 B,	 a	 polymer	 antimicrobial	 and	 a	 commercially-
available	 pre-blended	 antimicrobial,	 which	 is	 thought	 to	 contain	 a	 polymer	
antimicrobial,	Benzalkonium	chloride,	surfactants	and	silicone	siloxanes,	was	tested	
on	S.	aureus	ATCC	9538,	P.	aeruginosa	ATCC	9027	and	C.	albicans	ATCC	10231.	More	
specifically,	 the	 minimum	 biocidal	 concentration	 (MBC)	 and	 minimum	 biofilm	
eradication	 concentration	 (MBEC)	 was	 determined.	 MBC	 was	 defined	 as	 the	
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minimum	concentration	of	antimicrobial	that	eradicates	the	growth	of	the	dispersed,	
planktonic	cells	from	the	biofilm.	MBEC	was	defined	as	the	minimum	concentration	
of	antimicrobial	that	eradicates	the	biofilm.	
In	 this	 study,	 the	 pre-blended	 antimicrobial	 effectively	 inhibited	 the	 growth	 of	 P.	
aeruginosa,	 S.	 aureus	 and	 C.	 albicans	 at	 low	 concentrations,	 with	 MBC	 values	 of	
0.031%,	 0.0075%	 and	 0.0075%	 respectively	 (see	 Table	 II-A).	MBEC	 results	 showed	
that	 higher	 a	 concentration	 of	 the	 pre-blended	 antimicrobial	 was	 needed	 to	
eradicate	 biofilm	 growth,	 with	 values	 of	 0.063%,	 0.015%	 and	 0.015%	 for	 P.	
aeruginosa,	S.	aureus	and	C.	albicans.	 In	addition	to	this,	the	polymer	antimicrobial	
successfully	 eradicated	 planktonic	 cells	 and	 biofilm	 P.	 aeruginosa	 at	 the	 same	
concentration	as	 the	pre-blended	antimicrobial.	However,	higher	 concentrations	of	
polymer	 antimicrobial	 were	 needed	 to	 eradicated	 S.	 aureus	 and	 C.	 albicans	 when	
compared	 with	 the	 pre-blended	 antimicrobial,	 with	 MBC/MBEC	 values	 of	
0.031/0.031%	 and	 0.015/0.015%.	 Surfactants	 A	 and	 B	 both	 failed	 to	 eradicate	
planktonic	 and	 biofilm	 growth	 in	 all	 microorganisms	 at	 the	 highest	 concentration	
tested	 in	 the	 assay	 (2%-2.5%	 w/v).	 The	 chelating	 agent	 also	 failed	 to	 inhibit	 P.	
aeruginosa	and	S.	aureus	growth	at	the	highest	concentration	tested	in	the	assay	(2%	
w/v),	however	eradication	of	planktonic	C.	albicans	was	recorded,	with	a	MBC	value	
of	0.5%,	however	 the	highest	 concentration	of	 the	 chelating	agent	 failed	 to	 inhibit	
the	C.	albicans	biofilm	(see	Table	II-A).	
Checkerboard	 analysis	was	 used	 in	 order	 to	 test	whether	 polymer	 antimicrobial	 in	
combination	with	either	 the	 chelating	 agent,	 surfactant	A	or	 surfactant	B,	 reduced	
MBC	 and	MBEC	 values,	 potentially	 indicating	 synergy.	 Combinations	 the	 potential	
biofilm	 disruptor	 with	 polymer	 antimicrobial	 lead	 to	 the	 eradication	 of	 both	
planktonic	 cells	 and	 biofilms	 in	 all	 microorganisms	 (see	 Table	 II-B),	 however	 this	
appeared	 to	 be	 due	 to	 polymer	 antimicrobial	 and	 not	 the	 addition	 of	 potential	
biofilm-disruptor,	given	that	MBC	and	MBEC	values	for	polymer	antimicrobial	alone	
and	polymer	 antimicrobial	 in	 combination	with	 a	biofilm	disruptor	were	 the	 same.	
Nevertheless,	 the	 synergy	 of	 each	 combination,	 which	 can	 be	 determined	 by	
calculating	 the	 fractional	 biocidal	 concentration	 (FBC)	 and	 fractional	 biofilm	
eradication	concentration	(FBEC)	(see	Chapter	2,	Materials	and	Methods),	could	not	
Page	244	of	253	
	
be	 determined.	 This	 was	 due	 to	 MBC	 and	 MBEC	 values	 of	 the	 chelating	 agent,	
surfactant	 A	 and	 surfactant	 B	 alone	 being	 greater	 than	 the	 concentration	 tested.	
Exceptions	 were	 found	 with	 the	 combination	 of	 chelating	 agent/	 polymer	
antimicrobial	and	surfactant	A/	polymer	antimicrobial,	which	revealed	‘indifference’	
in	 the	 synergy	 of	 these	 substances	 for	 C.	 albicans	 (see	 Table	 II-C).
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	 Test	substance	(%	w/v)	
	 Pre-blended	
antimicrobial	
Polymer	
antimicrobial	
SB	 CA	 SA	
Microorganism	 MBC	 MBEC	 MBC	 MBEC	 MBC	 MBEC	 MBC	 MBEC	 MBC	 MBEC	
P.	aeruginosa	ATCC	9027	 0.031	 0.063	 0.031	 0.063	 >2	 >2	 >2	 >2	 >2.5	 >2.5	
S.	aureus	ATCC	6538	 0.0075	 0.015	 0.031	 0.031	 >2	 >2	 >2	 >2	 >2.5	 >2.5	
C.	albicans	ATCC	10231	 0.0075	 0.015	 0.015	 0.015	 >2	 >2	 0.5	 >2	 >2.5	 >2.5	
	
Table	II-A	Minimum	biocidal	concentration	(MBC)	and	minimum	biofilm	eradication	concentration	(MBEC)	for	potential	biofilm-disrupting	
substances	on	24-hour	biofilms.		
Abbreviations	 include,	 SB	 =	 surfactant	 B;	 CA	 =	 chelating	 agent,	 SA	 =	 surfactant	 A.	 The	 experiment	 was	 repeated	 three	 times	 (n=3).
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Table	 II-B	Minimum	biocidal	 concentration	 (MBC)	 and	minimum	biofilm	 eradication	 concentration	 (MBEC)	 of	 the	 polymer	 antimicrobial	
combination-treated	24-hour	biofilms:	Results	from	checkboard	analysis.		
Abbreviations	include,	SB	=	surfactant	B;	CA	=	chelating	agent,	SA	=	surfactant	A.	The	experiment	was	repeated	three	times	(n=3).		
	
	
	
	
	
	 Combinations	of	substances	(%	w/v)	
	 SB/	polymer	antimicrobial		 CA/	polymer	antimicrobial	 SA/	polymer	antimicrobial		
Microorganism	 MBC	 MBEC	 MBC	 MBEC	 MBC	 MBEC	
P.	aeruginosa	ATCC	9027	 0.031/	0.031	 0.063/	0.063	 0.125/	0.031	 2/	0.063	 0/	0.015	 0/	0.063	
S.	aureus	ATCC	6538	 0.015/	0.031	 0.063/	0.063	 0.031/	0.031	 0.031/	0.031	 0/	0.015	 2.5/	0.031	
C.	albicans	ATCC	10231	 0/	0.015	 0/	0.015	 0.5/	0.015	 0/	0.015	 0/	0.015	 0/	0.031	
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	 Substance	combinations	
	 SB	and	polymer	antimicrobial	 CA	and	polymer	antimicrobial	 SA	and	polymer	antimicrobial	
Microorganism	 FIC	 FBEC	 FIC	 FBEC	 FIC	 FBEC	
P.	aeruginosa	ATCC	9027	 ND	 ND	 ND	 ND	 ND	 ND	
S.	aureus	ATCC	6538	 ND	 ND	 ND	 ND	 ND	 ND	
C.	albicans	ATCC	10231	 ND	 ND	 2.0	
(Indifferent)	
ND	 2.0	
(Indifferent)	
ND	
	
Table	II-C	Determination	of	synergy	between	the	polymer	antimicrobial	and	other	potential	biofilm	disruptors.		
Abbreviations	include,	FIC	=	Fractional	inhibitory	concentration;	FBEC	=	Fractional	biofilm	eradication	concentration;	ND	=	Not	Determined;	SB	
=	 surfactant	 B;	 CA	 =	 chelating	 agent,	 SA	 =	 surfactant	 A.	 The	 experiment	 was	 repeated	 three	 times	 (n=3).
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The	effect	of	the	polymer	antimicrobial	and	the	pre-blended	antimicrobial	on	48-	and	
72-hour	biofilms	
It	 is	 thought	 that	 biofilms	 within	 a	 chronic	 wound	 are	 established	 structures	 and	
therefore,	the	efficacy	of	the	pre-blended	antimicrobial	and	polymer	antimicrobial	to	
eradicate	biofilms	grown	for	48	and	72	hours	was	tested.	In	this	portion	of	the	study,	
much	 lower	 concentrations	 of	 polymer	 antimicrobial	 and	 the	 pre-blended	
antimicrobial	were	tested.	Subsequently,	it	was	found	that	concentrations	as	low	as	
0.004%	 and	 0.0078%	 polymer	 antimicrobial	 respectively,	 were	 able	 to	 inhibit	 C.	
albicans	both	 in	 dispersed,	 planktonic	 and	 biofilm	 form	 after	 24,	 48	 and	 72-hours	
(see	Table	II-D).	The	MBC	value	for	S.	aureus	treated	with	polymer	antimicrobial	was	
higher	 in	 48-hour	 biofilms,	 however	 this	 value	 dropped	 in	 72-hour	 biofilms.	
Interestingly,	 MBEC	 values	 for	 S.	 aureus	 treated	 with	 polymer	 antimicrobial	 were	
lower	in	48-	and	72hour	biofilms,	when	compared	to	24-hour	biofilms.	P.	aeruginosa	
biofilms	treated	with	polymer	antimicrobial	resulted	in	higher	MBC	and	MBEC	values	
than	S.	aureus	and	C.	albicans,	with	MBC	values	 remaining	consistent	 (0.0156%)	 in	
24-,	 48-	 and	 72-hour	 biofilms.	 MBEC	 values	 for	 polymer	 antimicrobial-treated	 P.	
aeruginosa	were	 higher	 than	MBC	 values,	 however	 these	 values	 reduced	with	 the	
maturity	of	the	biofilm	(0.125%,	0.0625%	and	0.156%,	respectively).	
Treatment	of	C.	albicans	with	the	pre-blended	antimicrobial	resulted	in	low	MBC	and	
MBEC	values,	however	48-	 and	72-hour	biofilms	 required	higher	 concentrations	 to	
fully	eradicate	the	biofilm.	MBC	values	for	the	pre-blended	antimicrobial-treated	S.	
aureus	 increased	with	the	maturity	of	the	biofilm	(0.002%,	0.00375%	and	0.0075%,	
respectively),	however	MBEC	values	remained	consistent	in	the	24-,	48-	and	72-hour	
biofilms	 (0.002%).	 The	 pre-blended	 antimicrobial-treated	P.	 aeruginosa	 resulted	 in	
higher	MBC	and	MBEC	values	when	compared	with	S.	aureus	and	C.	albicans,	with	
48-hour	 biofilms	 requiring	 a	 higher	MBC	 and	MBEC	 than	 24-	 and	 72-hour	 biofilms	
(see	Table	II-D).	
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	 Test	Substance	(%	w/v)	
	 Pre-blended	antimicrobial	 Polymer	antimicrobial	
	 24	 48	 72	 24	 48	 72	
	Microorganism	 MBC	 MBEC	 MBC	 MBEC	 MBC	 MBEC	 MBC	 MBEC	 MBC	 MBEC	 MBC	 MBEC	
P.	 aeruginosa	 ATCC	
9027	
0.015	 0.031	 0.0075	 0.063	 0.00375	 0.031	 0.0156	 0.125	 0.0156	 0.0625	 0.0156	 0.0156	
S.	aureus	ATCC	6538	 0.002	 0.002	 0.00375	 0.002	 0.0075	 0.002	 0.0078	 0.03125	 0.03125	 0.0078	 0.0078	 0.0078	
C.	 albicans	 ATCC	
10231	
0.002	 0.002	 0.002	 0.00375	 0.002	 0.00375	 0.004	 0.004	 0.004	 0.004	 0.004	 0.0078	
	
Table	II-D	Minimum	biocidal	concentration	(MBC)	and	minimum	biofilm	eradication	concentration	(MBEC)	of	the	pre-blended	antimicrobial	
and	polymer	antimicrobial	on	24-	48-	and	72-hour	biofilms.		
The	 experiment	 was	 repeated	 three	 times	 (n=3).
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Discussion	
This	 chapter	 highlights	 the	 potential	 effectiveness	 of	 a	 novel	 natural	 fibre	 wound	
dressing	to	aid	the	absorption	of	excessively	produced	proteases	in	chronic	wounds.	
However,	 although	 there	 is	 a	 plethora	 of	 advanced	 wound	 dressing	 technologies	
available,	 the	management	of	chronic	wounds	still	 remains	a	major	health	concern	
and	 economic	 burden	 in	 healthcare	 settings	worldwide.	One	 reason	 for	 this	 is	 the	
complex	array	of	factors	affecting	the	status	of	a	wound,	not	only	involving	increased	
proteolytic	 activity,	 but	 ischemia,	 age,	 mechanical	 stress	 and	 infection.	 It	 is	
inappropriate	to	adopt	a	‘one-fits-all’	approach	in	wound	management	as	all	chronic	
wounds,	whether	they	are	venous	leg	ulcers,	pressure	ulcers	or	diabetic	foot	ulcers,	
are	 indeed,	 complex	 and	 differ	 greatly	 from	 each	 other.	 Therefore,	 although	 this	
novel	 natural	 fibre	 dressing	 showed	 the	 sequestration	 of	 MMPs,	 and	 may	 help	
control	 protease-rich	 exudate	within	 chronic	wounds,	 other	wound	 care	 strategies	
may	also	need	to	be	adopted.	
This	 study	 also	 showed	 the	 effectiveness	 of	 the	 polymer	 antimicrobial	 in	 the	
eradication	 of	 biofilms.	 The	 polymer	 antimicrobial	 used	 in	 this	 study	 became	 a	
popular	area	of	research	in	the	treatment	of	infection,	because	of	its	increasing	use	
as	an	antiseptic	worldwide,	and	thus,	there	is	a	plethora	of	in	vitro	and	in	vivo	studies	
demonstrating	 its	 efficacy	 in	 the	 control	 of	 wound	 bioburden.	 With	 a	 chemical	
structure	similar	to	that	of	chlorhexidine,	another	commonly	used	antiseptic	in	oral	
cavity	 care	 and	 skin	 disinfection,	 the	 polymer	 antimicrobial	 used	 in	 this	 study	 has	
been	effectively	used	in	the	decontamination	of	wounds	and	decolonisation	of	skin.	
As	this	study	used	a	commercially-available	pre-blended	antimicrobial,	it	was	an	aim	
to	 determine	 whether	 synergy	 occurred	 between	 the	 polymer	 antimicrobial	 and	
other	 potential	 biofilm-disrupting	 technologies	 such	 as	 a	 chealting	 agent	 and	
surfactants	 in	the	eradication	of	S.	aureus,	P.	aeruginosa	and	C.	albicans.	Chelating	
agents	have	indeed	been	linked	to	bacterial	biofilm	formation	with	in	vitro	evidence	
to	suggest	that	sub-inhibitory	doses	of	EGTA	can	either	augment	or	prevent	S.	aureus	
biofilm	formation	depending	on	the	strain	(Abraham	et	al.	2012).	Although	the	work	
presented	in	this	chapter	does	not	culture	biofilms	in	an	EGTA-rich	environment,	and	
instead	a	chelating	agent	 is	used	to	treat	the	biofilm,	the	chelating	agent	had	 little	
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effect	 on	 biofilm	 eradication.	 Furthermore,	 the	 potential	 use	 of	 chelating	 agent-
incorporated	 wound	 dressings	 for	 infected	 wounds	 may	 encourage	 biofilm	
development	rather	than	disrupt	the	biofilm.	There	is	 little	literature	on	the	effects	
of	 surfactants	 on	 biofilms.	 One	 study,	 in	 the	 context	 of	 biofouling	 and	 marine	
bacterial	 cultures,	 showed	 that	 the	 treatment	 of	 a	 polystyrene	 surface	 with	 a	
surfactant	 resulted	 in	 a	decreased	attachment	 and	 colonisation	of	marine	 cultures	
(Blainey	and	Marshall	1991).	Although	in	this	chapter,	the	surfactants	had	no	effect	
on	already	established	biofilms,	it	may	prevent	the	colonisation	of	wound	dressings	
used	 in	 infected	 chronic	 wounds,	 which	 may	 result	 in	 less	 surfaces	 in	 which	 the	
bacteria	can	attach	and	proliferate,	preventing	dissemination.		
	
Limitations	
The	main	limitation	of	this	study	concerns	the	focus	of	the	sequestration	of	just	one	
MMP.	 There	 are	 other	 well-documented	MMPs	 in	 the	 context	 of	 chronic	 wounds	
and	 therefore	 the	 assessment	 of	 the	 efficacy	 of	 these	 dressings	 on	 those	 MMPs	
would	be	beneficial.	Other	 studies	 into	 the	efficacy	of	 antimicrobial	 substances	on	
biofilms	 in	 vitro,	 use	24-hour	 (or	 less)	 cultured	biofilms,	which	may	not	 reflect	 the	
maturity	of	biofilms	that	reside	within	the	tissues	of	an	open	wound.	To	address	this	
issue,	the	experiments	in	this	chapter	investigated	potential	biofilm	disruptors	on	24-
,	48-	and	72-hour	biofilms.	However,	it	is	likely	that	the	use	of	microtitre	plates	with	
peg	lids	may	not	be	a	sufficient	model	to	investigate	72-hour	biofilms.	Crystal	violet	
staining	of	biofilms	in	this	chapter	shows	little	difference	in	biofilm	density	between	
48-	and	72-hours	and	 it	may	 therefore	mean	 that	 increased	bacterial	 cell	numbers	
and	 nutrient	 depletion,	 lead	 to	 bacterial	 cell	 death	 and	 reduced	 biofilm	
development.	
	
Key	points	
The	 assessment	 of	 MMP-2	 sequestration	 in	 a	 variety	 of	 commercially	 available	
wound	 dressings	 and	 a	 novel	 natural	 fibre	 dressing,	 resulted	 in	 the	 significant	
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sequestration	 of	 MMP-2	 by	 the	 collagen-substrate	 dressing.	 There	 were	 no	
significant	 differences	 in	 the	 efficacy	 of	 MMP-2	 sequestration	 between	 the	 novel	
natural	 fibre	dressing	and	the	collagen-substrate	dressing,	which	 indicates	that	this	
dressing	may	help	reduce	elevated	MMP	activity	within	chronic	wounds.	
Some	 of	 the	 potential	 biofilm-disruptor	 technologies	 examined	 in	 this	 study,	
including	the	chelating	agent	and	surfactants	A	and	B,	failed	to	show	biocidal	activity	
against	 P.	 aeruginosa,	 S.	 aureus	 and	 C.	 albicans	 in	 planktonic	 and	 biofilm	 form.	
However	 the	polymer	antimicrobial	 showed	 low	MBC	and	MBEC	values	along	with	
the	 commercially	 available	 pre-blended	 antimicrobial.	 Furthermore,	 no	 synergy	
between	 the	 polymer	 antimicrobial	 and	 the	 chelating	 agent,	 surfactant	 A	 or	
surfactant	 B	 on	 the	 eradication	 of	 24-hour	 biofilms	 was	 determined.	 Higher	
concentrations	 of	 the	 pre-blended	 antimicrobial	 and	 polymer	 antimicrobial	 alone	
were	 needed	 to	 eradicate	 48-	 and	 72-hour	P.	 aeruginosa	biofilms,	 however	 these	
concentrations	were	still	considered	low	level.	
	
	
	
	
	
	
